As filed with
the Securities and Exchange Commission on October 14, 2014
Registration
No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ADVANCED
CELL TECHNOLOGY, INC.
(Exact name of registrant as specified in its
charter)
Delaware |
33 Locke Drive
Marlborough, Massachusetts 01752
(508) 756-1212 |
87-0656515 |
(State or other jurisdiction of
incorporation or organization) |
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) |
(I.R.S. Employer
Identification Number) |
Dr. Paul K. Wotton
President and Chief Executive Officer
Advanced Cell Technology, Inc.
33 Locke Drive
Marlborough, Massachusetts 01752
(508) 756-1212
(Name, address, including zip code, and telephone
number,
including area code, of agent for service)
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to: |
Mitchell S. Bloom, Esq.
William D. Collins, Esq.
Goodwin Procter LLP
Exchange Place
53 State Street
Boston, MA 02109
(617) 570-1000 |
Approximate date of commencement of proposed
sale to the public:
From time to time after this Registration Statement becomes effective.
If
the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please
check the following box: o
If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415
under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans,
check the following box: ý
If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering. o
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If
this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall
become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. o
If
this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register
additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following
box. o
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of "large accelerated filer", "accelerated filer" and "smaller
reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o |
|
Accelerated filer ý |
|
Non-accelerated filer o
|
|
Smaller reporting company o |
|
|
|
(Do not check if a smaller reporting company) |
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class of securities
to be registered |
|
Amount to be
registered |
|
Proposed maximum
offering price per
unit |
|
Proposed maximum
aggregate offering
price |
|
Amount of
registration fee(1) |
|
Common Stock ($.001 par value) |
|
(2) |
|
(3) |
|
(3) |
|
— |
|
Preferred Stock ($.001 par value) |
|
(2) |
|
(3) |
|
(3) |
|
— |
|
Debt Securities |
|
(2) |
|
(3) |
|
(3) |
|
— |
|
Warrants |
|
(2) |
|
(3) |
|
(3) |
|
— |
|
Depositary Shares |
|
(2) |
|
(3) |
|
(3) |
|
— |
|
Stock Purchase Units or Contracts |
|
(2) |
|
(3) |
|
(3) |
|
— |
|
Subscription Rights |
|
(2) |
|
(3) |
|
(3) |
|
— |
|
Units |
|
(2) |
|
(3) |
|
(3) |
|
— |
|
Total |
|
(2) |
|
|
|
$100,000,000 |
|
$11,620.00 |
|
(1) Calculated pursuant to Rule 457(o) under the Securities
Act.
(2) Such indeterminate number or amount of common stock, preferred
stock, debt securities, warrants, depositary shares, stock purchase units or contracts, subscription rights and units is being
registered as may from time to time be issued at indeterminate prices at an aggregate initial offering price not to exceed $100,000,000.
This Registration Statement also includes such indeterminable amount of common stock, preferred stock and debt securities as may
be issued from time to time upon exercise of warrants or conversion or exchange of convertible or exchangeable securities being
registered hereunder or pursuant to anti-dilution provisions of any such securities registered hereunder. Pursuant to Rule 416
under the Securities Act, the securities being registered hereunder include such indeterminate number of securities as may be issuable
with respect to the securities being registered hereunder as a result of share splits, share dividends or similar transactions.
(3) The proposed maximum aggregate offering price per class of
security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities
registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3
under the Securities Act.
The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment that specifically states that this registration statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become
effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
The information contained in this prospectus
is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities
and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to
buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion, Dated
October 14, 2014
PROSPECTUS
$100,000,000
Common Stock
Preferred Stock
Debt Securities
Warrants
Depositary Shares
Stock Purchase Units or Contracts
Subscription Rights
Units
We may offer and sell, from time to time, in one or more offerings,
up to $100,000,000 of our common stock, preferred stock, debt securities, warrants, depositary shares, stock purchase units or
contracts, subscription rights or units described in this prospectus, either separately or together with other securities described
in this prospectus.
Each time securities are offered pursuant to this prospectus, we
will indicate the particular securities we offer and their specific terms in a supplement to this prospectus. In each case we will
describe the type and amount of securities we are offering, the initial public offering price, the net proceeds we expect to receive
and the other terms of the offering.
The securities may be sold directly by us to investors, through
agents designated from time to time or to or through underwriters or dealers. For additional information on the methods of sale,
you should refer to the section entitled "Plan of Distribution" in this prospectus and in the applicable prospectus supplement.
Our common stock is currently quoted on the OTCQB, under the
symbol “ACTC.” On October 14, 2014, the last reported sales price per share of our common stock on the
OTCQB was $7.97.
Investing in our securities involves risks. You should review
carefully the risks and uncertainties described under the heading “Risk Factors” contained
in the applicable prospectus supplement and any related free writing prospectus, and under similar headings in the other documents
that are incorporated by reference herein.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these securities or passed upon the adequacy or the accuracy of this prospectus.
Any representation to the contrary is a criminal offense.
Our principal executive office is at Advanced Cell Technology, Inc.;
33 Locke Drive, Marlborough, Massachusetts 01752, and our telephone number is (508) 756-1212.
The date of this prospectus is ,
2014.
TABLE OF CONTENTS
|
Page |
|
|
About This Prospectus |
1 |
|
|
Cautionary Note Regarding Forward-Looking Statements |
1 |
|
|
Our Company |
3 |
|
|
Risk Factors |
3 |
|
|
Selected Financial Data |
4 |
|
|
Ratio of Earnings to Combined Fixed Charges and Preference Stock Dividends |
7 |
|
|
Use of Proceeds |
7 |
|
|
Description of Our Common Stock |
8 |
|
|
Description of Our Preferred Stock |
9 |
|
|
Description of Our Debt Securities |
10 |
|
|
Description of Our Warrants |
15 |
|
|
Description of Our Depositary Shares |
18 |
|
|
Description of Our Stock Purchase Units and Contracts |
20 |
|
|
Description of Our Subscription Rights |
21 |
|
|
Description of Our Units |
22 |
|
|
Description of Certain Provisions of Delaware Law and Our Certificate Of Incorporation and By-Laws |
23 |
|
|
Legal Ownership of Securities |
25 |
|
|
Plan of Distribution |
28 |
|
|
Legal Matters |
30 |
|
|
Experts |
30 |
|
|
Documents Incorporated by Reference |
30 |
|
|
Where You Can Find More Information |
31 |
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement
we filed with the Securities and Exchange Commission, or the SEC, using a "shelf" registration process. Under this shelf
process, we may sell any combination of the securities described in this prospectus from time to time in one or more offerings
up to a total dollar amount of $100,000,000.
This prospectus provides you only with a general
description of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement containing specific
information about the terms of that offering. We may also authorize one or more free writing prospectuses to be provided to you
that may contain material information relating to these offerings. We may also add, update or change in the prospectus supplement
(and in any related free writing prospectus that we may authorize to be provided to you) any of the information contained in this
prospectus or in the documents that we have incorporated by reference into this prospectus. You should read both this prospectus
and any prospectus supplement or related free writing prospectus together with additional information described under the headings
"Where You Can Find More Information" and "Documents Incorporated By Reference."
You should rely only on the information incorporated
by reference or provided in this document. We have not authorized anyone to provide you with different information. If anyone provides
you with different or inconsistent information, you should not rely on it. We will not make an offer of these securities in any
jurisdiction where it is unlawful. You should assume that the information in this prospectus, as well as the information we have
previously filed with the SEC and incorporated by reference in this prospectus, is accurate only as of the date of the documents
containing the information.
References in this prospectus to the terms
"Advanced Cell," "company," "we," "our" or "us" or other similar terms means
Advanced Cell Technology, Inc.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS
Any statements in this prospectus or the applicable prospectus supplement
or free writing prospectus, including the documents that we incorporate by reference herein, about our expectations, beliefs, plans,
objectives, assumptions or future events or performance are not historical facts and are forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, or the "Securities Act," and Section 21E
of the Securities Exchange Act of 1934, as amended, or the "Exchange Act." You can identify these forward-looking statements
by the use of words or phrases such as "believe," "may," "could," "will," "estimate,"
"continue," "anticipate," "intend," "seek," "plan," "expect," "potential,"
"predict," "project," "should," or "would." Forward-looking statements contained in this
prospectus include, but are not limited to, statements about:
| · | our ability to conduct clinical trials, and the timing and results
of those clinical trials |
| · | our ability to maintain sufficient cash and other liquid resources
to meet our operating and any debt service requirements; |
| · | decisions by regulatory authorities regarding whether and when to
approve any treatment applications, as well as their decisions regarding labeling and other matters that could affect the potential
commercial potential of our products; |
| · | the speed with which regulatory authorizations, pricing approvals
and product launches may be achieved; |
| · | whether and when we will be able to enter into and consummate strategic
collaborations with respect to our products or product candidates on acceptable terms; |
| · | the success with which developed products may be commercialized; |
| · | competitive developments affecting our products or product candidates; |
| · | the effect of possible domestic and foreign legislation or regulatory
action affecting, among other things, pricing and reimbursement, including under Medicaid and Medicare in the United States, and
the trend toward managed care and health care cost containment; |
| · | our ability to protect our patents and other intellectual property; |
| · | claims and concerns that may arise regarding the safety or efficacy
of our product candidates; |
| · | governmental laws and regulations affecting our operations, including
those affecting taxation; and |
| · | growth in costs and expenses. |
Among the factors that could cause actual results
to differ materially from those indicated in the forward-looking statements are risks and uncertainties inherent in our business
including, without limitation, the timing and results of our clinical trials, acceptance among those in our industry of our therapeutic
candidates and trial results, the results of any pending proposals that require the approval of our shareholders, the development
of competitive therapeutic candidates, our research and development expenses, external expenses and the timing of our planned research
and development projects, and selling, general and administrative expenses; our belief regarding the potential impact of the adoption
of newly issued and future accounting guidance on our financial statements; our expectations for our cash, cash equivalents and
investments balances and information with respect to any other plans and strategies for our business; and other material risks
described under the heading "Risk Factors" in our most recent annual report on Form 10-K and our quarterly reports
on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC.
You should rely only on information contained,
or incorporated by reference, in this prospectus, the registration statement of which this prospectus is a part, the documents
incorporated by reference in this prospectus, and any applicable prospectus supplement or free writing prospectus and understand
that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements
in the foregoing documents by these cautionary statements.
Although we believe that the expectations reflected
in our forward-looking statements are reasonable, we cannot guarantee future results, events, levels of activity, performance or
achievement. Given these uncertainties, you should not place undue reliance on these forward-looking statements. The forward-looking
statements made or incorporated by reference in this prospectus relate only to events as of the date on which the statements are
made. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint
ventures or investments we may make. Except as required by law, we do not assume any intent to update any forward-looking statements
after the date on which the statement is made, whether as a result of new information, future events or circumstances or otherwise.
Before deciding to purchase our securities, you should carefully consider the risk factors incorporated herein by reference, in
addition to the other information set forth in this prospectus, any accompanying prospectus supplement, any free writing prospectus
and in the documents incorporated by reference.
OUR COMPANY
This business overview highlights information
contained in certain documents incorporated by reference into this prospectus. This business overview does not contain all of the
information that you should consider before investing in our securities. You should read the entire prospectus carefully, including
the "Risk Factors" section and the financial statements and the notes to those statements incorporated herein by reference,
before making an investment decision.
We are a biotechnology company focused on the
development and commercialization of novel cell-based therapies. Our therapeutic area of focus is ophthalmology and our most advanced
products are in clinical trials for the treatment of dry age-related macular degeneration, Stargardt’s macular degeneration
and myopic macular degeneration. We are also developing several pre-clinical cell therapies for the treatment of other ocular disorders.
Additionally, we have a number of pre-clinical stage assets in disease areas outside the field of ophthalmology, including autoimmune,
inflammatory and wound healing-related disorders. Our intellectual property
portfolio includes pluripotent human embryonic stem cell-induced pluripotent stem cell platforms; and other cell therapy research
programs. We have no therapeutic products currently available for sale and do not expect to have any therapeutic products commercially
available for sale for a period of years, if at all. These factors indicate that our ability to continue research and development
activities is dependent upon the ability of management to obtain additional financing as required.
Our common stock is currently quoted on the
OTCQB, under the symbol “ACTC.”
Our principal offices are located at Advanced
Cell Technology, Inc., 33 Locke Drive, Marlborough, Massachusetts 01752. Our website address is www.advancedcell.com. Information
found on, or accessible through, our website is not a part of, and is not incorporated into, this prospectus, and you should not
consider it part of this prospectus or part of any prospectus supplement. Our website address is included in this document as an
inactive textual reference only.
RISK FACTORS
An investment in our securities involves a high
degree of risk. In addition to the other information included in, or incorporated by reference into, this prospectus, the applicable
prospectus supplement and any related free writing prospectus, you should carefully consider the risk factors incorporated by reference
to our Annual Report on Form 10-K for the year ended December 31, 2013 and in our Quarterly Reports on Form 10-Q
for the quarters ended March 31, 2014, and June 30, 2014, as the same may be updated from time to time by our future
filings under the Exchange Act, when determining whether or not to purchase the securities offered under this prospectus and the
prospectus supplement.
Selected
Financial Data
You should read the following selected financial
data together with our financial statements and the related notes contained in Item 8 of Part II of our Annual Report on Form 10-K
for the fiscal year ended December 31, 2013, as amended, which are incorporated by reference into this prospectus, except that
share and per share information for the periods ended December 31, 2013, 2012, 2011, 2010 and 2009 have been revised to reflect
the one-for-100 reverse stock split for our outstanding shares of common stock effective August 27, 2014, as though the reverse
stock split was in effect for all periods presented.
The selected data in this section is not intended
to replace the consolidated financial statements included in our Annual Report on Form 10-K, except that share and per share information
for the periods ended December 31, 2013, 2012, 2011, 2010 and 2009 have been revised to reflect the one-for-100 reverse stock split.
|
Year
Ended December 31, |
|
|
2013 |
|
2012 |
|
2011 |
|
2010 |
|
2009 |
|
|
|
|
As
restated |
|
As
restated |
|
As
reported |
|
Adjustments |
|
As
restated |
|
As
reported |
|
Adjustments |
|
As
restated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
$ |
224,985 |
|
$ |
466,487 |
|
$ |
506,419 |
|
$ |
725,044 |
|
$ |
– |
|
$ |
725,044 |
|
$ |
1,415,979 |
|
$ |
– |
|
$ |
1,415,979 |
|
Cost of revenue |
|
82,436 |
|
|
117,436 |
|
|
343,950 |
|
|
216,600 |
|
|
– |
|
|
216,600 |
|
|
500,899 |
|
|
– |
|
|
500,899 |
|
Gross profit |
|
142,549 |
|
|
349,051 |
|
|
162,469 |
|
|
508,444 |
|
|
– |
|
|
508,444 |
|
|
915,080 |
|
|
– |
|
|
915,080 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
11,564,768 |
|
|
14,158,936 |
|
|
9,753,759 |
|
|
8,439,343 |
|
|
159,040 |
|
|
8,598,383 |
|
|
3,531,540 |
|
|
203,230 |
|
|
3,734,770 |
|
Grant reimbursements |
|
– |
|
|
– |
|
|
– |
|
|
(977,917 |
) |
|
– |
|
|
(977,917 |
) |
|
(136,840 |
) |
|
– |
|
|
(136,840 |
) |
General and administrative expenses |
|
12,057,067 |
|
|
11,432,866 |
|
|
7,435,709 |
|
|
15,506,191 |
|
|
(955,149 |
) |
|
14,551,042 |
|
|
3,439,085 |
|
|
(471,620 |
) |
|
2,967,465 |
|
Change in estimate of accrued liabilities |
|
– |
|
|
– |
|
|
– |
|
|
(1,263,009 |
) |
|
– |
|
|
(1,263,009 |
) |
|
– |
|
|
– |
|
|
– |
|
Change in estimate of loss on settlement
of litigation |
|
6,228,621 |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
Loss on settlement of litigation |
|
– |
|
|
– |
|
|
294,144 |
|
|
11,132,467 |
|
|
– |
|
|
11,132,467 |
|
|
4,903,949 |
|
|
– |
|
|
4,903,949 |
|
Total operating expenses |
|
29,850,456 |
|
|
25,591,802 |
|
|
17,483,612 |
|
|
32,837,075 |
|
|
(796,109 |
) |
|
32,040,966 |
|
|
11,737,734 |
|
|
(268,390 |
) |
|
11,469,344 |
|
Loss from operations |
|
(29,707,907 |
) |
|
(25,242,751 |
) |
|
(17,321,143 |
) |
|
(32,328,631 |
) |
|
796,109 |
|
|
(31,532,522 |
) |
|
(10,822,654 |
) |
|
268,390 |
|
|
(10,554,264 |
) |
Non-operating income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
165,918 |
|
|
15,581 |
|
|
35,114 |
|
|
16,724 |
|
|
– |
|
|
16,724 |
|
|
4,661 |
|
|
– |
|
|
4,661 |
|
Interest expense and late fees |
|
(1,437,584 |
) |
|
(1,104,602 |
) |
|
(1,510,693 |
) |
|
(11,726,120 |
) |
|
– |
|
|
(11,726,120 |
) |
|
(9,190,807 |
) |
|
– |
|
|
(9,190,807 |
) |
Finance gain (cost) |
|
95,162 |
|
|
(7,015,470 |
) |
|
(54,984,170 |
) |
|
(4,332,277 |
) |
|
– |
|
|
(4,332,277 |
) |
|
(1,705,691 |
) |
|
– |
|
|
(1,705,691 |
) |
Gain (loss) on disposal of fixed assets |
|
(962,227 |
) |
|
(17,138 |
) |
|
– |
|
|
9,500 |
|
|
– |
|
|
9,500 |
|
|
– |
|
|
– |
|
|
– |
|
Fines and penalties |
|
438,587 |
|
|
(3,500,000 |
) |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
Gain on extinguishment of debt |
|
– |
|
|
– |
|
|
– |
|
|
197,370 |
|
|
– |
|
|
197,370 |
|
|
598,425 |
|
|
– |
|
|
598,425 |
|
Loss attributable to equity method investments |
|
– |
|
|
– |
|
|
(820,000 |
) |
|
– |
|
|
– |
|
|
– |
|
|
(144,438 |
) |
|
– |
|
|
(144,438 |
) |
Loss on extinguishment of convertible
debentures |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
(8,200,984 |
) |
|
– |
|
|
(8,200,984 |
) |
Charges related to repricing derivative
liabilities |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
(30,316,708 |
) |
|
– |
|
|
(30,316,708 |
) |
Loss on warrant re-pricing |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
(83,680 |
) |
|
– |
|
|
(83,680 |
) |
Adjustments to fair value of unsettled
warrant obligation |
|
(107,438 |
) |
|
1,390,382 |
|
|
7,963,101 |
|
|
– |
|
|
(7,331,109 |
) |
|
(7,331,109 |
) |
|
– |
|
|
(5,814,327 |
) |
|
(5,814,327 |
) |
Adjustments to fair value of derivatives |
|
493,241 |
|
|
889,883 |
|
|
11,444,988 |
|
|
(6,209,898 |
) |
|
– |
|
|
(6,209,898 |
) |
|
23,103,668 |
|
|
– |
|
|
23,103,668 |
|
Total non-operating expense |
|
(1,314,341 |
) |
|
(9,341,364 |
) |
|
(37,871,660 |
) |
|
(22,044,701 |
) |
|
(7,331,109 |
) |
|
(29,375,810 |
) |
|
(25,935,554 |
) |
|
(5,814,327 |
) |
|
(31,749,881 |
) |
Loss before provision for income tax |
|
(31,022,248 |
) |
|
(34,584,115 |
) |
|
(55,192,803 |
) |
|
(54,373,332 |
) |
|
(6,535,000 |
) |
|
(60,908,332 |
) |
|
(36,758,208 |
) |
|
(5,545,937 |
) |
|
(42,304,145 |
) |
Provision for income tax |
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
|
– |
|
Net loss |
$ |
(31,022,248 |
) |
$ |
(34,584,115 |
) |
$ |
(55,192,803 |
) |
$ |
(54,373,332 |
) |
$ |
(6,535,000 |
) |
$ |
(60,908,332 |
) |
$ |
(36,758,208 |
) |
$ |
(5,545,937 |
) |
$ |
(42,304,145 |
) |
Loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
(0.01 |
) |
$ |
(0.02 |
) |
$ |
(0.03 |
) |
$ |
(0.04 |
) |
$ |
(0.01 |
) |
$ |
(0.05 |
) |
$ |
(0.07 |
) |
$ |
(0.01 |
) |
$ |
(0.08 |
) |
Diluted |
|
(1.24 |
) |
|
(1.66 |
) |
|
(3.49 |
) |
|
(4.46 |
) |
|
(0.54 |
) |
|
(5.00 |
) |
|
(7.05 |
) |
|
(1.06 |
) |
|
(8.11 |
) |
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
24,918,727 |
|
|
20,866,198 |
|
|
15,820,951 |
|
|
12,818,910 |
|
|
12,818,910 |
|
|
12,818,910 |
|
|
5,213,431 |
|
|
5,213,431 |
|
|
5,213,431 |
|
Diluted |
|
24,918,727 |
|
|
20,866,198 |
|
|
15,820,951 |
|
|
12,818,910 |
|
|
12,818,910 |
|
|
12,818,910 |
|
|
5,213,431 |
|
|
5,213,431 |
|
|
5,213,431 |
|
|
As
of December 31, |
|
|
2013 |
|
2012 |
|
2011 |
|
2010 |
|
2009 |
|
|
|
|
As
restated |
|
As
reported |
|
Adjustments |
|
As
restated |
|
As
reported |
|
Adjustments |
|
As
restated |
|
As
reported |
|
Adjustments |
|
As
restated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
1,743,485 |
|
$ |
7,241,852 |
|
$ |
13,103,007 |
|
$ |
– |
|
$ |
13,103,007 |
|
$ |
15,889,409 |
|
$ |
– |
|
$ |
15,889,409 |
|
$ |
2,538,838 |
|
$ |
– |
|
$ |
2,538,838 |
|
Current assets |
|
2,911,859 |
|
|
7,552,756 |
|
|
13,406,690 |
|
|
– |
|
|
13,406,690 |
|
|
15,981,007 |
|
|
– |
|
|
15,981,007 |
|
|
2,639,490 |
|
|
– |
|
|
2,639,490 |
|
Total assets |
|
3,907,919 |
|
|
8,496,542 |
|
|
15,185,326 |
|
|
– |
|
|
15,185,326 |
|
|
19,054,152 |
|
|
– |
|
|
19,054,152 |
|
|
5,088,008 |
|
|
– |
|
|
5,088,008 |
|
Current liabilities |
|
22,916,789 |
|
|
23,490,235 |
|
|
55,749,567 |
|
|
2,432,218 |
|
|
58,181,785 |
|
|
11,344,705 |
|
|
13,145,436 |
|
|
24,490,141 |
|
|
24,375,874 |
|
|
5,814,327 |
|
|
30,190,201 |
|
Total non-current liabilities |
|
3,524,740 |
|
|
6,551,988 |
|
|
4,130,477 |
|
|
– |
|
|
4,130,477 |
|
|
30,090,096 |
|
|
– |
|
|
30,090,096 |
|
|
25,887,022 |
|
|
– |
|
|
25,887,022 |
|
Total liabilities |
|
26,441,529 |
|
|
30,042,223 |
|
|
59,880,044 |
|
|
2,432,218 |
|
|
62,312,262 |
|
|
41,434,801 |
|
|
13,145,436 |
|
|
54,580,237 |
|
|
50,262,896 |
|
|
5,814,327 |
|
|
56,077,223 |
|
Series A-1 redeemable preferred stock |
|
– |
|
|
1,598,533 |
|
|
1,429,126 |
|
|
– |
|
|
1,429,126 |
|
|
1,272,441 |
|
|
– |
|
|
1,272,441 |
|
|
908,195 |
|
|
– |
|
|
908,195 |
|
Total stockholders' deficit |
|
22,533,610 |
|
|
23,144,214 |
|
|
46,123,844 |
|
|
2,432,218 |
|
|
48,556,062 |
|
|
23,653,090 |
|
|
13,145,436 |
|
|
36,798,526 |
|
|
46,083,083 |
|
|
5,814,327 |
|
|
51,897,410 |
|
RATIO OF EARNINGS TO COMBINED FIXED CHARGES
AND PREFERENCE STOCK DIVIDENDS
The following table sets forth our ratio of
earnings to fixed charges and the ratio of our combined fixed charges and preference stock dividends to earnings for the periods
indicated:
| |
Fiscal Year Ended December 31, 2009 | | |
Fiscal Year Ended December 31, 2010 | | |
Fiscal Year Ended December 31, 2011 | | |
Fiscal Year Ended December 31, 2012 | | |
Fiscal Year Ended
December 31, 2013 | | |
Nine Months Ended September 30, 2014 | |
Ratio of earnings to fixed charges | |
| 0.03 | | |
| (0.96) | | |
| 0.69 | | |
| (2.11) | | |
| (21.13) | | |
| (47.07) | |
Ratio of combined fixed charges and preference dividends to earnings | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | |
Deficiency of earnings available to cover fixed charges | |
| | | |
| (a) | | |
| | | |
| (b) | | |
| (c) | | |
| (d) | |
____________
| (a) | Earnings in fiscal year ended December 31, 2010 were inadequate to cover combined fixed charges and preference dividends.
The coverage deficiency was approximately $47.6 million. |
| (b) | Earnings in the fiscal year ended December 31, 2012 were inadequate to cover combined fixed charges and preference dividends.
The coverage deficiency was approximately $33.4 million. |
| (c) | Earnings in the fiscal year ended December 31, 2013 were inadequate to cover combined fixed charges and preference dividends.
The coverage deficiency was approximately $31.1 million. |
| (d) | Earnings in the nine months ended September 30, 2014 were inadequate to cover combined fixed charges and preference dividends.
The coverage deficiency was approximately $29.6 million. |
The ratios above were computed by dividing earnings
by fixed charges or by dividing earnings by combined fixed charges and preference dividends. For this purpose, earnings is calculated
by as follows: (i) adding (a) pre-tax income (loss) from continuing operations before adjustment for income or loss from
equity investees; (b) fixed charges; (c) amortization of capitalized interest; (d) distributed income of equity
investees; and (e) our share of pre-tax losses of equity investees for which charges arising from guarantees are included
in fixed charges; and (ii) then subtracting from such sum (a) interest capitalized; (b) preference security dividend
requirements of our consolidated subsidiaries; and (c) any noncontrolling interest in the pre-tax income (loss) of our subsidiaries
that have not incurred fixed charges. Equity investees are investments that we account for using the equity method of accounting.
Fixed charges consist of that portion of rental
expense associated with certain facility, equipment and vehicle leases considered to be a reasonable estimate of the interest factor.
We did not pay or accrue any preference dividends for the periods presented.
USE OF PROCEEDS
Unless otherwise described in a prospectus supplement
or related free writing prospectus, we intend to use the net proceeds from the sale of the offered securities for general corporate
purposes, which may include, but are not limited to, working capital, strategic acquisitions and other potential business development
activities, ongoing research and development activities, funding clinical trials and regulatory approval application processes,
and capital expenditures. Pending any specific utilization, the proceeds from the sale of the offered securities may be invested
in a manner designed to ensure levels of liquidity which correspond to our current and foreseeable cash needs. Such investments
may include, but may not be limited to, short-term investments, including government bonds, or other interest-bearing investments.
DESCRIPTION OF OUR COMMON STOCK
This section describes the general terms
of our common stock that we may offer from time to time. For more detailed information, a holder of our common stock should refer
to our certificate of incorporation, our by-laws and our rights agreement with respect to our preferred share purchase rights plan,
copies of which are filed with the SEC as exhibits to the registration statement of which this prospectus is a part.
As of September 30, 2014, we are
authorized to issue up to 37,500,000 shares of common stock, $0.001 par value per share. As of September 30, 2014,
approximately 34,358,658 shares of common stock were outstanding. On September 26, 2014, we filed a Definitive Proxy
Statement on Schedule 14A with the SEC which included a proposal to increase the number of authorize shares of our common
stock by 22,500,000. If this proposal is approved on November 12, 2014, at our annual meeting of stockholders, upon the
filing of the applicable amendment to our certificate of incorporation, we would be authorized to issue up to 60,000,000
shares of common stock.
Holders of our common stock are entitled to
one vote per share and vote together as a single class on all matters to be voted on by our stockholders. Pursuant to our certificate
of incorporation, there are no cumulative voting rights in the election of directors. The approval of corporate actions may also
require the approval of the holders of any series of our preferred stock. See "Description of Our Preferred Stock."
Our common stock will be the only type of our
capital stock entitled to vote in the election and removal of directors and other matters presented to our stockholders from time
to time, unless we issue voting preferred stock or our certificate of incorporation or the law requires otherwise.
Our common stockholders will be entitled to
receive dividends and distributions declared by our board of directors, or our board, to the extent permitted by outstanding series
of preferred stock and by our certificate of incorporation. If a dividend is declared, it will be distributed pro rata to our common
stockholders on a per share basis.
If we are liquidated or dissolved, our common
stockholders will be entitled to receive our assets and funds available for distribution to common stockholders in proportion to
the number of shares they hold. Our common stockholders may not receive any assets or funds until our creditors have been paid
in full and the preferential or participating rights of our preferred stockholders, if any, have been satisfied.
Holders of our common stock will not have any
preemptive, subscription or conversion rights with respect to shares of our common stock. We may issue additional shares of our
common stock, if authorized by our board, without the common stockholders' approval, unless required by Delaware law or a stock
exchange on which our securities are traded. The issuance of additional shares could have the effect of diluting any earnings per
share and the book value per share of outstanding shares of common stock. If we receive the appropriate payment, shares of our
common stock that we issue will be fully paid and nonassessable. There are no redemption or sinking fund provisions applicable
to our common stock.
Reference is made to the applicable prospectus
supplement relating to the common stock offered by that prospectus supplement for specific terms, including:
| · | amount and number of shares offered; |
| · | the initial offering price, if any, and market price; |
| · | information with respect to dividends; and |
| · | any listing of the common stock on any securities exchange or market.
|
Stock Exchange Listing
Our common stock is currently quoted on the
OTCQB, under the symbol “ACTC.”
Transfer Agent and Registrar
Interwest Transfer Co, Inc. is the transfer
agent and registrar for our common stock.
DESCRIPTION OF OUR PREFERRED STOCK
This section describes the general terms
and provisions of our preferred stock that we may offer from time to time. The applicable prospectus supplement will describe the
specific terms of the shares of preferred stock offered through that prospectus supplement, which may differ from the terms we
describe below. We will file a copy of the certificate of designation that contains the terms of each new series of preferred
stock with the SEC each time we issue a new series of preferred stock, and these certificates of designation will be incorporated
by reference into the registration statement of which this prospectus is a part. Each certificate of designation will establish
the number of shares included in a designated series and fix the designation, powers, privileges, preferences and rights of the
shares of each series as well as any applicable qualifications, limitations or restrictions. A holder of our preferred stock should
refer to the applicable certificate of designation, our certificate of incorporation and the applicable prospectus supplement (and
any related free writing prospectus that we may authorize to be provided to you) for more specific information.
We are authorized to issue up to 50,000,000
shares of preferred stock, $0.001 par value per share, in multiple series, subject to limitations provided in our certificate of
incorporation. As of September 30, 2014, no shares of our preferred stock were outstanding.
The issuance of preferred stock could adversely
affect the voting power of holders of common stock and reduce the likelihood that common stockholders will receive dividend payments
and payments upon liquidation. The issuance of preferred stock could have the effect of decreasing the market price of our common
stock. The issuance of preferred stock also could have the effect of delaying, deterring or preventing a change in control of our
company.
With respect to each new series of our preferred
stock, our board has the authority to fix, among other things, the following terms:
| · | the designation of the series; |
| · | the number of shares within the series; |
| · | whether the dividends are cumulative and, if cumulative, the dates from
which dividends are cumulative; |
| · | the rate of any dividends, any conditions upon which dividends are payable,
and the dates of payment of dividends; |
| · | whether the shares are redeemable, the redemption price and the terms
of redemption; |
| · | the amount payable to a holder for each share owned if we are dissolved
or liquidated; |
| · | whether the shares are convertible or exchangeable, the price or rate
of exchange, and the applicable terms and conditions; |
| · | any restrictions on issuance of shares in the same series or any other
series; |
| · | the voting rights, if any, of the shares of the series; |
| · | the provisions for a sinking fund, if any; and |
| · | any listing of the preferred stock on any securities exchange or market.
|
Holders of our preferred stock will not have
preemptive rights with respect to shares of our preferred stock. In addition, rights with respect to shares of our preferred stock
will be subordinate to the rights of our general creditors. If we receive the appropriate payment, shares of our preferred stock
that we issue will be fully paid and nonassessable.
Transfer Agent and Registrar. We
currently plan to retain Interwest Transfer Co, Inc. as the registrar and transfer agent of any series of our preferred stock.
DESCRIPTION OF OUR DEBT SECURITIES
This section describes the general terms
and provisions of our debt securities that we may issue from time to time. We may issue debt securities, in one or more series,
as either senior or subordinated debt or as senior or subordinated convertible debt. While the terms we have summarized below will
apply generally to any future debt securities we may offer under this prospectus, the applicable prospectus supplement or free
writing prospectus will describe the specific terms of any debt securities offered through that prospectus supplement or free writing
prospectus. The terms of any debt securities we offer under a prospectus supplement or free writing prospectus may differ from
the terms we describe below. Unless the context requires otherwise, whenever we refer to the "indentures," we also are
referring to any supplemental indentures that specify the terms of a particular series of debt securities.
We will issue any senior debt securities under
the senior indenture that we will enter into with the trustee named in the senior indenture. We will issue any subordinated debt
securities under the subordinated indenture that we will enter into with the trustee named in the subordinated indenture. We have
filed forms of these documents as exhibits to the registration statement, of which this prospectus is a part, and supplemental
indentures and forms of debt securities containing the terms of the debt securities being offered will be filed as exhibits to
the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we file with
the SEC.
The indentures will be qualified under the Trust
Indenture Act of 1939, as amended, or the Trust Indenture Act. We use the term "trustee" to refer to either the trustee
under the senior indenture or the trustee under the subordinated indenture, as applicable.
The following summaries of material provisions
of the senior debt securities, the subordinated debt securities and the indentures are subject to, and qualified in their entirety
by reference to, all of the provisions of the indenture applicable to a particular series of debt securities. We urge you to read
the applicable prospectus supplement or free writing prospectus and any related free writing prospectuses related to the debt securities
that we may offer under this prospectus, as well as the complete applicable indenture that contains the terms of the debt securities.
Except as we may otherwise indicate, the terms of the senior indenture and the subordinated indenture are identical.
General
We will describe in the applicable prospectus
supplement or free writing prospectus the terms of the series of debt securities being offered, including:
| · | the principal amount being offered, and if a series, the total amount
authorized and the total amount outstanding; |
| · | any limit on the amount that may be issued; |
| · | whether or not we will issue the series of debt securities in global
form, and, if so, the terms and who the depository will be; |
| · | whether and under what circumstances, if any, we will pay additional
amounts on any debt securities held by a person who is not a United States person for tax purposes, and whether we can redeem the
debt securities if we have to pay such additional amounts; |
| · | the annual interest rate, which may be fixed or variable, or the method
for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record
dates for interest payment dates or the method for determining such dates; |
| · | whether or not the debt securities will be secured or unsecured, and
the terms of any secured debt; |
| · | the terms of the subordination of any series of subordinated debt; |
| · | the place where payments will be payable; |
| · | restrictions on transfer, sale or other assignment, if any; |
| · | our right, if any, to defer payment of interest and the maximum length
of any such deferral period; |
| · | the date, if any, after which, the conditions upon which, and the price
at which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions
and the terms of those redemption provisions; |
| · | the date, if any, on which, and the price at which we are obligated,
pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder's option, to purchase,
the series of debt securities and the currency or currency unit in which the debt securities are payable; |
| · | whether the indenture will restrict our ability or the ability of
our subsidiaries to: |
| § | incur additional indebtedness; |
| § | issue additional securities; |
| § | pay dividends or make distributions in respect of our capital stock
or the capital stock of our subsidiaries; |
| § | place restrictions on our subsidiaries' ability to pay dividends, make
distributions or transfer assets; |
| § | make investments or other restricted payments; |
| § | sell or otherwise dispose of assets; |
| § | enter into sale-leaseback transactions; |
| § | engage in transactions with stockholders or affiliates; |
| § | issue or sell stock of our subsidiaries; or |
| § | effect a consolidation or merger; |
| · | whether the indenture will require us to maintain any interest coverage,
fixed charge, cash flow-based, asset-based or other financial ratios; |
| · | a discussion of certain material or special United States federal income
tax considerations applicable to the debt securities; |
| · | information describing any book-entry features; |
| · | provisions for a sinking fund purchase or other analogous fund, if any;
|
| · | the applicability of the provisions in the indenture on discharge; |
| · | whether the debt securities are to be offered at a price such that they
will be deemed to be offered at an "original issue discount" as defined in paragraph (a) of Section 1273 of
the Internal Revenue Code of 1986, as amended; |
| · | the denominations in which we will issue the series of debt securities,
if other than denominations of $1,000 and any integral multiple thereof; |
| · | the currency of payment of debt securities if other than U.S. dollars
and the manner of determining the equivalent amount in U.S. dollars; and |
| · | any other specific terms, preferences, rights or limitations of, or
restrictions on, the debt securities, including any additional events of default or covenants provided with respect to the debt
securities, and any terms that may be required by us or advisable under applicable laws or regulations or advisable in connection
with the marketing of the debt securities. |
Conversion or Exchange Rights
We will set forth in the applicable prospectus
supplement or free writing prospectus the terms on which a series of debt securities may be convertible into or exchangeable for
our common stock, our preferred stock or other securities (including securities of a third-party). We will include provisions as
to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant
to which the number of shares of our common stock, our preferred stock or other securities (including securities of a third-party)
that the holders of the series of debt securities receive would be subject to adjustment.
Consolidation, Merger or Sale
Unless we provide otherwise in the prospectus
supplement or free writing prospectus applicable to a particular series of debt securities, the indentures will not contain any
covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of all or substantially
all of our assets. However, any successor to or acquirer of such assets must assume all of our obligations under the indentures
or the debt securities, as appropriate. If the debt securities are convertible into or exchangeable for other securities of ours
or securities of other entities, the person with whom we consolidate or merge or to whom we sell all of our property must make
provisions for the conversion of the debt securities into securities that the holders of the debt securities would have received
if they had converted the debt securities before the consolidation, merger or sale.
Events of Default Under the Indenture
Unless we provide otherwise in the prospectus
supplement or free writing prospectus applicable to a particular series of debt securities, the following are events of default
under the indentures with respect to any series of debt securities that we may issue:
| · | if we fail to pay interest when due and payable and our failure continues
for 90 days and the time for payment has not been extended; |
| · | if we fail to pay the principal, premium or sinking fund payment, if
any, when due and payable at maturity, upon redemption or repurchase or otherwise, and the time for payment has not been extended;
|
| · | if we fail to observe or perform any other covenant contained in the
debt securities or the indentures, other than a covenant specifically relating to another series of debt securities, and our failure
continues for 90 days after we receive notice from the trustee or holders of at least 25% in aggregate principal amount of
the outstanding debt securities of the applicable series; and |
if specified events of bankruptcy, insolvency or reorganization
occur.
We will describe in each applicable prospectus
supplement or free writing prospectus any additional events of default relating to the relevant series of debt securities.
If an event of default with respect to debt
securities of any series occurs and is continuing, other than an event of default specified in the last bullet point above, the
trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series, by notice
to us in writing, and to the trustee if notice is given by such holders, may declare the unpaid principal, premium, if any, and
accrued interest, if any, due and payable immediately. If an event of default specified in the last bullet point above occurs with
respect to us, the unpaid principal, premium, if any, and accrued interest, if any, of each issue of debt securities then outstanding
shall be due and payable without any notice or other action on the part of the trustee or any holder.
The holders of a majority in principal amount
of the outstanding debt securities of an affected series may waive any default or event of default with respect to the series and
its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, unless we
have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default or event of default.
Subject to the terms of the indentures, if an
event of default under an indenture shall occur and be continuing, the trustee will be under no obligation to exercise any of its
rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities,
unless such holders have offered the trustee reasonable indemnity or security satisfactory to it against any loss, liability or
expense. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to
direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust
or power conferred on the trustee, with respect to the debt securities of that series, provided that:
| · | the direction so given by the holder is not in conflict with any law
or the applicable indenture; and |
| · | subject to its duties under the Trust Indenture Act, the trustee need
not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the
proceeding. |
A holder of the debt securities of any series
will have the right to institute a proceeding under the indentures or to appoint a receiver or trustee, or to seek other remedies
if:
| · | the holder has given written notice to the trustee of a continuing event
of default with respect to that series; |
| · | the holders of at least 25% in aggregate principal amount of the outstanding
debt securities of that series have made written request, and such holders have offered reasonable indemnity to the trustee or
security satisfactory to it against any loss, liability or expense or to be incurred in compliance with instituting the proceeding
as trustee; and |
| · | the trustee does not institute the proceeding, and does not receive
from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series other conflicting
directions within 90 days after the notice, request and offer. |
These limitations do not apply to a suit instituted
by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the debt securities,
or other defaults that may be specified in the applicable prospectus supplement or free writing prospectus.
We will periodically file statements with the
trustee regarding our compliance with specified covenants in the indentures.
Modification of Indenture; Waiver
Subject to the terms of the indenture for any
series of debt securities that we may issue, we and the trustee may change an indenture without the consent of any holders with
respect to the following specific matters:
| · | to fix any ambiguity, defect or inconsistency in the indenture; |
| · | to comply with the provisions described above under "Description
of Our Debt Securities—Consolidation, Merger or Sale;" |
| · | to comply with any requirements of the SEC in connection with the qualification
of any indenture under the Trust Indenture Act; |
| · | to add to, delete from or revise the conditions, limitations, and restrictions
on the authorized amount, terms, or purposes of issue, authentication and delivery of debt securities, as set forth in the indenture;
|
| · | to provide for the issuance of and establish the form and terms and
conditions of the debt securities of any series as provided under "Description of Our Debt Securities—General,"
to establish the form of any certifications required to be furnished pursuant to the terms of the indenture or any series of debt
securities, or to add to the rights of the holders of any series of debt securities; |
| · | to evidence and provide for the acceptance of appointment hereunder
by a successor trustee; |
| · | to provide for uncertificated debt securities and to make all appropriate
changes for such purpose; |
| · | to add to our covenants such new covenants, restrictions, conditions
or provisions for the benefit of the holders, to make the occurrence, or the occurrence and the continuance, of a default in any
such additional covenants, restrictions, conditions or provisions an event of default or to surrender any right or power conferred
to us in the indenture; or |
| · | to change anything that does not materially adversely affect the interests
of any holder of debt securities of any series. |
In addition, under the indentures, the rights
of holders of a series of debt securities may be changed by us and the trustee with the written consent of the holders of at least
a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, subject to
the terms of the indenture for any series of debt securities that we may issue or as otherwise provided in the prospectus supplement
or free writing prospectus applicable to a particular series of debt securities, we and the trustee may make the following changes
only with the consent of each holder of any outstanding debt securities affected:
| · | extending the stated maturity of the series of debt securities; |
| · | reducing the principal amount, reducing the rate of or extending the
time of payment of interest, or reducing any premium payable upon the redemption or repurchase of any debt securities; or |
| · | reducing the percentage of debt securities, the holders of which are
required to consent to any amendment, supplement, modification or waiver. |
Discharge
Each indenture provides that, subject to the
terms of the indenture and any limitation otherwise provided in the prospectus supplement or free writing prospectus applicable
to a particular series of debt securities, we can elect to be discharged from our obligations with respect to one or more series
of debt securities, except for specified obligations, including obligations to:
| · | register the transfer or exchange of debt securities of the series;
|
| · | replace stolen, lost or mutilated debt securities of the series; |
| · | maintain paying agencies; |
| · | hold monies for payment in trust; |
| · | recover excess money held by the trustee; |
| · | compensate and indemnify the trustee; and |
| · | appoint any successor trustee. |
In order to exercise our rights to be discharged,
we must deposit with the trustee money or government obligations sufficient to pay all the principal of, any premium and interest
on, the debt securities of the series on the dates payments are due.
Form, Exchange and Transfer
We will issue the debt securities of each series
only in fully registered form without coupons and, unless we otherwise specify in the applicable prospectus supplement or free
writing prospectus, in denominations of $1,000 and any integral multiple thereof. The indentures provide that we may issue debt
securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf
of, The Depository Trust Company or another depository named by us and identified in a prospectus supplement or free writing prospectus
with respect to that series.
At the option of the holder, subject to the
terms of the indentures and the limitations applicable to global securities described in the applicable prospectus supplement or
free writing prospectus, the holder of the debt securities of any series can exchange the debt securities for other debt securities
of the same series, in any authorized denomination and of like tenor and aggregate principal amount.
Subject to the terms of the indentures and the
limitations applicable to global securities set forth in the applicable prospectus supplement or free writing prospectus, holders
of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the
form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar
or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that
the holder presents for transfer or exchange, we will make no service charge for any registration of transfer or exchange, but
we may require payment of any taxes or other governmental charges.
We will name in the applicable prospectus supplement
or free writing prospectus the security registrar, and any transfer agent in addition to the security registrar, that we initially
designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer
agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer
agent in each place of payment for the debt securities of each series.
If we elect to redeem the debt securities of
any series, we will not be required to:
| · | issue, register the transfer of, or exchange any debt securities of
that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption
of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or |
| · | register the transfer of or exchange any debt securities so selected
for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part. |
Information Concerning the Trustee
The trustee, other than during the occurrence
and continuance of an event of default under an indenture, undertakes to perform only those duties as are specifically set forth
in the applicable indenture. Upon an event of default under an indenture, the trustee must use the same degree of care as a prudent
person would exercise or use in the conduct of his or her own affairs.
Subject to this provision, the trustee is under
no obligation to exercise any of the powers given it by the indentures at the request of any holder of debt securities unless it
is offered reasonable security and indemnity against the costs, expenses and liabilities that it might incur.
Payment and Paying Agents
Unless we otherwise indicate in the applicable
prospectus supplement or free writing prospectus, we will make payment of the interest on any debt securities on any interest payment
date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business
on the regular record date for the interest.
We will pay principal of and any premium and
interest on the debt securities of a particular series at the office of the paying agents designated by us, except that unless
we otherwise indicate in the applicable prospectus supplement or free writing prospectus, we will make interest payments by check
that we will mail to the holder or by wire transfer to certain holders. Unless we otherwise indicate in the applicable prospectus
supplement or free writing prospectus, we will designate the corporate trust office of the trustee as our sole paying agent for
payments with respect to debt securities of each series. We will name in the applicable prospectus supplement or free writing prospectus
any other paying agents that we initially designate for the debt securities of a particular series. We will maintain a paying agent
in each place of payment for the debt securities of a particular series.
All money we pay to a paying agent or the trustee
for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed at the end of two
years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the debt security
thereafter may look only to us for payment thereof.
Governing Law
The indentures and the debt securities will
be governed by and construed in accordance with the laws of the State of New York, except to the extent that the Trust Indenture
Act is applicable.
Ranking of Debt Securities
The subordinated debt securities will be subordinate
and junior in priority of payment to certain of our other indebtedness to the extent described in a prospectus supplement or free
writing prospectus. The subordinated indenture does not limit the amount of subordinated debt securities that we may issue. It
also does not limit us from issuing any other secured or unsecured debt.
The senior debt securities will rank equally
in right of payment to all our other senior unsecured debt. The senior indenture does not limit the amount of senior debt securities
that we may issue. It also does not limit us from issuing any other secured or unsecured debt.
DESCRIPTION OF OUR WARRANTS
The following description, together with
the additional information we include in any applicable prospectus supplements or free writing prospectus, summarizes the material
terms and provisions of the warrants that we may offer under this prospectus, which may consist of warrants to purchase common
stock, preferred stock and/or debt securities in one or more series. Warrants may be offered independently or together with common
stock, preferred stock and/or debt securities offered by any prospectus supplement or free writing prospectus, and may be attached
to or separate from those securities. While the terms we have summarized below will generally apply to any future warrants we may
offer under this prospectus, we will describe the particular terms of any warrants that we may offer in more detail in the applicable
prospectus supplement or free writing prospectus. The terms of any warrants we offer under a prospectus supplement or free writing
prospectus may differ from the terms we describe below.
We will issue the warrants under a warrant agreement
which we will enter into with a warrant agent to be selected by us. We have filed forms of these warrant agreements and forms of
the warrant certificates representing the warrants as exhibits to the registration statement, of which this prospectus is a part,
and the complete warrant agreements and forms of warrant certificates containing the terms of the warrants being offered will be
filed as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports
that we file with the SEC. We use the term "warrant agreement" to refer to any of these warrant agreements. We use the
term "warrant agent" to refer to the warrant agent under any of these warrant agreements. The warrant agent will act
solely as an agent of ours in connection with the warrants and will not act as an agent for the holders or beneficial owners of
the warrants.
The following summaries of material provisions
of the warrants and the warrant agreements are subject to, and qualified in their entirety by reference to, all the provisions
of the warrant agreement applicable to a particular series of warrants. We urge you to read the applicable prospectus supplements
or free writing prospectus related to the warrants that we sell under this prospectus, as well as the complete warrant agreements
that contain the terms of the warrants.
General
We will describe in the applicable prospectus
supplement or free writing prospectus the terms relating to a series of warrants. If warrants for the purchase of debt securities
are offered, the prospectus supplement or free writing prospectus will describe the following terms, to the extent applicable:
| · | the offering price and the aggregate number of warrants offered; |
| · | the currencies in which the warrants are being offered; |
| · | the designation, aggregate principal amount, currencies, denominations
and terms of the series of debt securities that can be purchased if a holder exercises a warrant; |
| · | the designation and terms of any series of debt securities with which
the warrants are being offered and the number of warrants offered with each such debt security; |
| · | the date on and after which the holder of the warrants can transfer
them separately from the related series of debt securities; |
| · | the principal amount of the series of debt securities that can be purchased
if a holder exercises a warrant and the price at which and currencies in which such principal amount may be purchased upon exercise;
|
| · | the terms of any rights to redeem or call the warrants; |
| · | the date on which the right to exercise the warrants begins and the
date on which such right expires; |
| · | federal income tax consequences of holding or exercising the warrants;
and |
| · | any other specific terms, preferences, rights or limitations of, or
restrictions on, the warrants. |
Warrants for the purchase of debt securities will be in registered
form only.
If warrants for the purchase of common stock
or preferred stock are offered, the prospectus supplement or free writing prospectus will describe the following terms, to the
extent applicable:
| · | the offering price and the aggregate number of warrants offered; |
| · | the total number of shares that can be purchased if a holder of the
warrants exercises them and, in the case of warrants for preferred stock, the designation, total number and terms of the series
of preferred stock that can be purchased upon exercise; |
| · | the designation and terms of any series of preferred stock with which
the warrants are being offered and the number of warrants being offered with each share of common stock or preferred stock; |
| · | the date on and after which the holder of the warrants can transfer
them separately from the related common stock or series of preferred stock; |
| · | the number of shares of common stock or preferred stock that can be
purchased if a holder exercises the warrant and the price at which such common stock or preferred stock may be purchased upon exercise,
including, if applicable, any provisions for changes to or adjustments in the exercise price and in the securities or other property
receivable upon exercise; |
| · | the terms of any rights to redeem or call, or accelerate the expiration
of, the warrants; |
| · | the date on which the right to exercise the warrants begins and the
date on which that right expires; |
| · | federal income tax consequences of holding or exercising the warrants;
and |
| · | any other specific terms, preferences, rights or limitations of, or
restrictions on, the warrants. |
Warrants for the purchase of common stock or preferred stock will
be in registered form only.
Exercise of Warrants
Each holder of a warrant is entitled to purchase
the principal amount of debt securities or number of shares of common stock or preferred stock, as the case may be, at the exercise
price described in the applicable prospectus supplement or free writing prospectus. After the close of business on the day when
the right to exercise terminates (or a later date if we extend the time for exercise), unexercised warrants will become void.
A holder of warrants may exercise them by following
the general procedure outlined below:
| · | delivering to the warrant agent the payment required by the applicable
prospectus supplement or free writing prospectus to purchase the underlying security; |
| · | properly completing and signing the reverse side of the warrant certificate
representing the warrants; and |
| · | delivering the warrant certificate representing the warrants to the
warrant agent within five business days of the warrant agent receiving payment of the exercise price. |
If you comply with the procedures described
above, your warrants will be considered to have been exercised when the warrant agent receives payment of the exercise price, subject
to the transfer books for the securities issuable upon exercise of the warrant not being closed on such date. After you have completed
those procedures and subject to the foregoing, we will, as soon as practicable, issue and deliver to you the debt securities, common
stock or preferred stock that you purchased upon exercise. If you exercise fewer than all of the warrants represented by a warrant
certificate, a new warrant certificate will be issued to you for the unexercised amount of warrants. Holders of warrants will be
required to pay any tax or governmental charge that may be imposed in connection with transferring the underlying securities in
connection with the exercise of the warrants.
Amendments and Supplements to the Warrant Agreements
We may amend or supplement a warrant agreement
without the consent of the holders of the applicable warrants to cure ambiguities in the warrant agreement, to cure or correct
a defective provision in the warrant agreement, or to provide for other matters under the warrant agreement that we and the warrant
agent deem necessary or desirable, so long as, in each case, such amendments or supplements do not materially adversely affect
the interests of the holders of the warrants.
Warrant Adjustments
Unless the applicable prospectus supplement
or free writing prospectus states otherwise, the exercise price of, and the number of securities covered by, a common stock warrant
or preferred stock warrant will be adjusted proportionately if we subdivide or combine our common stock or preferred stock, as
applicable. In addition, unless the prospectus supplement or free writing prospectus states otherwise, if we, without receiving
payment:
| · | issue capital stock or other securities convertible into or exchangeable
for common stock or preferred stock, or any rights to subscribe for, purchase or otherwise acquire any of the foregoing, as a dividend
or distribution to holders of our common stock or preferred stock; |
| · | pay any cash to holders of our common stock or preferred stock other
than a cash dividend paid out of our current or retained earnings or other than in accordance with the terms of the preferred stock;
|
| · | issue any evidence of our indebtedness or rights to subscribe for or
purchase our indebtedness to holders of our common stock or preferred stock; or |
| · | issue common stock or preferred stock or additional stock or other securities
or property to holders of our common stock or preferred stock by way of spinoff, split-up, reclassification, combination of shares
or similar corporate rearrangement, |
then the holders of common stock warrants and preferred stock warrants,
as applicable, will be entitled to receive upon exercise of the warrants, in addition to the securities otherwise receivable upon
exercise of the warrants and without paying any additional consideration, the amount of stock and other securities and property
such holders would have been entitled to receive had they held the common stock or preferred stock, as applicable, issuable under
the warrants on the dates on which holders of those securities received or became entitled to receive such additional stock and
other securities and property.
Except as stated above or as otherwise set forth
in the applicable prospectus supplement or free writing prospectus, the exercise price and number of securities covered by a common
stock warrant and preferred stock warrant, and the amounts of other securities or property to be received, if any, upon exercise
of those warrants, will not be adjusted or provided for if we issue those securities or any securities convertible into or exchangeable
for those securities, or securities carrying the right to purchase those securities or securities convertible into or exchangeable
for those securities.
Holders of common stock warrants and preferred
stock warrants may have additional rights under the following circumstances:
| · | certain reclassifications, capital reorganizations or changes of the
common stock or preferred stock, as applicable; |
| · | certain share exchanges, mergers, or similar transactions involving
us and which result in changes of the common stock or preferred stock, as applicable; or |
| · | certain sales or dispositions to another entity of all or substantially
all of our property and assets. |
If one of the above transactions occurs and
holders of our common stock or preferred stock are entitled to receive stock, securities or other property with respect to or in
exchange for their securities, the holders of the common stock warrants and preferred stock warrants then outstanding, as applicable,
will be entitled to receive upon exercise of their warrants the kind and amount of shares of stock and other securities or property
that they would have received upon the applicable transaction if they had exercised their warrants immediately before the transaction.
DESCRIPTION OF OUR DEPOSITARY SHARES
The following description, together with
the additional information we include in any applicable prospectus supplements or free writing prospectus, contains general terms
and provisions of the depositary shares that we may offer under this prospectus. The specific terms of the depositary shares offered
will be described in the applicable prospectus supplement or free writing prospectus relating to such depositary shares, and such
terms may differ from the terms we describe below. For more information, please refer to the provisions of the deposit agreement
we will enter into with a depository to be selected, and our certificate of incorporation, including the form of certificate of
designation for the applicable series of preferred stock.
General
We may, at our option, elect to offer depositary
shares rather than full shares of preferred stock. In the event such option is exercised, each of the depositary shares will represent
ownership of and entitlement to all rights and preferences of a fraction of a share of preferred stock of a specified series (including
dividend, voting, redemption and liquidation rights). The applicable fraction will be specified in a prospectus supplement. The
preferred stock represented by the depositary shares will be deposited with a depository named in the applicable prospectus supplement,
under a deposit agreement, among us, the depository and the holders of the certificates evidencing depositary shares, or depositary
receipts. Depositary receipts will be delivered to those persons purchasing depositary shares in the offering. The depository will
be the transfer agent, registrar and dividend disbursing agent for the depositary shares. Holders of depositary receipts agree
to be bound by the deposit agreement, which requires holders to take certain actions such as filing proof of residence and paying
certain charges.
Dividends
The depository will distribute all cash dividends
or other cash distributions received in respect of the series of preferred stock represented by the depositary shares to the record
holders of depositary receipts in proportion to the number of depositary shares owned by such holders on the relevant record date,
which will be the same date as the record date fixed by us for the applicable series of preferred stock. The depository, however,
will distribute only such amount as can be distributed without attributing to any depositary share a fraction of one cent, and
any balance not so distributed will be added to and treated as part of the next sum received by the depository for distribution
to record holders of depositary receipts then outstanding.
In the event of a distribution other than in
cash, the depository will distribute property received by it to the record holders of depositary receipts entitled thereto, in
proportion, as nearly as may be practicable, to the number of depositary shares owned by such holders on the relevant record date,
unless the depository determines (after consultation with us) that it is not feasible to make such distribution, in which case
the depository may (with our approval) adopt any other method for such distribution as it deems equitable and appropriate, including
the sale of such property (at such place or places and upon such terms as it may deem equitable and appropriate) and distribution
of the net proceeds from such sale to such holders.
Liquidation Preference
In the event of the liquidation, dissolution
or winding up of the affairs of the company, whether voluntary or involuntary, the holders of each depositary share will be entitled
to the fraction of the liquidation preference accorded each share of the applicable series of preferred stock as set forth in the
prospectus supplement.
Redemption
If the series of preferred stock represented
by the applicable series of depositary shares is redeemable, such depositary shares will be redeemed from the proceeds received
by the depository resulting from the redemption, in whole or in part, of preferred stock held by the depository. Whenever we redeem
any preferred stock held by the depository, the depository will redeem as of the same redemption date the number of depositary
shares representing the preferred stock so redeemed. The depository will mail the notice of redemption promptly upon receipt of
such notice from us and not less than 30 nor more than 60 days prior to the date fixed for redemption of the preferred stock
and the depositary shares to the record holders of the depositary receipts.
Voting
Promptly upon receipt of notice of any meeting
at which the holders of the series of preferred stock represented by the applicable series of depositary shares are entitled to
vote, the depository will mail the information contained in such notice of meeting to the record holders of the depositary receipts
as of the record date for such meeting. Each such record holder of depositary receipts will be entitled to instruct the depository
as to the exercise of the voting rights pertaining to the number of shares of preferred stock represented by such record holder's
depositary shares. The depository will endeavor, insofar as practicable, to vote such preferred stock represented by such depositary
shares in accordance with such instructions, and we will agree to take all action which may be deemed necessary by the depository
in order to enable the depository to do so. The depository will abstain from voting any of the shares of preferred stock to the
extent that it does not receive specific instructions from the holders of depositary receipts.
Withdrawal of Preferred Stock
Upon surrender of depositary receipts at the
principal office of the depository, upon payment of any unpaid amount due the depository, and subject to the terms of the deposit
agreement, the owner of the depositary shares evidenced thereby is entitled to delivery of the number of whole shares of preferred
stock and all money and other property, if any, represented by such depositary shares. Fractional shares of preferred stock will
not be issued. If the depositary receipts delivered by the holder evidence a number of depositary shares in excess of the number
of depositary shares representing the number of whole shares of preferred stock to be withdrawn, the depository will deliver to
such holder at the same time a new depositary receipt evidencing such excess number of depositary shares. Holders of shares of
preferred stock thus withdrawn will not thereafter be entitled to deposit such shares under the deposit agreement or to receive
depositary receipts evidencing depositary shares therefor.
Amendment and Termination of Deposit Agreement
The form of depositary receipt evidencing the
depositary shares and any provision of the deposit agreement may at any time and from time to time be amended by agreement between
us and the depository. However, any amendment which materially and adversely alters the rights of the holders (other than any change
in fees) of depositary shares will not be effective unless such amendment has been approved by the holders of at least a majority
of the depositary shares then outstanding. No such amendment may impair the right, subject to the terms of the deposit agreement,
of any owner of any depositary shares to surrender the depositary receipt evidencing such depositary shares with instructions to
the depository to deliver to the holder of shares of preferred stock and all money and other property, if any, represented thereby,
except in order to comply with mandatory provisions of applicable law.
The deposit agreement will be permitted to be
terminated by us upon not less than 30 days prior written notice to the applicable depository if a majority of each series
of preferred stock affected by such termination consents to such termination, whereupon such depository will be required to deliver
or make available to each holder of depositary receipts, upon surrender of the depositary receipts held by such holder, such number
of whole or fractional shares of preferred stock as are represented by the depositary shares evidenced by such depositary receipts
together with any other property held by such depository with respect to such depositary receipts. In addition, the deposit agreement
will automatically terminate if (i) all outstanding depositary shares thereunder shall have been redeemed, (ii) there
shall have been a final distribution in respect of the related shares of preferred stock in connection with any liquidation, dissolution
or winding up of our company and such distribution shall have been distributed to the holders of depositary receipts evidencing
the depositary shares representing such shares of preferred stock or (iii) each share of preferred stock shall have been converted
into shares of our common stock not so represented by depositary shares.
Charges of Depository
We will pay all transfer and other taxes and
governmental charges arising solely from the existence of the depositary arrangements. We will pay charges of the depository in
connection with the initial deposit of the shares of preferred stock and initial issuance of the depositary shares, and redemption
of the shares of preferred stock and all withdrawals of shares of preferred stock by owners of depositary shares. Holders of depositary
receipts will pay transfer, income and other taxes and governmental charges and certain other charges as are provided in the deposit
agreement to be for their accounts. In certain circumstances, the depository may refuse to transfer depositary shares, may withhold
dividends and distributions and sell the depositary shares evidenced by such depositary receipt if such charges are not paid.
Miscellaneous
The depository will forward to the holders of
depositary receipts all reports and communications from us which are delivered to the depository and which we are required to furnish
to the holders of the shares of preferred stock. In addition, the depository will make available for inspection by holders of depositary
receipts at the principal office of the depository, and at such other places as it may from time to time deem advisable, any reports
and communications received from us which are received by the depository as the holder of shares of preferred stock.
Neither we nor the depository assumes any obligation
or will be subject to any liability under the deposit agreement to holders of depositary receipts other than for its negligence
or willful misconduct. Neither we nor the depository will be liable if it is prevented or delayed by law or any circumstance beyond
its control in performing its obligations under the deposit agreement. Our obligations under the deposit agreement and the obligations
of the depository under the deposit agreement will be limited to performance in good faith of our and the depository's respective
duties thereunder, and neither we nor the depository will be obligated to prosecute or defend any legal proceeding in respect of
any depositary shares or shares of preferred stock unless satisfactory indemnity is furnished. We and the depository may rely on
written advice of counsel or accountants, on information provided by holders of the depositary receipts or other persons believed
in good faith to be competent to give such information and on documents believed to be genuine and to have been signed or presented
by the proper party or parties. In the event the depository shall receive conflicting claims, requests or instructions from any
holders of depositary receipts, on the one hand, and us, on the other hand, the depository shall be entitled to act on such claims,
requests or instructions received from us.
Resignation and Removal of Depository
The depository may resign at any time by delivering
to us notice of its election to do so, and we may at any time remove the depository, any such resignation or removal to take effect
upon the appointment of a successor depository and its acceptance of such appointment. Such successor depository must be appointed
within 60 days after delivery of the notice for resignation or removal and must be a bank or trust company having its principal
office in the United States of America and having a combined capital and surplus of at least $150,000,000.
DESCRIPTION OF OUR STOCK PURCHASE UNITS OR
CONTRACTS
This section outlines some of the provisions
of the stock purchase units or contracts, the stock purchase unit or contract agreement and the pledge agreement. This information
is not complete in all respects and is qualified entirely by reference to the stock purchase unit or contract agreement and pledge
agreement with respect to the stock purchase units or contracts of any particular series. The specific terms of any series of stock
purchase units or contracts will be described in the applicable prospectus supplement or free writing prospectus. If so described
in a prospectus supplement or free writing prospectus, the specific terms of any series of stock purchase units or contracts may
differ from the general description of terms presented below.
Unless otherwise specified in the applicable
prospectus supplement, we may issue stock purchase units or contracts, including contracts obligating holders to purchase from
us and us to sell to the holders, a specified number of shares of common stock, shares of preferred stock or depositary shares
at a future date or dates. Alternatively, the stock purchase units or contracts may obligate us to purchase from holders, and obligate
holders to sell to us, a specified or varying number of shares of common stock, shares of preferred stock or depositary shares.
The consideration per shares of common stock, share of preferred stock, or depositary share may be fixed at the time the stock
purchase units or contracts are issued or may be determined by a specific reference to a formula set forth in the stock purchase
units or contracts. The stock purchase units or contracts may provide for settlement by delivery by us or on our behalf of shares
of the underlying security, or they may provide for settlement by reference or linkage to the value, performance or trading price
of the underlying security. The stock purchase units or contracts may be issued separately or as part of stock purchase units consisting
of a stock purchase contract and debt securities, shares of preferred stock or debt obligations of third parties, including U.S.
treasury securities, other stock purchase contracts or common stock, or other securities or property, securing the holders' obligations
to purchase or sell, as the case may be, the shares of common stock, shares of preferred stock, depositary shares or other security
or property under the stock purchase units or contracts. The stock purchase units or contracts may require us to make periodic
payments to the holders of the stock purchase units or vice versa, and such payments may be unsecured or prefunded on some basis
and may be paid on a current or on a deferred basis. The stock purchase units or contracts may require holders to secure their
obligations thereunder in a specified manner and may provide for the prepayment of all or part of the consideration payable by
holders in connection with the purchase of the underlying security or other property pursuant to the stock purchase units or contracts.
The securities related to the stock purchase
units or contracts may be pledged to a collateral agent for our benefit pursuant to a pledge agreement to secure the obligations
of holders of stock purchase units or contracts to purchase the underlying security or property under the related stock purchase
units or contracts. The rights of holders of stock purchase units or contracts to the related pledged securities will be subject
to our security interest therein created by the pledge agreement. No holder of stock purchase units or contracts will be permitted
to withdraw the pledged securities related to such stock purchase units or contracts from the pledge arrangement.
DESCRIPTION OF OUR SUBSCRIPTION RIGHTS
The following is a general description of
the terms of the subscription rights we may issue from time to time. Particular terms of any subscription rights we offer will
be described in the prospectus supplement or free writing prospectus relating to such subscription rights, and may differ from
the terms described herein.
We may issue subscription rights to purchase
our securities. These subscription rights may be issued independently or together with any other security offered hereby and may
or may not be transferable by the stockholder receiving the subscription rights in such offering. In connection with any offering
of subscription rights, we may enter into a standby arrangement with one or more underwriters or other purchasers pursuant to which
the underwriters or other purchasers may be required to purchase any securities remaining unsubscribed for after such offering.
The applicable prospectus supplement will describe
the specific terms of any offering of subscription rights for which this prospectus is being delivered, including the following:
| · | whether common stock, preferred stock, or warrants for those securities
will be offered under the stockholder subscription rights; |
| · | the price, if any, for the subscription rights; |
| · | the exercise price payable for each security upon the exercise of the
subscription rights; |
| · | the number of subscription rights issued to each stockholder; |
| · | the number and terms of the securities which may be purchased per each
subscription right; |
| · | the extent to which the subscription rights are transferable; |
| · | any other terms of the subscription rights, including the terms, procedures
and limitations relating to the exchange and exercise of the subscription rights; |
| · | the date on which the right to exercise the subscription rights shall
commence, and the date on which the subscription rights shall expire; |
| · | the extent to which the subscription rights may include an over-subscription
privilege with respect to unsubscribed securities; |
| · | if appropriate, a discussion of material U.S. federal income tax considerations;
and |
| · | if applicable, the material terms of any standby underwriting or purchase
arrangement entered into by us in connection with the offering of subscription rights. |
The description in the applicable prospectus
supplement of any subscription rights we offer will not necessarily be complete and will be qualified in its entirety by reference
to the applicable subscription rights certificate or subscription rights agreement, which will be filed with the SEC if we offer
subscription rights.
DESCRIPTION OF OUR UNITS
This section outlines some of the provisions
of the units and the unit agreements. This information may not be complete in all respects and is qualified entirely by reference
to the unit agreement with respect to the units of any particular series. The specific terms of any series of units will be described
in the applicable prospectus supplement or free writing prospectus. If so described in a particular prospectus supplement or free
writing prospectus, the specific terms of any series of units may differ from the general description of terms presented below.
As specified in the applicable prospectus supplement,
we may issue units consisting of one or more shares of common stock, shares of preferred stock, debt securities, depositary shares,
warrants, stock purchase units or contracts, subscription rights or any combination of such securities.
The applicable prospectus supplement will specify
the following terms of any units in respect of which this prospectus is being delivered:
| · | the terms of the units and of any of the shares of common stock, shares
of preferred stock, debt securities, warrants, depositary shares, stock purchase units or contracts or subscription rights comprising
the units, including whether and under what circumstances the securities comprising the units may be traded separately; |
| · | a description of the terms of any unit agreement governing the units;
|
| · | if appropriate, a discussion of material U.S. federal income tax considerations;
and |
| · | a description of the provisions for the payment, settlement, transfer
or exchange of the units. |
DESCRIPTION OF CERTAIN PROVISIONS OF DELAWARE
LAW
AND OUR CERTIFICATE OF INCORPORATION AND BY-LAWS
We are organized as a Delaware corporation.
The following is a summary of our certificate of incorporation and by-laws and certain provisions of the Delaware General Corporation
Law, or the DGCL. Because it is a summary, it does not contain all the information that may be important to you. If you want more
information, you should read our entire certificate of incorporation and by-laws, copies of which are filed with the SEC as exhibits
to the registration statement of which this prospectus is a part. See "Where You Can Find More Information," or refer
to the provisions of Delaware law.
Classification of Directors
Our by-laws provide that, except as otherwise
required by specific provisions of the certificate of incorporation relating to the rights of holders of any class or series of
preferred stock to elect additional directors under specified circumstances, the number of our directors may be fixed from time
to time by a resolution adopted by a majority of our board but must not be less than three. Our board is not classified into classes.
At a meeting specifically called for that purpose, a director may be removed by the holders of a majority of the shares then entitled
to vote at an election of directors.
Special Meetings
Special meetings of stockholders may be called
at any time by the Board of Directors, the Chairman of the Board or the President, and shall be called by the President or, in
his absence or disability, by a vice president or by the Secretary upon the written request of the holders of not less than one-tenth
of all the shares entitled to vote at the meeting, such written request to state the purpose or purposes of the meeting and to
be delivered to the president, each vice president, or secretary. Business transacted at any special meeting of stockholders shall
be limited to matters relating to the purpose or purposes stated in the notice of meeting.
Limitation of Liability and Indemnification
Our certificate of incorporation provides that
we shall indemnify our directors and officers to the fullest extent that Delaware law permits. Our certificate of incorporation
also provides that we shall provide indemnification to our employees and agents with the same scope and effect as the indemnification
of our officers and directors. Delaware law permits a corporation to indemnify any director, officer, employee or agent made or
threatened to be made a party to any pending or completed proceeding if the person acted in good faith and in a manner that the
person reasonably believed to be in the best interests of the corporation and, with respect to any criminal proceeding, had no
reasonable cause to believe that his or her conduct was unlawful.
Our certificate of incorporation limits the
liability of our directors to the fullest extent permitted by the DGCL. Delaware law provides that directors will not be personally
liable for monetary damages for breach of their fiduciary duties as directors, except liability for:
| · | any breach of their duty of loyalty to the corporation or its stockholders;
|
| · | acts or omissions not in good faith or which involve intentional misconduct
or a knowing violation of law; |
| · | unlawful payments of dividends or unlawful stock repurchases or redemptions;
or |
| · | any transaction from which the director derived an improper personal
benefit. |
The effect of this provision may be to reduce
the likelihood of derivative litigation against directors for breach of their duty of care, even though the action, if successful,
might otherwise have benefited us and our stockholders. This provision has no effect on any non-monetary remedies that may be available
to us or our stockholders, nor does it relieve us or our officers or directors from compliance with federal or state securities
laws.
As permitted by our certificate of incorporation,
we have purchased and maintain insurance on behalf of our directors and officers for any expense, liability or loss incurred by
them arising out of their actions in that capacity if we would have the power to indemnify such person against such expense, liability
or loss under the DGCL.
Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers or persons controlling the registrant pursuant to the foregoing
provisions, the registrant has been informed that in the opinion of the SEC such indemnification is against public policy and is
therefore unenforceable.
Section 203 of the Delaware General Corporation Law
Section 203 of the DGCL prohibits a defined
set of transactions between a Delaware corporation, such as us, and an "interested stockholder." An interested stockholder
is defined as a person who, together with any affiliates or associates of such person, beneficially owns, directly or indirectly,
15% or more of the outstanding voting stock of a Delaware corporation. This provision may prohibit business combinations between
an interested stockholder and a corporation for a period of three years after the date the interested stockholder becomes an interested
stockholder. The term "business combination" is broadly defined to include mergers, consolidations, sales or other dispositions
of assets having a total value in excess of 10% of the consolidated assets of the corporation, and some other transactions that
would increase the interested stockholder's proportionate share ownership in the corporation.
This prohibition is effective unless:
| · | either the business combination or the transaction that resulted in
the interested stockholder becoming an interested stockholder is approved by our board prior to the time the interested stockholder
becomes an interested stockholder; |
| · | the interested stockholder owns at least 85% of our voting stock, other
than stock held by directors who are also officers or by qualified employee stock plans, upon completion of the transaction in
which it becomes an interested stockholder; or |
| · | the business combination is approved by a majority of our board and
by the affirmative vote of 662/3% of the outstanding voting stock that is not owned by the interested stockholder. |
In general, the prohibitions do not apply to
business combinations with persons who were interested stockholders prior to the corporation becoming subject to Section 203.
LEGAL OWNERSHIP OF SECURITIES
We can issue securities in registered form or
in the form of one or more global securities. We describe global securities in greater detail below. We refer to those persons
who have securities registered in their own names on the books that we or any applicable trustee or depository or warrant agent
maintain for this purpose as the "holders" of those securities. These persons are the legal holders of the securities.
We refer to those persons who, indirectly through others, own beneficial interests in securities that are not registered in their
own names, as "indirect holders" of those securities. As we discuss below, indirect holders are not legal holders, and
investors in securities issued in book-entry form or in street name will be indirect holders.
Book-Entry Holders
We may issue securities in book-entry form only,
as we will specify in the applicable prospectus supplement or free writing prospectus. This means securities may be represented
by one or more global securities registered in the name of a financial institution that holds them as depository on behalf of other
financial institutions that participate in the depository's book-entry system. These participating institutions, which are referred
to as participants, in turn, hold beneficial interests in the securities on behalf of themselves or their customers.
Only the person in whose name a security is
registered is recognized as the holder of that security. Global securities will be registered in the name of the depository or
its participants. Consequently, for global securities, we will recognize only the depository as the holder of the securities, and
we will make all payments on the securities to the depository. The depository passes along the payments it receives to its participants,
which in turn pass the payments along to their customers who are the beneficial owners. The depository and its participants do
so under agreements they have made with one another or with their customers; they are not obligated to do so under the terms of
the securities.
As a result, investors in a global security
will not own securities directly. Instead, they will own beneficial interests in a global security, through a bank, broker or other
financial institution that participates in the depository's book-entry system or holds an interest through a participant. As long
as the securities are issued in global form, investors will be indirect holders, and not holders, of the securities.
Street Name Holders
We may terminate a global security or issue
securities that are not issued in global form. In these cases, investors may choose to hold their securities in their own names
or in "street name." Securities held by an investor in street name would be registered in the name of a bank, broker
or other financial institution that the investor chooses, and the investor would hold only a beneficial interest in those securities
through an account he or she maintains at that institution.
For securities held in street name, we or any
applicable trustee or depository will recognize only the intermediary banks, brokers and other financial institutions in whose
names the securities are registered as the holders of those securities, and we or any such trustee or depository will make all
payments on those securities to them. These institutions pass along the payments they receive to their customers who are the beneficial
owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors
who hold securities in street name will be indirect holders, not holders, of those securities.
Our obligations, as well as the obligations
of any applicable trustee or third party employed by us or a trustee, run only to the legal holders of the securities. We do not
have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect means.
This will be the case whether an investor chooses to be an indirect holder of a security or has no choice because we are issuing
the securities only in global form.
For example, once we make a payment or give
a notice to the holder, we have no further responsibility for the payment or notice even if that holder is required, under agreements
with depository participants or customers or by law, to pass it along to the indirect holders but does not do so. Similarly, we
may want to obtain the approval of the holders to amend an indenture, to relieve us of the consequences of a default or of our
obligation to comply with a particular provision of an indenture, or for other purposes. In such an event, we would seek approval
only from the legal holders, and not the indirect holders, of the securities. Whether and how the holders contact the indirect
holders is up to the legal holders.
Special Considerations For Indirect Holders
If you hold securities through a bank, broker
or other financial institution, either in book-entry form because the securities are represented by one or more global securities
or in street name, you should check with your own institution to find out:
| · | how it handles securities payments and notices; |
| · | whether it imposes fees or charges; |
| · | how it would handle a request for the holders' consent, if ever required;
|
| · | whether and how you can instruct it to send you securities registered
in your own name so you can be a holder, if that is permitted in the future; |
| · | how it would exercise rights under the securities if there were a default
or other event triggering the need for holders to act to protect their interests; and |
| · | if the securities are global securities, how the depository's rules
and procedures will affect these matters. |
Global Securities
A global security is a security which represents
one or any other number of individual securities held by a depository. Generally, all securities represented by the same global
securities will have the same terms.
Each security issued in book-entry form will
be represented by a global security that we issue to, deposit with and register in the name of a financial institution or its nominee
that we select. The financial institution that we select for this purpose is called the depository. Unless we specify otherwise
in the applicable prospectus supplement or free writing prospectus, The Depository Trust Company, New York, New York, known as
DTC, will be the depository for all global securities issued under this prospectus.
A global security may not be transferred to
or registered in the name of anyone other than the depository, its nominee or a successor depository, unless special termination
situations arise. We describe those situations below under "—Special Situations When a Global Security Will Be Terminated."
As a result of these arrangements, the depository, or its nominee, will be the sole registered owner and holder of all securities
represented by a global security, and investors will be permitted to own only beneficial interests in a global security. Beneficial
interests must be held by means of an account with a broker, bank or other financial institution that in turn has an account with
the depository or with another institution that does. Thus, an investor whose security is represented by a global security will
not be a holder of the security, but only an indirect holder of a beneficial interest in the global security.
If the prospectus supplement or free writing
prospectus for a particular security indicates that the security will be issued as a global security, then the security will be
represented by a global security at all times unless and until the global security is terminated. If termination occurs, we may
issue the securities through another book-entry clearing system or decide that the securities may no longer be held through any
book-entry clearing system.
Special Considerations For Global Securities
As an indirect holder, an investor's rights
relating to a global security will be governed by the account rules of the investor's financial institution and of the depository,
as well as general laws relating to securities transfers. We do not recognize an indirect holder as a legal holder of securities
and instead deal only with the depository that holds the global security.
If securities are issued only as a global security,
an investor should be aware of the following:
| · | An investor cannot cause the securities to be registered in his or her
name, and cannot obtain non-global certificates for his or her interest in the securities, except in the special situations we
describe below; |
| · | An investor will be an indirect holder and must look to his or her own
bank or broker for payments on the securities and protection of his or her legal rights relating to the securities, as we describe
above; |
| · | An investor may not be able to sell interests in the securities to some
insurance companies and to other institutions that are required by law to own their securities in non-book-entry form; |
| · | An investor may not be able to pledge his or her interest in the global
security in circumstances where certificates representing the securities must be delivered to the lender or other beneficiary of
the pledge in order for the pledge to be effective; |
| · | The depository's policies, which may change from time to time, will
govern payments, transfers, exchanges and other matters relating to an investor's interest in the global security. We and any applicable
trustee have no responsibility for any aspect of the depository's actions or for its records of ownership interests in the global
security. We and the trustee also do not supervise the depository in any way; |
| · | The depository may, and we understand that DTC will, require that those
who purchase and sell interests in the global security within its book-entry system use immediately available funds, and your broker
or bank may require you to do so as well; and |
| · | Financial institutions that participate in the depository's book-entry
system, and through which an investor holds its interest in the global security, may also have their own policies affecting payments,
notices and other matters relating to the securities. There may be more than one financial intermediary in the chain of ownership
for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries. |
Special Situations When A Global Security Will Be Terminated
In a few special situations described below,
a global security will terminate and interests in it will be exchanged for physical certificates representing those interests.
After that exchange, the choice of whether to hold securities directly or in street name will be up to the investor. Investors
must consult their own banks or brokers to find out how to have their interests in securities transferred to their own name, so
that they will be direct holders. We have described the rights of holders and street name investors above.
A global security will terminate when the following
special situations occur:
| · | if the depository notifies us that it is unwilling, unable or no longer
qualified to continue as depository for that global security and we do not appoint another institution to act as depository within
90 days; |
| · | if we notify any applicable trustee that we wish to terminate that global
security; or |
| · | if an event of default has occurred with regard to securities represented
by that global security and has not been cured or waived. |
The prospectus supplement or free writing prospectus
may also list additional situations for terminating a global security that would apply only to the particular series of securities
covered by the prospectus supplement or free writing prospectus. When a global security terminates, the depository, and not we
or any applicable trustee, is responsible for deciding the names of the institutions that will be the initial direct holders.
PLAN OF DISTRIBUTION
We may sell the securities in and outside the
United States (a) through underwriters or dealers, (b) directly to purchasers, including our affiliates, (c) through
agents or (d) through a combination of any of these methods. The applicable prospectus supplement or free writing prospectus
will include the following information:
| · | the terms of the offering; |
| · | the names of any underwriters or agents; |
| · | the name or names of any managing underwriter or underwriters; |
| · | the purchase price of the securities; |
| · | the net proceeds from the sale of the securities; |
| · | any delayed delivery arrangements; |
| · | any underwriting discounts, commissions and other items constituting
underwriters' compensation; |
| · | any initial public offering price; |
| · | any discounts or concessions allowed or reallowed or paid to dealers;
and |
| · | any commissions paid to agents. |
The sale of the securities may be effected in
transactions (a) on any national or international securities exchange or quotation service on which the securities may be
listed or quoted at the time of sale, (b) in the over-the-counter market, (c) in transactions otherwise than on such
exchanges or in the over-the-counter market or (d) through the writing of options.
The distribution of offered securities may be
effected from time to time in one or more transactions at a fixed price or prices, which may be changed, at market prices prevailing
at the time of sale, at prices related to the market prices, or at negotiated prices.
Sale Through Underwriters or Dealers
If underwriters are used in the sale of any
of these securities, the underwriters will acquire the securities for their own account. The underwriters may resell the securities
from time to time in one or more transactions, including negotiated transactions, at a fixed public offering price or at varying
prices determined at the time of sale. Underwriters may offer securities to the public either through underwriting syndicates represented
by one or more managing underwriters or directly by one or more firms acting as underwriters. Unless we inform you otherwise in
any prospectus supplement or free writing prospectus, the obligations of the underwriters to purchase the securities will be subject
to certain conditions, and the underwriters will be obligated to purchase all the offered securities if they purchase any of them.
We may grant underwriters an option to purchase additional securities to cover over-allotment, if any, or otherwise in connection
with the distribution. The underwriters may change from time to time any initial public offering price and any discounts or concessions
allowed or reallowed or paid to dealers.
Any underwriter may engage in overallotment,
stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation M under the Exchange
Act. Overallotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit
bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. Short covering transactions
involve purchases of the securities in the open market after the distribution is completed to cover short positions. Penalty bids
permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased
in a covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it
would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time.
Any underwriters who are qualified market makers
on NASDAQ (or any exchange or quotation system on which our securities are listed) may engage in passive market making transactions
in our common stock, preferred stock, debt securities, warrants, depositary shares, stock purchase units or contracts, subscription
rights or units, as applicable, on NASDAQ in accordance with Rule 103 of Regulation M, during the business day prior
to the pricing of the offering, before the commencement of offers or sales of the securities. Passive market makers must comply
with applicable volume and price limitations and must be identified as passive market makers. In general, a passive market maker
must display its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered
below the passive market maker's bid, however, the passive market maker's bid must then be lowered when certain purchase limits
are exceeded.
Some or all of the securities that we offer
though this prospectus may be new issues of securities with no established trading market. Any underwriters to whom we sell these
securities for public offering and sale may make a market in those securities, but they will not be obligated to and they may discontinue
any market making at any time without notice. Accordingly, we cannot assure you of the liquidity of, or continued trading markets
for, any securities that we offer.
If dealers are used in the sale of securities,
we will sell the securities to them as principals. They may then resell those securities to the public at varying prices determined
by the dealers at the time of resale. We will include in the prospectus supplement or free writing prospectus the names of the
dealers and the terms of the transaction.
Direct Sales and Sales Through Agents
We may sell the securities directly, and not
through underwriters or agents. We may also sell the securities through agents designated from time to time. In the prospectus
supplement or free writing prospectus, we will name any agent involved in the offer or sale of the offered securities, and we will
describe any commissions payable to the agent. Unless we inform you otherwise in the prospectus supplement or free writing prospectus,
any agent will agree to use its reasonable best efforts to solicit purchases for the period of its appointment.
We may sell the securities directly to institutional
investors or others who may be deemed to be underwriters within the meaning of the Securities Act with respect to any sale of those
securities. We will describe the terms of any such sales in the prospectus supplement or free writing prospectus.
We may enter into derivative transactions with
third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the
applicable prospectus supplement or free writing prospectus indicates, in connection with those derivatives, the third parties
may sell securities covered by this prospectus and the applicable prospectus supplement or free writing prospectus, including in
short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those
sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives
to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and, if not
identified in this prospectus, will be identified in the applicable prospectus supplement or free writing prospectus (or a post-effective
amendment).
Delayed Delivery Contracts
If we so indicate in the prospectus supplement
or free writing prospectus, we may authorize agents, underwriters or dealers to solicit offers from certain types of institutions
to purchase securities from us at the public offering price under delayed delivery contracts. These contracts would provide for
payment and delivery on a specified date in the future. The contracts would be subject only to those conditions described in the
prospectus supplement or free writing prospectus. The prospectus supplement or free writing prospectus will describe any commission
payable for solicitation of those contracts.
Subscription Offerings
Direct sales to investors or our stockholders
may be accomplished through subscription offerings or through subscription rights distributed to stockholders. In connection with
subscription offerings or the distribution of subscription rights to stockholders, if all of the underlying securities are not
subscribed for, we may sell any unsubscribed securities to third parties directly or through underwriters or agents. In addition,
whether or not all of the underlying securities are subscribed for, we may concurrently offer additional securities to third parties
directly or through underwriters or agents. If securities are to be sold through subscription rights, the subscription rights will
be distributed as a dividend to the stockholders for which they will pay no separate consideration.
General Information
We may have agreements with the agents, dealers
and underwriters to indemnify them against certain civil liabilities, including liabilities under the Securities Act, or to contribute
with respect to payments that the agents, dealers or underwriters may be required to make. Agents, dealers and underwriters may
be customers of, engage in transactions with or perform services for us in the ordinary course of their businesses.
LEGAL MATTERS
Certain legal matters with respect to the securities
offered hereby have been passed upon by Goodwin Procter LLP, Boston, Massachusetts.
EXPERTS
The consolidated financial statements and the effectiveness
of internal control over financial reporting incorporated in this Prospectus by reference to the Annual Report on Form 10-K for
the year ended December 31, 2013, have been audited by SingerLewak LLP, an independent registered public accounting firm, as stated
in their reports incorporated by reference herein, and have been so incorporated in reliance upon such reports and upon the authority
of such firm as experts in accounting and auditing.
The report of SingerLewak LLP dated April, 2014, on the effectiveness
of internal control over financial reporting as of December 31, 2013, expressed an opinion that Advanced Cell Technology, Inc.
and Subsidiary had not maintained effective internal control over financial reporting as of December 31, 2013, based on criteria
established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the
Treadway Commission in 2013.
DOCUMENTS INCORPORATED BY REFERENCE
The SEC allows us to "incorporate by reference"
the information we file with it, which means that we can disclose important information to you by referring you to those documents.
The information we incorporate by reference is considered part of this prospectus. Statements in this prospectus regarding the
contents of any contract or other document may not be complete. You should refer to the copy of the contract or other document
filed as an exhibit to the registration statement. Later information filed with the SEC will update and supersede information we
have included or incorporated by reference in this prospectus.
We incorporate by reference the documents listed
below, which have been filed with the SEC (other than Current Reports or portions thereof furnished under Item 2.02 or Item 7.01
of Form 8-K):
1. Our Annual Report on
Form 10-K for the fiscal year ended December 31, 2013; as amended;
2. Our Quarterly Reports on Form 10-Q for the fiscal
quarters ended March 31, 2014 and June 30, 2014;
3. Our Current Reports on Form 8-K as filed on January
22, 2014, March 10, 2014, April 21, 2014, May 5, 2014, May 29, 2014, June 6, 2014, June 24, 2014, July 3, 2014, August 6, 2014,
August 27, 2014, September 23, 2014 and October 6, 2014; and
4.
The description of our common stock, which is registered under Section 12 of the Exchange Act, contained
in our registration statement on Form 8-A filed with the SEC on May 28, 2003, including any amendment or report filed for the purpose
of updating such descriptions.
We also incorporate by reference any filings
made after the date of the initial filing of the registration statement of which this prospectus forms a part including filings
made prior to the effectiveness of the registration statement, made with the SEC under Sections 13(a), 13(c), 14 or 15(d)
of the Securities Exchange Act of 1934 until the offering of the securities made by this prospectus is completed or terminated.
We will provide without charge to each person,
including any beneficial owner, to whom this prospectus is delivered, upon the written or oral request of that person, a copy of
any and all of the information that has been incorporated in this prospectus by reference other than exhibits unless those exhibits
are specifically incorporated by reference into the documents. Requests for these copies should be directed to our investor relations
department at the following address and telephone number: Advanced Cell Technology, Inc., 33 Locke Dr., Marlborough, MA 01752;
(508) 756-1212.
WHERE YOU CAN FIND MORE INFORMATION
We file reports, proxy statements and other
information with the SEC. You may read and copy the reports, proxy statements and other information that we file with the SEC at
the SEC's Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for information
about the operation of its Public Reference Room and for its prescribed rates to obtain copies of such material. The SEC also maintains
an Internet site that contains reports, proxy and information statements and other information regarding registrants, like us,
that file electronically with the SEC. The address of the SEC's Internet site is http://www.sec.gov. Our Internet site is
http://www.advancedcell.com. Information contained on our Internet site is not a part of this prospectus.
This prospectus provides you with a general
description of the common stock, preferred stock, debt securities, warrants, depositary shares, stock purchase units or contracts,
subscription rights and units being registered. This prospectus is part of a registration statement that we have filed with the
SEC. To see more detail, you should read the registration statement and the exhibits and schedules filed with, or incorporated
by reference into, our registration statement.
This registration statement, including the exhibits
contained or incorporated by reference therein, can be read at the SEC web site or at the SEC office referred to above. Any statement
made or incorporated by reference in this prospectus concerning the contents of any contract, agreement or other document is only
a summary of the actual contract, agreement or other document. If we have filed or incorporated by reference any contract, agreement
or other document as an exhibit to the registration statement, you should read the exhibit for a more complete understanding of
the document or matter involved. Each statement regarding a contract, agreement or other document is qualified in its entirety
by reference to the actual document.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance
and Distribution.
The following table sets forth the various expenses
to be incurred in connection with the sale and distribution of the securities being registered hereby, all of which will be borne
by Advanced Cell Technology:
|
|
|
|
|
SEC Registration Fee |
|
$ |
11,620 |
|
NASDAQ Fees |
|
$ |
|
* |
Transfer Agent Fees |
|
$ |
|
* |
Legal Fees and Expenses |
|
$ |
|
* |
Accounting Fees and Expenses |
|
$ |
|
* |
Printing and Miscellaneous Fees |
|
$ |
|
* |
|
|
|
|
Total |
|
$ |
|
* |
* These fees are calculated based on the securities offered
and the number of issuances and accordingly, cannot be estimated at this time.
Item 15. Indemnification of Directors
and Officers.
Section 145 of the General Corporation
Law of Delaware, or the DGCL, empowers a corporation to indemnify any person who was or is a party or is threatened to be made
a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative,
by reason of the fact that he or she is or was a director, officer, employee or agent of the corporation or another enterprise
if serving at the request of the corporation. Depending on the character of the proceeding, a corporation may indemnify against
expenses (including attorney's fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection
with such action, suit or proceeding if the person indemnified acted in good faith and in a manner he or she reasonably believed
to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his or her conduct was unlawful. In the case of an action by or in the right of the corporation, no
indemnification may be made in respect to any claim, issue or matter as to which such person shall have been adjudged to be liable
to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought
shall determine that despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly
and reasonably entitled to indemnity for such expenses that the court shall deem proper. Section 145 further provides that
to the extent a present or former director or officer of a corporation has been successful in the defense of any action, suit or
proceeding referred to above, or in defense of any claim, issue or matter therein, he or she shall be indemnified against expenses
(including attorney's fees) actually and reasonably incurred by him or her in connection therewith.
The registrant's certificate of incorporation,
as amended, provides that the registrant shall, to the fullest extent permitted by the DGCL, indemnify any director or officer
which it shall have the power to indemnify under the DGCL against any expenses, liabilities, or other matters referred to in or
covered by Section 145 of the DGCL. This indemnification continues after such person ceases to be a director or officer and
inures to the benefit of the heirs, executors and administrators of said person. The registrant shall not be required to indemnify
a person in connection with such action, suit or proceeding initiated by such person if it was not authorized by the registrant's
board except under limited circumstances. The certificate of incorporation also provides that the right to indemnification includes
the right to be paid by the registrant for the expenses incurred in defending any such proceeding in advance of its final disposition;
provided, however, that the payment of such expenses incurred by a director or officer in advance of the final disposition of a
proceeding shall be made only upon delivery by the registrant of an undertaking, by or on behalf of such director or officer, to
repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified
under the certificate of incorporation or otherwise. The certificate of incorporation provides that the registrant, by action of
its board, may provide indemnification to employees and agents of the registrant with the same scope and effect as the indemnification
of directors and officers. The certificate of incorporation also contains a provision eliminating the liability of directors of
the registrant to the registrant or its stockholders for monetary damage, to the fullest extent permitted by law. The certificate
of incorporation also permits the registrant to purchase and maintain insurance to protect itself and any director, officer, employee
or agent against any expense, liability, or loss incurred by him or her if the registrant would have the power to indemnify such
persons against such expense, liability or loss under the DGCL. The certificate of incorporation also permits the registrant to
enter into agreements with any director, officer, employee or agent providing for indemnification rights equivalent to or greater
than the indemnification rights set forth in the certificate of incorporation. The registrant has entered into indemnification
agreements with all of its directors and executive officers and maintains insurance for each director and executive officer.
Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers or persons controlling the registrant pursuant to the foregoing
provisions, the registrant has been informed that in the opinion of the SEC such indemnification is against public policy as expressed
in the Securities Act and is therefore unenforceable.
Item 16. Exhibits.
The following exhibits are filed as part of
this registration statement:
Exhibit No. |
|
Description of Documents |
|
*1.1 |
|
Form of Underwriting Agreement. |
|
3.1 |
|
Certificate of Incorporation of the Registrant dated November 17, 2005 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on November 21, 2005 and incorporated by reference herein). |
|
3.2 |
|
Certificate of Amendment to Certificate of Incorporation dated October 13, 2006 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K on October 13, 2006 and incorporated herein by reference). |
|
3.3 |
|
Certificate of the Powers, Designations, Preferences and Rights of the Series A-1 Convertible Preferred Stock dated March 5, 2009 (previously filed as Exhibit 4.1 to the Registrant’s Quarterly Report on Form 10-Q filed on July 20, 2009 and incorporated herein by reference). |
|
3.4 |
|
Certificate of Amendment to Certificate of Incorporation dated September 15, 2009 (previously filed as Exhibit 3.15 to the Registrant’s Registration Statement on Form S-1 filed November 18, 2009 and incorporated herein by reference). |
|
3.5 |
|
Certificate of Amendment to Certificate of Incorporation dated January 24, 2012 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on January 30, 2012 and incorporated herein by reference). |
|
3.6 |
|
Certificate of Amendment to Certificate of Incorporation dated October 24, 2013 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on October 24, 2013 and incorporated herein by reference). |
|
3.7 |
|
Certificate of Amendment to Certificate of Incorporation dated August 27, 2014 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on August 27, 2014 and incorporated herein by reference). |
|
**3.8 |
|
Form of Certificate of Amendment to Certificate of Incorporation, to be voted upon by the Registrant’s stockholders on November 12, 2014. |
|
3.9 |
|
Bylaws of the Registrant (previously filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on November 21, 2005 and incorporated by reference herein). |
|
3.10 |
|
Amendment No. 1 to Bylaws of the Registrant (previously filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on November 30, 2007 and incorporated by reference herein). |
|
4.1 |
|
Reference is made to Exhibits 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8 and 3.9 |
|
4.2 |
|
Specimen Stock Certificate (previously filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed on November 21, 2005 and incorporated by reference herein). |
|
*4.3 |
|
Form of Certificate of Designation of Preferred Stock. |
|
*4.4 |
|
Form of Preferred Stock Certificate. |
|
**4.5 |
|
Form of Senior Indenture between Registrant and one or more trustees to be named |
|
**4.6 |
|
Form of Subordinated Indenture between Registrant and one or more trustees to be named. |
|
*4.7 |
|
Form of Senior Note. |
|
*4.8 |
|
Form of Subordinated Note. |
|
**4.9 |
|
Form of Common Stock Warrant Agreement and Warrant Certificate. |
|
**4.10 |
|
Form of Preferred Stock Warrant Agreement and Warrant Certificate. |
|
**4.11 |
|
Form of Debt Securities Warrant Agreement and Warrant Certificate. |
|
*4.12 |
|
Form of Stock Purchase Unit or Contract Agreement. |
|
*4.13 |
|
Form of Deposit Agreement relating to the depositary shares (including form of depositary receipt). |
|
*4.14 |
|
Form of Unit Certificate. |
|
**5.1 |
|
Opinion of Goodwin Procter LLP as to the legality of the securities being registered. |
|
**12.1 |
|
Statement Regarding Computation of Ratio of Earnings to Combined Fixed Charges and Preference Dividends |
|
**23.1 |
|
Consent of SingerLewak LLP, independent registered public accounting firm. |
|
**23.2 |
|
Consent of Goodwin Procter LLP (included in Exhibit 5.1). |
|
**24 |
|
Powers of Attorney (included in the signature pages of this registration statement). |
|
***25.1 |
|
Statement of Eligibility of Trustee on Form T-1 under the Senior Debt Indenture. |
|
***25.2 |
|
Statement of Eligibility of Trustee on Form T-1 under the Subordinated Debt Indenture. |
* To be filed by amendment or incorporated by reference in connection
with the offering of any securities, as appropriate.
** Filed herewith.
*** To be filed as an exhibit to a Current Report on Form 8-K
or pursuant to Rule 305(b)(2) of the Trust Indenture Act and incorporated herein by reference.
Item 17. Undertakings.
(a) The undersigned registrant hereby undertakes:
(1) To file, during any period in which
offers or sales are being made, a post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually
or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would
not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the "Calculation
of Registration Fee" table in the effective registration statement;
(iii) To include any material information with respect to
the plan of distribution not previously disclosed in the registration statement or any material change to such information in the
registration statement;
provided, however, that paragraphs (1)(i), (1)(ii)
and (1)(iii) do not apply if the registration statement is on Form S-3 or Form F-3 and the information required to be
included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant
pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement,
or is contained in a form of prospectus filed pursuant to Rule 424(b) that is a part of this registration statement.
(2) That, for the purpose of determining any liability
under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of the offering.
(4) That, for the purpose of determining
liability under the Securities Act to any purchaser:
(i) Each prospectus filed by the registrant pursuant to
Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part
of and included in the registration statement; and
(ii)Each prospectus required to be filed pursuant to Rule 424(b)(2),
(b)(5), or (b)(7) as part of this registration statement or in reliance on Rule 430B relating to an offering made pursuant
to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the
Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form
of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described
in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter,
such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration
statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus
that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract or sale prior
to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part
of the registration statement or made in any such document immediately prior to such effective date; or
(5) That, for the purpose of determining liability of
the registrant under the Securities Act to any purchaser in the initial distribution of the securities:
The undersigned registrant undertakes
that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the
underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means
of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to
offer or sell such securities to such purchaser:
| (i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant
to Rule 424; |
| (ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred
to by the undersigned registrant; |
| (iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the undersigned registrant; and |
|
(iv) |
Any other communication that is an offer in the offering
made by the undersigned registrant to the purchaser. |
(b) The undersigned registrant hereby undertakes that, for purposes of determining
any liability under the Securities Act, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d)
of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d)
of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.
(c) The undersigned registrant hereby undertakes that:
(1) For purposes of determining liability under the Securities
Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A
and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities
Act shall be deemed to be part of this registration statement as of the time it was declared effective.
(2) For the purpose of determining any liability under
the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(d) The undersigned registrant hereby undertakes to file an application
for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust
Indenture Act (the "Act") in accordance with the rules and regulations prescribed by the SEC under Section 305(b)(2)
of the Act.
(e) Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling person of the registrant pursuant to Item 15, or otherwise,
the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other
than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the city of Marlborough, the Commonwealth of Massachusetts, on this 14th day of October, 2014.
|
ADVANCED CELL TECHNOLOGY, INC.,
a Delaware corporation |
|
|
|
By: /s/ Paul K. Wotton |
|
Paul K. Wotton President and Chief Executive Officer |
POWER OF ATTORNEY
We,
the undersigned officers and directors of Advanced Cell Technology, Inc. hereby severally constitute and appoint Paul K. Wotton
and Edward Myles, and each of them singly, our true and lawful attorneys, with full power to them and each of them singly, to sign
for us in our names in the capacities indicated below, any and all amendments (including post-effective amendments) to this registration
statement on Form S-3, and to file the same with the Securities and Exchange Commission, and generally to do all such things
in our names and on our behalf in our capacities as officers and directors to enable Advanced Cell Technology, Inc. to comply
with the provisions of the Securities Act, and all requirements of the Securities and Exchange Commission, hereby ratifying and
confirming our signatures as they may be signed by our said attorneys, or any of them, to said registration statement and any and
all amendments thereto.
Pursuant
to the requirements of the Securities Act of 1933, as amended, this registration statement on Form S-3 has been signed by
the following persons in the capacities and on the dates indicated. following persons in the capacities and on the dates
indicated.
/s/ Paul K. Wotton |
|
|
Paul
K. Wotton Chief Executive Officer and President
(Principal Executive Officer) |
|
October 14,
2014 |
|
|
|
/s/ Edward Myles |
|
|
Edward Myles |
|
October 14,
2014 |
Chief Operating Officer and Chief Financial Officer (Principal Financial and Accounting Officer) |
|
|
|
|
|
/s/ Robert Langer |
|
|
Robert Langer
Director |
|
October
14, 2014 |
|
|
|
/s/ Zohar Loshitzer |
|
|
Zohar Loshitzer
Director |
|
October 14, 2014 |
|
|
|
/s/ Gregory D. Perry |
|
|
Gregory D. Perry
Director |
|
October 14, 2014 |
|
|
|
/s/ Alan C. Shapiro |
|
|
Alan C. Shapiro
Director |
|
October 14, 2014 |
|
|
|
/s/ Michael T. Heffernan |
|
|
Michael T. Heffernan
Director and Chairman |
|
October 14,
2014 |
EXHIBIT INDEX
Exhibit No. |
|
Description of Documents |
|
*1.1 |
|
Form of Underwriting Agreement. |
|
3.1 |
|
Certificate of Incorporation of the Registrant dated November 17, 2005 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on November 21, 2005 and incorporated by reference herein). |
|
3.2 |
|
Certificate of Amendment to Certificate of Incorporation dated October 13, 2006 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K on October 13, 2006 and incorporated herein by reference). |
|
3.3 |
|
Certificate of the Powers, Designations, Preferences and Rights of the Series A-1 Convertible Preferred Stock dated March 5, 2009 (previously filed as Exhibit 4.1 to the Registrant’s Quarterly Report on Form 10-Q filed on July 20, 2009 and incorporated herein by reference). |
|
3.4 |
|
Certificate of Amendment to Certificate of Incorporation dated September 15, 2009 (previously filed as Exhibit 3.15 to the Registrant’s Registration Statement on Form S-1 filed November 18, 2009 and incorporated herein by reference). |
|
3.5 |
|
Certificate of Amendment to Certificate of Incorporation dated January 24, 2012 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on January 30, 2012 and incorporated herein by reference). |
|
3.6 |
|
Certificate of Amendment to Certificate of Incorporation dated October 24, 2013 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on October 24, 2013 and incorporated herein by reference). |
|
3.7 |
|
Certificate of Amendment to Certificate of Incorporation dated August 27, 2014 (previously filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on August 27, 2014 and incorporated herein by reference). |
|
**3.8 |
|
Form of Certificate of Amendment to Certificate of Incorporation, to be voted upon by the Registrant’s stockholders on November 12, 2014. |
|
3.9 |
|
Bylaws of the Registrant (previously filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on November 21, 2005 and incorporated by reference herein). |
|
3.10 |
|
Amendment No. 1 to Bylaws of the Registrant (previously filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on November 30, 2007 and incorporated by reference herein). |
|
4.1 |
|
Reference is made to Exhibits 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, and 3.8 |
|
4.2 |
|
Specimen Stock Certificate (previously filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed on November 21, 2005 and incorporated by reference herein). |
|
*4.3 |
|
Form of Certificate of Designation of Preferred Stock. |
|
*4.4 |
|
Form of Preferred Stock Certificate. |
|
**4.5 |
|
Form of Senior Indenture between Registrant and one or more trustees to be named |
|
**4.6 |
|
Form of Subordinated Indenture between Registrant and one or more trustees to be named. |
|
*4.7 |
|
Form of Senior Note. |
|
*4.8 |
|
Form of Subordinated Note. |
|
**4.9 |
|
Form of Common Stock Warrant Agreement and Warrant Certificate. |
|
**4.10 |
|
Form of Preferred Stock Warrant Agreement and Warrant Certificate. |
|
**4.11 |
|
Form of Debt Securities Warrant Agreement and Warrant Certificate. |
|
*4.12 |
|
Form of Stock Purchase Unit or Contract Agreement. |
|
*4.13 |
|
Form of Deposit Agreement relating to the depositary shares (including form of depositary receipt). |
|
*4.14 |
|
Form of Unit Certificate. |
|
**5.1 |
|
Opinion of Goodwin Procter LLP as to the legality of the securities being registered. |
|
**12.1 |
|
Statement Regarding Computation of Ratio of Earnings to Combined Fixed Charges and Preference Dividends |
|
**23.1 |
|
Consent of SingerLewak LLP, independent registered public accounting firm. |
|
**23.2 |
|
Consent of Goodwin Procter LLP (included in Exhibit 5.1). |
|
**24 |
|
Powers of Attorney (included in the signature pages of this registration statement). |
|
***25.1 |
|
Statement of Eligibility of Trustee on Form T-1 under the Senior Debt Indenture. |
|
***25.2 |
|
Statement of Eligibility of Trustee on Form T-1 under the Subordinated Debt Indenture. |
* To be filed by amendment or incorporated by reference in connection
with the offering of any securities, as appropriate.
** Filed herewith.
*** To be filed as an exhibit to a Current Report on Form 8-K
or pursuant to Rule 305(b)(2) of the Trust Indenture Act and incorporated herein by reference.
Exhibit 3.8
Certificate of Amendment
of
Certificate of Incorporation
of
Advanced Cell Technology, Inc.
Under Section 242 of the Delaware General
Corporation Law
Advanced Cell Technology,
Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”) hereby certifies
as follows:
1. The Certificate of Incorporation of
the Corporation is hereby amended by changing Article V, Section 1 so that, as amended, said Article V, Section 1 shall be and
read as follows:
|
Section 1. Number of Authorized Shares. The total number of shares of stock which the Corporation shall have the authority to issue shall be One Hundred Ten Million (110,000,000) shares. The Corporation shall be authorized to issue two classes of shares of stock, designated “Common Stock” and “Preferred Stock.” The Corporation shall be authorized to issue Sixty Million (60,000,000) shares of Common Stock, each share to have a par value of $.001 per share, and Fifty Million (50,000,000) shares of Preferred Stock, each share to have a par value of $.001 per share. |
2. The foregoing amendment has been duly
adopted in accordance with the provisions of Section 242 of the General Corporation law of the State of Delaware by the vote of
a majority of each class of outstanding stock of the Corporation entitled to vote thereon.
Exhibit 4.5
ADVANCED CELL TECHNOLOGY, INC.
Issuer
AND
[TRUSTEE],
Trustee
INDENTURE
Dated as of [·],
201[·]
Senior Debt Securities
TABLE OF CONTENTS
|
|
PAGE |
|
|
|
ARTICLE 1 DEFINITIONS |
1 |
|
|
|
Section 1.01 |
Definitions of Terms |
1 |
|
|
|
ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES |
4 |
|
|
|
Section 2.01 |
Designation and Terms of Securities |
4 |
|
|
|
Section 2.02 |
Form of Securities and Trustee’s Certificate |
6 |
|
|
|
Section 2.03 |
Denominations: Provisions for Payment |
6 |
|
|
|
Section 2.04 |
Execution and Authentications |
7 |
|
|
|
Section 2.05 |
Registration of Transfer and Exchange |
7 |
|
|
|
Section 2.06 |
Temporary Securities |
8 |
|
|
|
Section 2.07 |
Mutilated, Destroyed, Lost or Stolen Securities |
8 |
|
|
|
Section 2.08 |
Cancellation |
8 |
|
|
|
Section 2.09 |
Benefits of Indenture |
9 |
|
|
|
Section 2.10 |
Authenticating Agent |
9 |
|
|
|
Section 2.11 |
Global Securities |
9 |
|
|
|
ARTICLE 3 REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS |
10 |
|
|
|
Section 3.01 |
Redemption |
10 |
|
|
|
Section 3.02 |
Notice of Redemption |
10 |
|
|
|
Section 3.03 |
Payment Upon Redemption |
10 |
|
|
|
Section 3.04 |
Sinking Fund |
11 |
|
|
|
Section 3.05 |
Satisfaction of Sinking Fund Payments with Securities |
11 |
|
|
|
Section 3.06 |
Redemption of Securities for Sinking Fund |
11 |
|
|
|
ARTICLE 4 COVENANTS |
11 |
|
|
|
Section 4.01 |
Payment of Principal, Premium and Interest |
11 |
|
|
|
Section 4.02 |
Maintenance of Office or Agency |
12 |
|
|
|
Section 4.03 |
Paying Agents |
12 |
|
|
|
Section 4.04 |
Appointment to Fill Vacancy in Office of Trustee |
12 |
|
|
|
Section 4.05 |
Compliance with Consolidation Provisions |
13 |
|
|
|
ARTICLE 5 SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE |
13 |
|
|
|
|
PAGE |
|
|
|
Section 5.01 |
Company to Furnish Trustee Names and Addresses of Securityholders |
13 |
|
|
|
Section 5.02 |
Preservation Of Information; Communications With Securityholders |
13 |
|
|
|
Section 5.03 |
Reports by the Company |
13 |
|
|
|
Section 5.04 |
Reports by the Trustee |
14 |
|
|
|
ARTICLE 6 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT |
14 |
|
|
|
Section 6.01 |
Events of Default |
14 |
|
|
|
Section 6.02 |
Collection of Indebtedness and Suits for Enforcement by Trustee |
15 |
|
|
|
Section 6.03 |
Application of Moneys Collected |
16 |
|
|
|
Section 6.04 |
Limitation on Suits |
16 |
|
|
|
Section 6.05 |
Rights and Remedies Cumulative; Delay or Omission Not Waiver |
16 |
|
|
|
Section 6.06 |
Control by Securityholders |
17 |
|
|
|
Section 6.07 |
Undertaking to Pay Costs |
17 |
|
|
|
ARTICLE 7 CONCERNING THE TRUSTEE |
17 |
|
|
|
Section 7.01 |
Certain Duties and Responsibilities of Trustee |
17 |
|
|
|
Section 7.02 |
Certain Rights of Trustee |
18 |
|
|
|
Section 7.03 |
Trustee Not Responsible for Recitals or Issuance or Securities |
19 |
|
|
|
Section 7.04 |
May Hold Securities |
19 |
|
|
|
Section 7.05 |
Moneys Held in Trust |
19 |
|
|
|
Section 7.06 |
Compensation and Reimbursement |
19 |
|
|
|
Section 7.07 |
Reliance on Officer’s Certificate |
20 |
|
|
|
Section 7.08 |
Disqualification; Conflicting Interests |
20 |
|
|
|
Section 7.09 |
Corporate Trustee Required; Eligibility |
20 |
|
|
|
Section 7.10 |
Resignation and Removal; Appointment of Successor |
20 |
|
|
|
Section 7.11 |
Acceptance of Appointment By Successor |
21 |
|
|
|
Section 7.12 |
Merger, Conversion, Consolidation or Succession to Business |
22 |
|
|
|
Section 7.13 |
Preferential Collection of Claims Against the Company |
22 |
|
|
|
Section 7.14 |
Notice of Default |
22 |
ARTICLE 8 CONCERNING THE
SECURITYHOLDERS |
22 |
|
|
|
Section 8.01 |
Evidence of Action by Securityholders |
22 |
|
|
|
|
|
PAGE |
Section 8.02 |
Proof of Execution by Securityholders |
23 |
|
|
|
Section 8.03 |
Who May be Deemed Owners |
23 |
|
|
|
Section 8.04 |
Certain Securities Owned by Company Disregarded |
23 |
|
|
|
Section 8.05 |
Actions Binding on Future Securityholders |
23 |
|
|
|
ARTICLE 9 SUPPLEMENTAL INDENTURES |
24 |
|
|
|
Section 9.01 |
Supplemental Indentures Without the Consent of Securityholders |
24 |
|
|
|
Section 9.02 |
Supplemental Indentures With Consent of Securityholders |
24 |
|
|
|
Section 9.03 |
Effect of Supplemental Indentures |
25 |
|
|
|
Section 9.04 |
Securities Affected by Supplemental Indentures |
25 |
|
|
|
Section 9.05 |
Execution of Supplemental Indentures |
25 |
|
|
|
ARTICLE 10 SUCCESSOR ENTITY |
25 |
|
|
|
Section 10.01 |
Company May Consolidate, Etc. |
25 |
|
|
|
Section 10.02 |
Successor Entity Substituted |
26 |
|
|
|
ARTICLE 11 SATISFACTION AND DISCHARGE |
26 |
|
|
|
Section 11.01 |
Satisfaction and Discharge of Indenture |
26 |
|
|
|
Section 11.02 |
Discharge of Obligations |
26 |
|
|
|
Section 11.03 |
Deposited Moneys to be Held in Trust |
27 |
|
|
|
Section 11.04 |
Payment of Moneys Held by Paying Agents |
27 |
|
|
|
Section 11.05 |
Repayment to Company |
27 |
|
|
|
ARTICLE 12 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS |
27 |
|
|
|
Section 12.01 |
No Recourse |
27 |
|
|
|
ARTICLE 13 MISCELLANEOUS PROVISIONS |
27 |
|
|
|
Section 13.01 |
Effect on Successors and Assigns |
27 |
|
|
|
Section 13.02 |
Actions by Successor |
27 |
|
|
|
Section 13.03 |
Surrender of Company Powers |
28 |
|
|
|
Section 13.04 |
Notices |
28 |
|
|
|
Section 13.05 |
Governing Law |
28 |
|
|
|
Section 13.06 |
Treatment of Securities as Debt |
28 |
|
|
|
Section 13.07 |
Certificates and Opinions as to Conditions Precedent |
28 |
|
|
PAGE |
|
|
|
Section 13.08 |
Payments on Business Days |
28 |
|
|
|
Section 13.09 |
Conflict with Trust Indenture Act |
28 |
|
|
|
Section 13.10 |
Counterparts |
29 |
|
|
|
Section 13.11 |
Separability |
29 |
|
|
|
Section 13.12 |
Compliance Certificates |
29 |
(1)
This Table of Contents does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of
its terms or provisions.
INDENTURE
INDENTURE, dated as of [·],
201 , among ADVANCED CELL TECHNOLOGY, INC., a Delaware corporation (the “Company”), and[TRUSTEE],
as trustee (the “Trustee”):
WHEREAS, for its lawful corporate purposes,
the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter
referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one
or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate
of the Trustee;
WHEREAS, to provide the terms and conditions
upon which the Securities are to be authenticated, issued and delivered, the Company has duly authorized the execution of this
Indenture; and
WHEREAS, all things necessary to make
this Indenture a valid agreement of the Company, in accordance with its terms, have been done.
NOW, THEREFORE, in consideration of the
premises and the purchase of the Securities by the holders thereof, it is mutually covenanted and agreed as follows for the equal
and ratable benefit of the holders of Securities:
ARTICLE 1
DEFINITIONS
Section 1.01
Definitions of Terms.
The terms defined in this Section (except
as in this Indenture or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires)
for all purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this
Section and shall include the plural as well as the singular. All other terms used in this Indenture that are defined
in the Trust Indenture Act of 1939, as amended, or that are by reference in such Act defined in the Securities Act of 1933, as
amended (except as herein or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires),
shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date of
the execution of this instrument.
“Authenticating Agent”
means an authenticating agent with respect to all or any of the series of Securities appointed by the Trustee pursuant to Section 2.10.
“Bankruptcy Law” means
Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.
“Board of Directors”
means the Board of Directors (or the functional equivalent thereof) of the Company or any duly authorized committee of such Board.
“Board Resolution”
means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the
Board of Directors and to be in full force and effect on the date of such certification.
“Business Day” means,
with respect to any series of Securities, any day other than a day on which federal or state banking institutions in the Borough
of Manhattan, the City of New York, or in the city of the Corporate Trust Office of the Trustee, are authorized or obligated by
law, executive order or regulation to close.
“Certificate” means
a certificate signed by any Officer. The Certificate need not comply with the provisions of Section 13.07.
“Commission” means
the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act, or, if at any time after
the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture
Act, then the body performing such duties at such time.
“Company” means Advanced
Cell Technology, Inc., a corporation duly organized and existing under the laws of the State of Delaware, and, subject to
the provisions of Article Ten, shall also include its successors and assigns.
“Corporate Trust Office”
means the office of the Trustee at which, at any particular time, its corporate trust business shall be principally administered,
which office at the date hereof is located at .
“Custodian” means
any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.
“Defaulted Interest”
has the meaning set forth in Section 2.03.
“Depositary” means,
with respect to Securities of any series for which the Company shall determine that such Securities will be issued as a Global
Security, The Depository Trust Company, another clearing agency, or any successor registered as a clearing agency under the Exchange
Act, or other applicable statute or regulation, which, in each case, shall be designated by the Company pursuant to either Section 2.01
or 2.11.
“Event of Default”
means, with respect to Securities of a particular series, any event specified in Section 6.01, continued for the period of
time, if any, therein designated.
“Exchange Act” means
the United States Securities and Exchange Act of 1934, as amended, and the rules and regulations promulgated by the Commission
thereunder.
“Global Security”
means a Security issued to evidence all or a part of any series of Securities which is executed by the Company and authenticated
and delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction, all in accordance with the Indenture,
which shall be registered in the name of the Depositary or its nominee.
“Governmental Obligations”
means securities that are (a) direct obligations of the United States of America for the payment of which its full faith and
credit is pledged or (b) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of
the United States of America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United
States of America that, in either case, are not callable or redeemable at the option of the issuer thereof at any time prior to
the stated maturity of the Securities, and shall also include a depositary receipt issued by a bank or trust company as custodian
with respect to any such Governmental Obligation or a specific payment of principal of or interest on any such Governmental Obligation
held by such custodian for the account of the holder of such depositary receipt; provided, however, that (except as required by
law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from
any amount received by the custodian in respect of the Governmental Obligation or the specific payment of principal of or interest
on the Governmental Obligation evidenced by such depositary receipt.
“herein”, “hereof”
and “hereunder”, and other words of similar import, refer to this Indenture as a whole and not to any
particular Article, Section or other subdivision.
“Indenture” means
this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental
hereto entered into in accordance with the terms hereof and shall include the terms of particular series of Securities established
as contemplated by Section 2.01.
“Interest Payment Date”,
when used with respect to any installment of interest on a Security of a particular series, means the date specified in such Security
or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment
of interest with respect to Securities of that series is due and payable.
“Officer” means, with
respect to the Company, the chairman of the Board of Directors, a chief executive officer, a president, a chief financial officer,
a chief operating officer, any executive vice president, any senior vice president, any vice president, the treasurer or any assistant
treasurer, the controller or any assistant controller or the secretary or any assistant secretary.
“Officer’s Certificate”
means a certificate signed by any Officer. Each such certificate shall include the statements provided for in Section 13.07,
if and to the extent required by the provisions thereof.
“Opinion of Counsel”
means an opinion in writing subject to customary exceptions of legal counsel, who may be an employee of or counsel for the Company,
that is delivered to the Trustee in accordance with the terms hereof. Each such opinion shall include the statements provided
for in Section 13.07, if and to the extent required by the provisions thereof.
“Outstanding”, when
used with reference to Securities of any series, means, subject to the provisions of Section 8.04, as of any particular time,
all Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities
theretofore canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying agent for cancellation or that
have previously been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental
Obligations in the necessary amount shall have been deposited in trust with the Trustee or with any paying agent (other than the
Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its own paying agent);
provided, however, that if such Securities or portions of such Securities are to be redeemed prior to the maturity thereof, notice
of such redemption shall have been given as provided in Article Three, or provision satisfactory to the Trustee shall have
been made for giving such notice; and (c) Securities in lieu of or in substitution for which other Securities shall have been
authenticated and delivered pursuant to the terms of Section 2.07.
“Person” means any
individual, corporation, partnership, joint venture, joint-stock company, limited liability company, association, trust, unincorporated
organization, any other entity or organization, including a government or political subdivision or an agency or instrumentality
thereof.
“Predecessor Security”
of any particular Security means every previous Security evidencing all or a portion of the same debt as that evidenced by such
particular Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07
in lieu of a lost, destroyed or stolen Security shall be deemed to evidence the same debt as the lost, destroyed or stolen Security.
“Responsible Officer”
when used with respect to the Trustee means any officer of the Trustee assigned by the Trustee to administer its corporate trust
matters with respect to this Indenture (which, for the avoidance of doubt, includes without limitation any supplemental indenture
hereto).
“Securities” has the
meaning stated in the first recital of this Indenture and more particularly means any Securities authenticated and delivered under
this Indenture.
“Securityholder”,
“holder of Securities”, “registered holder”, or other similar term, means the
Person or Persons in whose name or names a particular Security is registered on the Security Register kept for that purpose in
accordance with the terms of this Indenture.
“Security Register”
and “Security Registrar” shall have the meanings as set forth in Section 2.05.
“Subsidiary” means,
with respect to any Person:
(1)
any corporation or company a majority of whose capital stock with voting power, under ordinary circumstances, to elect directors
is, at the date of determination, directly or indirectly, owned by such Person (a “subsidiary”), by one
or more subsidiaries of such Person or by such Person and one or more subsidiaries of such Person;
(2)
a partnership in which such Person or a subsidiary of such Person is, at the date of determination, a general partner of such partnership;
or
(3)
any partnership, limited liability company or other Person in which such Person, a subsidiary of such Person or such Person and
one or more subsidiaries of such Person, directly or indirectly, at the date of determination, have (x) at least a majority
ownership interest or (y) the power to elect or appoint or direct the election or appointment of the managing partner or member
of such Person or, if applicable, a majority of the directors or other governing body of such Person.
“Trustee” means ,
and, subject to the provisions of Article Seven, shall also include its successors and assigns, and, if at any time there
is more than one Person acting in such capacity hereunder, “Trustee” shall mean each such Person. The term “Trustee”
as used with respect to a particular series of the Securities shall mean the trustee with respect to that series.
“Trust Indenture Act”
means the Trust Indenture Act of 1939, as amended.
ARTICLE 2
ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION
AND EXCHANGE OF SECURITIES
Section 2.01
Designation and Terms of Securities.
(a)
The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited.
The Securities may be issued in one or more series up to the aggregate principal amount of Securities of that series from time
to time authorized by or pursuant to a Board Resolution or pursuant to one or more indentures supplemental hereto. Prior
to the initial issuance of Securities of any series, there shall be established in or pursuant to a Board Resolution, and set forth
in an Officer’s Certificate, or established in one or more indentures supplemental hereto:
(1)
the title of the Securities of the series (which shall distinguish the Securities of that series from all other Securities);
(2)
any limit upon the aggregate principal amount of the Securities of that series which may be authenticated and delivered under
this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu
of, other Securities of that series);
(3)
the date or dates on which the principal of the Securities of the series is payable;
(4)
if the price (expressed as a percentage of the aggregate principal amount thereof) at which such Securities will be issued
is a price other than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration
of the maturity thereof, or if applicable, the portion of the principal amount of such Securities that is convertible into another
security or the method by which any such portion shall be determined;
(5)
the rate or rates at which the Securities of the series shall bear interest or the manner of calculation of such rate or rates,
if any;
(6)
the date or dates from which such interest shall accrue, the Interest Payment Dates on which such interest will be payable
or the manner of determination of such Interest Payment Dates, the place(s) of payment, and the record date for the determination
of holders to whom interest is payable on any such Interest Payment Dates or the manner of determination of such record dates;
(7)
the right, if any, to extend the interest payment periods and the duration of such extension;
(8)
the period or periods within which, the price or prices at which and the terms and conditions upon which Securities of the
series may be redeemed, converted or exchanged, in whole or in part;
(9)
the obligation, if any, of the Company to redeem or purchase Securities of the series pursuant to any sinking fund, mandatory
redemption, or analogous provisions (including payments made in cash in satisfaction of future sinking fund obligations) or at
the option of a holder thereof and the period or periods within which, the price or prices at which, and the terms and conditions
upon which, Securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation;
(10)
the form of the Securities of the series including the form of the Certificate of Authentication for such series;
(11)
if other than denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, the denominations in which
the Securities of the series shall be issuable;
(12)
any and all other terms (including terms, to the extent applicable, relating to any auction or remarketing of the Securities
of that series and any security for the obligations of the Company with respect to such Securities) with respect to such series
(which terms shall not be inconsistent with the terms of this Indenture, as amended by any supplemental indenture) including any
terms which may be required by or advisable under United States laws or regulations or advisable in connection with the marketing
of Securities of that series;
(13)
whether the Securities of the series shall be issued in whole or in part in the form of a Global Security or Securities; the
terms and conditions, if any, upon which such Global Security or Securities may be exchanged in whole or in part for other individual
Securities; and the Depositary for such Global Security or Securities;
(14)
whether the Securities will be convertible into or exchangeable for shares of common stock, preferred stock or other securities
of the Company or any other Person and, if so, the terms and conditions upon which such Securities will be so convertible or exchangeable,
including the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any mandatory or optional
(at the Company’s option or the holders’ option) conversion or exchange features, and the applicable conversion or
exchange period;
(15)
if other than the full principal amount thereof, the portion of the principal amount of Securities of the series which shall
be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.01;
(16)
any additional or alternative events of default;
(17)
additional or alternative covenants (which may include, among other restrictions, restrictions on the Company’s ability
or the ability of the Company’s Subsidiaries to: incur additional indebtedness; issue additional securities; create
liens; pay dividends or make distributions in respect of the capital stock of the Company or the Company’s Subsidiaries;
redeem capital stock; place restrictions on the Company’s Subsidiaries’ ability to pay dividends, make distributions
or transfer assets; make investments or other restricted payments; sell or otherwise dispose of assets; enter into sale-leaseback
transactions; engage in transactions with stockholders or affiliates; issue or sell stock of the Company’s Subsidiaries;
or effect a consolidation or merger) or financial covenants (which may include, among other financial covenants, financial covenants
that require the Company and its Subsidiaries to maintain specified interest coverage, fixed charge, cash flow-based, asset-based
or other financial ratios) provided for with respect to the Securities of the series;
(18)
the currency or currencies, including composite currencies, in which payment of the principal of (and premium, if any) and
interest, if any, on such Securities shall be payable (if other than the currency of the United States of America), which unless
otherwise specified shall be the currency of the United States of America as at the time of payment is legal tender for payment
of public or private debts;
(19)
if the principal of (and premium, if any) or interest, if any, on such Securities is to be payable, at the election of the
Company or any Holder thereof, in a coin or currency other than that in which such Securities are stated to be payable, then the
period or periods within which, and the terms and conditions upon which, such election may be made;
(20)
whether interest will be payable in cash or additional Securities at the Company’s or the Securityholders’ option
and the terms and conditions upon which the election may be made;
(21)
the terms and conditions, if any, upon which the Company shall pay amounts in addition to the stated interest, premium, if
any and principal amounts of the Securities of the series to any Securityholder that is not a “United States person”
for federal tax purposes;
(22)
additional or alternative provisions, if any, related to defeasance and discharge of the offered Securities;
(23)
the applicability of any guarantees;
(24)
any restrictions on transfer, sale or assignment of the Securities of the series; and
(25)
any other terms of the series.
All Securities of any one series shall be substantially
identical except as may otherwise be provided in or pursuant to any such Board Resolution or in any indentures supplemental hereto.
If any of the terms of the series are established
by action taken pursuant to a Board Resolution of the Company, a copy of an appropriate record of such action shall be certified
by the secretary or an assistant secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officer’s
Certificate of the Company setting forth the terms of the series.
Securities of any particular series may be issued
at various times, with different dates on which the principal or any installment of principal is payable, with different rates
of interest, if any, or different methods by which rates of interest may be determined, with different dates on which such interest
may be payable and with different redemption dates.
Section 2.02
Form of Securities and Trustee’s Certificate.
The Securities of any series and the Trustee’s
certificate of authentication to be borne by such Securities shall be substantially of the tenor and purport as set forth in one
or more indentures supplemental hereto or as provided in a Board Resolution, and set forth in an Officer’s Certificate, and
they may have such letters, numbers or other marks of identification or designation and such legends or endorsements printed, lithographed
or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as
may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation
of any securities exchange on which Securities of that series may be listed, or to conform to usage.
Section 2.03
Denominations: Provisions for Payment.
The Securities shall be issuable as registered
Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section 2.01(a)(10).
The Securities of a particular series shall bear interest payable on the dates and at the rate specified with respect to that series.
Subject to Section 2.01(a)(16), the principal of and the interest on the Securities of any series, as well as any premium
thereon in case of redemption thereof prior to maturity, shall be payable in the coin or currency of the United States of America
that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose.
Each Security shall be dated the date of its authentication. Interest on the Securities shall be computed on the basis of
a 360-day year composed of twelve 30-day months.
The interest installment on any Security that
is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Securities of that series shall be paid
to the Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the
regular record date for such interest installment. In the event that any Security of
a particular series or portion thereof is called for redemption
and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such Interest
Payment Date, interest on such Security will be paid upon presentation and surrender of such Security as provided in Section 3.03.
Any interest on any Security that is payable,
but is not punctually paid or duly provided for, on any Interest Payment Date for Securities of the same series (herein called
“Defaulted Interest”) shall forthwith cease to be payable to the registered holder on the relevant regular record date
by virtue of having been such holder; and such Defaulted Interest shall be paid by the Company, at its election, as provided in
clause (1) or clause (2) below:
(1)
The Company may make payment of any Defaulted Interest on Securities to the Persons in whose names such Securities (or their
respective Predecessor Securities) are registered at the close of business on a special record date for the payment of such Defaulted
Interest, which shall be fixed in the following manner: the Company shall notify the Trustee in writing of the amount of Defaulted
Interest proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall
deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest
or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when
deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided.
Thereupon the Trustee shall fix a special record date for the payment of such Defaulted Interest which shall not be more than 15
nor less than 10 days prior to the date of the proposed payment and not less than 10 days after the receipt by the Trustee of the
notice of the proposed payment. The Trustee shall promptly notify the Company of such special record date and, in the name
and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and the special record
date therefor to be mailed, first class postage prepaid, to each Securityholder at his or her address as it appears in the Security
Register (as hereinafter defined), not less than 10 days prior to such special record date. Notice of the proposed payment
of such Defaulted Interest and the special record date therefor having been mailed as aforesaid, such Defaulted Interest shall
be paid to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered on such special
record date.
(2)
The Company may make payment of any Defaulted Interest on any Securities in any other lawful manner not inconsistent with the
requirements of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such
exchange, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of
payment shall be deemed practicable by the Trustee.
Unless otherwise set forth in a Board Resolution
or one or more indentures supplemental hereto establishing the terms of any series of Securities pursuant to Section 2.01
hereof, the term “regular record date” as used in this Section with respect to a series of Securities and any
Interest Payment Date for such series shall mean either the fifteenth day of the month immediately preceding the month in which
an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment
Date is the first day of a month, or the first day of the month in which an Interest Payment Date established for such series pursuant
to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date
is a Business Day.
Subject to the foregoing provisions of this
Section, each Security of a series delivered under this Indenture upon transfer of or in exchange for or in lieu of any other Security
of such series shall carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Security.
Section 2.04
Execution and Authentications.
The Securities shall be signed on behalf of
the Company by one of its Officers. Signatures may be in the form of a manual or facsimile signature.
The Company may use the facsimile signature
of any Person who shall have been an Officer, notwithstanding the fact that at the time the Securities shall be authenticated and
delivered or disposed of such Person shall have ceased to be such an officer of the Company. The Securities may contain such
notations, legends or endorsements required by law, stock exchange rule or usage. Each Security shall be dated the date
of its authentication by the Trustee.
A Security shall not be valid until authenticated
manually by an authorized signatory of the Trustee, or by an Authenticating Agent. Such signature shall be conclusive evidence
that the Security so authenticated has been duly authenticated and delivered hereunder and that the holder is entitled to the benefits
of this Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may
deliver Securities of any series executed by the Company to the Trustee for authentication, together with a written order of the
Company for the authentication and delivery of such Securities, signed by an Officer, and the Trustee in accordance with such written
order shall authenticate and deliver such Securities.
In authenticating such Securities and accepting
the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive,
if requested, and (subject to Section 7.01) shall be fully protected in relying upon, an Opinion of Counsel stating that the
form and terms thereof have been established in conformity with the provisions of this Indenture.
The Trustee shall not be required to authenticate
such Securities if the issue of such Securities pursuant to this Indenture will affect the Trustee’s own rights, duties or
immunities under the Securities and this Indenture or otherwise in a manner that is not reasonably acceptable to the Trustee.
Section 2.05
Registration of Transfer and Exchange.
(a)
Securities of any series may be exchanged upon presentation thereof at the office or agency of the Company designated for such
purpose, for other Securities of such series of authorized denominations, and for a like aggregate principal amount, upon payment
of a sum sufficient to cover any tax or other governmental charge in relation thereto, all as provided in this Section. In
respect of any Securities so surrendered for exchange, the Company shall execute, the Trustee shall authenticate and such office
or agency shall deliver in exchange therefor the Security or Securities of the same series that the Securityholder making the exchange
shall be entitled to receive, bearing numbers not contemporaneously outstanding.
(b)
The Company shall keep, or cause to be kept, at its office or agency designated for such purpose a register or registers (herein
referred to as the “Security Register”) in which, subject to such reasonable regulations as it may prescribe, the Company
shall register the Securities and the transfers of Securities as in this Article provided and which at all reasonable times
shall be open for inspection by the Trustee. The registrar for the purpose of registering Securities and transfer of Securities
as herein provided shall be appointed as authorized by Board Resolution (the “Security Registrar”).
Upon surrender for transfer of any Security
at the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee shall authenticate and
such office or agency shall deliver in the name of the transferee or transferees a new Security or Securities of the same series
as the Security presented for a like aggregate principal amount.
All Securities presented or surrendered for
exchange or registration of transfer, as provided in this Section, shall be accompanied (if so required by the Company or the Security
Registrar) by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly
executed by the registered holder or by such holder’s duly authorized attorney in writing.
(c)
Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and set forth in an Officer’s Certificate,
or established in one or more indentures supplemental to this Indenture, no service charge shall be made for any exchange or registration
of transfer of Securities, or issue of new Securities in case of partial redemption of any series, but the Company may require
payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, other than exchanges pursuant to
Section 2.06, Section 3.03(b) and Section 9.04 not involving any transfer.
(d)
The Company shall not be required (i) to issue, exchange or register the transfer of any Securities during a period beginning
at the opening of business 15 days before the day of the mailing of a notice of redemption of less than all the Outstanding Securities
of the same series and ending at the close of business on the day of such mailing, nor (ii) to register the transfer of or
exchange any Securities of any series or portions thereof called for redemption, other than the unredeemed portion of any such
Securities being redeemed in part. The provisions of this Section 2.05 are, with respect to any Global Security, subject
to Section 2.11 hereof.
The Trustee shall have no obligation or duty
to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable
law with respect to any transfer of any interest in any Security (including any transfers between or among depositary participants
or beneficial owners of interests in any Global Security) other than to require delivery of such certificates and other documentation
or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine
the same to determine substantial compliance as to form with the express requirements hereof.
Section 2.06
Temporary Securities.
Pending the preparation of definitive Securities
of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed, lithographed
or typewritten) of any authorized denomination. Such temporary Securities shall be substantially in the form of the definitive
Securities in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary
Securities, all as may be determined by the Company. Every temporary Security of any series shall be executed by the Company
and be authenticated by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as the
definitive Securities of such series. Without unnecessary delay the Company will execute and will furnish definitive Securities
of such series and thereupon any or all temporary Securities of such series may be surrendered in exchange therefor (without charge
to the holders), at the office or agency of the Company designated for the purpose, and the Trustee shall authenticate and such
office or agency shall deliver in exchange for such temporary Securities an equal aggregate principal amount of definitive Securities
of such series, unless the Company advises the Trustee to the effect that definitive Securities need not be executed and furnished
until further notice from the Company. Until so exchanged, the temporary Securities of such series shall be entitled to the
same benefits under this Indenture as definitive Securities of such series authenticated and delivered hereunder.
Section 2.07
Mutilated, Destroyed, Lost or Stolen Securities.
In case any temporary or definitive Security
shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute, and
upon the Company’s request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same
series, bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu
of and in substitution for the Security so destroyed, lost or stolen. In every case the applicant for a substituted Security
shall furnish to the Company and the Trustee such security or indemnity as may be required by them to save each of them harmless,
and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee evidence to their
satisfaction of the destruction, loss or theft of the applicant’s Security and of the ownership thereof. The Trustee
may authenticate any such substituted Security and deliver the same upon the written request or authorization of any officer of
the Company. Upon the issuance of any substituted Security, the Company may require the payment of a sum sufficient to cover
any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses
of the Trustee) connected therewith.
In case any Security that has matured or is
about to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security,
pay or authorize the payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant
for such payment shall furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless,
and, in case of destruction, loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss
or theft of such Security and of the ownership thereof.
Every replacement Security issued pursuant to
the provisions of this Section shall constitute an additional contractual obligation of the Company whether or not the mutilated,
destroyed, lost or stolen Security shall be found at any time, or be enforceable by anyone, and shall be entitled to all the benefits
of this Indenture equally and proportionately with any and all other Securities of the same series duly issued hereunder.
All Securities shall be held and owned upon the express condition that the foregoing provisions are exclusive with respect to the
replacement or payment of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the extent lawful) any and all
other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the
replacement or payment of negotiable instruments or other securities without their surrender.
Section 2.08
Cancellation.
All Securities surrendered for the purpose of
payment, redemption, exchange or registration of transfer shall, if surrendered to the Company or any paying agent, be delivered
to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be issued
in lieu thereof except as expressly required or permitted by any of the provisions of this Indenture. On request of the Company
at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee. In the absence
of such request the Trustee may dispose of canceled Securities in accordance with its standard procedures and deliver a certificate
of disposition to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall
not operate as a redemption or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered
to the Trustee for cancellation.
Section 2.09
Benefits of Indenture.
Nothing in this Indenture or in the Securities,
express or implied, shall give or be construed to give to any Person, other than the parties hereto and the holders of the Securities
any legal or equitable right, remedy or claim under or in respect of this Indenture, or under any covenant, condition or provision
herein contained; all such covenants, conditions and provisions being for the sole benefit of the parties hereto and of the holders
of the Securities.
Section 2.10
Authenticating Agent.
So long as any of the Securities of any series
remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall have the
right to appoint. Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities
of such series issued upon exchange, transfer or partial redemption thereof, and Securities so authenticated shall be entitled
to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder.
All references in this Indenture to the authentication of Securities by the Trustee shall be deemed to include authentication by
an Authenticating Agent for such series. Each Authenticating Agent shall be acceptable to the Company and shall be a corporation
that has a combined capital and surplus, as most recently reported or determined by it, sufficient under the laws of any jurisdiction
under which it is organized or in which it is doing business to conduct a trust business, and that is otherwise authorized under
such laws to conduct such business and is subject to supervision or examination by federal or state authorities. If at any
time any Authenticating Agent shall cease to be eligible in accordance with these provisions, it shall resign immediately.
Any Authenticating Agent may at any time resign
by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time (and upon request
by the Company shall) terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating
Agent and to the Company. Upon resignation, termination or cessation of eligibility of any Authenticating Agent, the Trustee
may appoint an eligible successor Authenticating Agent acceptable to the Company. Any successor Authenticating Agent, upon
acceptance of its appointment hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder
as if originally named as an Authenticating Agent pursuant hereto.
Section 2.11
Global Securities.
(a)
If the Company shall establish pursuant to Section 2.01 that the Securities of a particular series are to be issued as
a Global Security, then the Company shall execute and the Trustee shall, in accordance with Section 2.04, authenticate and
deliver, a Global Security that (i) shall represent, and shall be denominated in an amount equal to the aggregate principal
amount of, all of the Outstanding Securities of such series, (ii) shall be registered in the name of the Depositary or its
nominee, (iii) shall be delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction and (iv) shall
bear a legend substantially to the following effect: “Except as otherwise provided in Section 2.11 of the Indenture,
this Security may be transferred, in whole but not in part, only to another nominee of the Depositary or to a successor Depositary
or to a nominee of such successor Depositary.”
(b)
Notwithstanding the provisions of Section 2.05, the Global Security of a series may be transferred, in whole but not in
part and in the manner provided in Section 2.05, only to another nominee of the Depositary for such series, or to a successor
Depositary for such series selected or approved by the Company or to a nominee of such successor Depositary.
(c)
If at any time the Depositary for a series of the Securities notifies the Company that it is unwilling or unable to continue
as Depositary for such series or if at any time the Depositary for such series shall no longer be registered or in good standing
under the Exchange Act, or other applicable statute or regulation, and a successor Depositary for such series is not appointed
by the Company within 90 days after the Company receives such notice or becomes aware of such condition, as the case may be, or
if an Event of Default has occurred and is continuing and the Company has received a request from the Depositary or from the Trustee,
this Section 2.11 shall no longer be applicable to the Securities of such series and the Company will execute, and subject
to Section 2.04, the Trustee will authenticate and deliver the Securities of such series in definitive registered form without
coupons, in authorized denominations, and in an aggregate principal amount equal to the principal amount of the Global Security
of such series in exchange for such Global Security. In addition, the Company may at any time determine that the Securities
of any series shall no longer be represented by a Global Security and that the provisions of this Section 2.11 shall no longer
apply to the Securities of such series. In such event the Company will execute and, subject to Section 2.04, the Trustee,
upon receipt of an Officer’s Certificate evidencing such determination by the Company, will authenticate and deliver the
Securities of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal
amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. Upon the
exchange of the Global Security for such Securities in definitive registered form without coupons, in authorized denominations,
the Global Security shall be canceled by the Trustee. Such Securities in definitive registered form issued in exchange for
the Global Security pursuant to this Section 2.11(c) shall be registered in such names and in such authorized denominations
as the Depositary, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee.
The Trustee shall deliver such Securities to the Depositary for delivery to the Persons in whose names such Securities are so registered.
ARTICLE 3
REDEMPTION OF SECURITIES AND SINKING FUND
PROVISIONS
Section 3.01
Redemption.
The Company may redeem the Securities of any
series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant to Section 2.01
hereof.
Section 3.02
Notice of Redemption.
(a) In case the Company shall
desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of any series in accordance with
any right the Company reserved for itself to do so pursuant to Section 2.01 hereof, the Company shall, or shall cause the
Trustee to, give notice of such redemption to holders of the Securities of such series to be redeemed by mailing, first class postage
prepaid, a notice of such redemption not less than 30 days and not more than 90 days before the date fixed for redemption of that
series to such holders at their last addresses as they shall appear upon the Security Register, unless a shorter period is specified
in the Securities to be redeemed. Any notice that is mailed in the manner herein provided shall be conclusively presumed
to have been duly given, whether or not the registered holder receives the notice. In any case, failure duly to give such
notice to the holder of any Security of any series designated for redemption in whole or in part, or any defect in the notice,
shall not affect the validity of the proceedings for the redemption of any other Securities of such series or any other series.
In the case of any redemption of Securities prior to the expiration of any restriction on such redemption provided in the terms
of such Securities or elsewhere in this Indenture, the Company shall furnish the Trustee with an Officer’s Certificate evidencing
compliance with any such restriction.
Each such notice of redemption shall specify
the date fixed for redemption and the redemption price at which Securities of that series are to be redeemed, and shall state that
payment of the redemption price of such Securities to be redeemed will be made at the office or agency of the Company, upon presentation
and surrender of such Securities, that interest accrued to the date fixed for redemption will be paid as specified in said notice,
that from and after said date interest will cease to accrue and that the redemption is from a sinking fund, if such is the case.
If less than all the Securities of a series are to be redeemed, the notice to the holders of Securities of that series to be redeemed
in part shall specify the particular Securities to be so redeemed.
In case any Security is to be redeemed in part
only, the notice that relates to such Security shall state the portion of the principal amount thereof to be redeemed, and shall
state that on and after the redemption date, upon surrender of such Security, a new Security or Securities of such series in principal
amount equal to the unredeemed portion thereof will be issued.
(b)
If less than all the Securities of a series are to be redeemed, the Company shall give the Trustee at least 45 days’
notice (unless a shorter notice shall be satisfactory to the Trustee) in advance of the date fixed for redemption as to the aggregate
principal amount of Securities of the series to be redeemed, and thereupon the Trustee shall select, by lot or in such other manner
as it shall deem appropriate and fair in its discretion and that may provide for the selection of a portion or portions (equal
to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the principal amount of such Securities of a denomination
larger than $1,000, the Securities to be redeemed and shall thereafter promptly notify the Company in writing of the numbers of
the Securities to be redeemed, in whole or in part. The Company may, if and whenever it shall so elect, by delivery of instructions
signed on its behalf by an Officer, instruct the Trustee or any paying agent to call all or any part of the Securities of a particular
series for redemption and to give notice of redemption in the manner set forth in this Section, such notice to be in the name of
the Company or its own name as the Trustee or such paying agent may deem advisable. In any case in which notice of redemption
is to be given by the Trustee or any such paying agent, the Company shall deliver or cause to be delivered to, or permit to remain
with, the Trustee or such paying agent, as the case may be, such Security Register, transfer books or other records, or suitable
copies or extracts therefrom, sufficient to enable the Trustee or such paying agent to give any notice by mail that may be required
under the provisions of this Section.
Section 3.03
Payment Upon Redemption.
(a)
If the giving of notice of redemption shall have been completed as above provided, the Securities or portions of Securities
of the series to be redeemed specified in such notice shall become due and payable on the date and at the place stated in such
notice at the applicable redemption price, together with interest accrued to the date fixed for redemption and interest on such
Securities or portions of Securities shall cease to accrue on and after the date fixed for redemption, unless the Company shall
default in the payment of such redemption price and accrued interest with respect to any such Security or portion thereof.
On presentation and surrender of such Securities on or after the date fixed for redemption at the place of payment specified in
the notice, said Securities shall be paid and redeemed at the applicable redemption price for such series, together with interest
accrued thereon to the date fixed for redemption (but if the date fixed for redemption is an interest payment date, the interest
installment payable on such date shall be payable to the registered holder at the close of business on the applicable record date
pursuant to Section 2.03).
(b)
Upon presentation of any Security of such series that is to be redeemed in part only, the Company shall execute and the Trustee
shall authenticate and the office or agency where the Security is presented shall deliver to the holder thereof, at the expense
of the Company, a new Security of the same series of authorized denominations in principal amount equal to the unredeemed portion
of the Security so presented.
Section 3.04
Sinking Fund.
The provisions of Sections 3.04, 3.05 and 3.06
shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated
by Section 2.01 for Securities of such series.
The minimum amount of any sinking fund payment
provided for by the terms of Securities of any series is herein referred to as a “mandatory sinking fund payment,”
and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as
an “optional sinking fund payment”. If provided for by the terms of Securities of any series, the cash amount
of any sinking fund payment may be subject to reduction as provided in Section 3.05. Each sinking fund payment shall
be applied to the redemption of Securities of any series as provided for by the terms of Securities of such series.
Section 3.05
Satisfaction of Sinking Fund Payments with Securities.
The Company (i) may deliver Outstanding
Securities of a series and (ii) may apply as a credit Securities of a series that have been redeemed either at the election
of the Company pursuant to the terms of such Securities or through the application of permitted optional sinking fund payments
pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any sinking fund payment with respect
to the Securities of such series required to be made pursuant to the terms of such Securities as provided for by the terms of such
series, provided that such Securities have not been previously so credited. Such Securities shall be received and credited
for such purpose by the Trustee at the redemption price specified in such Securities for redemption through operation of the sinking
fund and the amount of such sinking fund payment shall be reduced accordingly.
Section 3.06
Redemption of Securities for Sinking Fund.
Not less than 45 days prior to each sinking
fund payment date for any series of Securities (unless a shorter period shall be satisfactory to the Trustee), the Company will
deliver to the Trustee an Officer’s Certificate specifying the amount of the next ensuing sinking fund payment for that series
pursuant to the terms of the series, the portion thereof, if any, that is to be satisfied by delivering and crediting Securities
of that series pursuant to Section 3.05 and the basis for such credit and will, together with such Officer’s Certificate,
deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date
the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02
and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided
in Section 3.02. Such notice having been duly given, the redemption of such Securities shall be made upon the terms
and in the manner stated in Section 3.03.
ARTICLE 4
COVENANTS
Section 4.01
Payment of Principal, Premium and Interest.
The Company will duly and punctually pay or
cause to be paid the principal of (and premium, if any) and interest on the Securities of that series at the time and place and
in the manner provided herein and established with respect to such Securities. Payments of principal on the Securities may be made
at the time provided herein and established with respect to such Securities by U.S. dollar check drawn on and mailed to the address
of the Securityholder entitled thereto as such address shall appear in the Security Register, or U.S. dollar wire transfer to,
a U.S. dollar account if such Securityholder shall have furnished wire instructions to the Trustee no later than 15 days prior
to the relevant payment date. Payments of interest on the Securities may be made at the time provided herein and established with
respect to such Securities by U.S. dollar check mailed to the address of the Securityholder entitled thereto as such address shall
appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account if such Securityholder shall have furnished
wire instructions in writing to the Security Registrar and the Trustee no later than 15 days prior to the relevant payment date.
Section 4.02
Maintenance of Office or Agency.
So long as any series of the Securities remain
Outstanding, the Company agrees to maintain an office or agency with respect to each such series and at such other location or
locations as may be designated as provided in this Section 4.02, where (i) Securities of that series may be presented
for payment, (ii) Securities of that series may be presented as herein above authorized for registration of transfer and exchange,
and (iii) notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be
given or served, such designation to continue with respect to such office or agency until the Company shall, by written notice
signed by any officer authorized to sign an Officer’s Certificate and delivered to the Trustee, designate some other office
or agency for such purposes or any of them. If at any time the Company shall fail to maintain any such required office or
agency or shall fail to furnish the Trustee with the address thereof, such presentations, notices and demands may be made or served
at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations,
notices and demands. The Company initially appoints the Corporate Trust Office of the Trustee as its paying agent with respect
to the Securities.
Section 4.03
Paying Agents.
(a) If the Company shall appoint
one or more paying agents for all or any series of the Securities, other than the Trustee, the Company will cause each such paying
agent to execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions
of this Section:
(1)
that it will hold all sums held by it as such agent for the payment of the principal of (and premium, if any) or interest on
the Securities of that series (whether such sums have been paid to it by the Company or by any other obligor of such Securities)
in trust for the benefit of the Persons entitled thereto;
(2)
that it will give the Trustee notice of any failure by the Company (or by any other obligor of such Securities) to make any
payment of the principal of (and premium, if any) or interest on the Securities of that series when the same shall be due and payable;
(3)
that it will, at any time during the continuance of any failure referred to in the preceding paragraph (a)(2) above, upon
the written request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such paying agent; and
(4)
that it will perform all other duties of paying agent as set forth in this Indenture.
(b)
If the Company shall act as its own paying agent with respect to any series of the Securities, it will on or before each due
date of the principal of (and premium, if any) or interest on Securities of that series, set aside, segregate and hold in trust
for the benefit of the Persons entitled thereto a sum sufficient to pay such principal (and premium, if any) or interest so becoming
due on Securities of that series until such sums shall be paid to such Persons or otherwise disposed of as herein provided and
will promptly notify the Trustee of such action, or any failure (by it or any other obligor on such Securities) to take such action.
Whenever the Company shall have one or more paying agents for any series of Securities, it will, prior to each due date of the
principal of (and premium, if any) or interest on any Securities of that series, deposit with the paying agent a sum sufficient
to pay the principal (and premium, if any) or interest so becoming due, such sum to be held in trust for the benefit of the Persons
entitled to such principal, premium or interest, and (unless such paying agent is the Trustee) the Company will promptly notify
the Trustee of this action or failure so to act.
(c)
Notwithstanding anything in this Section to the contrary, (i) the agreement to hold sums in trust as provided in
this Section is subject to the provisions of Section 11.05, and (ii) the Company may at any time, for the purpose
of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or direct any paying agent to pay,
to the Trustee all sums held in trust by the Company or such paying agent, such sums to be held by the Trustee upon the same terms
and conditions as those upon which such sums were held by the Company or such paying agent; and, upon such payment by the Company
or any paying agent to the Trustee, the Company or such paying agent shall be released from all further liability with respect
to such money.
Section 4.04
Appointment to Fill Vacancy in Office of Trustee.
The Company, whenever necessary to avoid or
fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 7.10, a Trustee, so that there shall
at all times be a Trustee hereunder.
Section 4.05
Compliance with Consolidation Provisions.
The Company will not, while any of the Securities
remain Outstanding, consolidate with or merge into any other Person, in either case where the Company is not the survivor of such
transaction, or sell or convey all or substantially all of its property to any other Person unless the provisions of Article Ten
hereof are complied with.
ARTICLE 5
SECURITYHOLDERS’ LISTS AND REPORTS
BY THE COMPANY AND THE TRUSTEE
Section 5.01
Company to Furnish Trustee Names and Addresses of Securityholders.
The Company will furnish or cause to be furnished
to the Trustee (a) within 15 days after each regular record date (as defined in Section 2.03) a list, in such form as
the Trustee may reasonably require, of the names and addresses of the holders of each series of Securities as of such regular record
date, provided that the Company shall not be obligated to furnish or cause to furnish such list at any time that the list shall
not differ in any respect from the most recent list furnished to the Trustee by the Company and (b) at such other times as
the Trustee may request in writing within 30 days after the receipt by the Company of any such request, a list of similar form
and content as of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case,
no such list need be furnished for any series for which the Trustee shall be the Security Registrar.
Section 5.02
Preservation Of Information; Communications With Securityholders.
(a)
The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses
of the holders of Securities contained in the most recent list furnished to it as provided in Section 5.01 and as to the names
and addresses of holders of Securities received by the Trustee in its capacity as Security Registrar (if acting in such capacity).
(b)
The Trustee may destroy any list furnished to it as provided in Section 5.01 upon receipt of a new list so furnished.
(c)
Securityholders may communicate as provided in Section 312(b) of the Trust Indenture Act with other Securityholders
with respect to their rights under this Indenture or under the Securities, and, in connection with any such communications, the
Trustee shall satisfy its obligations under Section 312(b) of the Trust Indenture Act in accordance with the provisions
of Section 312(b) of the Trust Indenture Act.
Section 5.03
Reports by the Company.
(a)
The Company covenants and agrees to provide (which delivery may be via electronic mail) to the Trustee within 30 days, after
the Company files the same with the Commission, copies of the annual reports and of the information, documents and other reports
(or copies of such portions of any of the foregoing as the Commission may from time to time by rules and regulations prescribe)
that the Company is required to file with the Commission pursuant to Section 13 or Section 15(d) of the Exchange
Act; provided, however, the Company shall not be required to deliver to the Trustee any materials for which the Company has sought
and received confidential treatment by the Commission; and provided further, that so long as such filings by the Company are available
on the Commission’s Electronic Data Gathering, Analysis and Retrieval System (EDGAR), or Interactive Data Electronic Applications
(IDEA), or any successor system, such filings shall be deemed to have been filed with the Trustee for purposes hereof without any
further action required by the Company; provided that an electronic link to such filing, together with an electronic notice of
such filing have been sent to the Trustee. For the avoidance of doubt, a failure by the Company to file annual reports, information
and other reports with the SEC within the time period prescribed thereof by the Commission shall not be deemed a breach of this
Section 5.03.
(b)
Delivery of reports, information and documents to the Trustee under Section 5.03 is for informational purposes only and
the information and the Trustee’s receipt of the foregoing shall not constitute constructive notice of any information contained
therein, or determinable from information contained therein including the Company’s compliance with any of their covenants
thereunder (as to which the Trustee is entitled to rely exclusively on an Officer’s Certificate).
Section 5.04
Reports by the Trustee.
(a)
If required by Section 313(a) of the Trust Indenture Act, the Trustee, within sixty (60) days after each May 1,
shall transmit by mail, first class postage prepaid, to the Securityholders, as their names and addresses appear upon the Security
Register, a brief report dated as of such May 1, which complies with Section 313(a) of the Trust Indenture Act.
(b)
The Trustee shall comply with Section 313(b) and 313(c) of the Trust Indenture Act.
(c)
A copy of each such report shall, at the time of such transmission to Securityholders, be filed by the Trustee with the Company,
with each securities exchange upon which any Securities are listed (if so listed) and also with the Commission. The Company
agrees to notify the Trustee when any Securities become listed on any securities exchange.
ARTICLE 6
REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS
ON EVENT OF DEFAULT
Section 6.01
Events of Default.
(a)
Whenever used herein with respect to Securities of a particular series, “Event of Default” means any one or more
of the following events that has occurred and is continuing:
(1)
the Company defaults in the payment of any installment of interest upon any of the Securities of that series, as and when the
same shall become due and payable, and such default continues for a period of 90 days; provided, however, that a valid extension
of an interest payment period by the Company in accordance with the terms of any indenture supplemental hereto shall not constitute
a default in the payment of interest for this purpose;
(2)
the Company defaults in the payment of the principal of (or premium, if any, on) any of the Securities of that series as and
when the same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment
required by any sinking or analogous fund established with respect to that series; provided, however, that a valid extension of
the maturity of such Securities in accordance with the terms of any indenture supplemental hereto shall not constitute a default
in the payment of principal or premium, if any;
(3)
the Company fails to observe or perform any other of its covenants or agreements with respect to that series contained in this
Indenture or otherwise established with respect to that series of Securities pursuant to Section 2.01 hereof (other than a
covenant or agreement that has been expressly included in this Indenture solely for the benefit of one or more series of Securities
other than such series) for a period of 90 days after the date on which written notice of such failure, requiring the same to be
remedied and stating that such notice is a “Notice of Default” hereunder, shall have been given to the Company by the
Trustee, by registered or certified mail, or to the Company and the Trustee by the holders of at least 25% in principal amount
of the Securities of that series at the time Outstanding;
(4)
the Company pursuant to or within the meaning of any Bankruptcy Law (i) commences a voluntary case, (ii) consents
to the entry of an order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of
it or for all or substantially all of its property or (iv) makes a general assignment for the benefit of its creditors; or
(5)
a court of competent jurisdiction enters an order under any Bankruptcy Law that (i) is for relief against the Company
in an involuntary case, (ii) appoints a Custodian of the Company for all or substantially all of its property or (iii) orders
the liquidation of the Company, and the order or decree remains unstayed and in effect for 90 days.
(b)
In each and every such case (other than an Event of Default specified in clause (4) or clause (5) above), unless
the principal of all the Securities of that series shall have already become due and payable, either the Trustee or the holders
of not less than 25% in aggregate principal amount of the Securities of that series then Outstanding hereunder, by notice in writing
to the Company (and to the Trustee if given by such Securityholders), may declare the principal of (and premium, if any, on) and
accrued and unpaid interest on all the Securities of that series to be due and payable immediately, and upon any such declaration
the same shall become and shall be immediately due and payable. If an Event of Default specified in clause (4) or clause
(5) above occurs, the principal of and accrued and unpaid interest on all the Securities of that series shall automatically
be immediately due and payable without any declaration or other act on the part of the Trustee or the holders of the Securities.
(c)
At any time after the principal of (and premium, if any, on) and accrued and unpaid interest on the Securities of that series
shall have been so declared due and payable, and before any judgment or decree for the payment of the moneys due shall have been
obtained or entered as hereinafter provided, the holders of a majority in aggregate principal amount of the Securities of that
series then Outstanding hereunder, by written notice to the Company and the Trustee, may rescind and annul such declaration and
its consequences if: (i) the Company has paid or deposited with the Trustee a sum sufficient to pay all matured installments
of interest upon all the Securities of that series and the principal of (and premium, if any, on) any and all Securities of that
series that shall have become due otherwise than by acceleration (with interest upon such principal and premium, if any, and, to
the extent that such payment is enforceable under applicable law, upon overdue installments of interest, at the rate per annum
expressed in the Securities of that series to the date of such payment or deposit) and the amount payable to the Trustee under
Section 7.06, and (ii) any and all Events of Default under the Indenture with respect to such series, other than the
nonpayment of principal on (and premium, if any, on) and accrued and unpaid interest on Securities of that series that shall not
have become due by their terms, shall have been remedied or waived as provided in Section 6.06.
No such rescission and annulment shall extend
to or shall affect any subsequent default or impair any right consequent thereon.
(d)
In case the Trustee shall have proceeded to enforce any right with respect to Securities of that series under this Indenture
and such proceedings shall have been discontinued or abandoned because of such rescission or annulment or for any other reason
or shall have been determined adversely to the Trustee, then and in every such case, subject to any determination in such proceedings,
the Company and the Trustee shall be restored respectively to their former positions and rights hereunder, and all rights, remedies
and powers of the Company and the Trustee shall continue as though no such proceedings had been taken.
Section 6.02
Collection of Indebtedness and Suits for Enforcement by Trustee.
(a)
The Company covenants that (i) in case it shall default in the payment of any installment of interest on any of the Securities
of a series, or in any payment required by any sinking or analogous fund established with respect to that series as and when the
same shall have become due and payable, and such default shall have continued for a period of 90 days, or (ii) in case it
shall default in the payment of the principal of (or premium, if any, on) any of the Securities of a series when the same shall
have become due and payable, whether upon maturity of the Securities of a series or upon redemption or upon declaration or otherwise
then, upon demand of the Trustee, the Company will pay to the Trustee, for the benefit of the holders of the Securities of that
series, the whole amount that then shall have been become due and payable on all such Securities for principal (and premium, if
any) or interest, or both, as the case may be, with interest upon the overdue principal (and premium, if any) and (to the extent
that payment of such interest is enforceable under applicable law) upon overdue installments of interest at the rate per annum
expressed in the Securities of that series; and, in addition thereto, such further amount as shall be sufficient to cover the costs
and expenses of collection, and the amount payable to the Trustee under Section 7.06.
(b)
If the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an
express trust, shall be entitled and empowered to institute any action or proceedings at law or in equity for the collection of
the sums so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such
judgment or final decree against the Company or other obligor upon the Securities of that series and collect the moneys adjudged
or decreed to be payable in the manner provided by law or equity out of the property of the Company or other obligor upon the Securities
of that series, wherever situated.
(c)
In case of any receivership, insolvency, liquidation, bankruptcy, reorganization, readjustment, arrangement, composition or
judicial proceedings affecting the Company, or its creditors or property, the Trustee shall have power to intervene in such proceedings
and take any action therein that may be permitted by the court and shall (except as may be otherwise provided by law) be entitled
to file such proofs of claim and other papers and documents as may be necessary or advisable in order to have the claims of the
Trustee and of the holders of Securities of such series allowed for the entire amount due and payable by the Company under the
Indenture at the date of institution of such proceedings and for any additional amount that may become due and payable by the Company
after such date, and to collect and receive any moneys or other property payable or deliverable on any such claim, and to distribute
the same after the deduction of the amount payable to the Trustee under Section 7.06; and any receiver, assignee or trustee
in bankruptcy or reorganization is hereby authorized by each of the holders of Securities of such series to make such payments
to the Trustee, and, in the event that the Trustee shall consent to the making of such payments directly to such Securityholders,
to pay to the Trustee any amount due it under Section 7.06.
(d)
All rights of action and of asserting claims under this Indenture, or under any of the terms established with respect to Securities
of that series, may be enforced by the Trustee without the possession of any of such Securities, or the production thereof at any
trial or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own
name as trustee of an express trust, and any recovery of judgment shall, after provision for payment to the Trustee of any amounts
due under Section 7.06, be for the ratable benefit of the holders of the Securities of such series.
In case of an Event of Default hereunder, the
Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial
proceedings as the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in
bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in the Indenture or in aid
of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee
by this Indenture or by law.
Nothing contained herein shall be deemed to
authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of reorganization,
arrangement, adjustment or composition affecting the Securities of that series or the rights of any holder thereof or to authorize
the Trustee to vote in respect of the claim of any Securityholder in any such proceeding.
Section 6.03
Application of Moneys Collected.
Any moneys collected by the Trustee pursuant
to this Article with respect to a particular series of Securities shall be applied in the following order, at the date or
dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal (or premium, if any) or interest,
upon presentation of the Securities of that series, and notation thereon of the payment, if only partially paid, and upon surrender
thereof if fully paid:
FIRST: To the payment of reasonable costs and
expenses of collection and of all amounts payable to the Trustee under Section 7.06;
SECOND: To the payment of the amounts then due
and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which or for the benefit
of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable
on such Securities for principal (and premium, if any) and interest, respectively; and
THIRD: To the payment of the remainder, if any,
to the Company or any other Person lawfully entitled thereto.
Section 6.04
Limitation on Suits.
No holder of any Security of any series shall
have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity
or at law upon or under or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other remedy
hereunder, unless (i) such holder previously shall have given to the Trustee written notice of an Event of Default and of
the continuance thereof with respect to the Securities of such series specifying such Event of Default, as hereinbefore provided;
(ii) the holders of not less than 25% in aggregate principal amount of the Securities of such series then Outstanding shall
have made written request upon the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder; (iii) such
holder or holders shall have offered to the Trustee such reasonable indemnity as it may require against the costs, expenses and
liabilities to be incurred therein or thereby; (iv) the Trustee for 90 days after its receipt of such notice, request and
offer of indemnity, shall have failed to institute any such action, suit or proceeding and (v) during such 90 day period,
the holders of a majority in principal amount of the Securities of that series do not give the Trustee a direction inconsistent
with the request.
Notwithstanding anything contained herein to
the contrary or any other provisions of this Indenture, the right of any holder of any Security to receive payment of the principal
of (and premium, if any) and interest on such Security, as therein provided, on or after the respective due dates expressed in
such Security (or in the case of redemption, on the redemption date), or to institute suit for the enforcement of any such payment
on or after such respective dates or redemption date, shall not be impaired or affected without the consent of such holder and
by accepting a Security hereunder it is expressly understood, intended and covenanted by the taker and holder of every Security
of such series with every other such taker and holder and the Trustee, that no one or more holders of Securities of such series
shall have any right in any manner whatsoever by virtue or by availing of any provision of this Indenture to affect, disturb or
prejudice the rights of the holders of any other of such Securities, or to obtain or seek to obtain priority over or preference
to any other such holder, or to enforce any right under this Indenture, except in the manner herein provided and for the equal,
ratable and common benefit of all holders of Securities of such series. For the protection and enforcement of the provisions
of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given either at law or
in equity.
Section 6.05
Rights and Remedies Cumulative; Delay or Omission Not Waiver.
(a)
Except as otherwise provided in Section 2.07, all powers and remedies given by this Article to the Trustee or to
the Securityholders shall, to the extent permitted by law, be deemed cumulative and not exclusive of any other powers and remedies
available to the Trustee or the holders of the Securities, by judicial proceedings or otherwise, to enforce the performance or
observance of the covenants and agreements contained in this Indenture or otherwise established with respect to such Securities.
(b)
No delay or omission of the Trustee or of any holder of any of the Securities to exercise any right or power accruing upon
any Event of Default occurring and continuing as aforesaid shall impair any such right or power, or shall be construed to be a
waiver of any such default or an acquiescence therein; and, subject to the provisions of Section 6.04, every power and remedy
given by this Article or by law to the Trustee or the Securityholders may be exercised from time to time, and as often as
shall be deemed expedient, by the Trustee or by the Securityholders.
Section 6.06
Control by Securityholders.
The holders of a majority in aggregate principal
amount of the Securities of any series at the time Outstanding, determined in accordance with Section 8.04, shall have the
right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising
any trust or power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in
conflict with any rule of law or with this Indenture or subject the Trustee in its sole discretion to personal liability.
Subject to the provisions of Section 7.01, the Trustee shall have the right to decline to follow any such direction if the
Trustee in good faith shall, by a Responsible Officer or officers of the Trustee, determine that the proceeding so directed, subject
to the Trustee’s duties under the Trust Indenture Act, would involve the Trustee in personal liability or might be unduly
prejudicial to the Securityholders not involved in the proceeding. The holders of a majority in aggregate principal amount
of the Securities of any series at the time Outstanding affected thereby, determined in accordance with Section 8.04, may
on behalf of the holders of all of the Securities of such series waive any past default in the performance of any of the covenants
contained herein or established pursuant to Section 2.01 with respect to such series and its consequences, except a default
in the payment of the principal of, or premium, if any, or interest on, any of the Securities of that series as and when the same
shall become due by the terms of such Securities otherwise than by acceleration (unless such default has been cured and a sum sufficient
to pay all matured installments of interest and principal and any premium has been deposited with the Trustee (in accordance with
Section 6.01(c)). Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes of
this Indenture and the Company, the Trustee and the holders of the Securities of such series shall be restored to their former
positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any
right consequent thereon.
Section 6.07
Undertaking to Pay Costs.
All parties to this Indenture agree, and each
holder of any Securities by such holder’s acceptance thereof shall be deemed to have agreed, that any court may in its discretion
require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any
action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such
suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against any
party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant;
but the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder,
or group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or
to any suit instituted by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest
on any Security of such series, on or after the respective due dates expressed in such Security or established pursuant to this
Indenture.
ARTICLE 7
CONCERNING THE TRUSTEE
Section 7.01
Certain Duties and Responsibilities of Trustee.
(a)
The Trustee, prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing
of all Events of Default with respect to the Securities of that series that may have occurred, shall undertake to perform with
respect to the Securities of such series such duties and only such duties as are specifically set forth in this Indenture, and
no implied covenants shall be read into this Indenture against the Trustee. In case an Event of Default with respect to the
Securities of a series has occurred (that has not been cured or waived), the Trustee shall exercise with respect to Securities
of that series such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in their
exercise, as a prudent man would exercise or use under the circumstances in the conduct of his own affairs.
(b)
No provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own
negligent failure to act, or its own willful misconduct, except that:
(i)
prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing or waiving of
all such Events of Default with respect to that series that may have occurred:
(A)
the duties and obligations of the Trustee shall with respect to the Securities of such series be determined solely by the express
provisions of this Indenture, and the Trustee shall not be liable with respect to the Securities of such series except for the
performance of such duties and obligations as are specifically set forth in this Indenture, and no implied covenants or obligations
shall be read into this Indenture against the Trustee; and
(B)
in the absence of bad faith on the part of the Trustee, the Trustee may with respect to the Securities of such series conclusively
rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions
furnished to the Trustee and conforming to the requirements of this Indenture; but in the case of any such certificates or opinions
that by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine
the same to determine whether or not they conform to the requirements of this Indenture;
(ii)
the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer or Responsible Officers
of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts;
(iii)
the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with
the direction of the holders of not less than a majority in principal amount of the Securities of any series at the time Outstanding
relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any
trust or power conferred upon the Trustee under this Indenture with respect to the Securities of that series; and
(iv)
none of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur
personal financial liability in the performance of any of its duties or in the exercise of any of its rights or powers if there
is reasonable ground for believing that the repayment of such funds or liability is not reasonably assured to it under the terms
of this Indenture or adequate indemnity against such risk is not reasonably assured to it.
Section 7.02
Certain Rights of Trustee.
Except as otherwise provided in Section 7.01:
(a)
The Trustee may rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, approval, bond, security or other paper or document believed by it
to be genuine and to have been signed or presented by the proper party or parties;
(b)
Any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by a Board Resolution
or an instrument signed in the name of the Company by any authorized officer of the Company (unless other evidence in respect thereof
is specifically prescribed herein);
(c)
The Trustee may consult with counsel and the written advice of such counsel or, if requested, any Opinion of Counsel shall
be full and complete authorization and protection in respect of any action taken or suffered or omitted hereunder in good faith
and in reliance thereon;
(d)
The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request,
order or direction of any of the Securityholders pursuant to the provisions of this Indenture, unless such Securityholders shall
have offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities that may be incurred therein
or thereby; nothing contained herein shall, however, relieve the Trustee of the obligation, upon the occurrence of an Event of
Default with respect to a series of the Securities (that has not been cured or waived), to exercise with respect to Securities
of that series such of the rights and powers vested in it by this Indenture, and to use the same degree of care and skill in their
exercise, as a prudent man would exercise or use under the circumstances in the conduct of his own affairs;
(e)
The Trustee shall not be liable for any action taken or omitted to be taken by it in good faith and believed by it to be authorized
or within the discretion or rights or powers conferred upon it by this Indenture;
(f)
The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, approval, bond, security, or other papers or documents, unless requested
in writing so to do by the holders of not less than a majority in principal amount of the Outstanding Securities of the particular
series affected thereby (determined as provided in Section 8.04); provided, however, that if the payment within a reasonable
time to the Trustee of the costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in
the opinion of the Trustee, not reasonably assured to the Trustee by the security afforded to it by the terms of this Indenture,
the Trustee may require reasonable indemnity against such costs, expenses or liabilities as a condition to so proceeding.
The reasonable expense of every such examination shall be paid by the Company or, if paid by the Trustee, shall be repaid by the
Company upon demand;
(g)
The Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through
agents or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney
appointed with due care by it hereunder;
(h)
In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder
arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages,
accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions,
loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee
shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon
as practicable under the circumstances;
(i)
In no event shall the Trustee be responsible or liable for special, indirect, or consequential loss or damage of any kind whatsoever
(including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such
loss or damage and regardless of the form of action; and
(j)
The Trustee agrees to accept and act upon instructions or directions pursuant to this Indenture sent by unsecured e-mail, facsimile
transmission or other similar unsecured electronic methods; provided, however, that (a) the party providing such written instructions,
subsequent to such transmission of written instructions, shall provide the originally executed instructions or directions to the
Trustee in a timely manner, and (b) such originally executed instructions or directions shall be signed by an authorized representative
of the party providing such instructions or directions. If the party elects to give the Trustee e-mail or facsimile instructions
(or instructions by a similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee’s
understanding of such instructions shall be deemed controlling. The Trustee shall not be liable for any losses, costs or
expenses arising directly or indirectly from the Trustee’s reliance upon and compliance with such instructions notwithstanding
such instructions conflict or are inconsistent with a subsequent written instruction. The party providing electronic instructions
agrees to assume all risks arising out of the use of such electronic methods to submit instructions and directions to the Trustee,
including without limitation the risk of the Trustee acting on unauthorized instructions, and the risk or interception and misuse
by third parties.
In addition, the Trustee shall not be deemed
to have knowledge of any Default or Event of Default until the Trustee shall have received written notification in the manner set
forth in this Indenture or a Responsible Officer of the Trustee shall have obtained actual knowledge.
Section 7.03
Trustee Not Responsible for Recitals or Issuance or Securities.
(a)
The recitals contained herein and in the Securities shall be taken as the statements of the Company, and the Trustee assumes
no responsibility for the correctness of the same.
(b)
The Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Securities.
(c)
The Trustee shall not be accountable for the use or application by the Company of any of the Securities or of the proceeds
of such Securities, or for the use or application of any moneys paid over by the Trustee in accordance with any provision of this
Indenture or established pursuant to Section 2.01, or for the use or application of any moneys received by any paying agent
other than the Trustee.
Section 7.04
May Hold Securities.
The Trustee or any paying agent or Security
Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would
have if it were not Trustee, paying agent or Security Registrar.
Section 7.05
Moneys Held in Trust.
Subject to the provisions of Section 11.05,
all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which
they were received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be
under no liability for interest on any moneys received by it hereunder except such as it may agree with the Company to pay thereon.
Section 7.06
Compensation and Reimbursement.
(a)
The Company covenants and agrees to pay to the Trustee, and the Trustee shall be entitled to, such reasonable compensation
(which shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust) as the Company
and the Trustee may from time to time agree in writing, for all services rendered by it in the execution of the trusts hereby created
and in the exercise and performance of any of the powers and duties hereunder of the Trustee, and, except as otherwise expressly
provided herein, the Company will pay or reimburse the Trustee upon its request for all reasonable expenses, disbursements and
advances incurred or made by the Trustee in accordance with any of the provisions of this Indenture (including the reasonable compensation
and the expenses and disbursements of its counsel and of all Persons not regularly in its employ), except any such expense, disbursement
or advance as may arise from its negligence or bad faith and except as the Company and Trustee may from time to time agree in writing.
The Company also covenants to indemnify the Trustee (and its officers, agents, directors and employees) for, and to hold it harmless
against, any loss, liability or expense incurred without negligence or bad faith on the part of the Trustee and arising out of
or in connection with the acceptance or administration of this trust, including the reasonable costs and expenses of defending
itself against any claim of liability in the premises.
(b)
The obligations of the Company under this Section to compensate and indemnify the Trustee and to pay or reimburse the
Trustee for reasonable expenses, disbursements and advances shall constitute additional indebtedness hereunder. Such additional
indebtedness shall be secured by a lien prior to that of the Securities upon all property and funds held or collected by the Trustee
as such, except funds held in trust for the benefit of the holders of particular Securities.
(c)
To ensure the Company’s payment obligations in this Section, the Trustee shall have a lien prior to the Securities on
all funds or property held or collected by the Trustee, except that held in trust to pay principal of or interest on particular
Securities. When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 6.01(4) or
(5), the expenses (including the reasonable fees and expenses of its counsel) and the compensation for services in connection therewith
are to constitute expenses of administration under any bankruptcy law. The provisions of this Section 7.06 shall survive
the termination of this Indenture and the resignation or removal of the Trustee.
Section 7.07
Reliance on Officer’s Certificate.
Except as otherwise provided in Section 7.01,
whenever in the administration of the provisions of this Indenture the Trustee shall deem it reasonably necessary or desirable
that a matter be proved or established prior to taking or suffering or omitting to take any action hereunder, such matter (unless
other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part
of the Trustee, be deemed to be conclusively proved and established by an Officer’s Certificate delivered to the Trustee
and such certificate, in the absence of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee
for any action taken, suffered or omitted to be taken by it under the provisions of this Indenture upon the faith thereof.
Section 7.08
Disqualification; Conflicting Interests.
If the Trustee has or shall acquire any “conflicting
interest” within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and the Company shall in
all respects comply with the provisions of Section 310(b) of the Trust Indenture Act.
Section 7.09
Corporate Trustee Required; Eligibility.
There shall at all times be a Trustee with respect
to the Securities issued hereunder which shall at all times be a corporation organized and doing business under the laws of the
United States of America or any state or territory thereof or of the District of Columbia, or a corporation or other Person permitted
to act as trustee by the Commission, authorized under such laws to exercise corporate trust powers, having a combined capital and
surplus of at least fifty million U.S. dollars ($50,000,000), and subject to supervision or examination by federal, state, territorial,
or District of Columbia authority.
If such corporation or other Person publishes
reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority,
then for the purposes of this Section, the combined capital and surplus of such corporation or other Person shall be deemed to
be its combined capital and surplus as set forth in its most recent report of condition so published. The Company may not,
nor may any Person directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee.
In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall
resign immediately in the manner and with the effect specified in Section 7.10.
Section 7.10
Resignation and Removal; Appointment of Successor.
(a)
The Trustee or any successor hereafter appointed may at any time resign with respect to the Securities of one or more series
by giving written notice thereof to the Company and by transmitting notice of resignation by mail, first class postage prepaid,
to the Securityholders of such series, as their names and addresses appear upon the Security Register. Upon receiving such
notice of resignation, the Company shall promptly appoint a successor trustee with respect to Securities of such series by written
instrument, in duplicate, executed by order of the Board of Directors, one copy of which instrument shall be delivered to the resigning
Trustee and one copy to the successor trustee. If no successor trustee shall have been so appointed and have accepted appointment
within 30 days after the mailing of such notice of resignation, the resigning Trustee may petition any court of competent jurisdiction
for the appointment of a successor trustee with respect to Securities of such series, or any Securityholder of that series who
has been a bona fide holder of a Security or Securities for at least six months may on behalf of himself and all others similarly
situated, petition any such court for the appointment of a successor trustee. Such court may thereupon after such notice,
if any, as it may deem proper and prescribe, appoint a successor trustee.
(b)
In case at any time any one of the following shall occur:
(i)
the Trustee shall fail to comply with the provisions of Section 7.08 after written request therefor by the Company or
by any Securityholder who has been a bona fide holder of a Security or Securities for at least six months; or
(ii)
the Trustee shall cease to be eligible in accordance with the provisions of Section 7.09 and shall fail to resign after
written request therefor by the Company or by any such Securityholder; or
(iii)
the Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy
proceeding, or a receiver of the Trustee or of its property shall be appointed or consented to, or any public officer shall take
charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation;
then, in any such case, the Company may remove
the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate, executed by order
of the Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor
trustee, or any Securityholder who has been a bona fide holder of a Security or Securities for at least six months may, on behalf
of that holder and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and
the appointment of a successor trustee. Such court may thereupon after such notice, if any, as it may deem proper and prescribe,
remove the Trustee and appoint a successor trustee.
(c)
The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding may at any
time remove the Trustee with respect to such series by so notifying the Trustee and the Company and may appoint a successor Trustee
for such series with the consent of the Company.
(d)
Any resignation or removal of the Trustee and appointment of a successor trustee with respect to the Securities of a series
pursuant to any of the provisions of this Section shall become effective upon acceptance of appointment by the successor trustee
as provided in Section 7.11.
(e)
Any successor trustee appointed pursuant to this Section may be appointed with respect to the Securities of one or more
series or all of such series, and at any time there shall be only one Trustee with respect to the Securities of any particular
series.
Section 7.11
Acceptance of Appointment By Successor.
(a)
In case of the appointment hereunder of a successor trustee with respect to all Securities, every such successor trustee so
appointed shall execute, acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment,
and thereupon the resignation or removal of the retiring Trustee shall become effective and such successor trustee, without any
further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee; but,
on the request of the Company or the successor trustee, such retiring Trustee shall, upon payment of its charges, execute and deliver
an instrument transferring to such successor trustee all the rights, powers, and trusts of the retiring Trustee and shall duly
assign, transfer and deliver to such successor trustee all property and money held by such retiring Trustee hereunder.
(b)
In case of the appointment hereunder of a successor trustee with respect to the Securities of one or more (but not all) series,
the Company, the retiring Trustee and each successor trustee with respect to the Securities of one or more series shall execute
and deliver an indenture supplemental hereto wherein each successor trustee shall accept such appointment and which (i) shall
contain such provisions as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all
the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series to which the
appointment of such successor trustee relates, (ii) shall contain such provisions as shall be deemed necessary or desirable
to confirm that all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those
series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring Trustee, and (iii) shall
add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration
of the trusts hereunder by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall
constitute such Trustees co-trustees of the same trust, that each such Trustee shall be trustee of a trust or trusts hereunder
separate and apart from any trust or trusts hereunder administered by any other such Trustee and that no Trustee shall be responsible
for any act or failure to act on the part of any other Trustee hereunder; and upon the execution and delivery of such supplemental
indenture the resignation or removal of the retiring Trustee shall become effective to the extent provided therein, such retiring
Trustee shall with respect to the Securities of that or those series to which the appointment of such successor trustee relates
have no further responsibility for the exercise of rights and powers or for the performance of the duties and obligations vested
in the Trustee under this Indenture, and each such successor trustee, without any further act, deed or conveyance, shall become
vested with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series
to which the appointment of such successor trustee relates; but, on request of the Company or any successor trustee, such retiring
Trustee shall duly assign, transfer and deliver to such successor trustee, to the extent contemplated by such supplemental indenture,
the property and money held by such retiring Trustee hereunder with respect to the Securities of that or those series to which
the appointment of such successor trustee relates.
(c)
Upon request of any such successor trustee, the Company shall execute any and all instruments for more fully and certainly
vesting in and confirming to such successor trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of
this Section, as the case may be.
(d)
No successor trustee shall accept its appointment unless at the time of such acceptance such successor trustee shall be qualified
and eligible under this Article.
(e)
Upon acceptance of appointment by a successor trustee as provided in this Section, the Company shall transmit notice of the
succession of such trustee hereunder by mail, first class postage prepaid, to the Securityholders, as their names and addresses
appear upon the Security Register. If the Company fails to transmit such notice within ten days after acceptance of appointment
by the successor trustee, the successor trustee shall cause such notice to be transmitted at the expense of the Company.
Section 7.12
Merger, Conversion, Consolidation or Succession to Business.
Any corporation into which the Trustee may be
merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation
to which the Trustee shall be a party, or any corporation succeeding to the corporate trust business of the Trustee, including
the administration of the trust created by this Indenture, shall be the successor of the Trustee hereunder, provided that such
corporation shall be qualified under the provisions of Section 7.08 and eligible under the provisions of Section 7.09,
without the execution or filing of any paper or any further act on the part of any of the parties hereto, anything herein to the
contrary notwithstanding. In case any Securities shall have been authenticated, but not delivered, by the Trustee then in
office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication and deliver
the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities.
Section 7.13
Preferential Collection of Claims Against the Company.
The Trustee shall comply with Section 311(a) of
the Trust Indenture Act, excluding any creditor relationship described in Section 311(b) of the Trust Indenture Act.
A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent
included therein.
Section 7.14
Notice of Default
If any Event of Default occurs and is continuing
and if such Event of Default is known to a Responsible Officer of the Trustee, the Trustee shall mail to each Securityholder in
the manner and to the extent provided in Section 313(c) of the Trust Indenture Act notice of the Event of Default within
the earlier of 90 days after it occurs and 30 days after it is known to a Responsible Officer of the Trustee or written notice
of it is received by the Trustee, unless such Event of Default has been cured; provided, however, that, except in the case
of a default in the payment of the principal of (or premium, if any) or interest on any Security, the Trustee shall be protected
in withholding such notice if and so long as the board of directors, the executive committee or a trust committee of directors
and/or Responsible Officers of the Trustee in good faith determine that the withholding of such notice is in the interest of the
Securityholders.
ARTICLE 8
CONCERNING THE SECURITYHOLDERS
Section 8.01
Evidence of Action by Securityholders.
Whenever in this Indenture it is provided that
the holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular series may take
any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other
action), the fact that at the time of taking any such action the holders of such majority or specified percentage of that series
have joined therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such holders of
Securities of that series in person or by agent or proxy appointed in writing.
If the Company shall solicit from the Securityholders
of any series any request, demand, authorization, direction, notice, consent, waiver or other action, the Company may, at its option,
as evidenced by an Officer’s Certificate, fix in advance a record date for such series for the determination of Securityholders
entitled to give such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company shall
have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent,
waiver or other action may be given before or after the record date, but only the Securityholders of record at the close of business
on the record date shall be deemed to be Securityholders for the purposes of determining whether Securityholders of the requisite
proportion of Outstanding Securities of that series have authorized or agreed or consented to such request, demand, authorization,
direction, notice, consent, waiver or other action, and for that purpose the Outstanding Securities of that series shall be computed
as of the record date; provided, however, that no such authorization, agreement or consent by such Securityholders on the record
date shall be deemed effective unless it shall become effective pursuant to the provisions of this Indenture not later than six
months after the record date.
Section 8.02
Proof of Execution by Securityholders.
Subject to the provisions of Section 7.01,
proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his agent or proxy and
proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:
(a)
The fact and date of the execution by any such Person of any instrument may be proved in any reasonable manner acceptable to
the Trustee.
(b)
The ownership of Securities shall be proved by the Security Register of such Securities or by a certificate of the Security
Registrar thereof.
The Trustee may require such additional proof of any matter referred
to in this Section as it shall deem necessary.
Section 8.03
Who May be Deemed Owners.
Prior to the due presentment for registration
of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and treat the Person
in whose name such Security shall be registered upon the books of the Company as the absolute owner of such Security (whether or
not such Security shall be overdue and notwithstanding any notice of ownership or writing thereon made by anyone other than the
Security Registrar) for the purpose of receiving payment of or on account of the principal of, premium, if any, and (subject to
Section 2.03) interest on such Security and for all other purposes; and neither the Company nor the Trustee nor any paying
agent nor any Security Registrar shall be affected by any notice to the contrary.
Section 8.04
Certain Securities Owned by Company Disregarded.
In determining whether the holders of the requisite
aggregate principal amount of Securities of a particular series have concurred in any direction, consent or waiver under this Indenture,
the Securities of that series that are owned by the Company or any other obligor on the Securities of that series or by any Person
directly or indirectly controlling or controlled by or under common control with the Company or any other obligor on the Securities
of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for
the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or waiver, only Securities
of such series that the Trustee actually knows are so owned shall be so disregarded. The Securities so owned that have been
pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee shall establish to the satisfaction
of the Trustee the pledgee’s right so to act with respect to such Securities and that the pledgee is not a Person directly
or indirectly controlling or controlled by or under direct or indirect common control with the Company or any such other obligor.
In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to
the Trustee.
Section 8.05
Actions Binding on Future Securityholders.
At any time prior to (but not after) the evidencing
to the Trustee, as provided in Section 8.01, of the taking of any action by the holders of the majority or percentage in aggregate
principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any holder
of a Security of that series that is shown by the evidence to be included in the Securities the holders of which have consented
to such action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke
such action so far as concerns such Security. Except as aforesaid any such action taken by the holder of any Security shall
be conclusive and binding upon such holder and upon all future holders and owners of such Security, and of any Security issued
in exchange therefor, on registration of transfer thereof or in place thereof, irrespective of whether or not any notation in regard
thereto is made upon such Security. Any action taken by the holders of the majority or percentage in aggregate principal
amount of the Securities of a particular series specified in this Indenture in connection with such action shall be conclusively
binding upon the Company, the Trustee and the holders of all the Securities of that series.
ARTICLE 9
SUPPLEMENTAL INDENTURES
Section 9.01
Supplemental Indentures Without the Consent of Securityholders.
In addition to any supplemental indenture otherwise
authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture or indentures
supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent of
the Securityholders, for one or more of the following purposes:
(a)
to cure any ambiguity, defect, or inconsistency herein or in the Securities of any series;
(b)
to comply with Article Ten;
(c)
to provide for uncertificated Securities in addition to or in place of certificated Securities;
(d)
to add to the covenants, restrictions, conditions or provisions relating to the Company for the benefit of the holders of all
or any series of Securities (and if such covenants, restrictions, conditions or provisions are to be for the benefit of less than
all series of Securities, stating that such covenants, restrictions, conditions or provisions are expressly being included solely
for the benefit of such series), to make the occurrence, or the occurrence and the continuance, of a default in any such additional
covenants, restrictions, conditions or provisions an Event of Default, or to surrender any right or power herein conferred upon
the Company;
(e)
to add to, delete from, or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes
of issue, authentication, and delivery of Securities, as herein set forth;
(f)
to make any change that does not adversely affect the rights of any Securityholder in any material respect;
(g)
to provide for the issuance of and establish the form and terms and conditions of the Securities of any series as provided
in Section 2.01, to establish the form of any certifications required to be furnished pursuant to the terms of this Indenture
or any series of Securities, or to add to the rights of the holders of any series of Securities;
(h)
to evidence and provide for the acceptance of appointment hereunder by a successor trustee; or
(i)
to comply with any requirements of the Commission or any successor in connection with the qualification of this Indenture under
the Trust Indenture Act.
The Trustee is hereby authorized to join with
the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations
that may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects
the Trustee’s own rights, duties or immunities under this Indenture or otherwise.
Any supplemental indenture authorized by the
provisions of this Section may be executed by the Company and the Trustee without the consent of the holders of any of the
Securities at the time Outstanding, notwithstanding any of the provisions of Section 9.02.
Section 9.02
Supplemental Indentures With Consent of Securityholders.
With the consent (evidenced as provided in Section 8.01)
of the holders of not less than a majority in aggregate principal amount of the Securities of each series affected by such supplemental
indenture or indentures at the time Outstanding, the Company, when authorized by a Board Resolution, and the Trustee may from time
to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the
Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating any
of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner not covered by Section 9.01
the rights of the holders of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture
shall, without the consent of the holders of each Security then Outstanding and affected thereby, (a) extend the fixed maturity
of any Securities of any series, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest
thereon, or reduce any premium payable upon the redemption thereof or (b) reduce the aforesaid percentage of Securities, the
holders of which are required to consent to any such supplemental indenture.
It shall not be necessary for the consent of
the Securityholders of any series affected thereby under this Section to approve the particular form of any proposed supplemental
indenture, but it shall be sufficient if such consent shall approve the substance thereof.
Section 9.03
Effect of Supplemental Indentures.
Upon the execution of any supplemental indenture
pursuant to the provisions of this Article or of Section 10.01, this Indenture shall, with respect to such series, be
and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations,
duties and immunities under this Indenture of the Trustee, the Company and the holders of Securities of the series affected thereby
shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments,
and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions
of this Indenture for any and all purposes.
Section 9.04
Securities Affected by Supplemental Indentures.
Securities of any series affected by a supplemental
indenture, authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions of this Article or
of Section 10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of any securities
exchange upon which such series may be listed, as to any matter provided for in such supplemental indenture. If the Company
shall so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors, to any modification
of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee and
delivered in exchange for the Securities of that series then Outstanding.
Section 9.05
Execution of Supplemental Indentures.
Upon the request of the Company, accompanied
by its Board Resolutions authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of
evidence of the consent of Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company in
the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties
or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion but shall not be obligated to
enter into such supplemental indenture. The Trustee, subject to the provisions of Section 7.01, shall receive an Officer’s
Certificate or an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article is
authorized or permitted by the terms of this Article and that all conditions precedent to the execution of the supplemental
indenture have been complied with; provided, however, that such Officer’s Certificate or Opinion of Counsel need not be provided
in connection with the execution of a supplemental indenture that establishes the terms of a series of Securities pursuant to Section 2.01
hereof.
Promptly after the execution by the Company
and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Company shall (or shall direct the
Trustee to) transmit by mail, first class postage prepaid, a notice, setting forth in general terms the substance of such supplemental
indenture, to the Securityholders of all series affected thereby .as their names and addresses appear upon the Security Register.
Any failure of the Company to mail, or cause the mailing of, such notice, or any defect therein, shall not, however, in any way
impair or affect the validity of any such supplemental indenture.
ARTICLE 10
SUCCESSOR ENTITY
Section 10.01
Company May Consolidate, Etc.
Nothing contained in this Indenture shall prevent
any consolidation or merger of the Company with or into any other Person (whether or not affiliated with the Company) or successive
consolidations or mergers in which the Company or its successor or successors shall be a party or parties, or shall prevent any
sale, conveyance, transfer or other disposition of the property of the Company or its successor or successors as an entirety, or
substantially as an entirety, to any other corporation (whether or not affiliated with the Company or its successor or successors)
authorized to acquire and operate the same; provided, however, (a) the Company hereby covenants and agrees that, upon any
such consolidation or merger (in each case, if the Company is not the survivor of such transaction), sale, conveyance, transfer
or other disposition, the due and punctual payment of the principal of (premium, if any) and interest on all of the Securities
of all series in accordance with the terms of each series, according to their tenor, and the due and punctual performance and observance
of all the covenants and conditions of this Indenture with respect to each series or established with respect to such series pursuant
to Section 2.01 to be kept or performed by the Company shall be expressly assumed, by supplemental indenture (which shall
conform to the provisions of the Trust Indenture Act, as then in effect) reasonably satisfactory in form to the Trustee executed
and delivered to the Trustee by the entity formed by such consolidation, or into which the Company shall have been merged, or by
the entity which shall have acquired such property and (b) in the event that the Securities of any series then Outstanding
are convertible into or exchangeable for shares of common stock or other securities of the Company, such entity shall, by such
supplemental indenture, make provision so that the Securityholders of Securities of that series shall thereafter be entitled to
receive upon conversion or exchange of such Securities the number of securities or property to which a holder of the number of
shares of common stock or other securities of the Company deliverable upon conversion or exchange of those Securities would have
been entitled had such conversion or exchange occurred immediately prior to such consolidation, merger, sale, conveyance, transfer
or other disposition.
Section 10.02
Successor Entity Substituted.
(a) In case of any such consolidation,
merger, sale, conveyance, transfer or other disposition and upon the assumption by the successor entity by supplemental indenture,
executed and delivered to the Trustee and satisfactory in form to the Trustee, of the obligations set forth under Section 10.01
on all of the Securities of all series Outstanding, such successor entity shall succeed to and be substituted for the Company with
the same effect as if it had been named as the Company herein, and thereupon the predecessor corporation shall be relieved of all
obligations and covenants under this Indenture and the Securities.
(b) In case of any such consolidation,
merger, sale, conveyance, transfer or other disposition, such changes in phraseology and form (but not in substance) may be made
in the Securities thereafter to be issued as may be appropriate.
(c) Nothing contained in this
Article shall require any action by the Company in the case of a consolidation or merger of any Person into the Company where
the Company is the survivor of such transaction, or the acquisition by the Company, by purchase or otherwise, of all or any part
of the property of any other Person (whether or not affiliated with the Company).
ARTICLE 11
SATISFACTION AND DISCHARGE
Section 11.01
Satisfaction and Discharge of Indenture.
If at any time: (a) the Company shall have
delivered to the Trustee for cancellation all Securities of a series theretofore authenticated and not delivered to the Trustee
for cancellation (other than any Securities that shall have been destroyed, lost or stolen and that shall have been replaced or
paid as provided in Section 2.07 and Securities for whose payment money or Governmental Obligations have theretofore been
deposited in trust or segregated and held in trust by the Company and thereupon repaid to the Company or discharged from such trust,
as provided in Section 11.05); or (b) all such Securities of a particular series not theretofore delivered to the Trustee
for cancellation shall have become due and payable, or are by their terms to become due and payable within one year or are to be
called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and
the Company shall deposit or cause to be deposited with the Trustee as trust funds the entire amount in moneys or Governmental
Obligations or a combination thereof, sufficient in the opinion of a nationally recognized firm of independent public accountants
expressed in a written certification thereof delivered to the Trustee, to pay at maturity or upon redemption all Securities of
that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due
or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or
cause to be paid all other sums payable hereunder with respect to such series by the Company then this Indenture shall thereupon
cease to be of further effect with respect to such series except for the provisions of Sections 2.03, 2.05, 2.07, 4.01, 4.02, 4.03
and 7.10, that shall survive until the date of maturity or redemption date, as the case may be, and Sections 7.06 and 11.05, that
shall survive to such date and thereafter, and the Trustee, on demand of the Company and at the cost and expense of the Company
shall execute proper instruments acknowledging satisfaction of and discharging this Indenture with respect to such series.
Section 11.02
Discharge of Obligations.
If at any time all such Securities of a particular
series not heretofore delivered to the Trustee for cancellation or that have not become due and payable as described in Section 11.01
shall have been paid by the Company by depositing irrevocably with the Trustee as trust funds moneys or an amount of Governmental
Obligations sufficient to pay at maturity or upon redemption all such Securities of that series not theretofore delivered to the
Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date of maturity
or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable
hereunder by the Company with respect to such series, then after the date such moneys or Governmental Obligations, as the case
may be, are deposited with the Trustee the obligations of the Company under this Indenture with respect to such series shall cease
to be of further effect except for the provisions of Sections 2.03, 2.05, 2.07, 4,01, 4.02, 4,03, 7.06, 7.10 and 11.05 hereof that
shall survive until such Securities shall mature and be paid.
Thereafter, Sections 7.06 and 11.05 shall survive.
Section 11.03
Deposited Moneys to be Held in Trust.
All moneys or Governmental Obligations deposited
with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment as due, either directly
or through any paying agent (including the Company acting as its own paying agent), to the holders of the particular series of
Securities for the payment or redemption of which such moneys or Governmental Obligations have been deposited with the Trustee.
Section 11.04
Payment of Moneys Held by Paying Agents.
In connection with the satisfaction and discharge
of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions of this Indenture shall,
upon demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability
with respect to such moneys or Governmental Obligations.
Section 11.05
Repayment to Company.
Any moneys or Governmental Obligations deposited
with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of or premium, if any, or
interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for
at least two years after the date upon which the principal of (and premium, if any) or interest on such Securities shall have respectively
become due and payable, or such other shorter period set forth in applicable escheat or abandoned or unclaimed property law, shall
be repaid to the Company on May 31 of each year or upon the Company’s request or (if then held by the Company) shall
be discharged from such trust; and thereupon the paying agent and the Trustee shall be released from all further liability with
respect to such moneys or Governmental Obligations, and the holder of any of the Securities entitled to receive such payment shall
thereafter, as a general creditor, look only to the Company for the payment thereof.
ARTICLE 12
IMMUNITY OF INCORPORATORS, STOCKHOLDERS,
OFFICERS AND DIRECTORS
Section 12.01
No Recourse.
No recourse under or upon any obligation, covenant
or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof, shall be had
against any incorporator, stockholder, officer or director, past, present or future as such, of the Company or of any predecessor
or successor corporation, either directly or through the Company or any such predecessor or successor corporation, whether by virtue
of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly
understood that this Indenture and the obligations issued hereunder are solely corporate obligations, and that no such personal
liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, officers or directors as such,
of the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness hereby
authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities
or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in equity
or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, stockholder, officer
or director as such, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants
or agreements contained in this Indenture or in any of the Securities or implied therefrom, are hereby expressly waived and released
as a condition of, and as a consideration for, the execution of this Indenture and the issuance of such Securities.
ARTICLE 13
MISCELLANEOUS PROVISIONS
Section 13.01
Effect on Successors and Assigns.
All the covenants, stipulations, promises and
agreements in this Indenture made by or on behalf of the Company shall bind its successors and assigns, whether so expressed or
not.
Section 13.02
Actions by Successor.
Any act or proceeding by any provision of this
Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done
and performed with like force and effect by the corresponding board, committee or officer of any corporation that shall at the
time be the lawful successor of the Company.
Section 13.03
Surrender of Company Powers.
The Company by instrument in writing executed
by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the Company, and
thereupon such power so surrendered shall terminate both as to the Company and as to any successor corporation.
Section 13.04
Notices.
Except as otherwise expressly provided herein,
any notice, request or demand that by any provision of this Indenture is required or permitted to be given, made or served by the
Trustee or by the holders of Securities or by any other Person pursuant to this Indenture to or on the Company may be given or
served by being deposited in first class mail, postage prepaid, addressed (until another address is filed in writing by the Company
with the Trustee), as follows: .
Any notice, election, request or demand by the Company or any Securityholder or by any other Person pursuant to this Indenture
to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or made in writing at
the Corporate Trust Office of the Trustee.
Section 13.05
Governing Law.
This Indenture and each Security shall be deemed
to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with
the laws of said State, except to the extent that the Trust Indenture Act is applicable.
Section 13.06
Treatment of Securities as Debt.
It is intended that the Securities will be treated
as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be interpreted
to further this intention.
Section 13.07
Certificates and Opinions as to Conditions Precedent.
(a) Upon any application or
demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall furnish
to the Trustee an Officer’s Certificate stating that all conditions precedent provided for in this Indenture (other than
the certificate to be delivered pursuant to Section 13.12) relating to the proposed action have been complied with and, if
requested, an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been complied with,
except that in the case of any such application or demand as to which the furnishing of such documents is specifically required
by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need
be furnished.
(b) Each certificate or opinion
provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant in this Indenture
shall include (i) a statement that the Person making such certificate or opinion has read such covenant or condition; (ii) a
brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained
in such certificate or opinion are based; (iii) a statement that, in the opinion of such Person, he has made such examination
or investigation as is reasonably necessary to enable him to express an informed opinion as to whether or not such covenant or
condition has been complied with; and (iv) a statement as to whether or not, in the opinion of such Person, such condition
or covenant has been complied with.
Section 13.08
Payments on Business Days.
Except as provided pursuant to Section 2.01
pursuant to a Board Resolution, and set forth in an Officer’s Certificate, or established in one or more indentures supplemental
to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date of redemption of
any Security shall not be a Business Day, then payment of interest or principal (and premium, if any) may be made on the next succeeding
Business Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest shall accrue
for the period after such nominal date.
Section 13.09
Conflict with Trust Indenture Act.
If and to the extent that any provision of this
Indenture limits, qualifies or conflicts with the duties imposed by Sections 310 to 317, inclusive, of the Trust Indenture Act,
such imposed duties shall control.
Section 13.10
Counterparts.
This Indenture may be executed in any number
of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument.
Section 13.11
Separability.
In case any one or more of the provisions contained
in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable in any
respect,
such invalidity, illegality or unenforceability shall not affect
any other provisions of this Indenture or of such Securities, but this Indenture and such Securities shall be construed as if such
invalid or illegal or unenforceable provision had never been contained herein or therein.
Section 13.12
Compliance Certificates.
The Company shall deliver to the Trustee, within
120 days after the end of each fiscal year during which any Securities of any series were outstanding, an officer’s certificate
stating whether or not the signers know of any Event of Default that occurred during such fiscal year. Such certificate shall
contain a certification from the principal executive officer, principal financial officer or principal accounting officer of the
Company that a review has been conducted of the activities of the Company and the Company’s performance under this Indenture
and that the Company has complied with all conditions and covenants under this Indenture. For purposes of this Section 13.12,
such compliance shall be determined without regard to any period of grace or requirement of notice provided under this Indenture.
If the officer of the Company signing such certificate has knowledge of such an Event of Default, the certificate shall describe
any such Event of Default and its status.
IN WITNESS WHEREOF, the parties hereto
have caused this Indenture to be duly executed all as of the day and year first above written.
|
ADVANCED CELL TECHNOLOGY, INC. |
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
|
[TRUSTEE], as Trustee |
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
CROSS-REFERENCE TABLE (1)
Section of Trust Indenture Act of 1939, as Amended |
|
Section of Indenture |
310(a) |
|
7.09 |
310(b) |
|
7.08 |
|
|
7.10 |
310(c) |
|
Inapplicable |
311(a) |
|
7.13 |
311(b) |
|
7.13 |
311(c) |
|
Inapplicable |
312(a) |
|
5.01 |
|
|
5.02(a) |
312(b) |
|
5.02(c) |
312(c) |
|
5.02(c) |
313(a) |
|
5.04(a) |
313(b) |
|
5.04(b) |
313(c) |
|
5.04(a) |
|
|
5.04(b) |
313(d) |
|
5.04(c) |
314(a) |
|
5.03 |
|
|
13.12 |
314(b) |
|
Inapplicable |
314(c) |
|
13.07(a) |
314(d) |
|
Inapplicable |
314(e) |
|
13.07(b) |
314(f) |
|
Inapplicable |
315(a) |
|
7.01(a) |
|
|
7.01(b) |
315(b) |
|
7.14 |
315(c) |
|
7.01 |
315(d) |
|
7.01(b) |
315(e) |
|
6.07 |
316(a) |
|
6.06 |
|
|
8.04 |
316(b) |
|
6.04 |
316(c) |
|
8.01 |
317(a) |
|
6.02 |
317(b) |
|
4.03 |
318(a) |
|
13.09 |
(1)
This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any
of its terms or provisions.
Exhibit 4.6
ADVANCED CELL TECHNOLOGY, INC.
Issuer
AND
[TRUSTEE],
Trustee
INDENTURE
Dated as of [·],
201[·]
Subordinated Debt Securities
TABLE OF CONTENTS
|
PAGE |
|
|
ARTICLE 1 DEFINITIONS |
1 |
|
|
|
Section 1.01 |
Definitions of Terms |
1 |
|
|
|
ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES |
4 |
|
|
|
Section 2.01 |
Designation and Terms of Securities |
4 |
|
|
|
Section 2.02 |
Form of Securities and Trustee’s Certificate |
6 |
|
|
|
Section 2.03 |
Denominations: Provisions for Payment |
6 |
|
|
|
Section 2.04 |
Execution and Authentications |
7 |
|
|
|
Section 2.05 |
Registration of Transfer and Exchange |
7 |
|
|
|
Section 2.06 |
Temporary Securities |
8 |
|
|
|
Section 2.07 |
Mutilated, Destroyed, Lost or Stolen Securities |
8 |
|
|
|
Section 2.08 |
Cancellation |
9 |
|
|
|
Section 2.09 |
Benefits of Indenture |
9 |
|
|
|
Section 2.10 |
Authenticating Agent |
9 |
|
|
|
Section 2.11 |
Global Securities |
9 |
|
|
|
ARTICLE 3 REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS |
10 |
|
|
|
Section 3.01 |
Redemption |
10 |
|
|
|
Section 3.02 |
Notice of Redemption |
10 |
|
|
|
Section 3.03 |
Payment Upon Redemption |
11 |
|
|
|
Section 3.04 |
Sinking Fund |
11 |
|
|
|
Section 3.05 |
Satisfaction of Sinking Fund Payments with Securities |
17 |
|
|
|
Section 3.06 |
Redemption of Securities for Sinking Fund |
12 |
|
|
|
ARTICLE 4 COVENANTS |
12 |
|
|
|
Section 4.01 |
Payment of Principal, Premium and Interest |
12 |
|
|
|
Section 4.02 |
Maintenance of Office or Agency |
12 |
|
|
|
Section 4.03 |
Paying Agents |
12 |
|
|
|
Section 4.04 |
Appointment to Fill Vacancy in Office of Trustee |
13 |
|
|
|
Section 4.05 |
Compliance with Consolidation Provisions |
13 |
|
|
|
ARTICLE 5 SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE |
13 |
|
PAGE |
|
|
Section 5.01 |
Company to Furnish Trustee Names and Addresses of Securityholders |
13 |
|
|
|
Section 5.02 |
Preservation Of Information; Communications With Securityholders |
13 |
|
|
|
Section 5.03 |
Reports by the Company |
14 |
|
|
|
Section 5.04 |
Reports by the Trustee |
14 |
|
|
|
ARTICLE 6 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT |
14 |
|
|
|
Section 6.01 |
Events of Default |
14 |
|
|
|
Section 6.02 |
Collection of Indebtedness and Suits for Enforcement by Trustee |
15 |
|
|
|
Section 6.03 |
Application of Moneys Collected |
16 |
|
|
|
Section 6.04 |
Limitation on Suits |
17 |
|
|
|
Section 6.05 |
Rights and Remedies Cumulative; Delay or Omission Not Waiver |
17 |
|
|
|
Section 6.06 |
Control by Securityholders |
17 |
|
|
|
Section 6.07 |
Undertaking to Pay Costs |
18 |
|
|
|
ARTICLE 7 CONCERNING THE TRUSTEE |
18 |
|
|
|
Section 7.01 |
Certain Duties and Responsibilities of Trustee |
18 |
|
|
|
Section 7.02 |
Certain Rights of Trustee |
19 |
|
|
|
Section 7.03 |
Trustee Not Responsible for Recitals or Issuance or Securities |
20 |
|
|
|
Section 7.04 |
May Hold Securities |
20 |
|
|
|
Section 7.05 |
Moneys Held in Trust |
20 |
|
|
|
Section 7.06 |
Compensation and Reimbursement |
20 |
|
|
|
Section 7.07 |
Reliance on Officer’s Certificate |
21 |
|
|
|
Section 7.08 |
Disqualification; Conflicting Interests |
21 |
|
|
|
Section 7.09 |
Corporate Trustee Required; Eligibility |
21 |
|
|
|
Section 7.10 |
Resignation and Removal; Appointment of Successor |
21 |
|
|
|
Section 7.11 |
Acceptance of Appointment By Successor |
22 |
|
|
|
Section 7.12 |
Merger, Conversion, Consolidation or Succession to Business |
23 |
|
|
|
Section 7.13 |
Preferential Collection of Claims Against the Company |
23 |
|
|
|
Section 7.14 |
Notice of Default |
23 |
|
PAGE |
|
|
ARTICLE 8 CONCERNING THE SECURITYHOLDERS |
23 |
|
|
|
Section 8.01 |
Evidence of Action by Securityholders |
23 |
|
|
|
Section 8.02 |
Proof of Execution by Securityholders |
24 |
|
|
|
Section 8.03 |
Who May be Deemed Owners |
24 |
|
|
|
Section 8.04 |
Certain Securities Owned by Company Disregarded |
24 |
|
|
|
Section 8.05 |
Actions Binding on Future Securityholders |
24 |
|
|
|
ARTICLE 9 SUPPLEMENTAL INDENTURES |
25 |
|
|
|
Section 9.01 |
Supplemental Indentures Without the Consent of Securityholders |
25 |
|
|
|
Section 9.02 |
Supplemental Indentures With Consent of Securityholders |
25 |
|
|
|
Section 9.03 |
Effect of Supplemental Indentures |
26 |
|
|
|
Section 9.04 |
Securities Affected by Supplemental Indentures |
26 |
|
|
|
Section 9.05 |
Execution of Supplemental Indentures |
26 |
|
|
|
ARTICLE 10 SUCCESSOR ENTITY |
26 |
|
|
|
Section 10.01 |
Company May Consolidate, Etc. |
26 |
|
|
|
Section 10.02 |
Successor Entity Substituted |
27 |
|
|
|
ARTICLE 11 SATISFACTION AND DISCHARGE |
27 |
|
|
|
Section 11.01 |
Satisfaction and Discharge of Indenture |
27 |
|
|
|
Section 11.02 |
Discharge of Obligations |
27 |
|
|
|
Section 11.03 |
Deposited Moneys to be Held in Trust |
28 |
|
|
|
Section 11.04 |
Payment of Moneys Held by Paying Agents |
28 |
|
|
|
Section 11.05 |
Repayment to Company |
28 |
|
|
|
ARTICLE 12 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS |
28 |
|
|
|
Section 12.01 |
No Recourse |
28 |
|
|
|
ARTICLE 13 MISCELLANEOUS PROVISIONS |
28 |
|
|
|
Section 13.01 |
Effect on Successors and Assigns |
28 |
|
|
|
Section 13.02 |
Actions by Successor |
29 |
|
|
|
Section 13.03 |
Surrender of Company Powers |
29 |
|
|
|
Section 13.04 |
Notices |
29 |
|
|
|
|
PAGE |
Section 13.05 |
Governing Law |
29 |
Section 13.06 |
Treatment of Securities as Debt |
29 |
|
|
|
Section 13.07 |
Certificates and Opinions as to Conditions Precedent |
29 |
|
|
|
Section 13.08 |
Payments on Business Days |
29 |
|
|
|
Section 13.09 |
Conflict with Trust Indenture Act |
30 |
|
|
|
Section 13.10 |
Counterparts |
30 |
|
|
|
Section 13.11 |
Separability |
30 |
|
|
|
Section 13.12 |
Compliance Certificates |
30 |
|
|
|
ARTICLE 14 SUBORDINATION OF SECURITIES |
30 |
|
|
|
Section 14.01 |
Subordination Terms |
30 |
(1)
This Table of Contents does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of
its terms or provisions.
INDENTURE
INDENTURE, dated as of [·],
201 , among ADVANCED CELL TECHNOLOGY, INC., a Delaware corporation (the “Company”), and[TRUSTEE],
as trustee (the “Trustee”):
WHEREAS, for its lawful corporate purposes,
the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of subordinated debt securities
(hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to
time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the
certificate of the Trustee;
WHEREAS, to provide the terms and conditions
upon which the Securities are to be authenticated, issued and delivered, the Company has duly authorized the execution of this
Indenture; and
WHEREAS, all things necessary to make
this Indenture a valid agreement of the Company, in accordance with its terms, have been done.
NOW, THEREFORE, in consideration of the
premises and the purchase of the Securities by the holders thereof, it is mutually covenanted and agreed as follows for the equal
and ratable benefit of the holders of Securities:
ARTICLE 1
DEFINITIONS
Section 1.01
Definitions of Terms.
The terms defined in this Section (except
as in this Indenture or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires)
for all purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this
Section and shall include the plural as well as the singular. All other terms used in this Indenture that are defined
in the Trust Indenture Act of 1939, as amended, or that are by reference in such Act defined in the Securities Act of 1933, as
amended (except as herein or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires),
shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date of
the execution of this instrument.
“Authenticating Agent”
means an authenticating agent with respect to all or any of the series of Securities appointed by the Trustee pursuant to Section 2.10.
“Bankruptcy Law” means
Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.
“Board of Directors”
means the Board of Directors (or the functional equivalent thereof) of the Company or any duly authorized committee of such Board.
“Board Resolution”
means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the
Board of Directors and to be in full force and effect on the date of such certification.
“Business Day” means,
with respect to any series of Securities, any day other than a day on which federal or state banking institutions in the Borough
of Manhattan, the City of New York, or in the city of the Corporate Trust Office of the Trustee, are authorized or obligated by
law, executive order or regulation to close.
“Certificate” means
a certificate signed by any Officer. The Certificate need not comply with the provisions of Section 13.07.
“Commission” means
the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act, or, if at any time after
the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the Trust Indenture
Act, then the body performing such duties at such time.
“Company” means Advanced
Cell Technology, Inc., a corporation duly organized and existing under the laws of the State of Delaware, and, subject to
the provisions of Article Ten, shall also include its successors and assigns.
“Corporate Trust Office”
means the office of the Trustee at which, at any particular time, its corporate trust business shall be principally administered,
which office at the date hereof is located at .
“Custodian” means
any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.
“Defaulted Interest”
has the meaning set forth in Section 2.03.
“Depositary” means,
with respect to Securities of any series for which the Company shall determine that such Securities will be issued as a Global
Security, The Depository Trust Company, another clearing agency, or any successor registered as a clearing agency under the Exchange
Act, or other applicable statute or regulation, which, in each case, shall be designated by the Company pursuant to either Section 2.01
or 2.11.
“Event of Default”
means, with respect to Securities of a particular series, any event specified in Section 6.01, continued for the period of
time, if any, therein designated.
“Exchange Act” means
the United States Securities and Exchange Act of 1934, as amended, and the rules and regulations promulgated by the Commission
thereunder.
“Global Security”
means a Security issued to evidence all or a part of any series of Securities which is executed by the Company and authenticated
and delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction, all in accordance with the Indenture,
which shall be registered in the name of the Depositary or its nominee.
“Governmental Obligations”
means securities that are (a) direct obligations of the United States of America for the payment of which its full faith and
credit is pledged or (b) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of
the United States of America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United
States of America that, in either case, are not callable or redeemable at the option of the issuer thereof at any time prior to
the stated maturity of the Securities, and shall also include a depositary receipt issued by a bank or trust company as custodian
with respect to any such Governmental Obligation or a specific payment of principal of or interest on any such Governmental Obligation
held by such custodian for the account of the holder of such depositary receipt; provided, however, that (except as required by
law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from
any amount received by the custodian in respect of the Governmental Obligation or the specific payment of principal of or interest
on the Governmental Obligation evidenced by such depositary receipt.
“herein”, “hereof”
and “hereunder”, and other words of similar import, refer to this Indenture as a whole and not to any
particular Article, Section or other subdivision.
“Indenture” means
this instrument as originally executed or as it may from time to time be supplemented or amended by one or more indentures supplemental
hereto entered into in accordance with the terms hereof and shall include the terms of particular series of Securities established
as contemplated by Section 2.01.
“Interest Payment Date”,
when used with respect to any installment of interest on a Security of a particular series, means the date specified in such Security
or in a Board Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment
of interest with respect to Securities of that series is due and payable.
“Officer” means, with
respect to the Company, the chairman of the Board of Directors, a chief executive officer, a president, a chief financial officer,
a chief operating officer, any executive vice president, any senior vice president, any vice president, the treasurer or any assistant
treasurer, the controller or any assistant controller or the secretary or any assistant secretary.
“Officer’s Certificate”
means a certificate signed by any Officer. Each such certificate shall include the statements provided for in Section 13.07,
if and to the extent required by the provisions thereof.
“Opinion of Counsel”
means an opinion in writing subject to customary exceptions of legal counsel, who may be an employee of or counsel for the Company,
that is delivered to the Trustee in accordance with the terms hereof. Each such opinion shall include the statements provided
for in Section 13.07, if and to the extent required by the provisions thereof.
“Outstanding”, when
used with reference to Securities of any series, means, subject to the provisions of Section 8.04, as of any particular time,
all Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities
theretofore canceled by the Trustee or any paying agent, or delivered to the Trustee or any paying agent for cancellation or that
have previously been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental
Obligations in the necessary amount shall have been deposited in trust with the Trustee or with any paying agent (other than the
Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its own paying agent);
provided, however, that if such Securities or portions of such Securities are to be redeemed prior to the maturity thereof, notice
of such redemption shall have been given as provided in Article Three, or provision satisfactory to the Trustee shall have
been made for giving such notice; and (c) Securities in lieu of or in substitution for which other Securities shall have been
authenticated and delivered pursuant to the terms of Section 2.07.
“Person” means any
individual, corporation, partnership, joint venture, joint-stock company, limited liability company, association, trust, unincorporated
organization, any other entity or organization, including a government or political subdivision or an agency or instrumentality
thereof.
“Predecessor Security”
of any particular Security means every previous Security evidencing all or a portion of the same debt as that evidenced by such
particular Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07
in lieu of a lost, destroyed or stolen Security shall be deemed to evidence the same debt as the lost, destroyed or stolen Security.
“Responsible Officer”
when used with respect to the Trustee means any officer of the Trustee assigned by the Trustee to administer its corporate trust
matters with respect to this Indenture (which, for the avoidance of doubt, includes without limitation any supplemental indenture
hereto).
“Securities” has the
meaning stated in the first recital of this Indenture and more particularly means any Securities authenticated and delivered under
this Indenture.
“Securityholder”,
“holder of Securities”, “registered holder”, or other similar term, means the
Person or Persons in whose name or names a particular Security is registered on the Security Register kept for that purpose in
accordance with the terms of this Indenture.
“Security Register”
and “Security Registrar” shall have the meanings as set forth in Section 2.05.
“Subsidiary” means,
with respect to any Person:
(1)
any corporation or company a majority of whose capital stock with voting power, under ordinary circumstances, to elect directors
is, at the date of determination, directly or indirectly, owned by such Person (a “subsidiary”), by one
or more subsidiaries of such Person or by such Person and one or more subsidiaries of such Person;
(2)
a partnership in which such Person or a subsidiary of such Person is, at the date of determination, a general partner of such partnership;
or
(3)
any partnership, limited liability company or other Person in which such Person, a subsidiary of such Person or such Person and
one or more subsidiaries of such Person, directly or indirectly, at the date of determination, have (x) at least a majority
ownership interest or (y) the power to elect or appoint or direct the election or appointment of the managing partner or member
of such Person or, if applicable, a majority of the directors or other governing body of such Person.
“Trustee” means ,
and, subject to the provisions of Article Seven, shall also include its successors and assigns, and, if at any time there
is more than one Person acting in such capacity hereunder, “Trustee” shall mean each such Person. The term “Trustee”
as used with respect to a particular series of the Securities shall mean the trustee with respect to that series.
“Trust Indenture Act”
means the Trust Indenture Act of 1939, as amended.
ARTICLE 2
ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES
Section 2.01
Designation and Terms of Securities.
(a)
The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited.
The Securities may be issued in one or more series up to the aggregate principal amount of Securities of that series from time
to time authorized by or pursuant to a Board Resolution or pursuant to one or more indentures supplemental hereto. Prior
to the initial issuance of Securities of any series, there shall be established in or pursuant to a Board Resolution, and set forth
in an Officer’s Certificate, or established in one or more indentures supplemental hereto:
(1) the title of the Securities
of the series (which shall distinguish the Securities of that series from all other Securities);
(2) any limit upon the aggregate
principal amount of the Securities of that series which may be authenticated and delivered under this Indenture (except for Securities
authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of that series);
(3) the date or dates on which
the principal of the Securities of the series is payable;
(4) if the price (expressed
as a percentage of the aggregate principal amount thereof) at which such Securities will be issued is a price other than the principal
amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity thereof, or
if applicable, the portion of the principal amount of such Securities that is convertible into another security or the method by
which any such portion shall be determined;
(5) the rate or rates at which
the Securities of the series shall bear interest or the manner of calculation of such rate or rates, if any;
(6) the date or dates from
which such interest shall accrue, the Interest Payment Dates on which such interest will be payable or the manner of determination
of such Interest Payment Dates, the place(s) of payment, and the record date for the determination of holders to whom interest
is payable on any such Interest Payment Dates or the manner of determination of such record dates;
(7) the right, if any, to
extend the interest payment periods and the duration of such extension;
(8) the period or periods
within which, the price or prices at which and the terms and conditions upon which Securities of the series may be redeemed, converted
or exchanged, in whole or in part;
(9) the obligation, if any,
of the Company to redeem or purchase Securities of the series pursuant to any sinking fund, mandatory redemption, or analogous
provisions (including payments made in cash in satisfaction of future sinking fund obligations) or at the option of a holder thereof
and the period or periods within which, the price or prices at which, and the terms and conditions upon which, Securities of the
series shall be redeemed or purchased, in whole or in part, pursuant to such obligation;
(10) the form of the Securities
of the series including the form of the Certificate of Authentication for such series;
(11) if other than denominations
of one thousand U.S. dollars ($1,000) or any integral multiple thereof, the denominations in which the Securities of the series
shall be issuable;
(12) any and all other terms
(including terms, to the extent applicable, relating to any auction or remarketing of the Securities of that series and any security
for the obligations of the Company with respect to such Securities) with respect to such series (which terms shall not be inconsistent
with the terms of this Indenture, as amended by any supplemental indenture) including any terms which may be required by or advisable
under United States laws or regulations or advisable in connection with the marketing of Securities of that series;
(13) whether the Securities
of the series shall be issued in whole or in part in the form of a Global Security or Securities; the terms and conditions, if
any, upon which such Global Security or Securities may be exchanged in whole or in part for other individual Securities; and the
Depositary for such Global Security or Securities;
(14) whether the Securities
will be convertible into or exchangeable for shares of common stock, preferred stock or other securities of the Company or any
other Person and, if so, the terms and conditions upon which such Securities will be so convertible or exchangeable, including
the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any mandatory or optional (at
the Company’s option or the holders’ option) conversion or exchange features, and the applicable conversion or exchange
period;
(15) if other than the full
principal amount thereof, the portion of the principal amount of Securities of the series which shall be payable upon declaration
of acceleration of the maturity thereof pursuant to Section 6.01;
(16) any additional or alternative
events of default;
(17) additional or alternative
covenants (which may include, among other restrictions, restrictions on the Company’s ability or the ability of the Company’s
Subsidiaries to: incur additional indebtedness; issue additional securities; create liens; pay dividends or make distributions
in respect of the capital stock of the Company or the Company’s Subsidiaries; redeem capital stock; place restrictions on
the Company’s Subsidiaries’ ability to pay dividends, make distributions or transfer assets; make investments or other
restricted payments; sell or otherwise dispose of assets; enter into sale-leaseback transactions; engage in transactions with stockholders
or affiliates; issue or sell stock of the Company’s Subsidiaries; or effect a consolidation or merger) or financial covenants
(which may include, among other financial covenants, financial covenants that require the Company and its Subsidiaries to maintain
specified interest coverage, fixed charge, cash flow-based, asset-based or other financial ratios) provided for with respect to
the Securities of the series;
(18) the currency or currencies,
including composite currencies, in which payment of the principal of (and premium, if any) and interest, if any, on such Securities
shall be payable (if other than the currency of the United States of America), which unless otherwise specified shall be the currency
of the United States of America as at the time of payment is legal tender for payment of public or private debts;
(19) if the principal of (and
premium, if any) or interest, if any, on such Securities is to be payable, at the election of the Company or any Holder thereof,
in a coin or currency other than that in which such Securities are stated to be payable, then the period or periods within which,
and the terms and conditions upon which, such election may be made;
(20) whether interest will
be payable in cash or additional Securities at the Company’s or the Securityholders’ option and the terms and conditions
upon which the election may be made;
(21) the terms and conditions,
if any, upon which the Company shall pay amounts in addition to the stated interest, premium, if any and principal amounts of the
Securities of the series to any Securityholder that is not a “United States person” for federal tax purposes;
(22) additional or alternative
provisions, if any, related to defeasance and discharge of the offered Securities;
(23) the applicability of
any guarantees;
(24) any restrictions on transfer,
sale or assignment of the Securities of the series;
(25) any other terms of the
series; and
(26) the subordination terms
of the Securities of the series.
All Securities of any one series shall be substantially
identical except as may otherwise be provided in or pursuant to any such Board Resolution or in any indentures supplemental hereto.
If any of the terms of the series are established
by action taken pursuant to a Board Resolution of the Company, a copy of an appropriate record of such action shall be certified
by the secretary or an assistant secretary of the Company and delivered to the Trustee at or prior to the delivery of the Officer’s
Certificate of the Company setting forth the terms of the series.
Securities of any particular series may be issued
at various times, with different dates on which the principal or any installment of principal is payable, with different rates
of interest, if any, or different methods by which rates of interest may be determined, with different dates on which such interest
may be payable and with different redemption dates.
Section 2.02
Form of Securities and Trustee’s Certificate.
The Securities of any series and the Trustee’s
certificate of authentication to be borne by such Securities shall be substantially of the tenor and purport as set forth in one
or more indentures supplemental hereto or as provided in a Board Resolution, and set forth in an Officer’s Certificate, and
they may have such letters, numbers or other marks of identification or designation and such legends or endorsements printed, lithographed
or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as
may be required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation
of any securities exchange on which Securities of that series may be listed, or to conform to usage.
Section 2.03
Denominations: Provisions for Payment.
The Securities shall be issuable as registered
Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section 2.01(a)(10).
The Securities of a particular series shall bear interest payable on the dates and at the rate specified with respect to that series.
Subject to Section 2.01(a)(16), the principal of and the interest on the Securities of any series, as well as any premium
thereon in case of redemption thereof prior to maturity, shall be payable in the coin or currency of the United States of America
that at the time is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose.
Each Security shall be dated the date of its authentication. Interest on the Securities shall be computed on the basis of
a 360-day year composed of twelve 30-day months.
The interest installment on any Security that
is payable, and is punctually paid or duly provided for, on any Interest Payment Date for Securities of that series shall be paid
to the Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the
regular record date for such interest installment. In the event that any Security of a particular series or portion thereof
is called for redemption and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date
and prior to such Interest Payment Date, interest on such Security will be paid upon presentation and surrender of such Security
as provided in Section 3.03.
Any interest on any Security that is payable,
but is not punctually paid or duly provided for, on any Interest Payment Date for Securities of the same series (herein called
“Defaulted Interest”) shall forthwith cease to be payable to the registered holder on the relevant regular record date
by virtue of having been such holder; and such Defaulted Interest shall be paid by the Company, at its election, as provided in
clause (1) or clause (2) below:
(1)
The Company may make payment of any Defaulted Interest on Securities to the Persons in whose names such Securities (or their
respective Predecessor Securities) are registered at the close of business on a special record date for the payment of such Defaulted
Interest, which shall be fixed in the following manner: the Company shall notify the Trustee in writing of the amount of Defaulted
Interest proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall
deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such Defaulted Interest
or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when
deposited to be held in trust for the benefit of the Persons entitled to such Defaulted Interest as in this clause provided.
Thereupon the Trustee shall fix a special record date for the payment of such Defaulted Interest which shall not be more than 15
nor less than 10 days prior to the date of the proposed payment and not less than 10 days after the receipt by the Trustee of the
notice of the proposed payment. The Trustee shall promptly notify the Company of such special record date and, in the name
and at the expense of the Company, shall cause notice of the proposed payment of such Defaulted Interest and the special record
date therefor to be mailed, first class postage prepaid, to each Securityholder at his or her address as it appears in the Security
Register (as hereinafter defined), not less than 10 days prior to such special record date. Notice of the proposed payment
of such Defaulted Interest and the special record date therefor having been mailed as aforesaid, such Defaulted Interest shall
be paid to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered on such special
record date.
(2)
The Company may make payment of any Defaulted Interest on any Securities in any other lawful manner not inconsistent with the
requirements of any securities exchange on which such Securities may be listed, and upon such notice as may be required by such
exchange, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of
payment shall be deemed practicable by the Trustee.
Unless otherwise set forth in a Board Resolution
or one or more indentures supplemental hereto establishing the terms of any series of Securities pursuant to Section 2.01
hereof, the term “regular record date” as used in this Section with respect to a series of Securities and any
Interest Payment Date for such series shall mean either the fifteenth day of the month immediately preceding the month in which
an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment
Date is the first day of a month, or the first day of the month in which an Interest Payment Date established for such series pursuant
to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date
is a Business Day.
Subject to the foregoing provisions of this
Section, each Security of a series delivered under this Indenture upon transfer of or in exchange for or in lieu of any other Security
of such series shall carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Security.
Section 2.04
Execution and Authentications.
The Securities shall be signed on behalf of
the Company by one of its Officers. Signatures may be in the form of a manual or facsimile signature.
The Company may use the facsimile signature
of any Person who shall have been an Officer, notwithstanding the fact that at the time the Securities shall be authenticated and
delivered or disposed of such Person shall have ceased to be such an officer of the Company. The Securities may contain such
notations, legends or endorsements required by law, stock exchange rule or usage. Each Security shall be dated the date
of its authentication by the Trustee.
A Security shall not be valid until authenticated
manually by an authorized signatory of the Trustee, or by an Authenticating Agent. Such signature shall be conclusive evidence
that the Security so authenticated has been duly authenticated and delivered hereunder and that the holder is entitled to the benefits
of this Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may
deliver Securities of any series executed by the Company to the Trustee for authentication, together with a written order of the
Company for the authentication and delivery of such Securities, signed by an Officer, and the Trustee in accordance with such written
order shall authenticate and deliver such Securities.
In authenticating such Securities and accepting
the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be entitled to receive,
if requested, and (subject to Section 7.01) shall be fully protected in relying upon, an Opinion of Counsel stating that the
form and terms thereof have been established in conformity with the provisions of this Indenture.
The Trustee shall not be required to authenticate
such Securities if the issue of such Securities pursuant to this Indenture will affect the Trustee’s own rights, duties or
immunities under the Securities and this Indenture or otherwise in a manner that is not reasonably acceptable to the Trustee.
Section 2.05
Registration of Transfer and Exchange.
(a)
Securities of any series may be exchanged upon presentation thereof at the office or agency of the Company designated for such
purpose, for other Securities of such series of authorized denominations, and for a like aggregate principal amount, upon payment
of a sum sufficient to cover any tax or other governmental charge in relation thereto, all as provided in this Section. In
respect of any Securities so surrendered for exchange, the Company shall execute, the Trustee shall authenticate and such office
or agency shall deliver in exchange therefor the Security or Securities of the same series that the Securityholder making the exchange
shall be entitled to receive, bearing numbers not contemporaneously outstanding.
(b)
The Company shall keep, or cause to be kept, at its office or agency designated for such purpose a register or registers (herein
referred to as the “Security Register”) in which, subject to such reasonable regulations as it may prescribe, the Company
shall register the Securities and the transfers of Securities as in this Article provided and which at all reasonable times
shall be open for inspection by the Trustee. The registrar for the purpose of registering Securities and transfer of Securities
as herein provided shall be appointed as authorized by Board Resolution (the “Security Registrar”).
Upon surrender for transfer of any Security
at the office or agency of the Company designated for such purpose, the Company shall execute, the Trustee shall authenticate and
such office or agency shall deliver in the name of the transferee or transferees a new Security or Securities of the same series
as the Security presented for a like aggregate principal amount.
All Securities presented or surrendered for
exchange or registration of transfer, as provided in this Section, shall be accompanied (if so required by the Company or the Security
Registrar) by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly
executed by the registered holder or by such holder’s duly authorized attorney in writing.
(c)
Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and set forth in an Officer’s Certificate,
or established in one or more indentures supplemental to this Indenture, no service charge shall be made for any exchange or registration
of transfer of Securities, or issue of new Securities in case of partial redemption of any series, but the Company may require
payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, other than exchanges pursuant to
Section 2.06, Section 3.03(b) and Section 9.04 not involving any transfer.
(d)
The Company shall not be required (i) to issue, exchange or register the transfer of any Securities during a period beginning
at the opening of business 15 days before the day of the mailing of a notice of redemption of less than all the Outstanding Securities
of the same series and ending at the close of business on the day of such mailing, nor (ii) to register the transfer of or
exchange any Securities of any series or portions thereof called for redemption, other than the unredeemed portion of any such
Securities being redeemed in part. The provisions of this Section 2.05 are, with respect to any Global Security, subject
to Section 2.11 hereof.
The Trustee shall have no obligation or duty
to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable
law with respect to any transfer of any interest in any Security (including any transfers between or among depositary participants
or beneficial owners of interests in any Global Security) other than to require delivery of such certificates and other documentation
or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Indenture, and to examine
the same to determine substantial compliance as to form with the express requirements hereof.
Section 2.06
Temporary Securities.
Pending the preparation of definitive Securities
of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed, lithographed
or typewritten) of any authorized denomination. Such temporary Securities shall be substantially in the form of the definitive
Securities in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary
Securities, all as may be determined by the Company. Every temporary Security of any series shall be executed by the Company
and be authenticated by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as the
definitive Securities of such series. Without unnecessary delay the Company will execute and will furnish definitive Securities
of such series and thereupon any or all temporary Securities of such series may be surrendered in exchange therefor (without charge
to the holders), at the office or agency of the Company designated for the purpose, and the Trustee shall authenticate and such
office or agency shall deliver in exchange for such temporary Securities an equal aggregate principal amount of definitive Securities
of such series, unless the Company advises the Trustee to the effect that definitive Securities need not be executed and furnished
until further notice from the Company. Until so exchanged, the temporary Securities of such series shall be entitled to the
same benefits under this Indenture as definitive Securities of such series authenticated and delivered hereunder.
Section 2.07
Mutilated, Destroyed, Lost or Stolen Securities.
In case any temporary or definitive Security
shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute, and
upon the Company’s request the Trustee (subject as aforesaid) shall authenticate and deliver, a new Security of the same
series, bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu
of and in substitution for the Security so destroyed, lost or stolen. In every case the applicant for a substituted Security
shall furnish to the Company and the Trustee such security or indemnity as may be required by them to save each of them harmless,
and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee evidence to their
satisfaction of the destruction, loss or theft of the applicant’s Security and of the ownership thereof. The Trustee
may authenticate any such substituted Security and deliver the same upon the written request or authorization of any officer of
the Company. Upon the issuance of any substituted Security, the Company may require the payment of a sum sufficient to cover
any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses
of the Trustee) connected therewith.
In case any Security that has matured or is
about to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security,
pay or authorize the payment of the same (without surrender thereof except in the case of a mutilated Security) if the applicant
for such payment shall furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless,
and, in case of destruction, loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss
or theft of such Security and of the ownership thereof.
Every replacement Security issued pursuant to
the provisions of this Section shall constitute an additional contractual obligation of the Company whether or not the mutilated,
destroyed, lost or stolen Security shall be found at any time, or be enforceable by anyone, and shall be entitled to all the benefits
of this Indenture equally and proportionately with any and all other Securities of the same series duly issued hereunder.
All Securities shall be held and owned upon the express condition that the foregoing provisions are exclusive with respect to the
replacement or payment of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the extent lawful) any and all
other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the
replacement or payment of negotiable instruments or other securities without their surrender.
Section 2.08
Cancellation.
All Securities surrendered for the purpose of
payment, redemption, exchange or registration of transfer shall, if surrendered to the Company or any paying agent, be delivered
to the Trustee for cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be issued
in lieu thereof except as expressly required or permitted by any of the provisions of this Indenture. On request of the Company
at the time of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee. In the absence
of such request the Trustee may dispose of canceled Securities in accordance with its standard procedures and deliver a certificate
of disposition to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall
not operate as a redemption or satisfaction of the indebtedness represented by such Securities unless and until the same are delivered
to the Trustee for cancellation.
Section 2.09
Benefits of Indenture.
Nothing in this Indenture or in the Securities,
express or implied, shall give or be construed to give to any Person, other than the parties hereto and the holders of the Securities
(and, with respect to the provisions of Article Fourteen, the holders of any indebtedness of the Company to which the Securities
of any series are subordinated) any legal or equitable right, remedy or claim under or in respect of this Indenture, or under any
covenant, condition or provision herein contained; all such covenants, conditions and provisions being for the sole benefit of
the parties hereto and of the holders of the Securities (and, with respect to the provisions of Article Fourteen, the holders
of any indebtedness of the Company to which the Securities of any series are subordinated).
Section 2.10
Authenticating Agent.
So long as any of the Securities of any series
remain Outstanding there may be an Authenticating Agent for any or all such series of Securities which the Trustee shall have the
right to appoint. Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities
of such series issued upon exchange, transfer or partial redemption thereof, and Securities so authenticated shall be entitled
to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder.
All references in this Indenture to the authentication of Securities by the Trustee shall be deemed to include authentication by
an Authenticating Agent for such series. Each Authenticating Agent shall be acceptable to the Company and shall be a corporation
that has a combined capital and surplus, as most recently reported or determined by it, sufficient under the laws of any jurisdiction
under which it is organized or in which it is doing business to conduct a trust business, and that is otherwise authorized under
such laws to conduct such business and is subject to supervision or examination by federal or state authorities. If at any
time any Authenticating Agent shall cease to be eligible in accordance with these provisions, it shall resign immediately.
Any Authenticating Agent may at any time resign
by giving written notice of resignation to the Trustee and to the Company. The Trustee may at any time (and upon request
by the Company shall) terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating
Agent and to the Company. Upon resignation, termination or cessation of eligibility of any Authenticating Agent, the Trustee
may appoint an eligible successor Authenticating Agent acceptable to the Company. Any successor Authenticating Agent, upon
acceptance of its appointment hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder
as if originally named as an Authenticating Agent pursuant hereto.
Section 2.11
Global Securities.
(a)
If the Company shall establish pursuant to Section 2.01 that the Securities of a particular series are to be issued as
a Global Security, then the Company shall execute and the Trustee shall, in accordance with Section 2.04, authenticate and
deliver, a Global Security that (i) shall represent, and shall be denominated in an amount equal to the aggregate principal
amount of, all of the Outstanding Securities of such series, (ii) shall be registered in the name of the Depositary or its
nominee, (iii) shall be delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction and (iv) shall
bear a legend substantially to the following effect: “Except as otherwise provided in Section 2.11 of the Indenture,
this Security may be transferred, in whole but not in part, only to another nominee of the Depositary or to a successor Depositary
or to a nominee of such successor Depositary.”
(b)
Notwithstanding the provisions of Section 2.05, the Global Security of a series may be transferred, in whole but not in
part and in the manner provided in Section 2.05, only to another nominee of the Depositary for such series, or to a successor
Depositary for such series selected or approved by the Company or to a nominee of such successor Depositary.
(c)
If at any time the Depositary for a series of the Securities notifies the Company that it is unwilling or unable to continue
as Depositary for such series or if at any time the Depositary for such series shall no longer be registered or in good standing
under the Exchange Act, or other applicable statute or regulation, and a successor Depositary for such series is not appointed
by the Company within 90 days after the Company receives such notice or becomes aware of such condition, as the case may be, or
if an Event of Default has occurred and is continuing and the Company has received a request from the Depositary or from the Trustee,
this Section 2.11 shall no longer be applicable to the Securities of such series and the Company will execute, and subject
to Section 2.04, the Trustee will authenticate and deliver the Securities of such series in definitive registered form without
coupons, in authorized denominations, and in an aggregate principal amount equal to the principal amount of the Global Security
of such series in exchange for such Global Security. In addition, the Company may at any time determine that the Securities
of any series shall no longer be represented by a Global Security and that the provisions of this Section 2.11 shall no longer
apply to the Securities of such series. In such event the Company will execute and, subject to Section 2.04, the Trustee,
upon receipt of an Officer’s Certificate evidencing such determination by the Company, will authenticate and deliver the
Securities of such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal
amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. Upon the
exchange of the Global Security for such Securities in definitive registered form without coupons, in authorized denominations,
the Global Security shall be canceled by the Trustee. Such Securities in definitive registered form issued in exchange for
the Global Security pursuant to this Section 2.11(c) shall be registered in such names and in such authorized denominations
as the Depositary, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Trustee.
The Trustee shall deliver such Securities to the Depositary for delivery to the Persons in whose names such Securities are so registered.
ARTICLE 3
REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS
Section 3.01
Redemption.
The Company may redeem the Securities of any
series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant to Section 2.01
hereof.
Section 3.02
Notice of Redemption.
(a)
In case the Company shall desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of
any series in accordance with any right the Company reserved for itself to do so pursuant to Section 2.01 hereof, the Company
shall, or shall cause the Trustee to, give notice of such redemption to holders of the Securities of such series to be redeemed
by mailing, first class postage prepaid, a notice of such redemption not less than 30 days and not more than 90 days before the
date fixed for redemption of that series to such holders at their last addresses as they shall appear upon the Security Register,
unless a shorter period is specified in the Securities to be redeemed. Any notice that is mailed in the manner herein provided
shall be conclusively presumed to have been duly given, whether or not the registered holder receives the notice. In any
case, failure duly to give such notice to the holder of any Security of any series designated for redemption in whole or in part,
or any defect in the notice, shall not affect the validity of the proceedings for the redemption of any other Securities of such
series or any other series. In the case of any redemption of Securities prior to the expiration of any restriction on such
redemption provided in the terms of such Securities or elsewhere in this Indenture, the Company shall furnish the Trustee with
an Officer’s Certificate evidencing compliance with any such restriction.
Each such notice of redemption shall specify
the date fixed for redemption and the redemption price at which Securities of that series are to be redeemed, and shall state that
payment of the redemption price of such Securities to be redeemed will be made at the office or agency of the Company, upon presentation
and surrender of such Securities, that interest accrued to the date fixed for redemption will be paid as specified in said notice,
that from and after said date interest will cease to accrue and that the redemption is from a sinking fund, if such is the case.
If less than all the Securities of a series are to be redeemed, the notice to the holders of Securities of that series to be redeemed
in part shall specify the particular Securities to be so redeemed.
In case any Security is to be redeemed in part
only, the notice that relates to such Security shall state the portion of the principal amount thereof to be redeemed, and shall
state that on and after the redemption date, upon surrender of such Security, a new Security or Securities of such series in principal
amount equal to the unredeemed portion thereof will be issued.
(b)
If less than all the Securities of a series are to be redeemed, the Company shall give the Trustee at least 45 days’
notice (unless a shorter notice shall be satisfactory to the Trustee) in advance of the date fixed for redemption as to the aggregate
principal amount of Securities of the series to be redeemed, and thereupon the Trustee shall select, by lot or in such other manner
as it shall deem appropriate and fair in its discretion and that may provide for the selection of a portion or portions (equal
to one thousand U.S. dollars ($1,000) or any integral multiple thereof) of the principal amount of such Securities of a denomination
larger than $1,000, the Securities to be redeemed and shall thereafter promptly notify the Company in writing of the numbers of
the Securities to be redeemed, in whole or in part. The Company may, if and whenever it shall so elect, by delivery of instructions
signed on its behalf by an Officer, instruct the Trustee or any paying agent to call all or any part of the Securities of a particular
series for redemption and to give notice of redemption in the manner set forth in this Section, such notice to be in the name of
the Company or its own name as the Trustee or such paying agent may deem advisable. In any case in which notice of redemption
is to be given by the Trustee or any such paying agent, the Company shall deliver or cause to be delivered to, or permit to remain
with, the Trustee or such paying agent, as the case may be, such Security Register, transfer books or other records, or suitable
copies or extracts therefrom, sufficient to enable the Trustee or such paying agent to give any notice by mail that may be required
under the provisions of this Section.
Section 3.03
Payment Upon Redemption.
(a)
If the giving of notice of redemption shall have been completed as above provided, the Securities or portions of Securities
of the series to be redeemed specified in such notice shall become due and payable on the date and at the place stated in such
notice at the applicable redemption price, together with interest accrued to the date fixed for redemption and interest on such
Securities or portions of Securities shall cease to accrue on and after the date fixed for redemption, unless the Company shall
default in the payment of such redemption price and accrued interest with respect to any such Security or portion thereof.
On presentation and surrender of such Securities on or after the date fixed for redemption at the place of payment specified in
the notice, said Securities shall be paid and redeemed at the applicable redemption price for such series, together with interest
accrued thereon to the date fixed for redemption (but if the date fixed for redemption is an interest payment date, the interest
installment payable on such date shall be payable to the registered holder at the close of business on the applicable record date
pursuant to Section 2.03).
(b)
Upon presentation of any Security of such series that is to be redeemed in part only, the Company shall execute and the Trustee
shall authenticate and the office or agency where the Security is presented shall deliver to the holder thereof, at the expense
of the Company, a new Security of the same series of authorized denominations in principal amount equal to the unredeemed portion
of the Security so presented.
Section 3.04
Sinking Fund.
The provisions of Sections 3.04, 3.05 and 3.06
shall be applicable to any sinking fund for the retirement of Securities of a series, except as otherwise specified as contemplated
by Section 2.01 for Securities of such series.
The minimum amount of any sinking fund payment
provided for by the terms of Securities of any series is herein referred to as a “mandatory sinking fund payment,”
and any payment in excess of such minimum amount provided for by the terms of Securities of any series is herein referred to as
an “optional sinking fund payment”. If provided for by the terms of Securities of any series, the cash amount
of any sinking fund payment may be subject to reduction as provided in Section 3.05. Each sinking fund payment shall
be applied to the redemption of Securities of any series as provided for by the terms of Securities of such series.
Section 3.05
Satisfaction of Sinking Fund Payments with Securities.
The Company (i) may deliver Outstanding
Securities of a series and (ii) may apply as a credit Securities of a series that have been redeemed either at the election
of the Company pursuant to the terms of such Securities or through the application of permitted optional sinking fund payments
pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any sinking fund payment with respect
to the Securities of such series required to be made pursuant to the terms of such Securities as provided for by the terms of such
series, provided that such Securities have not been previously so credited. Such Securities shall be received and credited
for such purpose by the Trustee at the redemption price specified in such Securities for redemption through operation of the sinking
fund and the amount of such sinking fund payment shall be reduced accordingly.
Section 3.06
Redemption of Securities for Sinking Fund.
Not less than 45 days prior to each sinking
fund payment date for any series of Securities (unless a shorter period shall be satisfactory to the Trustee), the Company will
deliver to the Trustee an Officer’s Certificate specifying the amount of the next ensuing sinking fund payment for that series
pursuant to the terms of the series, the portion thereof, if any, that is to be satisfied by delivering and crediting Securities
of that series pursuant to Section 3.05 and the basis for such credit and will, together with such Officer’s Certificate,
deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date
the Trustee shall select the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.02
and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided
in Section 3.02. Such notice having been duly given, the redemption of such Securities shall be made upon the terms
and in the manner stated in Section 3.03.
ARTICLE 4
COVENANTS
Section 4.01
Payment of Principal, Premium and Interest.
The Company will duly and punctually pay or
cause to be paid the principal of (and premium, if any) and interest on the Securities of that series at the time and place and
in the manner provided herein and established with respect to such Securities. Payments of principal on the Securities may be made
at the time provided herein and established with respect to such Securities by U.S. dollar check drawn on and mailed to the address
of the Securityholder entitled thereto as such address shall appear in the Security Register, or U.S. dollar wire transfer to,
a U.S. dollar account if such Securityholder shall have furnished wire instructions to the Trustee no later than 15 days prior
to the relevant payment date. Payments of interest on the Securities may be made at the time provided herein and established with
respect to such Securities by U.S. dollar check mailed to the address of the Securityholder entitled thereto as such address shall
appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account if such Securityholder shall have furnished
wire instructions in writing to the Security Registrar and the Trustee no later than 15 days prior to the relevant payment date.
Section 4.02
Maintenance of Office or Agency.
So long as any series of the Securities remain
Outstanding, the Company agrees to maintain an office or agency with respect to each such series and at such other location or
locations as may be designated as provided in this Section 4.02, where (i) Securities of that series may be presented
for payment, (ii) Securities of that series may be presented as herein above authorized for registration of transfer and exchange,
and (iii) notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be
given or served, such designation to continue with respect to such office or agency until the Company shall, by written notice
signed by any officer authorized to sign an Officer’s Certificate and delivered to the Trustee, designate some other office
or agency for such purposes or any of them. If at any time the Company shall fail to maintain any such required office or
agency or shall fail to furnish the Trustee with the address thereof, such presentations, notices and demands may be made or served
at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations,
notices and demands. The Company initially appoints the Corporate Trust Office of the Trustee as its paying agent with respect
to the Securities.
Section 4.03
Paying Agents.
(a)
If the Company shall appoint one or more paying agents for all or any series of the Securities, other than the Trustee, the
Company will cause each such paying agent to execute and deliver to the Trustee an instrument in which such agent shall agree with
the Trustee, subject to the provisions of this Section:
(1)
that it will hold all sums held by it as such agent for the payment of the principal of (and premium, if any) or interest on
the Securities of that series (whether such sums have been paid to it by the Company or by any other obligor of such Securities)
in trust for the benefit of the Persons entitled thereto;
(2)
that it will give the Trustee notice of any failure by the Company (or by any other obligor of such Securities) to make any
payment of the principal of (and premium, if any) or interest on the Securities of that series when the same shall be due and payable;
(3)
that it will, at any time during the continuance of any failure referred to in the preceding paragraph (a)(2) above, upon
the written request of the Trustee, forthwith pay to the Trustee all sums so held in trust by such paying agent; and
(4)
that it will perform all other duties of paying agent as set forth in this Indenture.
(b)
If the Company shall act as its own paying agent with respect to any series of the Securities, it will on or before each due
date of the principal of (and premium, if any) or interest on Securities of that series, set aside, segregate and hold in trust
for the benefit of the Persons entitled thereto a sum sufficient to pay such principal (and premium, if any) or interest so becoming
due on Securities of that series until such sums shall be paid to such Persons or otherwise disposed of as herein provided and
will promptly notify the Trustee of such action, or any failure (by it or any other obligor on such Securities) to take such action.
Whenever the Company shall have one or more paying agents for any series of Securities, it will, prior to each due date of the
principal of (and premium, if any) or interest on any Securities of that series, deposit with the paying agent a sum sufficient
to pay the principal (and premium, if any) or interest so becoming due, such sum to be held in trust for the benefit of the Persons
entitled to such principal, premium or interest, and (unless such paying agent is the Trustee) the Company will promptly notify
the Trustee of this action or failure so to act.
(c)
Notwithstanding anything in this Section to the contrary, (i) the agreement to hold sums in trust as provided in
this Section is subject to the provisions of Section 11.05, and (ii) the Company may at any time, for the purpose
of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or direct any paying agent to pay,
to the Trustee all sums held in trust by the Company or such paying agent, such sums to be held by the Trustee upon the same terms
and conditions as those upon which such sums were held by the Company or such paying agent; and, upon such payment by the Company
or any paying agent to the Trustee, the Company or such paying agent shall be released from all further liability with respect
to such money.
Section 4.04
Appointment to Fill Vacancy in Office of Trustee.
The Company, whenever necessary to avoid or
fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 7.10, a Trustee, so that there shall
at all times be a Trustee hereunder.
Section 4.05
Compliance with Consolidation Provisions.
The Company will not, while any of the Securities
remain Outstanding, consolidate with or merge into any other Person, in either case where the Company is not the survivor of such
transaction, or sell or convey all or substantially all of its property to any other Person unless the provisions of Article Ten
hereof are complied with.
ARTICLE 5
SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE
Section 5.01
Company to Furnish Trustee Names and Addresses of Securityholders.
The Company will furnish or cause to be furnished
to the Trustee (a) within 15 days after each regular record date (as defined in Section 2.03) a list, in such form as
the Trustee may reasonably require, of the names and addresses of the holders of each series of Securities as of such regular record
date, provided that the Company shall not be obligated to furnish or cause to furnish such list at any time that the list shall
not differ in any respect from the most recent list furnished to the Trustee by the Company and (b) at such other times as
the Trustee may request in writing within 30 days after the receipt by the Company of any such request, a list of similar form
and content as of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case,
no such list need be furnished for any series for which the Trustee shall be the Security Registrar.
Section 5.02
Preservation Of Information; Communications With Securityholders.
(a)
The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses
of the holders of Securities contained in the most recent list furnished to it as provided in Section 5.01 and as to the names
and addresses of holders of Securities received by the Trustee in its capacity as Security Registrar (if acting in such capacity).
(b)
The Trustee may destroy any list furnished to it as provided in Section 5.01 upon receipt of a new list so furnished.
(c)
Securityholders may communicate as provided in Section 312(b) of the Trust Indenture Act with other Securityholders
with respect to their rights under this Indenture or under the Securities, and, in connection with any such communications, the
Trustee shall satisfy its obligations under Section 312(b) of the Trust Indenture Act in accordance with the provisions
of Section 312(b) of the Trust Indenture Act.
Section 5.03
Reports by the Company.
(a)
The Company covenants and agrees to provide (which delivery may be via electronic mail) to the Trustee within 30 days, after
the Company files the same with the Commission, copies of the annual reports and of the information, documents and other reports
(or copies of such portions of any of the foregoing as the Commission may from time to time by rules and regulations prescribe)
that the Company is required to file with the Commission pursuant to Section 13 or Section 15(d) of the Exchange
Act; provided, however, the Company shall not be required to deliver to the Trustee any materials for which the Company has sought
and received confidential treatment by the Commission; and provided further, that so long as such filings by the Company are available
on the Commission’s Electronic Data Gathering, Analysis and Retrieval System (EDGAR), or Interactive Data Electronic Applications
(IDEA), or any successor system, such filings shall be deemed to have been filed with the Trustee for purposes hereof without any
further action required by the Company; provided that an electronic link to such filing, together with an electronic notice of
such filing have been sent to the Trustee. For the avoidance of doubt, a failure by the Company to file annual reports, information
and other reports with the SEC within the time period prescribed thereof by the Commission shall not be deemed a breach of this
Section 5.03.
(b)
Delivery of reports, information and documents to the Trustee under Section 5.03 is for informational purposes only and
the information and the Trustee’s receipt of the foregoing shall not constitute constructive notice of any information contained
therein, or determinable from information contained therein including the Company’s compliance with any of their covenants
thereunder (as to which the Trustee is entitled to rely exclusively on an Officer’s Certificate).
Section 5.04
Reports by the Trustee.
(a)
If required by Section 313(a) of the Trust Indenture Act, the Trustee, within sixty (60) days after each May 1,
shall transmit by mail, first class postage prepaid, to the Securityholders, as their names and addresses appear upon the Security
Register, a brief report dated as of such May 1, which complies with Section 313(a) of the Trust Indenture Act.
(b)
The Trustee shall comply with Section 313(b) and 313(c) of the Trust Indenture Act.
(c)
A copy of each such report shall, at the time of such transmission to Securityholders, be filed by the Trustee with the Company,
with each securities exchange upon which any Securities are listed (if so listed) and also with the Commission. The Company
agrees to notify the Trustee when any Securities become listed on any securities exchange.
ARTICLE 6
REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT
Section 6.01
Events of Default.
(a)
Whenever used herein with respect to Securities of a particular series, “Event of Default” means any one or more
of the following events that has occurred and is continuing:
(1)
the Company defaults in the payment of any installment of interest upon any of the Securities of that series, as and when the
same shall become due and payable, and such default continues for a period of 90 days; provided, however, that a valid extension
of an interest payment period by the Company in accordance with the terms of any indenture supplemental hereto shall not constitute
a default in the payment of interest for this purpose;
(2)
the Company defaults in the payment of the principal of (or premium, if any, on) any of the Securities of that series as and
when the same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment
required by any sinking or analogous fund established with respect to that series; provided, however, that a valid extension of
the maturity of such Securities in accordance with the terms of any indenture supplemental hereto shall not constitute a default
in the payment of principal or premium, if any;
(3)
the Company fails to observe or perform any other of its covenants or agreements with respect to that series contained in this
Indenture or otherwise established with respect to that series of Securities pursuant to Section 2.01 hereof (other than a
covenant or agreement that has been expressly included in this Indenture solely for the benefit of one or more series of Securities
other than such series) for a period of 90 days after the date on which written notice of such failure, requiring the same to be
remedied and stating that such notice is a “Notice of Default” hereunder, shall have been given to the Company by the
Trustee, by registered or certified mail, or to the Company and the Trustee by the holders of at least 25% in principal amount
of the Securities of that series at the time Outstanding;
(4)
the Company pursuant to or within the meaning of any Bankruptcy Law (i) commences a voluntary case, (ii) consents
to the entry of an order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of
it or for all or substantially all of its property or (iv) makes a general assignment for the benefit of its creditors; or
(5)
a court of competent jurisdiction enters an order under any Bankruptcy Law that (i) is for relief against the Company
in an involuntary case, (ii) appoints a Custodian of the Company for all or substantially all of its property or (iii) orders
the liquidation of the Company, and the order or decree remains unstayed and in effect for 90 days.
(b)
In each and every such case (other than an Event of Default specified in clause (4) or clause (5) above), unless
the principal of all the Securities of that series shall have already become due and payable, either the Trustee or the holders
of not less than 25% in aggregate principal amount of the Securities of that series then Outstanding hereunder, by notice in writing
to the Company (and to the Trustee if given by such Securityholders), may declare the principal of (and premium, if any, on) and
accrued and unpaid interest on all the Securities of that series to be due and payable immediately, and upon any such declaration
the same shall become and shall be immediately due and payable. If an Event of Default specified in clause (4) or clause
(5) above occurs, the principal of and accrued and unpaid interest on all the Securities of that series shall automatically
be immediately due and payable without any declaration or other act on the part of the Trustee or the holders of the Securities.
(c)
At any time after the principal of (and premium, if any, on) and accrued and unpaid interest on the Securities of that series
shall have been so declared due and payable, and before any judgment or decree for the payment of the moneys due shall have been
obtained or entered as hereinafter provided, the holders of a majority in aggregate principal amount of the Securities of that
series then Outstanding hereunder, by written notice to the Company and the Trustee, may rescind and annul such declaration and
its consequences if: (i) the Company has paid or deposited with the Trustee a sum sufficient to pay all matured installments
of interest upon all the Securities of that series and the principal of (and premium, if any, on) any and all Securities of that
series that shall have become due otherwise than by acceleration (with interest upon such principal and premium, if any, and, to
the extent that such payment is enforceable under applicable law, upon overdue installments of interest, at the rate per annum
expressed in the Securities of that series to the date of such payment or deposit) and the amount payable to the Trustee under
Section 7.06, and (ii) any and all Events of Default under the Indenture with respect to such series, other than the
nonpayment of principal on (and premium, if any, on) and accrued and unpaid interest on Securities of that series that shall not
have become due by their terms, shall have been remedied or waived as provided in Section 6.06.
No such rescission and annulment shall extend
to or shall affect any subsequent default or impair any right consequent thereon.
(d)
In case the Trustee shall have proceeded to enforce any right with respect to Securities of that series under this Indenture
and such proceedings shall have been discontinued or abandoned because of such rescission or annulment or for any other reason
or shall have been determined adversely to the Trustee, then and in every such case, subject to any determination in such proceedings,
the Company and the Trustee shall be restored respectively to their former positions and rights hereunder, and all rights, remedies
and powers of the Company and the Trustee shall continue as though no such proceedings had been taken.
Section 6.02
Collection of Indebtedness and Suits for Enforcement by Trustee.
(a)
The Company covenants that (i) in case it shall default in the payment of any installment of interest on any of the Securities
of a series, or in any payment required by any sinking or analogous fund established with respect to that series as and when the
same shall have become due and payable, and such default shall have continued for a period of 90 days, or (ii) in case it
shall default in the payment of the principal of (or premium, if any, on) any of the Securities of a series when the same shall
have become due and payable, whether upon maturity of the Securities of a series or upon redemption or upon declaration or otherwise
then, upon demand of the Trustee, the Company will pay to the Trustee, for the benefit of the holders of the Securities of that
series, the whole amount that then shall have been become due and payable on all such Securities for principal (and premium, if
any) or interest, or both, as the case may be, with interest upon the overdue principal (and premium, if any) and (to the extent
that payment of such interest is enforceable under applicable law) upon overdue installments of interest at the rate per annum
expressed in the Securities of that series; and, in addition thereto, such further amount as shall be sufficient to cover the costs
and expenses of collection, and the amount payable to the Trustee under Section 7.06.
(b)
If the Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an
express trust, shall be entitled and empowered to institute any action or proceedings at law or in equity for the collection of
the sums so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such
judgment or final decree against the Company or other obligor upon the Securities of that series and collect the moneys adjudged
or decreed to be payable in the manner provided by law or equity out of the property of the Company or other obligor upon the Securities
of that series, wherever situated.
(c)
In case of any receivership, insolvency, liquidation, bankruptcy, reorganization, readjustment, arrangement, composition or
judicial proceedings affecting the Company, or its creditors or property, the Trustee shall have power to intervene in such proceedings
and take any action therein that may be permitted by the court and shall (except as may be otherwise provided by law) be entitled
to file such proofs of claim and other papers and documents as may be necessary or advisable in order to have the claims of the
Trustee and of the holders of Securities of such series allowed for the entire amount due and payable by the Company under the
Indenture at the date of institution of such proceedings and for any additional amount that may become due and payable by the Company
after such date, and to collect and receive any moneys or other property payable or deliverable on any such claim, and to distribute
the same after the deduction of the amount payable to the Trustee under Section 7.06; and any receiver, assignee or trustee
in bankruptcy or reorganization is hereby authorized by each of the holders of Securities of such series to make such payments
to the Trustee, and, in the event that the Trustee shall consent to the making of such payments directly to such Securityholders,
to pay to the Trustee any amount due it under Section 7.06.
(d)
All rights of action and of asserting claims under this Indenture, or under any of the terms established with respect to Securities
of that series, may be enforced by the Trustee without the possession of any of such Securities, or the production thereof at any
trial or other proceeding relative thereto, and any such suit or proceeding instituted by the Trustee shall be brought in its own
name as trustee of an express trust, and any recovery of judgment shall, after provision for payment to the Trustee of any amounts
due under Section 7.06, be for the ratable benefit of the holders of the Securities of such series.
In case of an Event of Default hereunder, the
Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial
proceedings as the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in
bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in the Indenture or in aid
of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee
by this Indenture or by law.
Nothing contained herein shall be deemed to
authorize the Trustee to authorize or consent to or accept or adopt on behalf of any Securityholder any plan of reorganization,
arrangement, adjustment or composition affecting the Securities of that series or the rights of any holder thereof or to authorize
the Trustee to vote in respect of the claim of any Securityholder in any such proceeding.
Section 6.03
Application of Moneys Collected.
Any moneys collected by the Trustee pursuant
to this Article with respect to a particular series of Securities shall be applied in the following order, at the date or
dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal (or premium, if any) or interest,
upon presentation of the Securities of that series, and notation thereon of the payment, if only partially paid, and upon surrender
thereof if fully paid:
FIRST: To the payment of all indebtedness of
the Company to which such series of Securities is subordinated to the extent required by Section 7.06 and any subordination
terms of the series specified as contemplated by Article Fourteen;
SECOND: To the payment of the amounts then due
and unpaid upon Securities of such series for principal (and premium, if any) and interest, in respect of which or for the benefit
of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable
on such Securities for principal (and premium, if any) and interest, respectively; and
THIRD: To the payment of the remainder, if any,
to the Company or any other Person lawfully entitled thereto.
Section 6.04
Limitation on Suits.
No holder of any Security of any series shall
have any right by virtue or by availing of any provision of this Indenture to institute any suit, action or proceeding in equity
or at law upon or under or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other remedy
hereunder, unless (i) such holder previously shall have given to the Trustee written notice of an Event of Default and of
the continuance thereof with respect to the Securities of such series specifying such Event of Default, as hereinbefore provided;
(ii) the holders of not less than 25% in aggregate principal amount of the Securities of such series then Outstanding shall
have made written request upon the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder; (iii) such
holder or holders shall have offered to the Trustee such reasonable indemnity as it may require against the costs, expenses and
liabilities to be incurred therein or thereby; (iv) the Trustee for 90 days after its receipt of such notice, request and
offer of indemnity, shall have failed to institute any such action, suit or proceeding and (v) during such 90 day period,
the holders of a majority in principal amount of the Securities of that series do not give the Trustee a direction inconsistent
with the request.
Notwithstanding anything contained herein to
the contrary or any other provisions of this Indenture, the right of any holder of any Security to receive payment of the principal
of (and premium, if any) and interest on such Security, as therein provided, on or after the respective due dates expressed in
such Security (or in the case of redemption, on the redemption date), or to institute suit for the enforcement of any such payment
on or after such respective dates or redemption date, shall not be impaired or affected without the consent of such holder and
by accepting a Security hereunder it is expressly understood, intended and covenanted by the taker and holder of every Security
of such series with every other such taker and holder and the Trustee, that no one or more holders of Securities of such series
shall have any right in any manner whatsoever by virtue or by availing of any provision of this Indenture to affect, disturb or
prejudice the rights of the holders of any other of such Securities, or to obtain or seek to obtain priority over or preference
to any other such holder, or to enforce any right under this Indenture, except in the manner herein provided and for the equal,
ratable and common benefit of all holders of Securities of such series. For the protection and enforcement of the provisions
of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given either at law or
in equity.
Section 6.05
Rights and Remedies Cumulative; Delay or Omission Not Waiver.
(a)
Except as otherwise provided in Section 2.07, all powers and remedies given by this Article to the Trustee or to
the Securityholders shall, to the extent permitted by law, be deemed cumulative and not exclusive of any other powers and remedies
available to the Trustee or the holders of the Securities, by judicial proceedings or otherwise, to enforce the performance or
observance of the covenants and agreements contained in this Indenture or otherwise established with respect to such Securities.
(b)
No delay or omission of the Trustee or of any holder of any of the Securities to exercise any right or power accruing upon
any Event of Default occurring and continuing as aforesaid shall impair any such right or power, or shall be construed to be a
waiver of any such default or an acquiescence therein; and, subject to the provisions of Section 6.04, every power and remedy
given by this Article or by law to the Trustee or the Securityholders may be exercised from time to time, and as often as
shall be deemed expedient, by the Trustee or by the Securityholders.
Section 6.06
Control by Securityholders.
The holders of a majority in aggregate principal
amount of the Securities of any series at the time Outstanding, determined in accordance with Section 8.04, shall have the
right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising
any trust or power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in
conflict with any rule of law or with this Indenture or subject the Trustee in its sole discretion to personal liability.
Subject to the provisions of Section 7.01, the Trustee shall have the right to decline to follow any such direction if the
Trustee in good faith shall, by a Responsible Officer or officers of the Trustee, determine that the proceeding so directed, subject
to the Trustee’s duties under the Trust Indenture Act, would involve the Trustee in personal liability or might be unduly
prejudicial to the Securityholders not involved in the proceeding. The holders of a majority in aggregate principal amount
of the Securities of any series at the time Outstanding affected thereby, determined in accordance with Section 8.04, may
on behalf of the holders of all of the Securities of such series waive any past default in the performance of any of the covenants
contained herein or established pursuant to Section 2.01 with respect to such series and its consequences, except a default
in the payment of the principal of, or premium, if any, or interest on, any of the Securities of that series as and when the same
shall become due by the terms of such Securities otherwise than by acceleration (unless such default has been cured and a sum sufficient
to pay all matured installments of interest and principal and any premium has been deposited with the Trustee (in accordance with
Section 6.01(c)). Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes of
this Indenture and the Company, the Trustee and the holders of the Securities of such series shall be restored to their former
positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any
right consequent thereon.
Section 6.07
Undertaking to Pay Costs.
All parties to this Indenture agree, and each
holder of any Securities by such holder’s acceptance thereof shall be deemed to have agreed, that any court may in its discretion
require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any
action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such
suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against any
party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant;
but the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder,
or group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or
to any suit instituted by any Securityholder for the enforcement of the payment of the principal of (or premium, if any) or interest
on any Security of such series, on or after the respective due dates expressed in such Security or established pursuant to this
Indenture.
ARTICLE 7
CONCERNING THE TRUSTEE
Section 7.01
Certain Duties and Responsibilities of Trustee.
(a)
The Trustee, prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing
of all Events of Default with respect to the Securities of that series that may have occurred, shall undertake to perform with
respect to the Securities of such series such duties and only such duties as are specifically set forth in this Indenture, and
no implied covenants shall be read into this Indenture against the Trustee. In case an Event of Default with respect to the
Securities of a series has occurred (that has not been cured or waived), the Trustee shall exercise with respect to Securities
of that series such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in their
exercise, as a prudent man would exercise or use under the circumstances in the conduct of his own affairs.
(b)
No provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own
negligent failure to act, or its own willful misconduct, except that:
(i)
prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing or waiving of
all such Events of Default with respect to that series that may have occurred:
(A)
the duties and obligations of the Trustee shall with respect to the Securities of such series be determined solely by the express
provisions of this Indenture, and the Trustee shall not be liable with respect to the Securities of such series except for the
performance of such duties and obligations as are specifically set forth in this Indenture, and no implied covenants or obligations
shall be read into this Indenture against the Trustee; and
(B)
in the absence of bad faith on the part of the Trustee, the Trustee may with respect to the Securities of such series conclusively
rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any certificates or opinions
furnished to the Trustee and conforming to the requirements of this Indenture; but in the case of any such certificates or opinions
that by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine
the same to determine whether or not they conform to the requirements of this Indenture;
(ii)
the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer or Responsible Officers
of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts;
(iii)
the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with
the direction of the holders of not less than a majority in principal amount of the Securities of any series at the time Outstanding
relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any
trust or power conferred upon the Trustee under this Indenture with respect to the Securities of that series; and
(iv)
none of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur
personal financial liability in the performance of any of its duties or in the exercise of any of its rights or powers if there
is reasonable ground for believing that the repayment of such funds or liability is not reasonably assured to it under the terms
of this Indenture or adequate indemnity against such risk is not reasonably assured to it.
Section 7.02
Certain Rights of Trustee.
Except as otherwise provided in Section 7.01:
(a)
The Trustee may rely and shall be protected in acting or refraining from acting upon any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, approval, bond, security or other paper or document believed by it
to be genuine and to have been signed or presented by the proper party or parties;
(b)
Any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by a Board Resolution
or an instrument signed in the name of the Company by any authorized officer of the Company (unless other evidence in respect thereof
is specifically prescribed herein);
(c)
The Trustee may consult with counsel and the written advice of such counsel or, if requested, any Opinion of Counsel shall
be full and complete authorization and protection in respect of any action taken or suffered or omitted hereunder in good faith
and in reliance thereon;
(d)
The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request,
order or direction of any of the Securityholders pursuant to the provisions of this Indenture, unless such Securityholders shall
have offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities that may be incurred therein
or thereby; nothing contained herein shall, however, relieve the Trustee of the obligation, upon the occurrence of an Event of
Default with respect to a series of the Securities (that has not been cured or waived), to exercise with respect to Securities
of that series such of the rights and powers vested in it by this Indenture, and to use the same degree of care and skill in their
exercise, as a prudent man would exercise or use under the circumstances in the conduct of his own affairs;
(e)
The Trustee shall not be liable for any action taken or omitted to be taken by it in good faith and believed by it to be authorized
or within the discretion or rights or powers conferred upon it by this Indenture;
(f)
The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, approval, bond, security, or other papers or documents, unless requested
in writing so to do by the holders of not less than a majority in principal amount of the Outstanding Securities of the particular
series affected thereby (determined as provided in Section 8.04); provided, however, that if the payment within a reasonable
time to the Trustee of the costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in
the opinion of the Trustee, not reasonably assured to the Trustee by the security afforded to it by the terms of this Indenture,
the Trustee may require reasonable indemnity against such costs, expenses or liabilities as a condition to so proceeding.
The reasonable expense of every such examination shall be paid by the Company or, if paid by the Trustee, shall be repaid by the
Company upon demand;
(g)
The Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through
agents or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney
appointed with due care by it hereunder;
(h)
In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder
arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages,
accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions,
loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Trustee
shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon
as practicable under the circumstances;
(i)
In no event shall the Trustee be responsible or liable for special, indirect, or consequential loss or damage of any kind whatsoever
(including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such
loss or damage and regardless of the form of action; and
(j)
The Trustee agrees to accept and act upon instructions or directions pursuant to this Indenture sent by unsecured e-mail, facsimile
transmission or other similar unsecured electronic methods; provided, however, that (a) the party providing such written instructions,
subsequent to such transmission of written instructions, shall provide the originally executed instructions or directions to the
Trustee in a timely manner, and (b) such originally executed instructions or directions shall be signed by an authorized representative
of the party providing such instructions or directions. If the party elects to give the Trustee e-mail or facsimile instructions
(or instructions by a similar electronic method) and the Trustee in its discretion elects to act upon such instructions, the Trustee’s
understanding of such instructions shall be deemed controlling. The Trustee shall not be liable for any losses, costs or
expenses arising directly or indirectly from the Trustee’s reliance upon and compliance with such instructions notwithstanding
such instructions conflict or are inconsistent with a subsequent written instruction. The party providing electronic instructions
agrees to assume all risks arising out of the use of such electronic methods to submit instructions and directions to the Trustee,
including without limitation the risk of the Trustee acting on unauthorized instructions, and the risk or interception and misuse
by third parties.
In addition, the Trustee shall not be deemed
to have knowledge of any Default or Event of Default until the Trustee shall have received written notification in the manner set
forth in this Indenture or a Responsible Officer of the Trustee shall have obtained actual knowledge.
Section 7.03
Trustee Not Responsible for Recitals or Issuance or Securities.
(a)
The recitals contained herein and in the Securities shall be taken as the statements of the Company, and the Trustee assumes
no responsibility for the correctness of the same.
(b)
The Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Securities.
(c)
The Trustee shall not be accountable for the use or application by the Company of any of the Securities or of the proceeds
of such Securities, or for the use or application of any moneys paid over by the Trustee in accordance with any provision of this
Indenture or established pursuant to Section 2.01, or for the use or application of any moneys received by any paying agent
other than the Trustee.
Section 7.04
May Hold Securities.
The Trustee or any paying agent or Security
Registrar, in its individual or any other capacity, may become the owner or pledgee of Securities with the same rights it would
have if it were not Trustee, paying agent or Security Registrar.
Section 7.05
Moneys Held in Trust.
Subject to the provisions of Section 11.05,
all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which
they were received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be
under no liability for interest on any moneys received by it hereunder except such as it may agree with the Company to pay thereon.
Section 7.06
Compensation and Reimbursement.
(a)
The Company covenants and agrees to pay to the Trustee, and the Trustee shall be entitled to, such reasonable compensation
(which shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust) as the Company
and the Trustee may from time to time agree in writing, for all services rendered by it in the execution of the trusts hereby created
and in the exercise and performance of any of the powers and duties hereunder of the Trustee, and, except as otherwise expressly
provided herein, the Company will pay or reimburse the Trustee upon its request for all reasonable expenses, disbursements and
advances incurred or made by the Trustee in accordance with any of the provisions of this Indenture (including the reasonable compensation
and the expenses and disbursements of its counsel and of all Persons not regularly in its employ), except any such expense, disbursement
or advance as may arise from its negligence or bad faith and except as the Company and Trustee may from time to time agree in writing.
The Company also covenants to indemnify the Trustee (and its officers, agents, directors and employees) for, and to hold it harmless
against, any loss, liability or expense incurred without negligence or bad faith on the part of the Trustee and arising out of
or in connection with the acceptance or administration of this trust, including the reasonable costs and expenses of defending
itself against any claim of liability in the premises.
(b)
The obligations of the Company under this Section to compensate and indemnify the Trustee and to pay or reimburse the
Trustee for reasonable expenses, disbursements and advances shall constitute indebtedness of the Company to which the Securities
are subordinated. Such additional indebtedness shall be secured by a lien prior to that of the Securities upon all property
and funds held or collected by the Trustee as such, except funds held in trust for the benefit of the holders of particular Securities.
(c)
To ensure the Company’s payment obligations in this Section, the Trustee shall have a lien prior to the Securities on
all funds or property held or collected by the Trustee, except that held in trust to pay principal of or interest on particular
Securities. When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 6.01(4) or
(5), the expenses (including the reasonable fees and expenses of its counsel) and the compensation for services in connection therewith
are to constitute expenses of administration under any bankruptcy law. The provisions of this Section 7.06 shall survive
the termination of this Indenture and the resignation or removal of the Trustee.
Section 7.07
Reliance on Officer’s Certificate.
Except as otherwise provided in Section 7.01,
whenever in the administration of the provisions of this Indenture the Trustee shall deem it reasonably necessary or desirable
that a matter be proved or established prior to taking or suffering or omitting to take any action hereunder, such matter (unless
other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part
of the Trustee, be deemed to be conclusively proved and established by an Officer’s Certificate delivered to the Trustee
and such certificate, in the absence of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee
for any action taken, suffered or omitted to be taken by it under the provisions of this Indenture upon the faith thereof.
Section 7.08
Disqualification; Conflicting Interests.
If the Trustee has or shall acquire any “conflicting
interest” within the meaning of Section 310(b) of the Trust Indenture Act, the Trustee and the Company shall in
all respects comply with the provisions of Section 310(b) of the Trust Indenture Act.
Section 7.09
Corporate Trustee Required; Eligibility.
There shall at all times be a Trustee with respect
to the Securities issued hereunder which shall at all times be a corporation organized and doing business under the laws of the
United States of America or any state or territory thereof or of the District of Columbia, or a corporation or other Person permitted
to act as trustee by the Commission, authorized under such laws to exercise corporate trust powers, having a combined capital and
surplus of at least fifty million U.S. dollars ($50,000,000), and subject to supervision or examination by federal, state, territorial,
or District of Columbia authority.
If such corporation or other Person publishes
reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority,
then for the purposes of this Section, the combined capital and surplus of such corporation or other Person shall be deemed to
be its combined capital and surplus as set forth in its most recent report of condition so published. The Company may not,
nor may any Person directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee.
In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall
resign immediately in the manner and with the effect specified in Section 7.10.
Section 7.10
Resignation and Removal; Appointment of Successor.
(a)
The Trustee or any successor hereafter appointed may at any time resign with respect to the Securities of one or more series
by giving written notice thereof to the Company and by transmitting notice of resignation by mail, first class postage prepaid,
to the Securityholders of such series, as their names and addresses appear upon the Security Register. Upon receiving such
notice of resignation, the Company shall promptly appoint a successor trustee with respect to Securities of such series by written
instrument, in duplicate, executed by order of the Board of Directors, one copy of which instrument shall be delivered to the resigning
Trustee and one copy to the successor trustee. If no successor trustee shall have been so appointed and have accepted appointment
within 30 days after the mailing of such notice of resignation, the resigning Trustee may petition any court of competent jurisdiction
for the appointment of a successor trustee with respect to Securities of such series, or any Securityholder of that series who
has been a bona fide holder of a Security or Securities for at least six months may on behalf of himself and all others similarly
situated, petition any such court for the appointment of a successor trustee. Such court may thereupon after such notice,
if any, as it may deem proper and prescribe, appoint a successor trustee.
(b)
In case at any time any one of the following shall occur:
(i)
the Trustee shall fail to comply with the provisions of Section 7.08 after written request therefor by the Company or
by any Securityholder who has been a bona fide holder of a Security or Securities for at least six months; or
(ii)
the Trustee shall cease to be eligible in accordance with the provisions of Section 7.09 and shall fail to resign after
written request therefor by the Company or by any such Securityholder; or
(iii)
the Trustee shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or commence a voluntary bankruptcy
proceeding, or a receiver of the Trustee or of its property shall be appointed or consented to, or any public officer shall take
charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation;
then, in any such case, the Company may remove
the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate, executed by order
of the Board of Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor
trustee, or any Securityholder who has been a bona fide holder of a Security or Securities for at least six months may, on behalf
of that holder and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and
the appointment of a successor trustee. Such court may thereupon after such notice, if any, as it may deem proper and prescribe,
remove the Trustee and appoint a successor trustee.
(c)
The holders of a majority in aggregate principal amount of the Securities of any series at the time Outstanding may at any
time remove the Trustee with respect to such series by so notifying the Trustee and the Company and may appoint a successor Trustee
for such series with the consent of the Company.
(d)
Any resignation or removal of the Trustee and appointment of a successor trustee with respect to the Securities of a series
pursuant to any of the provisions of this Section shall become effective upon acceptance of appointment by the successor trustee
as provided in Section 7.11.
(e)
Any successor trustee appointed pursuant to this Section may be appointed with respect to the Securities of one or more
series or all of such series, and at any time there shall be only one Trustee with respect to the Securities of any particular
series.
Section 7.11
Acceptance of Appointment By Successor.
(a)
In case of the appointment hereunder of a successor trustee with respect to all Securities, every such successor trustee so
appointed shall execute, acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment,
and thereupon the resignation or removal of the retiring Trustee shall become effective and such successor trustee, without any
further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee; but,
on the request of the Company or the successor trustee, such retiring Trustee shall, upon payment of its charges, execute and deliver
an instrument transferring to such successor trustee all the rights, powers, and trusts of the retiring Trustee and shall duly
assign, transfer and deliver to such successor trustee all property and money held by such retiring Trustee hereunder.
(b)
In case of the appointment hereunder of a successor trustee with respect to the Securities of one or more (but not all) series,
the Company, the retiring Trustee and each successor trustee with respect to the Securities of one or more series shall execute
and deliver an indenture supplemental hereto wherein each successor trustee shall accept such appointment and which (i) shall
contain such provisions as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all
the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series to which the
appointment of such successor trustee relates, (ii) shall contain such provisions as shall be deemed necessary or desirable
to confirm that all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those
series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring Trustee, and (iii) shall
add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration
of the trusts hereunder by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall
constitute such Trustees co-trustees of the same trust, that each such Trustee shall be trustee of a trust or trusts hereunder
separate and apart from any trust or trusts hereunder administered by any other such Trustee and that no Trustee shall be responsible
for any act or failure to act on the part of any other Trustee hereunder; and upon the execution and delivery of such supplemental
indenture the resignation or removal of the retiring Trustee shall become effective to the extent provided therein, such retiring
Trustee shall with respect to the Securities of that or those series to which the appointment of such successor trustee relates
have no further responsibility for the exercise of rights and powers or for the performance of the duties and obligations vested
in the Trustee under this Indenture, and each such successor trustee, without any further act, deed or conveyance, shall become
vested with all the rights, powers, trusts and duties of the retiring Trustee with respect to the Securities of that or those series
to which the appointment of such successor trustee relates; but, on request of the Company or any successor trustee, such retiring
Trustee shall duly assign, transfer and deliver to such successor trustee, to the extent contemplated by such supplemental indenture,
the property and money held by such retiring Trustee hereunder with respect to the Securities of that or those series to which
the appointment of such successor trustee relates.
(c)
Upon request of any such successor trustee, the Company shall execute any and all instruments for more fully and certainly
vesting in and confirming to such successor trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of
this Section, as the case may be.
(d)
No successor trustee shall accept its appointment unless at the time of such acceptance such successor trustee shall be qualified
and eligible under this Article.
(e)
Upon acceptance of appointment by a successor trustee as provided in this Section, the Company shall transmit notice of the
succession of such trustee hereunder by mail, first class postage prepaid, to the Securityholders, as their names and addresses
appear upon the Security Register. If the Company fails to transmit such notice within ten days after acceptance of appointment
by the successor trustee, the successor trustee shall cause such notice to be transmitted at the expense of the Company.
Section 7.12
Merger, Conversion, Consolidation or Succession to Business.
Any corporation into which the Trustee may be
merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation
to which the Trustee shall be a party, or any corporation succeeding to the corporate trust business of the Trustee, including
the administration of the trust created by this Indenture, shall be the successor of the Trustee hereunder, provided that such
corporation shall be qualified under the provisions of Section 7.08 and eligible under the provisions of Section 7.09,
without the execution or filing of any paper or any further act on the part of any of the parties hereto, anything herein to the
contrary notwithstanding. In case any Securities shall have been authenticated, but not delivered, by the Trustee then in
office, any successor by merger, conversion or consolidation to such authenticating Trustee may adopt such authentication and deliver
the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities.
Section 7.13
Preferential Collection of Claims Against the Company.
The Trustee shall comply with Section 311(a) of
the Trust Indenture Act, excluding any creditor relationship described in Section 311(b) of the Trust Indenture Act.
A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent
included therein.
Section 7.14
Notice of Default
If any Event of Default occurs and is continuing
and if such Event of Default is known to a Responsible Officer of the Trustee, the Trustee shall mail to each Securityholder in
the manner and to the extent provided in Section 313(c) of the Trust Indenture Act notice of the Event of Default within
the earlier of 90 days after it occurs and 30 days after it is known to a Responsible Officer of the Trustee or written notice
of it is received by the Trustee, unless such Event of Default has been cured; provided, however, that, except in the case
of a default in the payment of the principal of (or premium, if any) or interest on any Security, the Trustee shall be protected
in withholding such notice if and so long as the board of directors, the executive committee or a trust committee of directors
and/or Responsible Officers of the Trustee in good faith determine that the withholding of such notice is in the interest of the
Securityholders.
ARTICLE 8
CONCERNING THE SECURITYHOLDERS
Section 8.01
Evidence of Action by Securityholders.
Whenever in this Indenture it is provided that
the holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular series may take
any action (including the making of any demand or request, the giving of any notice, consent or waiver or the taking of any other
action), the fact that at the time of taking any such action the holders of such majority or specified percentage of that series
have joined therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such holders of
Securities of that series in person or by agent or proxy appointed in writing.
If the Company shall solicit from the Securityholders
of any series any request, demand, authorization, direction, notice, consent, waiver or other action, the Company may, at its option,
as evidenced by an Officer’s Certificate, fix in advance a record date for such series for the determination of Securityholders
entitled to give such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company shall
have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent,
waiver or other action may be given before or after the record date, but only the Securityholders of record at the close of business
on the record date shall be deemed to be Securityholders for the purposes of determining whether Securityholders of the requisite
proportion of Outstanding Securities of that series have authorized or agreed or consented to such request, demand, authorization,
direction, notice, consent, waiver or other action, and for that purpose the Outstanding Securities of that series shall be computed
as of the record date; provided, however, that no such authorization, agreement or consent by such Securityholders on the record
date shall be deemed effective unless it shall become effective pursuant to the provisions of this Indenture not later than six
months after the record date.
Section 8.02
Proof of Execution by Securityholders.
Subject to the provisions of Section 7.01,
proof of the execution of any instrument by a Securityholder (such proof will not require notarization) or his agent or proxy and
proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner:
(a)
The fact and date of the execution by any such Person of any instrument may be proved in any reasonable manner acceptable to
the Trustee.
(b)
The ownership of Securities shall be proved by the Security Register of such Securities or by a certificate of the Security
Registrar thereof.
The Trustee may require such additional proof of any matter referred
to in this Section as it shall deem necessary.
Section 8.03
Who May be Deemed Owners.
Prior to the due presentment for registration
of transfer of any Security, the Company, the Trustee, any paying agent and any Security Registrar may deem and treat the Person
in whose name such Security shall be registered upon the books of the Company as the absolute owner of such Security (whether or
not such Security shall be overdue and notwithstanding any notice of ownership or writing thereon made by anyone other than the
Security Registrar) for the purpose of receiving payment of or on account of the principal of, premium, if any, and (subject to
Section 2.03) interest on such Security and for all other purposes; and neither the Company nor the Trustee nor any paying
agent nor any Security Registrar shall be affected by any notice to the contrary.
Section 8.04
Certain Securities Owned by Company Disregarded.
In determining whether the holders of the requisite
aggregate principal amount of Securities of a particular series have concurred in any direction, consent or waiver under this Indenture,
the Securities of that series that are owned by the Company or any other obligor on the Securities of that series or by any Person
directly or indirectly controlling or controlled by or under common control with the Company or any other obligor on the Securities
of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for
the purpose of determining whether the Trustee shall be protected in relying on any such direction, consent or waiver, only Securities
of such series that the Trustee actually knows are so owned shall be so disregarded. The Securities so owned that have been
pledged in good faith may be regarded as Outstanding for the purposes of this Section, if the pledgee shall establish to the satisfaction
of the Trustee the pledgee’s right so to act with respect to such Securities and that the pledgee is not a Person directly
or indirectly controlling or controlled by or under direct or indirect common control with the Company or any such other obligor.
In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full protection to
the Trustee.
Section 8.05
Actions Binding on Future Securityholders.
At any time prior to (but not after) the evidencing
to the Trustee, as provided in Section 8.01, of the taking of any action by the holders of the majority or percentage in aggregate
principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any holder
of a Security of that series that is shown by the evidence to be included in the Securities the holders of which have consented
to such action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke
such action so far as concerns such Security. Except as aforesaid any such action taken by the holder of any Security shall
be conclusive and binding upon such holder and upon all future holders and owners of such Security, and of any Security issued
in exchange therefor, on registration of transfer thereof or in place thereof, irrespective of whether or not any notation in regard
thereto is made upon such Security. Any action taken by the holders of the majority or percentage in aggregate principal
amount of the Securities of a particular series specified in this Indenture in connection with such action shall be conclusively
binding upon the Company, the Trustee and the holders of all the Securities of that series.
ARTICLE 9
SUPPLEMENTAL INDENTURES
Section 9.01
Supplemental Indentures Without the Consent of Securityholders.
In addition to any supplemental indenture otherwise
authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture or indentures
supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent of
the Securityholders, for one or more of the following purposes:
(a)
to cure any ambiguity, defect, or inconsistency herein or in the Securities of any series;
(b)
to comply with Article Ten;
(c)
to provide for uncertificated Securities in addition to or in place of certificated Securities;
(d)
to add to the covenants, restrictions, conditions or provisions relating to the Company for the benefit of the holders of all
or any series of Securities (and if such covenants, restrictions, conditions or provisions are to be for the benefit of less than
all series of Securities, stating that such covenants, restrictions, conditions or provisions are expressly being included solely
for the benefit of such series), to make the occurrence, or the occurrence and the continuance, of a default in any such additional
covenants, restrictions, conditions or provisions an Event of Default, or to surrender any right or power herein conferred upon
the Company;
(e)
to add to, delete from, or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes
of issue, authentication, and delivery of Securities, as herein set forth;
(f)
to make any change that does not adversely affect the rights of any Securityholder in any material respect;
(g)
to provide for the issuance of and establish the form and terms and conditions of the Securities of any series as provided
in Section 2.01, to establish the form of any certifications required to be furnished pursuant to the terms of this Indenture
or any series of Securities, or to add to the rights of the holders of any series of Securities;
(h)
to evidence and provide for the acceptance of appointment hereunder by a successor trustee; or
(i)
to comply with any requirements of the Commission or any successor in connection with the qualification of this Indenture under
the Trust Indenture Act.
The Trustee is hereby authorized to join with
the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations
that may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture that affects
the Trustee’s own rights, duties or immunities under this Indenture or otherwise.
Any supplemental indenture authorized by the
provisions of this Section may be executed by the Company and the Trustee without the consent of the holders of any of the
Securities at the time Outstanding, notwithstanding any of the provisions of Section 9.02.
Section 9.02
Supplemental Indentures With Consent of Securityholders.
With the consent (evidenced as provided in Section 8.01)
of the holders of not less than a majority in aggregate principal amount of the Securities of each series affected by such supplemental
indenture or indentures at the time Outstanding, the Company, when authorized by a Board Resolution, and the Trustee may from time
to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the
Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any manner or eliminating any
of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner not covered by Section 9.01
the rights of the holders of the Securities of such series under this Indenture; provided, however, that no such supplemental indenture
shall, without the consent of the holders of each Security then Outstanding and affected thereby, (a) extend the fixed maturity
of any Securities of any series, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest
thereon, or reduce any premium payable upon the redemption thereof or (b) reduce the aforesaid percentage of Securities, the
holders of which are required to consent to any such supplemental indenture.
It shall not be necessary for the consent of
the Securityholders of any series affected thereby under this Section to approve the particular form of any proposed supplemental
indenture, but it shall be sufficient if such consent shall approve the substance thereof.
Section 9.03
Effect of Supplemental Indentures.
Upon the execution of any supplemental indenture
pursuant to the provisions of this Article or of Section 10.01, this Indenture shall, with respect to such series, be
and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations,
duties and immunities under this Indenture of the Trustee, the Company and the holders of Securities of the series affected thereby
shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments,
and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions
of this Indenture for any and all purposes.
Section 9.04
Securities Affected by Supplemental Indentures.
Securities of any series affected by a supplemental
indenture, authenticated and delivered after the execution of such supplemental indenture pursuant to the provisions of this Article or
of Section 10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of any securities
exchange upon which such series may be listed, as to any matter provided for in such supplemental indenture. If the Company
shall so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors, to any modification
of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee and
delivered in exchange for the Securities of that series then Outstanding.
Section 9.05
Execution of Supplemental Indentures.
Upon the request of the Company, accompanied
by its Board Resolutions authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of
evidence of the consent of Securityholders required to consent thereto as aforesaid, the Trustee shall join with the Company in
the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties
or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion but shall not be obligated to
enter into such supplemental indenture. The Trustee, subject to the provisions of Section 7.01, shall receive an Officer’s
Certificate or an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article is
authorized or permitted by the terms of this Article and that all conditions precedent to the execution of the supplemental
indenture have been complied with; provided, however, that such Officer’s Certificate or Opinion of Counsel need not be provided
in connection with the execution of a supplemental indenture that establishes the terms of a series of Securities pursuant to Section 2.01
hereof.
Promptly after the execution by the Company
and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Company shall (or shall direct the
Trustee to) transmit by mail, first class postage prepaid, a notice, setting forth in general terms the substance of such supplemental
indenture, to the Securityholders of all series affected thereby .as their names and addresses appear upon the Security Register.
Any failure of the Company to mail, or cause the mailing of, such notice, or any defect therein, shall not, however, in any way
impair or affect the validity of any such supplemental indenture.
ARTICLE 10
SUCCESSOR ENTITY
Section 10.01
Company May Consolidate, Etc.
Nothing contained in this Indenture shall prevent
any consolidation or merger of the Company with or into any other Person (whether or not affiliated with the Company) or successive
consolidations or mergers in which the Company or its successor or successors shall be a party or parties, or shall prevent any
sale, conveyance, transfer or other disposition of the property of the Company or its successor or successors as an entirety, or
substantially as an entirety, to any other corporation (whether or not affiliated with the Company or its successor or successors)
authorized to acquire and operate the same; provided, however, (a) the Company hereby covenants and agrees that, upon any
such consolidation or merger (in each case, if the Company is not the survivor of such transaction), sale, conveyance, transfer
or other disposition, the due and punctual payment of the principal of (premium, if any) and interest on all of the Securities
of all series in accordance with the terms of each series, according to their tenor, and the due and punctual performance and observance
of all the covenants and conditions of this Indenture with respect to each series or established with respect to such series pursuant
to Section 2.01 to be kept or performed by the Company shall be expressly assumed, by supplemental indenture (which shall
conform to the provisions of the Trust Indenture Act, as then in effect) reasonably satisfactory in form to the Trustee executed
and delivered to the Trustee by the entity formed by such consolidation, or into which the Company shall have been merged, or by
the entity which shall have acquired such property and (b) in the event that the Securities of any series then Outstanding
are convertible into or exchangeable for shares of common stock or other securities of the Company, such entity shall, by such
supplemental indenture, make provision so that the Securityholders of Securities of that series shall thereafter be entitled to
receive upon conversion or exchange of such Securities the number of securities or property to which a holder of the number of
shares of common stock or other securities of the Company deliverable upon conversion or exchange of those Securities would have
been entitled had such conversion or exchange occurred immediately prior to such consolidation, merger, sale, conveyance, transfer
or other disposition.
Section 10.02
Successor Entity Substituted.
(a)
In case of any such consolidation, merger, sale, conveyance, transfer or other disposition and upon the assumption by the successor
entity by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the obligations
set forth under Section 10.01 on all of the Securities of all series Outstanding, such successor entity shall succeed to and
be substituted for the Company with the same effect as if it had been named as the Company herein, and thereupon the predecessor
corporation shall be relieved of all obligations and covenants under this Indenture and the Securities.
(b)
In case of any such consolidation, merger, sale, conveyance, transfer or other disposition, such changes in phraseology and
form (but not in substance) may be made in the Securities thereafter to be issued as may be appropriate.
(c)
Nothing contained in this Article shall require any action by the Company in the case of a consolidation or merger of
any Person into the Company where the Company is the survivor of such transaction, or the acquisition by the Company, by purchase
or otherwise, of all or any part of the property of any other Person (whether or not affiliated with the Company).
ARTICLE 11
SATISFACTION AND DISCHARGE
Section 11.01
Satisfaction and Discharge of Indenture.
If at any time: (a) the Company shall have
delivered to the Trustee for cancellation all Securities of a series theretofore authenticated and not delivered to the Trustee
for cancellation (other than any Securities that shall have been destroyed, lost or stolen and that shall have been replaced or
paid as provided in Section 2.07 and Securities for whose payment money or Governmental Obligations have theretofore been
deposited in trust or segregated and held in trust by the Company and thereupon repaid to the Company or discharged from such trust,
as provided in Section 11.05); or (b) all such Securities of a particular series not theretofore delivered to the Trustee
for cancellation shall have become due and payable, or are by their terms to become due and payable within one year or are to be
called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and
the Company shall deposit or cause to be deposited with the Trustee as trust funds the entire amount in moneys or Governmental
Obligations or a combination thereof, sufficient in the opinion of a nationally recognized firm of independent public accountants
expressed in a written certification thereof delivered to the Trustee, to pay at maturity or upon redemption all Securities of
that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due
or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or
cause to be paid all other sums payable hereunder with respect to such series by the Company then this Indenture shall thereupon
cease to be of further effect with respect to such series except for the provisions of Sections 2.03, 2.05, 2.07, 4.01, 4.02, 4.03
and 7.10, that shall survive until the date of maturity or redemption date, as the case may be, and Sections 7.06 and 11.05, that
shall survive to such date and thereafter, and the Trustee, on demand of the Company and at the cost and expense of the Company
shall execute proper instruments acknowledging satisfaction of and discharging this Indenture with respect to such series.
Section 11.02
Discharge of Obligations.
If at any time all such Securities of a particular
series not heretofore delivered to the Trustee for cancellation or that have not become due and payable as described in Section 11.01
shall have been paid by the Company by depositing irrevocably with the Trustee as trust funds moneys or an amount of Governmental
Obligations sufficient to pay at maturity or upon redemption all such Securities of that series not theretofore delivered to the
Trustee for cancellation, including principal (and premium, if any) and interest due or to become due to such date of maturity
or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable
hereunder by the Company with respect to such series, then after the date such moneys or Governmental Obligations, as the case
may be, are deposited with the Trustee the obligations of the Company under this Indenture with respect to such series shall cease
to be of further effect except for the provisions of Sections 2.03, 2.05, 2.07, 4,01, 4.02, 4,03, 7.06, 7.10 and 11.05 hereof that
shall survive until such Securities shall mature and be paid.
Thereafter, Sections 7.06 and 11.05 shall survive.
Section 11.03
Deposited Moneys to be Held in Trust.
All moneys or Governmental Obligations deposited
with the Trustee pursuant to Sections 11.01 or 11.02 shall be held in trust and shall be available for payment as due, either directly
or through any paying agent (including the Company acting as its own paying agent), to the holders of the particular series of
Securities for the payment or redemption of which such moneys or Governmental Obligations have been deposited with the Trustee.
Section 11.04
Payment of Moneys Held by Paying Agents.
In connection with the satisfaction and discharge
of this Indenture all moneys or Governmental Obligations then held by any paying agent under the provisions of this Indenture shall,
upon demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability
with respect to such moneys or Governmental Obligations.
Section 11.05
Repayment to Company.
Any moneys or Governmental Obligations deposited
with any paying agent or the Trustee, or then held by the Company, in trust for payment of principal of or premium, if any, or
interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for
at least two years after the date upon which the principal of (and premium, if any) or interest on such Securities shall have respectively
become due and payable, or such other shorter period set forth in applicable escheat or abandoned or unclaimed property law, shall
be repaid to the Company on May 31 of each year or upon the Company’s request or (if then held by the Company) shall
be discharged from such trust; and thereupon the paying agent and the Trustee shall be released from all further liability with
respect to such moneys or Governmental Obligations, and the holder of any of the Securities entitled to receive such payment shall
thereafter, as a general creditor, look only to the Company for the payment thereof.
ARTICLE 12
IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS
Section 12.01
No Recourse.
No recourse under or upon any obligation, covenant
or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof, shall be had
against any incorporator, stockholder, officer or director, past, present or future as such, of the Company or of any predecessor
or successor corporation, either directly or through the Company or any such predecessor or successor corporation, whether by virtue
of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly
understood that this Indenture and the obligations issued hereunder are solely corporate obligations, and that no such personal
liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, officers or directors as such,
of the Company or of any predecessor or successor corporation, or any of them, because of the creation of the indebtedness hereby
authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities
or implied therefrom; and that any and all such personal liability of every name and nature, either at common law or in equity
or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, stockholder, officer
or director as such, because of the creation of the indebtedness hereby authorized, or under or by reason of the obligations, covenants
or agreements contained in this Indenture or in any of the Securities or implied therefrom, are hereby expressly waived and released
as a condition of, and as a consideration for, the execution of this Indenture and the issuance of such Securities.
ARTICLE 13
MISCELLANEOUS PROVISIONS
Section 13.01
Effect on Successors and Assigns.
All the covenants, stipulations, promises and
agreements in this Indenture made by or on behalf of the Company shall bind its successors and assigns, whether so expressed or
not.
Section 13.02
Actions by Successor.
Any act or proceeding by any provision of this
Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done
and performed with like force and effect by the corresponding board, committee or officer of any corporation that shall at the
time be the lawful successor of the Company.
Section 13.03
Surrender of Company Powers.
The Company by instrument in writing executed
by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the Company, and
thereupon such power so surrendered shall terminate both as to the Company and as to any successor corporation.
Section 13.04
Notices.
Except as otherwise expressly provided herein,
any notice, request or demand that by any provision of this Indenture is required or permitted to be given, made or served by the
Trustee or by the holders of Securities or by any other Person pursuant to this Indenture to or on the Company may be given or
served by being deposited in first class mail, postage prepaid, addressed (until another address is filed in writing by the Company
with the Trustee), as follows:
.
Any notice, election, request or demand by the Company or any Securityholder or by any other Person pursuant to this Indenture
to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or made in writing at
the Corporate Trust Office of the Trustee.
Section 13.05
Governing Law.
This Indenture and each Security shall be deemed
to be a contract made under the internal laws of the State of New York, and for all purposes shall be construed in accordance with
the laws of said State, except to the extent that the Trust Indenture Act is applicable.
Section 13.06
Treatment of Securities as Debt.
It is intended that the Securities will be treated
as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be interpreted
to further this intention.
Section 13.07
Certificates and Opinions as to Conditions Precedent.
(a)
Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture,
the Company shall furnish to the Trustee an Officer’s Certificate stating that all conditions precedent provided for in this
Indenture (other than the certificate to be delivered pursuant to Section 13.12) relating to the proposed action have been
complied with and, if requested, an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent
have been complied with, except that in the case of any such application or demand as to which the furnishing of such documents
is specifically required by any provision of this Indenture relating to such particular application or demand, no additional certificate
or opinion need be furnished.
(b)
Each certificate or opinion provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition
or covenant in this Indenture shall include (i) a statement that the Person making such certificate or opinion has read such
covenant or condition; (ii) a brief statement as to the nature and scope of the examination or investigation upon which the
statements or opinions contained in such certificate or opinion are based; (iii) a statement that, in the opinion of such
Person, he has made such examination or investigation as is reasonably necessary to enable him to express an informed opinion as
to whether or not such covenant or condition has been complied with; and (iv) a statement as to whether or not, in the opinion
of such Person, such condition or covenant has been complied with.
Section 13.08
Payments on Business Days.
Except as provided pursuant to Section 2.01
pursuant to a Board Resolution, and set forth in an Officer’s Certificate, or established in one or more indentures supplemental
to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date of redemption of
any Security shall not be a Business Day, then payment of interest or principal (and premium, if any) may be made on the next succeeding
Business Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest shall accrue
for the period after such nominal date.
Section 13.09
Conflict with Trust Indenture Act.
If and to the extent that any provision of this
Indenture limits, qualifies or conflicts with the duties imposed by Sections 310 to 317, inclusive, of the Trust Indenture Act,
such imposed duties shall control.
Section 13.10
Counterparts.
This Indenture may be executed in any number
of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument.
Section 13.11
Separability.
In case any one or more of the provisions contained
in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable in any
respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities,
but this Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never been
contained herein or therein.
Section 13.12
Compliance Certificates.
The Company shall deliver to the Trustee, within
120 days after the end of each fiscal year during which any Securities of any series were outstanding, an officer’s certificate
stating whether or not the signers know of any Event of Default that occurred during such fiscal year. Such certificate shall
contain a certification from the principal executive officer, principal financial officer or principal accounting officer of the
Company that a review has been conducted of the activities of the Company and the Company’s performance under this Indenture
and that the Company has complied with all conditions and covenants under this Indenture. For purposes of this Section 13.12,
such compliance shall be determined without regard to any period of grace or requirement of notice provided under this Indenture.
If the officer of the Company signing such certificate has knowledge of such an Event of Default, the certificate shall describe
any such Event of Default and its status.
ARTICLE 14
SUBORDINATION OF SECURITIES
Section 14.01
Subordination Terms.
The payment by the Company of the principal
of, premium, if any, and interest on any series of Securities issued hereunder shall be subordinated to the extent set forth in
an indenture supplemental hereto relating to such series.
IN WITNESS WHEREOF, the parties hereto
have caused this Indenture to be duly executed all as of the day and year first above written.
|
ADVANCED CELL TECHNOLOGY, INC. |
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
|
|
[TRUSTEE], as Trustee |
|
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
CROSS-REFERENCE TABLE (1)
Section of Trust Indenture Act of 1939, as Amended |
|
Section of Indenture |
310(a) |
|
7.09 |
310(b) |
|
7.08 |
|
|
7.10 |
310(c) |
|
Inapplicable |
311(a) |
|
7.13 |
311(b) |
|
7.13 |
311(c) |
|
Inapplicable |
312(a) |
|
5.01 |
|
|
5.02(a) |
312(b) |
|
5.02(c) |
312(c) |
|
5.02(c) |
313(a) |
|
5.04(a) |
313(b) |
|
5.04(b) |
313(c) |
|
5.04(a) |
|
|
5.04(b) |
313(d) |
|
5.04(c) |
314(a) |
|
5.03 |
|
|
13.12 |
314(b) |
|
Inapplicable |
314(c) |
|
13.07(a) |
314(d) |
|
Inapplicable |
314(e) |
|
13.07(b) |
314(f) |
|
Inapplicable |
315(a) |
|
7.01(a) |
|
|
7.01(b) |
315(b) |
|
7.14 |
315(c) |
|
7.01 |
315(d) |
|
7.01(b) |
315(e) |
|
6.07 |
316(a) |
|
6.06 |
|
|
8.04 |
316(b) |
|
6.04 |
316(c) |
|
8.01 |
317(a) |
|
6.02 |
317(b) |
|
4.03 |
318(a) |
|
13.09 |
(1) This
Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of
its terms or provisions.
EXHIBIT 4.9
ADVANCED CELL TECHNOLOGY, INC.
and
[·],
AS WARRANT AGENT
FORM OF COMMON STOCK
WARRANT AGREEMENT
DATED AS OF [·]
ADVANCED CELL TECHNOLOGY, INC.
FORM OF COMMON STOCK WARRANT AGREEMENT
COMMON STOCK WARRANT AGREEMENT (this
“Agreement”), dated as of
between Advanced Cell Technology, Inc. , a Delaware corporation (the “Company”) and
, a [corporation] [national banking association] organized and existing under the laws of
and having a corporate trust office in
, as warrant agent (the “Warrant Agent”).
WHEREAS, the Company proposes to sell
[if Warrants are sold with other securities—[title of such other securities being offered] (the “Other
Securities”) with] warrant certificates evidencing one or more warrants (the “Warrants” or, individually,
a “Warrant”) representing the right to purchase Common Stock of the Company, par value $0.01 per share (the
“Warrant Securities”), such warrant certificates and other warrant certificates issued pursuant to this Agreement
being herein called the “Warrant Certificates,” and
WHEREAS, the Company desires the Warrant
Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance, registration,
transfer, exchange, exercise and replacement of the Warrant Certificates, and in this Agreement wishes to set forth, among other
things, the form and provisions of the Warrant Certificates and the terms and conditions on which they may be issued, registered,
transferred, exchanged, exercised and replaced.
NOW THEREFORE, in consideration of the
premises and of the mutual agreements herein contained, the parties hereto agree as follows:
ARTICLE 1
ISSUANCE OF WARRANTS AND EXECUTION AND DELIVERY
OF WARRANT CERTIFICATES
1.1 Issuance
Of Warrants. [If Warrants alone—Upon issuance, each Warrant Certificate shall evidence one or
more Warrants.] [If Other Securities and Warrants— Warrant Certificates shall be [initially] issued in connection
with the issuance of the Other Securities [but shall be separately transferable on and after
(the “Detachable Date”)] [and shall not be separately transferable] and each Warrant Certificate shall evidence
one or more Warrants.] Each Warrant evidenced thereby shall represent the right, subject to the provisions contained herein and
therein, to purchase one Warrant Security. [If Other Securities and Warrants— Warrant Certificates
shall be initially issued in units with the Other Securities and each Warrant Certificate included in such a unit shall evidence
Warrants for each [$ principal amount] [
shares] of Other Securities included in such unit.]
1.2 Execution
And Delivery Of Warrant Certificates. Each Warrant Certificate, whenever issued, shall be in registered form substantially
in the form set forth in Exhibit A hereto, shall be dated the date of its countersignature by the Warrant
Agent and may have such letters, numbers, or other marks of identification or designation and such legends or endorsements printed,
lithographed or engraved thereon as the officers of the Company executing the same may approve (execution thereof to be conclusive
evidence of such approval) and as are not inconsistent with the provisions of this Agreement, or as may be required to comply with
any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange
on which the Warrants may be listed, or to conform to usage. The Warrant Certificates shall be signed on behalf of the
Company by any of its present or future chief executive officers, presidents, senior vice presidents, vice presidents, chief financial
officers, chief legal officers, treasurers, assistant treasurers, controllers, assistant controllers, secretaries or assistant
secretaries under its corporate seal reproduced thereon. Such signatures may be manual or facsimile signatures of such
authorized officers and may be imprinted or otherwise reproduced on the Warrant Certificates. The seal of the Company
may be in the form of a facsimile thereof and may be impressed, affixed, imprinted or otherwise reproduced on the Warrant Certificates.
No Warrant Certificate shall be valid for any
purpose, and no Warrant evidenced thereby shall be exercisable, until such Warrant Certificate has been countersigned by the manual
signature of the Warrant Agent. Such signature by the Warrant Agent upon any Warrant Certificate executed by the Company
shall be conclusive evidence that the Warrant Certificate so countersigned has been duly issued hereunder.
In case any officer of the Company who shall
have signed any of the Warrant Certificates either manually or by facsimile signature shall cease to be such officer before the
Warrant Certificates so signed shall have been countersigned and delivered by the Warrant Agent, such Warrant Certificates may
be countersigned and delivered notwithstanding that the person who signed Warrant Certificates ceased to be such officer of the
Company; and any Warrant Certificate may be signed on behalf of the Company by such persons as, at the actual date of the execution
of such Warrant Certificate, shall be the proper officers of the Company, although at the date of the execution of this Agreement
any such person was not such officer.
The term “holder” or “holder
of a Warrant Certificate” as used herein shall mean any person in whose name at the time any Warrant Certificate shall be
registered upon the books to be maintained by the Warrant Agent for that purpose [ If Other Securities and Warrants are not
immediately detachable— or upon the registration of the Other Securities prior to the Detachable Date. Prior
to the Detachable Date, the Company will, or will cause the registrar of the Other Securities to, make available at all times to
the Warrant Agent such information as to holders of the Other Securities as may be necessary to keep the Warrant Agent’s
records up to date].
1.3 Issuance
Of Warrant Certificates. Warrant Certificates evidencing the right to purchase Warrant Securities may be executed
by the Company and delivered to the Warrant Agent upon the execution of this Warrant Agreement or from time to time thereafter. The
Warrant Agent shall, upon receipt of Warrant Certificates duly executed on behalf of the Company, countersign such Warrant Certificates
and shall deliver such Warrant Certificates to or upon the order of the Company.
ARTICLE 2
WARRANT PRICE, DURATION AND EXERCISE OF WARRANTS
2.1 Warrant
Price. During the period specified in Section 2.2, each Warrant shall, subject to the terms of this Warrant
Agreement and the applicable Warrant Certificate, entitle the holder thereof to purchase the number of Warrant Securities specified
in the applicable Warrant Certificate at an exercise price of $
per Warrant Security, subject to adjustment upon the occurrence of certain events, as hereinafter provided. Such purchase
price per Warrant Security is referred to in this Agreement as the “Warrant Price.”
2.2 Duration
Of Warrants. Each Warrant Certificate may be exercised in whole or in part at any time, as specified herein, on
or after [the date thereof] [
] and at or before [ ] p.m., [
] time, on [ ]
or such later date as the Company may designate by notice to the Warrant Agent and the holders of Warrant Certificates mailed to
their addresses as set forth in the record books of the Warrant Agent (the “Expiration Date”). Each
Warrant not exercised at or before [ ] p.m., [
] time, on the Expiration Date shall become void, and all rights of the holder of the Warrant Certificate evidencing such Warrant
under this Agreement shall cease.
2.3 Exercise
Of Warrants.
(a) During
the period specified in Section 2.2, the Warrants may be exercised to purchase a whole number of Warrant Securities in registered
form by providing certain information as set forth on the reverse side of the Warrant Certificate and by paying in full, in lawful
money of the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds]
[by bank wire transfer in immediately available funds] the Warrant Price for each Warrant Security with respect to which a Warrant
is being exercised to the Warrant Agent at its corporate trust office, provided that such exercise is subject to receipt within
five business days of such payment by the Warrant Agent of the Warrant Certificate with the form of election to purchase Warrant
Securities set forth on the reverse side of the Warrant Certificate properly completed and duly executed. The date on
which payment in full of the Warrant Price is received by the Warrant Agent shall, subject to receipt of the Warrant Certificate
as aforesaid, be deemed to be the date on which the Warrant is exercised; provided, however, that if, at the date of receipt of
such Warrant Certificates and payment in full of the Warrant Price, the transfer books for the Warrant Securities purchasable upon
the exercise of such Warrants shall be closed, no such receipt of such Warrant Certificates and no such payment of such Warrant
Price shall be effective to constitute the person so designated to be named as the holder of record of such Warrant Securities
on such date, but shall be effective to constitute such person as the holder of record of such Warrant Securities for all purposes
at the opening of business on the next succeeding day on which the transfer books for the Warrant Securities purchasable upon the
exercise of such Warrants shall be opened, and the certificates for the Warrant Securities in respect of which such Warrants are
then exercised shall be issuable as of the date on such next succeeding day on which the transfer books shall next be opened, and
until such date the Company shall be under no duty to deliver any certificate for such Warrant Securities. The Warrant
Agent shall deposit all funds received by it in payment of the Warrant Price in an account of the Company maintained with it and
shall advise the Company by telephone at the end of each day on which a payment for the exercise of Warrants is received of the
amount so deposited to its account. The Warrant Agent shall promptly confirm such telephone advice to the Company in
writing.
(b) The
Warrant Agent shall, from time to time, as promptly as practicable, advise the Company of (i) the number of Warrant Securities
with respect to which Warrants were exercised, (ii) the instructions of each holder of the Warrant Certificates evidencing
such Warrants with respect to delivery of the Warrant Securities to which such holder is entitled upon such exercise, (iii) delivery
of Warrant Certificates evidencing the balance, if any, of the Warrants for the remaining Warrant Securities after such exercise,
and (iv) such other information as the Company shall reasonably require.
(c) As
soon as practicable after the exercise of any Warrant, the Company shall issue to or upon the order of the holder of the Warrant
Certificate evidencing such Warrant the Warrant Securities to which such holder is entitled, in fully registered form, registered
in such name or names as may be directed by such holder. If fewer than all of the Warrants evidenced by such Warrant
Certificate are exercised, the Company shall execute, and an authorized officer of the Warrant Agent shall manually countersign
and deliver, a new Warrant Certificate evidencing Warrants for the number of Warrant Securities remaining unexercised.
(d) The
Company shall not be required to pay any stamp or other tax or other governmental charge required to be paid in connection with
any transfer involved in the issue of the Warrant Securities, and in the event that any such transfer is involved, the Company
shall not be required to issue or deliver any Warrant Security until such tax or other charge shall have been paid or it has been
established to the Company’s satisfaction that no such tax or other charge is due.
(e) Prior
to the issuance of any Warrants there shall have been reserved, and the Company shall at all times through the Expiration Date
keep reserved, out of its authorized but unissued Warrant Securities, a number of shares sufficient to provide for the exercise
of the Warrants.
ARTICLE 3
OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS
OF WARRANT CERTIFICATES
3.1 No
Rights As Warrant Securityholder Conferred By Warrants Or Warrant Certificates. No Warrant Certificate or Warrant
evidenced thereby shall entitle the holder thereof to any of the rights of a holder of Warrant Securities, including, without limitation,
the right to receive the payment of dividends or distributions, if any, on the Warrant Securities or to exercise any voting rights,
except to the extent expressly set forth in this Agreement or the applicable Warrant Certificate.
3.2 Lost,
Stolen, Mutilated Or Destroyed Warrant Certificates. Upon receipt by the Warrant Agent of evidence reasonably satisfactory
to it and the Company of the ownership of and the loss, theft, destruction or mutilation of any Warrant Certificate and/or indemnity
reasonably satisfactory to the Warrant Agent and the Company and, in the case of mutilation, upon surrender of the mutilated Warrant
Certificate to the Warrant Agent for cancellation, then, in the absence of notice to the Company or the Warrant Agent that such
Warrant Certificate has been acquired by a bona fide purchaser, the Company shall execute, and an authorized officer of the Warrant
Agent shall manually countersign and deliver, in exchange for or in lieu of the lost, stolen, destroyed or mutilated Warrant Certificate,
a new Warrant Certificate of the same tenor and evidencing Warrants for a like number of Warrant Securities. Upon the
issuance of any new Warrant Certificate under this Section 3.2, the Company may require the payment of a sum sufficient to
cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and
expenses of the Warrant Agent) in connection therewith. Every substitute Warrant Certificate executed and delivered
pursuant to this Section 3.2 in lieu of any lost, stolen or destroyed Warrant Certificate shall represent an additional contractual
obligation of the Company, whether or not the lost, stolen or destroyed Warrant Certificate shall be at any time enforceable by
anyone, and shall be entitled to the benefits of this Agreement equally and proportionately with any and all other Warrant Certificates
duly executed and delivered hereunder. The provisions of this Section 3.2 are exclusive and shall preclude (to
the extent lawful) all other rights and remedies with respect to the replacement of mutilated, lost, stolen or destroyed Warrant
Certificates.
3.3 Holder
Of Warrant Certificate May Enforce Rights. Notwithstanding any of the provisions of this Agreement, any holder
of a Warrant Certificate, without the consent of the Warrant Agent, the holder of any Warrant Securities or the holder of any other
Warrant Certificate, may, in such holder’s own behalf and for such holder’s own benefit, enforce, and may institute
and maintain any suit, action or proceeding against the Company suitable to enforce, or otherwise in respect of, such holder’s
right to exercise the Warrants evidenced by such holder’s Warrant Certificate in the manner provided in such holder’s
Warrant Certificate and in this Agreement.
3.4 Adjustments.
(a) In
case the Company shall at any time subdivide its outstanding shares of Common Stock into a greater number of shares, the Warrant
Price in effect immediately prior to such subdivision shall be proportionately reduced and the number of Warrant Securities purchasable
under the Warrants shall be proportionately increased. Conversely, in case the outstanding shares of Common Stock of
the Company shall be combined into a smaller number of shares, the Warrant Price in effect immediately prior to such combination
shall be proportionately increased and the number of Warrant Securities purchasable under the Warrants shall be proportionately
decreased.
(b) If
at any time or from time to time the holders of Common Stock (or any shares of stock or other securities at the time receivable
upon the exercise of the Warrants) shall have received or become entitled to receive, without payment therefore,
(i) Common
Stock or any shares of stock or other securities which are at any time directly or indirectly convertible into or exchangeable
for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend
or other distribution;
(ii)
any cash paid or payable otherwise than as a cash dividend paid or payable out of the Company’s current
or retained earnings;
(iii) any
evidence of the Company’s indebtedness or rights to subscribe for or purchase the Company’s indebtedness; or
(iv)
Common Stock or additional stock or other securities or property (including cash) by way of spinoff, split-up,
reclassification, combination of shares or similar corporate rearrangement (other than shares of Common Stock issued as a stock
split or adjustments in respect of which shall be covered by the terms of Section 3.4(a) above), then and in each such case,
the holder of each Warrant shall, upon the exercise of the Warrant, be entitled to receive, in addition to the number of Warrant
Securities receivable thereupon, and without payment of any additional consideration therefore, the amount of stock and other securities
and property (including cash and indebtedness or rights to subscribe for or purchase indebtedness) which such holder would hold
on the date of such exercise had he been the holder of record of such Warrant Securities as of the date on which holders of Common
Stock received or became entitled to receive such shares or all other additional stock and other securities and property.
(c) In
case of (i) any reclassification, capital reorganization, or change in the Common Stock of the Company (other than as a result
of a subdivision, combination, or stock dividend provided for in Section 3.4(a) or Section 3.4(b) above), (ii) share
exchange, merger or similar transaction of the Company with or into another person or entity (other than a share exchange, merger
or similar transaction in which the Company is the acquiring or surviving corporation and which does not result in any change in
the Common Stock other than the issuance of additional shares of Common Stock) or (iii) the sale, exchange, lease, transfer
or other disposition of all or substantially all of the properties and assets of the Company as an entirety (in any such case,
a “Reorganization Event”), then, as a condition of such Reorganization Event, lawful provisions shall be made,
and duly executed documents evidencing the same from the Company or its successor shall be delivered to the holders of the Warrants,
so that the holders of the Warrants shall have the right at any time prior to the expiration of the Warrants to purchase, at a
total price equal to that payable upon the exercise of the Warrants, the kind and amount of shares of stock and other securities
and property receivable in connection with such Reorganization Event by a holder of the same number of Warrant Securities as were
purchasable by the holders of the Warrants immediately prior to such Reorganization Event. In any such case appropriate
provisions shall be made with respect to the rights and interests of the holders of the Warrants so that the provisions hereof
shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise the
Warrants, and appropriate adjustments shall be made to the Warrant Price payable hereunder provided the aggregate purchase price
shall remain the same. In the case of any transaction described in clauses (ii) and (iii) above, the Company
shall thereupon be relieved of any further obligation hereunder or under the Warrants, and the Company as the predecessor corporation
may thereupon or at any time thereafter be dissolved, wound up or liquidated. Such successor or assuming entity thereupon
may cause to be signed, and may issue either in its own name or in the name of the Company, any or all of the Warrants issuable
hereunder which heretofore shall not have been signed by the Company, and may execute and deliver securities in its own name, in
fulfillment of its obligations to deliver Warrant Securities upon exercise of the Warrants. All the Warrants so issued
shall in all respects have the same legal rank and benefit under this Agreement as the Warrants theretofore or thereafter issued
in accordance with the terms of this Agreement as though all of such Warrants had been issued at the date of the execution hereof. In
any case of any such Reorganization Event, such changes in phraseology and form (but not in substance) may be made in the Warrants
thereafter to be issued as may be appropriate. The Warrant Agent may receive a written opinion of legal counsel as conclusive
evidence that any such Reorganization Event complies with the provisions of this Section 3.4.
(d) The
Company may, at its option, at any time until the Expiration Date, reduce the then current Warrant Price to any amount deemed appropriate
by the Board of Directors of the Company for any period not exceeding twenty consecutive days (as evidenced in a resolution adopted
by such Board of Directors), but only upon giving the notices required by Section 3.5 at least ten days prior to taking such
action.
(e) Except
as herein otherwise expressly provided, no adjustment in the Warrant Price shall be made by reason of the issuance of shares of
Common Stock, or securities convertible into or exchangeable for shares of Common Stock, or securities carrying the right to purchase
any of the foregoing or for any other reason whatsoever.
(f) No
fractional Warrant Securities shall be issued upon the exercise of Warrants. If more than one Warrant shall be exercised
at one time by the same holder, the number of full Warrant Securities which shall be issuable upon such exercise shall be computed
on the basis of the aggregate number of Warrant Securities purchased pursuant to the Warrants so exercised. Instead
of any fractional Warrant Security which would otherwise be issuable upon exercise of any Warrant, the Company shall pay a cash
adjustment in respect of such fraction in an amount equal to the same fraction of the last reported sale price (or bid price if
there were no sales) per Warrant Security, in either case as reported on the principal registered national securities exchange
on which the Warrant Securities are listed or admitted to trading on the business day that next precedes the day of exercise or,
if the Warrant Securities are not then listed or admitted to trading on any registered national securities exchange, the average
of the closing high bid and low asked prices as reported on the OTC Bulletin Board Service (the “OTC Bulletin Board”)
operated by the Financial Industry Regulatory Authority, Inc. (“FINRA”) or, if not available on the OTC
Bulletin Board, then the average of the closing high bid and low asked prices as reported on any other U.S. quotation medium or
inter-dealer quotation system on such date, or if on any such date the Warrant Securities are not listed or admitted to trading
on a registered national securities exchange, are not included in the OTC Bulletin Board, and are not quoted on any other U.S.
quotation medium or inter-dealer quotation system, an amount equal to the same fraction of the average of the closing bid and asked
prices as furnished by any FINRA member firm selected from time to time by the Company for that purpose at the close of business
on the business day that next precedes the day of exercise.
(g) Whenever
the Warrant Price then in effect is adjusted as herein provided, the Company shall mail to each holder of the Warrants at such
holder’s address as it shall appear on the books of the Company a statement setting forth the adjusted Warrant Price then
and thereafter effective under the provisions hereof, together with the facts, in reasonable detail, upon which such adjustment
is based.
(h)
Notwithstanding anything to the contrary herein, in no event shall the Warrant Price, as adjusted in accordance with the terms
hereof, be less than the par value per share of Common Stock.
3.5 Notice
To Warrantholders. In case the Company shall (a) effect any dividend or distribution described in Section 3.4(b),
(b) effect any Reorganization Event, (c) make any distribution on or in respect of the Common Stock in connection with
the dissolution, liquidation or winding up of the Company, or (d) reduce the then current Warrant Price pursuant to Section 3.4(d),
then the Company shall mail to each holder of Warrants at such holder’s address as it shall appear on the books of the Warrant
Agent, at least ten days prior to the applicable date hereinafter specified, a notice stating (x) the record date for such
dividend or distribution, or, if a record is not to be taken, the date as of which the holders of record of Common Stock that will
be entitled to such dividend or distribution are to be determined, (y) the date on which such Reorganization Event, dissolution,
liquidation or winding up is expected to become effective, and the date as of which it is expected that holders of Common Stock
of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such Reorganization
Event, dissolution, liquidation or winding up, or (z) the first date on which the then current Warrant Price shall be reduced
pursuant to Section 3.4(d). No failure to mail such notice nor any defect therein or in the mailing thereof shall
affect any such transaction or any adjustment in the Warrant Price required by Section 3.4.
3.6 [If
The Warrants Are Subject To Acceleration By The Company, Insert—Acceleration Of Warrants By The Company.
(a) At
any time on or after ,
the Company shall have the right to accelerate any or all Warrants at any time by causing them to expire at the close of business
on the day next preceding a specified date (the “Acceleration Date”), if the Market Price (as hereinafter defined)
of the Common Stock equals or exceeds percent (
%) of the then effective Warrant Price on any twenty Trading
Days (as hereinafter defined) within a period of thirty consecutive Trading Days ending no more than five Trading Days prior to
the date on which the Company gives notice to the Warrant Agent of its election to accelerate the Warrants.
(b) “Market
Price” for each Trading Day shall be, if the Common Stock is listed or admitted to trading on any registered national
securities exchange, the last reported sale price, regular way (or, if no such price is reported, the average of the reported closing
bid and asked prices, regular way) of Common Stock, in either case as reported on the principal registered national securities
exchange on which the Common Stock is listed or admitted to trading or, if not listed or admitted to trading on any registered
national securities exchange, the average of the closing high bid and low asked prices as reported on the OTC Bulletin Board operated
by FINRA, or if not available on the OTC Bulletin Board, then the average of the closing high bid and low asked prices as reported
on any other U.S. quotation medium or inter-dealer quotation system, or if on any such date the shares of Common Stock are not
listed or admitted to trading on a registered national securities exchange, are not included in the OTC Bulletin Board, and are
not quoted on any other U.S. quotation medium or inter-dealer quotation system, the average of the closing bid and asked prices
as furnished by any FINRA member firm selected from time to time by the Company for that purpose. “Trading Day”
shall be each Monday through Friday, other than any day on which securities are not traded in the system or on the exchange that
is the principal market for the Common Stock, as determined by the Board of Directors of the Company.
(c) In
the event of an acceleration of less than all of the Warrants, the Warrant Agent shall select the Warrants to be accelerated by
lot, pro rata or in such other manner as it deems, in its discretion, to be fair and appropriate.
(d) Notice
of an acceleration specifying the Acceleration Date shall be sent by mail first class, postage prepaid, to each registered holder
of a Warrant Certificate representing a Warrant accelerated at such holder’s address appearing on the books of the Warrant
Agent not more than sixty days nor less than thirty days before the Acceleration Date. Such notice of an acceleration
also shall be given no more than twenty days, and no less than ten days, prior to the mailing of notice to registered holders of
Warrants pursuant to this Section 3.6, by publication at least once in a newspaper of general circulation in the City of New
York.
(e) Any
Warrant accelerated may be exercised until [ ] p.m.,
[ ] time, on the business day next preceding the Acceleration
Date. The Warrant Price shall be payable as provided in Section 2.]
ARTICLE 4
EXCHANGE AND TRANSFER OF WARRANT CERTIFICATES
4.1 Exchange
And Transfer Of Warrant Certificates. [If Other Securities with Warrants which are immediately detachable—
Upon] [If Other Securities with Warrants which are not immediately detachable— Prior to the Detachable Date,
a Warrant Certificate may be exchanged or transferred only together with the Other Security to which the Warrant Certificate was
initially attached, and only for the purpose of effecting or in conjunction with an exchange or transfer of such Other Security. Prior
to any Detachable Date, each transfer of the Other Security shall operate also to transfer the related Warrant Certificates. After
the Detachable Date, upon] surrender at the corporate trust office of the Warrant Agent, Warrant Certificates evidencing Warrants
may be exchanged for Warrant Certificates in other denominations evidencing such Warrants or the transfer thereof may be registered
in whole or in part; provided that such other Warrant Certificates evidence Warrants for the same aggregate number of Warrant Securities
as the Warrant Certificates so surrendered. The Warrant Agent shall keep, at its corporate trust office, books in which,
subject to such reasonable regulations as it may prescribe, it shall register Warrant Certificates and exchanges and transfers
of outstanding Warrant Certificates, upon surrender of the Warrant Certificates to the Warrant Agent at its corporate trust office
for exchange or registration of transfer, properly endorsed or accompanied by appropriate instruments of registration of transfer
and written instructions for transfer, all in form satisfactory to the Company and the Warrant Agent. No service charge
shall be made for any exchange or registration of transfer of Warrant Certificates, but the Company may require payment of a sum
sufficient to cover any stamp or other tax or other governmental charge that may be imposed in connection with any such exchange
or registration of transfer. Whenever any Warrant Certificates are so surrendered for exchange or registration of transfer,
an authorized officer of the Warrant Agent shall manually countersign and deliver to the person or persons entitled thereto a Warrant
Certificate or Warrant Certificates duly authorized and executed by the Company, as so requested. The Warrant Agent
shall not be required to effect any exchange or registration of transfer which will result in the issuance of a Warrant Certificate
evidencing a Warrant for a fraction of a Warrant Security or a number of Warrants for a whole number of Warrant Securities and
a fraction of a Warrant Security. All Warrant Certificates issued upon any exchange or registration of transfer of Warrant
Certificates shall be the valid obligations of the Company, evidencing the same obligations and entitled to the same benefits under
this Agreement as the Warrant Certificate surrendered for such exchange or registration of transfer.
4.2 Treatment
Of Holders Of Warrant Certificates. [If Other Securities and Warrants are not immediately detachable—
Prior to the Detachable Date, the Company, the Warrant Agent and all other persons may treat the owner of the Other Security as
the owner of the Warrant Certificates initially attached thereto for any purpose and as the person entitled to exercise the rights
represented by the Warrants evidenced by such Warrant Certificates, any notice to the contrary notwithstanding. After
the Detachable Date and prior to due presentment of a Warrant Certificate for registration of transfer, the] [The] Company, the
Warrant Agent and all other persons may treat the registered holder of a Warrant Certificate as the absolute owner thereof for
any purpose and as the person entitled to exercise the rights represented by the Warrants evidenced thereby, any notice to the
contrary notwithstanding.
4.3 Cancellation
Of Warrant Certificates. Any Warrant Certificate surrendered for exchange, registration of transfer or exercise
of the Warrants evidenced thereby shall, if surrendered to the Company, be delivered to the Warrant Agent and all Warrant Certificates
surrendered or so delivered to the Warrant Agent shall be promptly canceled by the Warrant Agent and shall not be reissued and,
except as expressly permitted by this Agreement, no Warrant Certificate shall be issued hereunder in exchange therefor or in lieu
thereof.
The Warrant Agent shall deliver to the Company
from time to time or otherwise dispose of canceled Warrant Certificates in a manner satisfactory to the Company.
ARTICLE 5
CONCERNING THE WARRANT AGENT
5.1 Warrant
Agent. The Company hereby appoints
as Warrant Agent of the Company in respect of the Warrants and the Warrant Certificates upon the terms and subject to the conditions
herein set forth, and
hereby accepts such appointment. The Warrant Agent shall have the powers and authority granted to and conferred
upon it in the Warrant Certificates and hereby and such further powers and authority to act on behalf of the Company as the Company
may hereafter grant to or confer upon it. All of the terms and provisions with respect to such powers and authority
contained in the Warrant Certificates are subject to and governed by the terms and provisions hereof.
5.2 Conditions
Of Warrant Agent’s Obligations. The Warrant Agent accepts its obligations herein set forth upon the terms
and conditions hereof, including the following to all of which the Company agrees and to all of which the rights hereunder of the
holders from time to time of the Warrant Certificates shall be subject:
(a) Compensation
And Indemnification. The Company agrees promptly to pay the Warrant Agent the compensation to be agreed upon with
the Company for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket expenses
(including reasonable counsel fees) incurred without negligence, bad faith or willful misconduct by the Warrant Agent in connection
with the services rendered hereunder by the Warrant Agent. The Company also agrees to indemnify the Warrant Agent for,
and to hold it harmless against, any loss, liability or expense incurred without negligence, bad faith or willful misconduct on
the part of the Warrant Agent, arising out of or in connection with its acting as Warrant Agent hereunder, including the reasonable
costs and expenses of defending against any claim of such liability.
(b) Agent
For The Company. In acting under this Warrant Agreement and in connection with the Warrant Certificates, the Warrant
Agent is acting solely as agent of the Company and does not assume any obligations or relationship of agency or trust for or with
any of the holders of Warrant Certificates or beneficial owners of Warrants.
(c) Counsel. The
Warrant Agent may consult with counsel satisfactory to it, which may include counsel for the Company, and the written advice of
such counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it
hereunder in good faith and in accordance with the advice of such counsel.
(d) Documents. The
Warrant Agent shall be protected and shall incur no liability for or in respect of any action taken or omitted by it in reliance
upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement or other paper or document reasonably
believed by it to be genuine and to have been presented or signed by the proper parties.
(e) Certain
Transactions. The Warrant Agent, and its officers, directors and employees, may become the owner of, or acquire
any interest in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to
the extent permitted by applicable law, it or they may engage or be interested in any financial or other transaction with the Company
and may act on, or as depositary, trustee or agent for, any committee or body of holders of Warrant Securities or other obligations
of the Company as freely as if it were not the Warrant Agent hereunder. Nothing in this Warrant Agreement shall be deemed
to prevent the Warrant Agent from acting as trustee under any indenture to which the Company is a party.
(f) No
Liability For Interest. Unless otherwise agreed with the Company, the Warrant Agent shall have no liability for
interest on any monies at any time received by it pursuant to any of the provisions of this Agreement or of the Warrant Certificates.
(g) No
Liability For Invalidity. The Warrant Agent shall have no liability with respect to any invalidity of this Agreement
or any of the Warrant Certificates (except as to the Warrant Agent’s countersignature thereon).
(h) No
Responsibility For Representations. The Warrant Agent shall not be responsible for any of the recitals or representations
herein or in the Warrant Certificates (except as to the Warrant Agent’s countersignature thereon), all of which are made
solely by the Company.
(i) No
Implied Obligations. The Warrant Agent shall be obligated to perform only such duties as are herein and in the Warrant
Certificates specifically set forth and no implied duties or obligations shall be read into this Agreement or the Warrant Certificates
against the Warrant Agent. The Warrant Agent shall not be under any obligation to take any action hereunder which may
tend to involve it in any expense or liability, the payment of which within a reasonable time is not, in its reasonable opinion,
assured to it. The Warrant Agent shall not be accountable or under any duty or responsibility for the use by the Company
of any of the Warrant Certificates authenticated by the Warrant Agent and delivered by it to the Company pursuant to this Agreement
or for the application by the Company of the proceeds of the Warrant Certificates. The Warrant Agent shall have no duty
or responsibility in case of any default by the Company in the performance of its covenants or agreements contained herein or in
the Warrant Certificates or in the case of the receipt of any written demand from a holder of a Warrant Certificate with respect
to such default, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt
to initiate any proceedings at law or otherwise or, except as provided in Section 6.2 hereof, to make any demand upon the
Company.
5.3 Resignation,
Removal And Appointment Of Successors.
(a) The
Company agrees, for the benefit of the holders from time to time of the Warrant Certificates, that there shall at all times be
a Warrant Agent hereunder until all the Warrants have been exercised or are no longer exercisable.
(b) The
Warrant Agent may at any time resign as agent by giving written notice to the Company of such intention on its part, specifying
the date on which its desired resignation shall become effective; provided that such date shall not be less than three months after
the date on which such notice is given unless the Company otherwise agrees. The Warrant Agent hereunder may be removed
at any time by the filing with it of an instrument in writing signed by or on behalf of the Company and specifying such removal
and the intended date when it shall become effective. Such resignation or removal shall take effect upon the appointment
by the Company, as hereinafter provided, of a successor Warrant Agent (which shall be a bank or trust company authorized under
the laws of the jurisdiction of its organization to exercise corporate trust powers) and the acceptance of such appointment by
such successor Warrant Agent. The obligation of the Company under Section 5.2(a) shall continue to the extent
set forth therein notwithstanding the resignation or removal of the Warrant Agent.
(c) In
case at any time the Warrant Agent shall resign, or shall be removed, or shall become incapable of acting, or shall be adjudged
a bankrupt or insolvent, or shall commence a voluntary case under the Federal bankruptcy laws, as now or hereafter constituted,
or under any other applicable Federal or state bankruptcy, insolvency or similar law or shall consent to the appointment of or
taking possession by a receiver, custodian, liquidator, assignee, trustee, sequestrator (or other similar official) of the Warrant
Agent or its property or affairs, or shall make an assignment for the benefit of creditors, or shall admit in writing its inability
to pay its debts generally as they become due, or shall take corporate action in furtherance of any such action, or a decree or
order for relief by a court having jurisdiction in the premises shall have been entered in respect of the Warrant Agent in an involuntary
case under the Federal bankruptcy laws, as now or hereafter constituted, or any other applicable Federal or state bankruptcy, insolvency
or similar law, or a decree or order by a court having jurisdiction in the premises shall have been entered for the appointment
of a receiver, custodian, liquidator, assignee, trustee, sequestrator (or similar official) of the Warrant Agent or of its property
or affairs, or any public officer shall take charge or control of the Warrant Agent or of its property or affairs for the purpose
of rehabilitation, conservation, winding up or liquidation, a successor Warrant Agent, qualified as aforesaid, shall be appointed
by the Company by an instrument in writing, filed with the successor Warrant Agent. Upon the appointment as aforesaid
of a successor Warrant Agent and acceptance by the successor Warrant Agent of such appointment, the Warrant Agent shall cease to
be Warrant Agent hereunder.
(d) Any
successor Warrant Agent appointed hereunder shall execute, acknowledge and deliver to its predecessor and to the Company an instrument
accepting such appointment hereunder, and thereupon such successor Warrant Agent, without any further act, deed or conveyance,
shall become vested with all the authority, rights, powers, trusts, immunities, duties and obligations of such predecessor with
like effect as if originally named as Warrant Agent hereunder, and such predecessor, upon payment of its charges and disbursements
then unpaid, shall thereupon become obligated to transfer, deliver and pay over, and such successor Warrant Agent shall be entitled
to receive, all monies, securities and other property on deposit with or held by such predecessor, as Warrant Agent hereunder.
(e) Any
corporation into which the Warrant Agent hereunder may be merged or converted or any corporation with which the Warrant Agent may
be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Warrant Agent shall be
a party, or any corporation to which the Warrant Agent shall sell or otherwise transfer all or substantially all the assets and
business of the Warrant Agent, provided that it shall be qualified as aforesaid, shall be the successor Warrant Agent under this
Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto.
ARTICLE 6
MISCELLANEOUS
6.1 Amendment. This
Agreement may be amended by the parties hereto, without the consent of the holder of any Warrant Certificate, for the purpose of
curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein, or making any other provisions
with respect to matters or questions arising under this Agreement as the Company and the Warrant Agent may deem necessary or desirable;
provided that such action shall not materially adversely affect the interests of the holders of the Warrant Certificates.
6.2 Notices
And Demands To The Company And Warrant Agent. If the Warrant Agent shall receive any notice or demand addressed
to the Company by the holder of a Warrant Certificate pursuant to the provisions of the Warrant Certificates, the Warrant Agent
shall promptly forward such notice or demand to the Company.
6.3 Addresses. Any
communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to
, Attention: and any
communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Advanced
Cell Technology, Inc., 33 Locke Dr., Marlborough, MA 01752; Attention: Chief Financial Officer (or such other address
as shall be specified in writing by the Warrant Agent or by the Company).
6.4 Governing
Law. This Agreement and each Warrant Certificate issued hereunder shall be governed by and construed in accordance
with the laws of the State of New York.
6.5 Delivery
Of Prospectus. The Company shall furnish to the Warrant Agent sufficient copies of a prospectus meeting the requirements
of the Securities Act of 1933, as amended, relating to the Warrant Securities deliverable upon exercise of the Warrants (the “Prospectus”),
and the Warrant Agent agrees that upon the exercise of any Warrant, the Warrant Agent will deliver to the holder of the Warrant
Certificate evidencing such Warrant, prior to or concurrently with the delivery of the Warrant Securities issued upon such exercise,
a Prospectus.
The Warrant Agent shall not, by reason of any
such delivery, assume any responsibility for the accuracy or adequacy of such Prospectus.
6.6 Obtaining
Of Governmental Approvals. The Company will from time to time take all action which may be necessary to obtain and
keep effective any and all permits, consents and approvals of governmental agencies and authorities and securities act filings
under United States Federal and state laws (including without limitation a registration statement in respect of the Warrants and
Warrant Securities under the Securities Act of 1933, as amended), which may be or become requisite in connection with the issuance,
sale, transfer, and delivery of the Warrant Securities issued upon exercise of the Warrants, the issuance, sale, transfer and delivery
of the Warrants or upon the expiration of the period during which the Warrants are exercisable.
6.7 Persons
Having Rights Under Warrant Agreement. Nothing in this Agreement shall give to any person other than the Company,
the Warrant Agent and the holders of the Warrant Certificates any right, remedy or claim under or by reason of this Agreement.
6.8 Headings. The
descriptive headings of the several Articles and Sections of this Agreement are inserted for convenience only and shall not control
or affect the meaning or construction of any of the provisions hereof.
6.9 Counterparts. This
Agreement may be executed in any number of counterparts, each of which as so executed shall be deemed to be an original, but such
counterparts shall together constitute but one and the same instrument.
6.10 Inspection
Of Agreement. A copy of this Agreement shall be available at all reasonable times at the principal corporate trust
office of the Warrant Agent for inspection by the holder of any Warrant Certificate. The Warrant Agent may require such
holder to submit his Warrant Certificate for inspection by it.
IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be duly executed, all as of the day and year first above written.
|
ADVANCED CELL TECHNOLOGY, INC. |
|
|
|
|
By: |
|
|
|
|
|
Its: |
|
|
|
|
|
|
|
|
WARRANT AGENT |
|
|
|
|
By: |
|
|
|
|
|
Its: |
|
[SIGNATURE PAGE TO COMMON STOCK WARRANT AGREEMENT]
EXHIBIT A
FORM OF WARRANT CERTIFICATE
[FACE OF WARRANT CERTIFICATE]
[[Form if Warrants are attached to Other Securities and are not immediately detachable.] |
|
|
|
[Prior to , this Warrant Certificate cannot be transferred or exchanged unless attached to a [Title of Other Securities].] |
|
|
|
|
|
[Form of Legend if Warrants are not immediately exercisable.] |
|
|
|
[Prior to , Warrants evidenced by this Warrant Certificate cannot be exercised.] |
EXERCISABLE ONLY IF COUNTERSIGNED BY THE WARRANT
AGENT AS PROVIDED HEREIN
VOID AFTER [ ] P.M.,
[ ] TIME, ON ,
ADVANCED CELL TECHNOLOGY,
INC.
WARRANT CERTIFICATE REPRESENTING
WARRANTS TO PURCHASE
COMMON STOCK, PAR VALUE $0.01 PER SHARE
This certifies that
or registered assigns is the registered owner of the above indicated number of Warrants, each Warrant entitling such owner [if
Warrants are attached to Other Securities and are not immediately detachable— , subject to the registered owner qualifying
as a “Holder” of this Warrant Certificate, as hereinafter defined),] to purchase, at any time [after [
] p.m., [ ] time, [on
and] on or before [ ] p.m., [
] time, on ,
shares of Common Stock, par value $0.01 per share (the “Warrant Securities”), of Advanced Cell Technology, Inc. (the
“Company”) on the following basis: during the period from
, through and including
, the exercise price per Warrant Security will be $ ,
subject to adjustment as provided in the Warrant Agreement (as hereinafter defined) (the “Warrant Price”). The
Holder may exercise the Warrants evidenced hereby by providing certain information set forth on the back hereof and by paying in
full, in lawful money of the United States of America, [in cash or by certified check or official bank check in New York Clearing
House funds] [by bank wire transfer in immediately available funds], the Warrant Price for each Warrant Security with respect to
which this Warrant is exercised to the Warrant Agent (as hereinafter defined) and by surrendering this Warrant Certificate, with
the purchase form on the back hereof duly executed, at the corporate trust office of [name of Warrant Agent], or its successor
as warrant agent (the “Warrant Agent”), which is, on the date hereof, at the address specified on the reverse
hereof, and upon compliance with and subject to the conditions set forth herein and in the Warrant Agreement (as hereinafter defined).
The term “Holder” as used
herein shall mean [if Warrants are attached to Other Securities and are not immediately detachable—prior to
, (the “Detachable Date”),
the registered owner of the Company’s [title of Other Securities] to which this Warrant Certificate was initially attached,
and after such Detachable Date,] the person in whose name at the time this Warrant Certificate shall be registered upon the books
to be maintained by the Warrant Agent for that purpose pursuant to Section 4 of the Warrant Agreement.
The Warrants evidenced by this Warrant Certificate
may be exercised to purchase a whole number of Warrant Securities in registered form. Upon any exercise of fewer than
all of the Warrants evidenced by this Warrant Certificate, there shall be issued to the Holder hereof a new Warrant Certificate
evidencing Warrants for the number of Warrant Securities remaining unexercised.
This Warrant Certificate is issued under and
in accordance with the Warrant Agreement dated as of ,
(the “Warrant Agreement”), between
the Company and the Warrant Agent and is subject to the terms and provisions contained in the Warrant Agreement, to all of which
terms and provisions the Holder of this Warrant Certificate consents by acceptance hereof. Copies of the Warrant Agreement
are on file at the above-mentioned office of the Warrant Agent.
[If Warrants are attached to Other Securities
and are not immediately detachable - Prior to the Detachable Date, this Warrant Certificate may be exchanged or transferred
only together with the [Title of Other Securities] (the “Other Securities”) to which this Warrant Certificate
was initially attached, and only for the purpose of effecting or in conjunction with, an exchange or transfer of such Other Security. Additionally,
on or prior to the Detachable Date, each transfer of such Other Security on the register of the Other Securities shall operate
also to transfer this Warrant Certificate. After such date, transfer of this] [If Warrants are attached to Other
Securities and are immediately detachable - Transfer of this] Warrant Certificate may be registered when this Warrant
Certificate is surrendered at the corporate trust office of the Warrant Agent by the registered owner or such owner’s assigns,
in the manner and subject to the limitations provided in the Warrant Agreement.
[If Other Securities with Warrants which
are not immediately detachable - Except as provided in the immediately preceding paragraph, after] [If Other Securities
with Warrants which are immediately detachable or Warrants alone - After] countersignature by the Warrant Agent and
prior to the expiration of this Warrant Certificate, this Warrant Certificate may be exchanged at the corporate trust office of
the Warrant Agent for Warrant Certificates representing Warrants for the same aggregate number of Warrant Securities.
This Warrant Certificate shall not entitle
the Holder hereof to any of the rights of a holder of the Warrant Securities, including, without limitation, the right to receive
payments of dividends or distributions, if any, on the Warrant Securities (except to the extent set forth in the Warrant Agreement)
or to exercise any voting rights.
Reference is hereby made to the further provisions
of this Warrant Certificate set forth on the reverse hereof, which further provisions shall for all purposes have the same effect
as if set forth at this place.
This Warrant Certificate shall not be valid
or obligatory for any purpose until countersigned by the Warrant Agent.
IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed in its name and on its behalf by the facsimile signatures of its duly authorized officers.
Dated: |
|
|
|
|
|
|
|
|
|
|
ADVANCED CELL TECHNOLOGY, INC. |
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
Its: |
|
|
|
|
|
|
|
|
|
|
|
Countersigned: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As Warrant Agent |
|
|
|
|
|
|
By: |
|
|
|
|
Authorized Signature |
[REVERSE OF WARRANT CERTIFICATE]
(Instructions for Exercise of Warrant)
To exercise any Warrants evidenced hereby for
Warrant Securities (as hereinafter defined), the Holder must pay, in lawful money of the United States of America, [in cash or
by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available funds],
the Warrant Price in full for Warrants exercised, to [Warrant Agent] [address of Warrant Agent], Attn:
, which payment must specify the name of the Holder and the number of Warrants exercised by such Holder. In addition,
the Holder must complete the information required below and present this Warrant Certificate in person or by mail (certified or
registered mail is recommended) to the Warrant Agent at the appropriate address set forth above. This Warrant Certificate,
completed and duly executed, must be received by the Warrant Agent within five business days of the payment.
(To be executed upon exercise of Warrants)
The undersigned hereby irrevocably elects to
exercise
Warrants, evidenced by this Warrant Certificate, to purchase
shares of the Common Stock, par value $0.01 per share (the “Warrant Securities”), of Advanced Cell Technology, Inc.
and represents that he has tendered payment for such Warrant Securities, in lawful money of the United States of America, [in cash
or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available
funds], to the order of Advanced Cell Technology, Inc., c/o [insert name and address of Warrant Agent], in the amount of $
in accordance with the terms hereof. The
undersigned requests that said Warrant Securities be in fully registered form in the authorized denominations, registered in such
names and delivered all as specified in accordance with the instructions set forth below.
If the number of Warrants exercised is less
than all of the Warrants evidenced hereby, the undersigned requests that a new Warrant Certificate evidencing the Warrants for
the number of Warrant Securities remaining unexercised be issued and delivered to the undersigned unless otherwise specified in
the instructions below.
Dated: |
|
|
Name: |
|
|
|
|
Please Print |
|
|
|
|
|
|
|
|
Address: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Insert Social Security or Other Identifying Number of Holder) |
|
|
|
|
|
|
Signature Guaranteed: |
|
|
|
|
Signature |
|
|
|
|
|
|
|
|
(Signature must conform in all respects to name of holder as specified
on the face of this Warrant Certificate and must bear a signature guarantee by a FINRA member firm).
This Warrant may be exercised at the following addresses:
[Instructions as to form and delivery of Warrant Securities and,
if applicable, Warrant Certificates evidencing Warrants for the number of Warrant Securities remaining unexercised—complete
as appropriate.]
ASSIGNMENT
[Form of assignment to be executed if Warrant
Holder desires to transfer Warrant)
FOR VALUE RECEIVED,
hereby sells, assigns and transfers unto:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Please print name and address including zip code) |
|
Please print Social Security or other identifying number |
the right represented by the within Warrant to purchase
shares of [Title of Warrant Securities] of Advanced Cell Technology, Inc. to which the within Warrant relates and appoints
attorney to transfer such right on the books of the Warrant Agent with full power of substitution in the premises.
(Signature must conform in all respects to name
of holder as specified on the face of the Warrant)
EXHIBIT 4.10
ADVANCED CELL TECHNOLOGY, INC.
and
[·],
AS WARRANT AGENT
FORM OF PREFERRED STOCK
WARRANT AGREEMENT
DATED AS OF [·]
ADVANCED CELL TECHNOLOGY, INC.
FORM OF PREFERRED STOCK WARRANT AGREEMENT
PREFERRED STOCK WARRANT AGREEMENT (this
“Agreement”), dated as of
between Advanced Cell Technology, Inc. , a Delaware corporation (the “Company”) and
, a [corporation] [national banking association] organized and existing under the laws of and
having a corporate trust office in
, as warrant agent (the “Warrant Agent”).
WHEREAS, the Company proposes to sell
[if Warrants are sold with other securities - [title of such other securities being offered] (the “Other
Securities”) with] warrant certificates evidencing one or more warrants (the “Warrants” or, individually,
a “Warrant”) representing the right to purchase [title of Preferred Stock purchasable through exercise of Warrants]
(the “Warrant Securities”), such warrant certificates and other warrant certificates issued pursuant to this
Agreement being herein called the “Warrant Certificates,” and
WHEREAS, the Company desires the Warrant
Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance, registration,
transfer, exchange, exercise and replacement of the Warrant Certificates, and in this Agreement wishes to set forth, among other
things, the form and provisions of the Warrant Certificates and the terms and conditions on which they may be issued, registered,
transferred, exchanged, exercised and replaced.
NOW THEREFORE, in consideration of the
premises and of the mutual agreements herein contained, the parties hereto agree as follows:
ARTICLE 1
ISSUANCE OF WARRANTS AND EXECUTION AND DELIVERY
OF WARRANT CERTIFICATES
1.1 Issuance
of Warrants. [If Warrants alone - Upon issuance, each Warrant Certificate shall evidence one or more Warrants.]
[ If Other Securities and Warrants — Warrant Certificates shall be [initially] issued in connection with
the issuance of the Other Securities [but shall be separately transferable on and after
(the “Detachable Date”)] [and shall not be separately transferable] and each Warrant Certificate shall evidence
one or more Warrants.] Each Warrant evidenced thereby shall represent the right, subject to the provisions contained herein and
therein, to purchase one Warrant Security. [If Other Securities and Warrants - Warrant Certificates shall be
initially issued in units with the Other Securities and each Warrant Certificate included in such a unit shall evidence
Warrants for each [$
principal amount] [ shares] of Other Securities included in such unit.]
1.2 Execution
And Delivery Of Warrant Certificates. Each Warrant Certificate, whenever issued, shall be in registered form substantially
in the form set forth in Exhibit A hereto, shall be dated the date of its countersignature by the Warrant
Agent and may have such letters, numbers, or other marks of identification or designation and such legends or endorsements printed,
lithographed or engraved thereon as the officers of the Company executing the same may approve (execution thereof to be conclusive
evidence of such approval) and as are not inconsistent with the provisions of this Agreement, or as may be required to comply with
any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange
on which the Warrants may be listed, or to conform to usage. The Warrant Certificates shall be signed on behalf of the Company
by any of its present or future chief executive officers, presidents, senior vice presidents, vice presidents, chief financial
officers, chief legal officers, treasurers, assistant treasurers, controllers, assistant controllers, secretaries or assistant
secretaries under its corporate seal reproduced thereon. Such signatures may be manual or facsimile signatures of such authorized
officers and may be imprinted or otherwise reproduced on the Warrant Certificates. The seal of the Company may be in the form of
a facsimile thereof and may be impressed, affixed, imprinted or otherwise reproduced on the Warrant Certificates.
No Warrant Certificate shall be valid for any
purpose, and no Warrant evidenced thereby shall be exercisable, until such Warrant Certificate has been countersigned by the manual
signature of the Warrant Agent. Such signature by the Warrant Agent upon any Warrant Certificate executed by the Company shall
be conclusive evidence that the Warrant Certificate so countersigned has been duly issued hereunder.
In case any officer of the Company who shall
have signed any of the Warrant Certificates either manually or by facsimile signature shall cease to be such officer before the
Warrant Certificates so signed shall have been countersigned and delivered by the Warrant Agent, such Warrant Certificates may
be countersigned and delivered notwithstanding that the person who signed Warrant Certificates ceased to be such officer of the
Company; and any Warrant Certificate may be signed on behalf of the Company by such
persons as, at the actual date of the execution of such Warrant
Certificate, shall be the proper officers of the Company, although at the date of the execution of this Agreement any such person
was not such officer.
The term “holder” or “holder
of a Warrant Certificate” as used herein shall mean any person in whose name at the time any Warrant Certificate shall
be registered upon the books to be maintained by the Warrant Agent for that purpose [ If Other Securities and Warrants are
not immediately detachable— or upon the registration of the Other Securities prior to the Detachable Date. Prior
to the Detachable Date, the Company will, or will cause the registrar of the Other Securities to, make available at all times to
the Warrant Agent such information as to holders of the Other Securities as may be necessary to keep the Warrant Agent’s
records up to date].
1.3 Issuance
Of Warrant Certificates. Warrant Certificates evidencing the right to purchase Warrant Securities may be executed by the Company
and delivered to the Warrant Agent upon the execution of this Warrant Agreement or from time to time thereafter. The Warrant Agent
shall, upon receipt of Warrant Certificates duly executed on behalf of the Company, countersign such Warrant Certificates and shall
deliver such Warrant Certificates to or upon the order of the Company.
ARTICLE 2
WARRANT PRICE, DURATION AND EXERCISE OF WARRANTS
2.1 Warrant
Price. During the period specified in Section 2.2, each Warrant shall, subject to the terms of this Warrant Agreement
and the applicable Warrant Certificate, entitle the holder thereof to purchase the number of Warrant Securities specified in the
applicable Warrant Certificate at an exercise price of $ per Warrant
Security, subject to adjustment upon the occurrence of certain events, as hereinafter provided. Such purchase price per Warrant
Security is referred to in this Agreement as the “Warrant Price.”
2.2 Duration
Of Warrants. Each Warrant Certificate may be exercised in whole or in part at any time, as specified herein, on or after [the
date thereof] [
] and at or before [ ] p.m., [ ]
time, on
or such later date as the Company may designate by notice to the Warrant Agent and the holders of Warrant Certificates mailed to
their addresses as set forth in the record books of the Warrant Agent (the “Expiration Date”). Each Warrant
not exercised at or before [ ] p.m., [ ]
time, on the Expiration Date shall become void, and all rights of the holder of the Warrant Certificate evidencing such Warrant
under this Agreement shall cease.
2.3 Exercise
Of Warrants.
(a)
During the period specified in Section 2.2, the Warrants may be exercised to purchase a whole
number of Warrant Securities in registered form by providing certain information as set forth on the reverse side of the Warrant
Certificate and by paying in full, in lawful money of the United States of America, [in cash or by certified check or official
bank check in New York Clearing House funds] [by bank wire transfer in immediately available funds] the Warrant Price for each
Warrant Security with respect to which a Warrant is being exercised to the Warrant Agent at its corporate trust office, provided
that such exercise is subject to receipt within five business days of such payment by the Warrant Agent of the Warrant Certificate
with the form of election to purchase Warrant Securities set forth on the reverse side of the Warrant Certificate properly completed
and duly executed. The date on which payment in full of the Warrant Price is received by the Warrant Agent shall, subject to receipt
of the Warrant Certificate as aforesaid, be deemed to be the date on which the Warrant is exercised; provided, however, that if,
at the date of receipt of such Warrant Certificates and payment in full of the Warrant Price, the transfer books for the Warrant
Securities purchasable upon the exercise of such Warrants shall be closed, no such receipt of such Warrant Certificates and no
such payment of such Warrant Price shall be effective to constitute the person so designated to be named as the holder of record
of such Warrant Securities on such date, but shall be effective to constitute such person as the holder of record of such Warrant
Securities for all purposes at the opening of business on the next succeeding day on which the transfer books for the Warrant Securities
purchasable upon the exercise of such Warrants shall be opened, and the certificates for the Warrant Securities in respect of which
such Warrants are then exercised shall be issuable as of the date on such next succeeding day on which the transfer books shall
next be opened, and until such date the Company shall be under no duty to deliver any certificate for such Warrant Securities.
The Warrant Agent shall deposit all funds received by it in payment of the Warrant Price in an account of the Company maintained
with it and shall advise the Company by telephone at the end of each day on which a payment for the exercise of Warrants is received
of the amount so deposited to its account. The Warrant Agent shall promptly confirm such telephone advice to the Company in writing.
(b) The
Warrant Agent shall, from time to time, as promptly as practicable, advise the Company of (i) the number of Warrant Securities
with respect to which Warrants were exercised, (ii) the instructions of each holder of the Warrant Certificates evidencing
such Warrants with respect to delivery of the Warrant Securities to which such holder is entitled upon such exercise, (iii) delivery
of Warrant Certificates evidencing the balance, if any, of the Warrants for the remaining Warrant Securities after such exercise,
and (iv) such other information as the Company shall reasonably require.
(c)
As soon as practicable after the exercise of any Warrant, the Company shall issue to or upon the order of
the holder of the Warrant Certificate evidencing such Warrant the
Warrant Securities to which such holder is entitled, in fully registered form, registered in such name or names as may be directed
by such holder. If fewer than all of the Warrants evidenced by such Warrant Certificate are exercised, the Company shall execute,
and an authorized officer of the Warrant Agent shall manually countersign and deliver, a new Warrant Certificate evidencing Warrants
for the number of Warrant Securities remaining unexercised.
(d)
The Company shall not be required to pay any stamp or other tax or other governmental charge required to be paid in connection
with any transfer involved in the issue of the Warrant Securities, and in the event that any such transfer is involved, the Company
shall not be required to issue or deliver any Warrant Security until such tax or other charge shall have been paid or it has been
established to the Company’s satisfaction that no such tax or other charge is due.
(e)
Prior to the issuance of any Warrants there shall have been reserved, and the Company shall at all times through the Expiration
Date keep reserved, out of its authorized but unissued Warrant Securities, a number of shares sufficient to provide for the exercise
of the Warrants.
ARTICLE 3
OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS
OF WARRANT CERTIFICATES
3.1 No
Rights As Warrant Securityholder Conferred By Warrants or Warrant Certificates. No Warrant Certificate or Warrant evidenced
thereby shall entitle the holder thereof to any of the rights of a holder of Warrant Securities, including, without limitation,
the right to receive the payment of dividends or distributions, if any, on the Warrant Securities or to exercise any voting rights,
except to the extent expressly set forth in this Agreement or the applicable Warrant Certificate.
3.2 Lost,
Stolen, Mutilated or Destroyed Warrant Certificates. Upon receipt by the Warrant Agent of evidence reasonably satisfactory
to it and the Company of the ownership of and the loss, theft, destruction or mutilation of any Warrant Certificate and/or indemnity
reasonably satisfactory to the Warrant Agent and the Company and, in the case of mutilation, upon surrender of the mutilated Warrant
Certificate to the Warrant Agent for cancellation, then, in the absence of notice to the Company or the Warrant Agent that such
Warrant Certificate has been acquired by a bona fide purchaser, the Company shall execute, and an authorized officer of the Warrant
Agent shall manually countersign and deliver, in exchange for or in lieu of the lost, stolen, destroyed or mutilated Warrant Certificate,
a new Warrant Certificate of the same tenor and evidencing Warrants for a like number of Warrant Securities. Upon the issuance
of any new Warrant Certificate under this Section 3.2, the Company may require the payment of a sum sufficient to cover any
tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses
of the Warrant Agent) in connection therewith. Every substitute Warrant Certificate executed and delivered pursuant to this Section 3.2
in lieu of any lost, stolen or destroyed Warrant Certificate shall represent an additional contractual obligation of the Company,
whether or not the lost, stolen or destroyed Warrant Certificate shall be at any time enforceable by anyone, and shall be entitled
to the benefits of this Agreement equally and proportionately with any and all other Warrant Certificates duly executed and delivered
hereunder. The provisions of this Section 3.2 are exclusive and shall preclude (to the extent lawful) all other rights and
remedies with respect to the replacement of mutilated, lost, stolen or destroyed Warrant Certificates.
3.3 Holder
of Warrant Certificate May Enforce Rights. Notwithstanding any of the provisions of this Agreement, any holder of a Warrant
Certificate, without the consent of the Warrant Agent, the holder of any Warrant Securities or the holder of any other Warrant
Certificate, may, in such holder’s own behalf and for such holder’s own benefit, enforce, and may institute and maintain
any suit, action or proceeding against the Company suitable to enforce, or otherwise in respect of, such holder’s right to
exercise the Warrants evidenced by such holder’s Warrant Certificate in the manner provided in such holder’s Warrant
Certificate and in this Agreement.
3.4 Adjustments.
(a)
In case the Company shall at any time subdivide its outstanding shares of [title of Preferred Stock purchasable
through exercise of Warrants] into a greater number of shares, the Warrant Price in effect immediately prior to such subdivision
shall be proportionately reduced and the number of Warrant Securities purchasable under the Warrants shall be proportionately increased.
Conversely, in case the outstanding shares of [title of Preferred Stock purchasable through exercise of Warrants] of the Company
shall be combined into a smaller number of shares, the Warrant Price in effect immediately prior to such combination shall be proportionately
increased and the number of Warrant Securities purchasable under the Warrants shall be proportionately decreased.
(b) If
at any time or from time to time the holders of [title of Preferred Stock purchasable through exercise of Warrants] (or any shares
of stock or other securities at the time receivable upon the exercise of the Warrants) shall have received or become entitled to
receive, without payment therefore,
(i)
[title of Preferred Stock purchasable through exercise of Warrants] or any shares of stock or
other securities which are at any time directly or indirectly convertible into or exchangeable for [title of Preferred Stock purchasable
through exercise of Warrants], or any rights or options to subscribe
for, purchase or otherwise acquire any of the foregoing by way of dividend or other distribution;
(ii) any
cash paid or payable otherwise than in accordance with the terms of [title of Preferred Stock purchasable through exercise of Warrants]
or otherwise than as a cash dividend paid or payable out of the Company’s current or retained earnings;
(iii) any
evidence of the Company’s indebtedness or rights to subscribe for or purchase the Company’s indebtedness; or
(iv) [title
of Preferred Stock purchasable through exercise of Warrants] or additional stock or other securities or property (including cash)
by way of spinoff, split-up, reclassification, combination of shares or similar corporate rearrangement (other than shares of [title
of Preferred Stock purchasable through exercise of Warrants] issued as a stock split or adjustments in respect of which shall be
covered by the terms of Section 3.4(a) above), then and in each such case, the holder of each Warrant shall, upon the
exercise of the Warrant, be entitled to receive, in addition to the number of Warrant Securities receivable thereupon, and without
payment of any additional consideration therefore, the amount of stock and other securities and property (including cash and indebtedness
or rights to subscribe for or purchase indebtedness) which such holder would hold on the date of such exercise had he been the
holder of record of such Warrant Securities as of the date on which holders of [title of Preferred Stock purchasable through exercise
of Warrants] received or became entitled to receive such shares or all other additional stock and other securities and property.
(c)
In case of (i) any reclassification, capital reorganization, or change in the [title of Preferred
Stock purchasable through the exercise of the Warrants] of the Company (other than as a result of a subdivision, combination or
stock dividend provided for in Section 3.4(a) or Section 3.4(b) above), (ii) share exchange, merger or
similar transaction of the Company with or into another person or entity (other than a share exchange, merger or similar transaction
in which the Company is the acquiring or surviving corporation and which does not result in any change in the [title of Preferred
Stock purchasable through the exercise of the Warrants] other than the issuance of additional shares of [title of Preferred Stock
purchasable through the exercise of the Warrants]) or (iii) the sale, exchange, lease, transfer or other disposition of all
or substantially all of the properties and assets of the Company as an entirety (in any such case, a “Reorganization Event”),
then, as a condition of such Reorganization Event, lawful provisions shall be made, and duly executed documents evidencing the
same from the Company or its successor shall be delivered to the holders of the Warrants, so that the holders of the Warrants shall
have the right at any time prior to the expiration of the Warrants to purchase, at a total price equal to that payable upon the
exercise of the Warrants, the kind and amount of shares of stock and other securities and property receivable in connection with
such Reorganization Event by a holder of the same number of shares of [title of Preferred Stock purchasable through the exercise
of the Warrants] as were purchasable by the holders of the Warrants immediately prior to such Reorganization Event. In any such
case appropriate provisions shall be made with respect to the rights and interests of the holders of the Warrants so that the provisions
hereof shall thereafter be applicable with respect to any shares of stock or other securities and property deliverable upon exercise
the Warrants, and appropriate adjustments shall be made to the Warrant Price payable hereunder provided the aggregate purchase
price shall remain the same. In the case of any transaction described in clauses (ii) and (iii) above, the Company shall
thereupon be relieved of any further obligation hereunder or under the Warrants, and the Company as the predecessor corporation
may thereupon or at any time thereafter be dissolved, wound up or liquidated. Such successor or assuming entity thereupon may cause
to be signed, and may issue either in its own name or in the name of the Company, any or all of the Warrants issuable hereunder
which heretofore shall not have been signed by the Company, and may execute and deliver securities in its own name, in fulfillment
of its obligations to deliver Warrant Securities upon exercise of the Warrants. All the Warrants so issued shall in all respects
have the same legal rank and benefit under this Agreement as the Warrants theretofore or thereafter issued in accordance with the
terms of this Agreement as though all of such Warrants had been issued at the date of the execution hereof. In any case of any
such Reorganization Event, such changes in phraseology and form (but not in substance) may be made in the Warrants thereafter to
be issued as may be appropriate. The Warrant Agent may receive a written opinion of legal counsel as conclusive evidence
that any such Reorganization Event complies with the provisions of this Section 3.4.
(d) The
Company may, at its option, at any time until the Expiration Date, reduce the then current Warrant Price to any amount deemed appropriate
by the Board of Directors of the Company for any period not exceeding twenty consecutive days (as evidenced in a resolution adopted
by such Board of Directors), but only upon giving the notices required by Section 3.5 at least ten days prior to taking such
action.
(e) Except
as herein otherwise expressly provided, no adjustment in the Warrant Price shall be made by reason of the issuance of any securities
of the Company or for any other reason whatsoever.
(f)
No fractional Warrant Securities shall be issued upon the exercise of Warrants. If more than one Warrant
shall be exercised at one time by the same holder, the number of full Warrant Securities which shall be issuable upon such exercise
shall be computed on the basis of the aggregate number of Warrant Securities purchased pursuant to the Warrants so exercised. Instead
of any fractional Warrant Security which would otherwise be issuable upon exercise of any Warrant, the Company shall pay a cash
adjustment in respect of such fraction in an amount equal to the same fraction of the last reported sale price (or bid price if
there were no sales) per Warrant Security, in either case as reported on the principal registered national securities exchange
on which the Warrant Securities are listed or admitted to trading on the business day that next precedes the day of exercise or,
if the Warrant Securities are not then listed or admitted to trading on any registered national securities exchange, the average
of the closing high bid and low asked prices as reported on the OTC Bulletin Board Service (the “OTC Bulletin Board”)
operated by the Financial Industry Regulatory Authority, Inc. (“FINRA”) or, if not available on the OTC
Bulletin Board, then the average of the closing high bid and low asked prices as reported on any other U.S. quotation medium or
inter-dealer quotation system on such date, or if on any such date the Warrant Securities are not listed or admitted to trading
on a registered national securities exchange, are not included in the OTC Bulletin Board, and are not quoted on any other U.S.
quotation medium or inter-dealer quotation system, an amount equal to the same fraction of the average of the closing bid and asked
prices as furnished by any FINRA member firm selected from time to time by the Company for that purpose at the close of business
on the business day that next precedes the day of exercise.
(g) Whenever
the Warrant Price then in effect is adjusted as herein provided, the Company shall mail to each holder of the Warrants at such
holder’s address as it shall appear on the books of the Company a statement setting forth the adjusted Warrant Price then
and thereafter effective under the provisions hereof, together with the facts, in reasonable detail, upon which such adjustment
is based.
(h) Notwithstanding
anything to the contrary herein, in no event shall the Warrant Price, as adjusted in accordance with the terms hereof, be less
than the par value per share of [title of Preferred Stock purchasable through exercise of Warrants].
3.5 Notice
to Warrantholders. In case the Company shall (a) effect any dividend or distribution described in Section 3.4(b),
(b) effect any Reorganization Event, (c) make any distribution on or in respect of the [title of Preferred Stock purchasable
through the exercise of the Warrants] in connection with the dissolution, liquidation or winding up of the Company, or (d) reduce
the then current Warrant Price pursuant to Section 3.4(d), then the Company shall mail to each holder of Warrants at such
holder’s address as it shall appear on the books of the Warrant Agent, at least ten days prior to the applicable date hereinafter
specified, a notice stating (x) the record date for such dividend or distribution, or, if a record is not to be taken, the
date as of which the holders of record of [title of Preferred Stock purchasable through the exercise of Warrants] that will be
entitled to such dividend or distribution are to be determined, (y) the date on which such Reorganization Event, dissolution,
liquidation or winding up is expected to become effective, and the date as of which it is expected that holders of [title of Preferred
Stock purchasable through the exercise of the Warrants] of record shall be entitled to exchange their shares of [title of Preferred
Stock purchasable through the exercise of the Warrants] for securities or other property deliverable upon such Reorganization Event,
dissolution, liquidation or winding up, or (z) the first date on which the then current Warrant Price shall be reduced pursuant
to Section 3.4(d). No failure to mail such notice nor any defect therein or in the mailing thereof shall affect any such transaction
or any adjustment in the Warrant Price required by Section 3.4.
3.6 [IF
THE WARRANTS ARE SUBJECT TO ACCELERATION BY THE COMPANY, INSERT—ACCELERATION OF WARRANTS BY THE COMPANY.
(a)
At any time on or after ,
the Company shall have the right to accelerate any or all Warrants at any time by causing them to expire at the close of business
on the day next preceding a specified date (the “Acceleration Date”), if the Market Price (as hereinafter defined)
of the [title of Preferred Stock purchasable through the exercise of the Warrants] equals or exceeds
percent ( %) of the then effective Warrant Price on any twenty Trading Days
(as hereinafter defined) within a period of thirty consecutive Trading Days ending no more than five Trading Days prior to the
date on which the Company gives notice to the Warrant Agent of its election to accelerate the Warrants.
(b)
“Market Price” for each Trading Day shall be, if the [title of Preferred Stock purchasable through
the exercise of the Warrants] is listed or admitted to trading on any registered national securities exchange, the last reported
sale price, regular way (or, if no such price is reported, the average of the reported closing bid and asked prices, regular way)
of [title of Preferred Stock purchasable through the exercise of the Warrants], in either case as reported on the principal registered
national securities exchange on which the [title of Preferred Stock purchasable through the exercise of the Warrants] is listed
or admitted to trading or, if not listed or admitted to trading on any registered national securities exchange, the average of
the closing high bid and low asked prices as reported on the OTC Bulletin Board operated by FINRA, or if not available on
the OTC Bulletin Board, then the average of the closing high bid and low asked prices as reported on any other U.S. quotation medium
or inter-dealer quotation system, or if on any such date the shares of [title of Preferred Stock purchasable through the exercise
of the Warrants] are not listed or admitted to trading on a registered national securities exchange, are not included in the OTC
Bulletin Board, and are not quoted on any other U.S. quotation medium or inter-dealer quotation system, the average of the closing
bid and asked prices as furnished by any FINRA member firm selected from time to time by the Company for that purpose. “Trading
Day” shall be each Monday through Friday, other than any day on which securities are not traded in the system or on the exchange
that is the principal market for the [title of Preferred Stock purchasable through the exercise of the Warrants], as determined
by the Board of Directors of the Company.
(c)
In the event of an acceleration of less than all of the Warrants, the Warrant Agent shall select the Warrants
to be accelerated by lot, pro rata or in such other manner as it deems, in its discretion, to be fair and appropriate.
(d)
Notice of an acceleration specifying the Acceleration Date shall be sent by mail first class, postage
prepaid, to each registered holder of a Warrant Certificate representing a Warrant accelerated at such holder’s address appearing
on the books of the Warrant Agent not more than sixty days nor less than thirty days before the Acceleration Date. Such notice
of an acceleration also shall be given no more than twenty days, and no less than ten days, prior to the mailing of notice to registered
holders of Warrants pursuant to this Section 3.6, by publication at least once in a newspaper of general circulation in the
City of New York.
(e)
Any Warrant accelerated may be exercised until [ ] p.m.,
[ ] time, on the business day next preceding
the Acceleration Date. The Warrant Price shall be payable as provided in Section 2.]
ARTICLE 4
EXCHANGE AND TRANSFER OF WARRANT CERTIFICATES
4.1 Exchange
and Transfer of Warrant Certificates. [If Other Securities with Warrants which are immediately detachable—
Upon] [ If Other Securities with Warrants which are not immediately detachable— Prior to the Detachable Date,
a Warrant Certificate may be exchanged or transferred only together with the Other Security to which the Warrant Certificate was
initially attached, and only for the purpose of effecting or in conjunction with an exchange or transfer of such Other Security.
Prior to any Detachable Date, each transfer of the Other Security shall operate also to transfer the related Warrant Certificates.
After the Detachable Date, upon] surrender at the corporate trust office of the Warrant Agent, Warrant Certificates evidencing
Warrants may be exchanged for Warrant Certificates in other denominations evidencing such Warrants or the transfer thereof may
be registered in whole or in part; provided that such other Warrant Certificates evidence Warrants for the same aggregate number
of Warrant Securities as the Warrant Certificates so surrendered. The Warrant Agent shall keep, at its corporate trust office,
books in which, subject to such reasonable regulations as it may prescribe, it shall register Warrant Certificates and exchanges
and transfers of outstanding Warrant Certificates, upon surrender of the Warrant Certificates to the Warrant Agent at its corporate
trust office for exchange or registration of transfer, properly endorsed or accompanied by appropriate instruments of registration
of transfer and written instructions for transfer, all in form satisfactory to the Company and the Warrant Agent. No service charge
shall be made for any exchange or registration of transfer of Warrant Certificates, but the Company may require payment of a sum
sufficient to cover any stamp or other tax or other governmental charge that may be imposed in connection with any such exchange
or registration of transfer. Whenever any Warrant Certificates are so surrendered for exchange or registration of transfer, an
authorized officer of the Warrant Agent shall manually countersign and deliver to the person or persons entitled thereto a Warrant
Certificate or Warrant Certificates duly authorized and executed by the Company, as so requested. The Warrant Agent shall not be
required to effect any exchange or registration of transfer which will result in the issuance of a Warrant Certificate evidencing
a Warrant for a fraction of a Warrant Security or a number of Warrants for a whole number of Warrant Securities and a fraction
of a Warrant Security. All Warrant Certificates issued upon any exchange or registration of transfer of Warrant Certificates shall
be the valid obligations of the Company, evidencing the same obligations and entitled to the same benefits under this Agreement
as the Warrant Certificate surrendered for such exchange or registration of transfer.
4.2 Treatment
of Holders of Warrant Certificates. [If Other Securities and Warrants are not immediately detachable— Prior
to the Detachable Date, the Company, the Warrant Agent and all other persons may treat the owner of the Other Security as the owner
of the Warrant Certificates initially attached thereto for any purpose and as the person entitled to exercise the rights represented
by the Warrants evidenced by such Warrant Certificates, any notice to the contrary notwithstanding. After the Detachable Date and
prior to due presentment of a Warrant Certificate for registration of transfer, the] [The] Company, the Warrant Agent and all other
persons may treat the registered holder of a Warrant Certificate as the absolute owner thereof for any purpose and as the person
entitled to exercise the rights represented by the Warrants evidenced thereby, any notice to the contrary notwithstanding.
4.3 Cancellation
of Warrant Certificates. Any Warrant Certificate surrendered for exchange, registration of transfer or exercise of the Warrants
evidenced thereby shall, if surrendered to the Company, be delivered to the Warrant Agent and all Warrant Certificates surrendered
or so delivered to the Warrant Agent shall be promptly canceled by the Warrant Agent and shall not be reissued and, except as expressly
permitted by this Agreement, no Warrant Certificate shall be issued hereunder in exchange therefor or in lieu thereof. The Warrant
Agent shall deliver to the Company from time to time or otherwise dispose of canceled Warrant Certificates in a manner satisfactory
to the Company.
ARTICLE 5
CONCERNING THE WARRANT AGENT
5.1 Warrant
Agent. The Company hereby appoints
as Warrant Agent of the Company in respect of the Warrants and the Warrant Certificates upon the terms and subject to the conditions
herein set forth, and
hereby accepts such appointment. The Warrant Agent shall have the powers and authority granted to and conferred upon it in the
Warrant Certificates and hereby and such further powers and authority to act on behalf of the Company as the Company may hereafter
grant to or confer upon it. All of the terms and provisions with respect to such powers and authority contained in the Warrant
Certificates are subject to and governed by the terms and provisions hereof.
5.2 Conditions
of Warrant Agent’s Obligations. The Warrant Agent accepts its obligations herein set forth upon the terms and conditions
hereof, including the following to all of which the Company agrees and to all of which the rights hereunder of the holders from
time to time of the Warrant Certificates shall be subject:
(a)
Compensation and Indemnification. The Company agrees promptly to pay the Warrant Agent the compensation to
be agreed upon with the Company for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for reasonable
out-of-pocket expenses (including reasonable counsel fees) incurred without negligence, bad faith or willful misconduct by the
Warrant Agent in connection with the services rendered hereunder by the Warrant Agent. The Company also agrees to indemnify the
Warrant Agent for, and to hold it harmless against, any loss, liability or expense incurred without negligence, bad faith or willful
misconduct on the part of the Warrant Agent, arising out of or in connection with its acting as Warrant Agent hereunder, including
the reasonable costs and expenses of defending against any claim of such liability.
(b)
Agent for the Company. In acting under this Warrant Agreement and in connection with the Warrant Certificates,
the Warrant Agent is acting solely as agent of the Company and does not assume any obligations or relationship of agency or trust
for or with any of the holders of Warrant Certificates or beneficial owners of Warrants.
(c)
Counsel. The Warrant Agent may consult with counsel satisfactory to it, which may include counsel for the Company, and the
written advice of such counsel shall be full and complete authorization and protection in respect of any action taken, suffered
or omitted by it hereunder in good faith and in accordance with the advice of such counsel.
(d)
Documents. The Warrant Agent shall be protected and shall incur no liability for or in respect of any action taken or omitted
by it in reliance upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement or other paper or
document reasonably believed by it to be genuine and to have been presented or signed by the proper parties.
(e) Certain
Transactions. The Warrant Agent, and its officers, directors and employees, may become the owner of, or acquire any interest
in, Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to the extent permitted
by applicable law, it or they may engage or be interested in any financial or other transaction with the Company and may act on,
or as depositary, trustee or agent for, any committee or body of holders of Warrant Securities or other obligations of the Company
as freely as if it were not the Warrant Agent hereunder. Nothing in this Warrant Agreement shall be deemed to prevent the Warrant
Agent from acting as trustee under any indenture to which the Company is a party.
(f) No
Liability for Interest. Unless otherwise agreed with the Company, the Warrant Agent shall have no liability for interest on
any monies at any time received by it pursuant to any of the provisions of this Agreement or of the Warrant Certificates.
(g) No
Liability for Invalidity. The Warrant Agent shall have no liability with respect to any invalidity of this Agreement or any
of the Warrant Certificates (except as to the Warrant Agent’s countersignature thereon).
(h) No
Responsibility for Representations. The Warrant Agent shall not be responsible for any of the recitals or representations herein
or in the Warrant Certificates (except as to the Warrant Agent’s countersignature thereon), all of which are made solely
by the Company.
(i) No
Implied Obligations. The Warrant Agent shall be obligated to perform only such duties as are herein and in the Warrant Certificates
specifically set forth and no implied duties or obligations shall be read into this Agreement or the Warrant Certificates against
the Warrant Agent. The Warrant Agent shall not be under any obligation to take any action hereunder which may tend to involve it
in any expense or liability, the payment of which within a reasonable time is not, in its reasonable opinion, assured to it. The
Warrant Agent shall not be accountable or under any duty or responsibility for the use by the Company of any of the Warrant Certificates
authenticated by the Warrant Agent and delivered by it to the Company pursuant to this Agreement or for the application by the
Company of the proceeds of the Warrant Certificates. The Warrant Agent shall have no duty or responsibility in case of any default
by the Company in the performance of its covenants or agreements contained herein or in the Warrant Certificates or in the case
of the receipt of any written demand from a holder of a Warrant Certificate with respect to such default, including, without limiting
the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise
or, except as provided in Section 6.2 hereof, to make any demand upon the Company.
5.3 Resignation,
Removal and Appointment of Successors.
(a) The
Company agrees, for the benefit of the holders from time to time of the Warrant Certificates, that there shall at all times be
a Warrant Agent hereunder until all the Warrants have been exercised or are no longer exercisable.
(b)
The Warrant Agent may at any time resign as agent by giving written notice to the Company of such intention
on its part, specifying the date on which its desired resignation shall become effective; provided that such date shall not be
less than three months after the date on which such notice is given unless the Company otherwise agrees. The Warrant Agent hereunder
may be removed at any time by the filing with it of an instrument in writing signed by or on behalf of the Company and specifying
such removal and the intended date when it shall become effective. Such resignation or removal shall take effect upon the appointment
by the Company, as hereinafter provided, of a successor Warrant Agent (which shall be a bank or trust company authorized under
the laws of the jurisdiction of its organization to exercise corporate trust powers) and the acceptance of such appointment by
such successor Warrant Agent. The obligation of the Company under Section 5.2(a) shall continue to the extent set forth
therein notwithstanding the resignation or removal of the Warrant Agent.
(c)
In case at any time the Warrant Agent shall resign, or shall be removed, or shall become incapable of acting, or
shall be adjudged a bankrupt or insolvent, or shall commence a voluntary case under the Federal bankruptcy laws, as now or hereafter
constituted, or under any other applicable Federal or state bankruptcy, insolvency or similar law or shall consent to the appointment
of or taking possession by a receiver, custodian, liquidator, assignee, trustee, sequestrator (or other similar official) of the
Warrant Agent or its property or affairs, or shall make an assignment for the benefit of creditors, or shall admit in writing its
inability to pay its debts generally as they become due, or shall take corporate action in furtherance of any such action, or a
decree or order for relief by a court having jurisdiction in the premises shall have been entered in respect of the Warrant Agent
in an involuntary case under the Federal bankruptcy laws, as now or hereafter constituted, or any other applicable Federal or state
bankruptcy, insolvency or similar law, or a decree or order by a court having jurisdiction in the premises shall have been entered
for the appointment of a receiver, custodian, liquidator, assignee, trustee, sequestrator (or similar official) of the Warrant
Agent or of its property or affairs, or any public officer shall take charge or control of the Warrant Agent or of its property
or affairs for the purpose of rehabilitation, conservation, winding up or liquidation, a successor Warrant Agent, qualified as
aforesaid, shall be appointed by the Company by an instrument in writing, filed with the successor Warrant Agent. Upon the appointment
as aforesaid of a successor Warrant Agent and acceptance by the successor Warrant Agent of such appointment, the Warrant Agent
shall cease to be Warrant Agent hereunder.
(d)
Any successor Warrant Agent appointed hereunder shall execute, acknowledge and deliver to its predecessor
and to the Company an instrument accepting such appointment hereunder, and thereupon such successor Warrant Agent, without any
further act, deed or conveyance, shall become vested with all the authority, rights, powers, trusts, immunities, duties and obligations
of such predecessor with like effect as if originally named as Warrant Agent hereunder, and such predecessor, upon payment of its
charges and disbursements then unpaid, shall thereupon become obligated to transfer, deliver and pay over, and such successor Warrant
Agent shall be entitled to receive, all monies, securities and other property on deposit with or held by such predecessor, as Warrant
Agent hereunder.
(e)
Any corporation into which the Warrant Agent hereunder may be merged or converted or any corporation with
which the Warrant Agent may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which
the Warrant Agent shall be a party, or any corporation to which the Warrant Agent shall sell or otherwise transfer all or substantially
all the assets and business of the Warrant Agent, provided that it shall be qualified as aforesaid, shall be the successor Warrant
Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto.
ARTICLE 6
MISCELLANEOUS
6.1 Amendment.
This Agreement may be amended by the parties hereto, without the consent of the holder of any Warrant Certificate, for the purpose
of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein, or making any other
provisions with respect to matters or questions arising under this Agreement as the Company and the Warrant Agent may deem necessary
or desirable; provided that such action shall not materially adversely affect the interests of the holders of the Warrant Certificates.
6.2 Notices
and Demands to the Company and Warrant Agent. If the Warrant Agent shall receive any notice or demand addressed to the Company
by the holder of a Warrant Certificate pursuant to the provisions of the Warrant Certificates, the Warrant Agent shall promptly
forward such notice or demand to the Company.
6.3 Addresses.
Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to
, Attention:
and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Advanced
Cell Technology, Inc., 33 Locke Dr., Marlborough, MA 01752, Attention: Chief Financial Officer (or such other address
as shall be specified in writing by the Warrant Agent or by the Company).
6.4 Governing
Law. This Agreement and each Warrant Certificate issued hereunder shall be governed by and construed in accordance with the
laws of the State of New York.
6.5 Delivery
of Prospectus. The Company shall furnish to the Warrant Agent sufficient copies of a prospectus meeting the requirements of
the Securities Act of 1933, as amended, relating to the Warrant Securities deliverable upon exercise of the Warrants (the “Prospectus”),
and the Warrant Agent agrees that upon the exercise of any Warrant, the Warrant Agent will deliver to the holder of the Warrant
Certificate evidencing such Warrant, prior to or concurrently with the delivery of the Warrant Securities issued upon such exercise,
a Prospectus.
The Warrant Agent shall not, by reason of any
such delivery, assume any responsibility for the accuracy or adequacy of such Prospectus.
6.6 Obtaining
of Governmental Approvals. The Company will from time to time take all action which may be necessary to obtain and keep effective
any and all permits, consents and approvals of governmental agencies and authorities and securities act filings under United States
Federal and state laws (including without limitation a registration statement in respect of the Warrants and Warrant Securities
under the Securities Act of 1933, as amended), which may be or become requisite in connection with the issuance, sale, transfer,
and delivery of the Warrant Securities issued upon exercise of the Warrants, the issuance, sale, transfer and delivery of the Warrants
or upon the expiration of the period during which the Warrants are exercisable.
6.7 Persons
Having Rights Under Warrant Agreement. Nothing in this Agreement shall give to any person other than the Company, the Warrant
Agent and the holders of the Warrant Certificates any right, remedy or claim under or by reason of this Agreement.
6.8 Headings.
The descriptive headings of the several Articles and Sections of this Agreement are inserted for convenience only and shall not
control or affect the meaning or construction of any of the provisions hereof.
6.9 Counterparts.
This Agreement may be executed in any number of counterparts, each of which as so executed shall be deemed to be an original, but
such counterparts shall together constitute but one and the same instrument.
6.10 Inspection
of Agreement. A copy of this Agreement shall be available at all reasonable times at the principal corporate trust office of
the Warrant Agent for inspection by the holder of any Warrant Certificate. The Warrant Agent may require such holder to submit
his Warrant Certificate for inspection by it.
IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be duly executed, all as of the day and year first above written.
|
ADVANCED CELL TECHNOLOGY, INC. |
|
|
|
|
By |
|
|
|
|
|
Its |
|
|
|
|
|
|
|
|
WARRANT AGENT |
|
|
|
|
By |
|
|
|
|
|
Its |
|
[SIGNATURE PAGE TO PREFERRED STOCK WARRANT AGREEMENT]
EXHIBIT A
FORM OF WARRANT CERTIFICATE
[FACE OF WARRANT CERTIFICATE]
[[Form if Warrants are attached to Other Securities and are not immediately detachable.] |
|
[Prior to , this Warrant Certificate cannot be transferred or exchanged unless attached to a [Title of Other Securities].] |
[Form of Legend if Warrants are not immediately exercisable.] |
|
[Prior to , Warrants evidenced by this Warrant Certificate cannot be exercised.] |
EXERCISABLE ONLY IF COUNTERSIGNED BY THE WARRANT
AGENT AS PROVIDED HEREIN
VOID AFTER [ ] P.M.,
[ ] TIME, ON ,
ADVANCED CELL TECHNOLOGY, INC.
WARRANT CERTIFICATE REPRESENTING
WARRANTS TO PURCHASE
[TITLE OF WARRANT SECURITIES]
This certifies that
or registered assigns is the registered owner of the above indicated number of Warrants, each Warrant entitling such owner [
if Warrants are attached to Other Securities and are not immediately detachable—, subject to the registered owner
qualifying as a “Holder” of this Warrant Certificate, as hereinafter defined),] to purchase, at any time [after [
] p.m., [ ] time, on
and] on or before [ ] p.m., [ ]
time, on
shares of [Title of Warrant Securities] (the “Warrant Securities”), of Advanced Cell Technology, Inc. (the
“Company”) on the following basis: during the period from
, through and including
, the exercise price per Warrant Security will be $ , subject to adjustment
as provided in the Warrant Agreement (as hereinafter defined) (the “Warrant Price”). The Holder may exercise
the Warrants evidenced hereby by providing certain information set forth on the back hereof and by paying in full, in lawful money
of the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank
wire transfer in immediately available funds], the Warrant Price for each Warrant Security with respect to which this Warrant is
exercised to the Warrant Agent (as hereinafter defined) and by surrendering this Warrant Certificate, with the purchase form on
the back hereof duly executed, at the corporate trust office of [name of Warrant Agent], or its successor as warrant agent (the
“Warrant Agent”), which is, on the date hereof, at the address specified on the reverse hereof, and upon compliance
with and subject to the conditions set forth herein and in the Warrant Agreement (as hereinafter defined).
The term “Holder” as used
herein shall mean [if Warrants are attached to Other Securities and are not immediately detachable— prior to
(the “Detachable Date”), the registered owner of the Company’s [title of Other Securities] to which this
Warrant Certificate was initially attached, and after such Detachable Date,] the person in whose name at the time this Warrant
Certificate shall be registered upon the books to be maintained by the Warrant Agent for that purpose pursuant to Section 4
of the Warrant Agreement.
The Warrants evidenced by this Warrant Certificate
may be exercised to purchase a whole number of Warrant Securities in registered form. Upon any exercise of fewer than all of the
Warrants evidenced by this Warrant Certificate, there shall be issued to the Holder hereof a new Warrant Certificate evidencing
Warrants for the number of Warrant Securities remaining unexercised.
This Warrant Certificate is issued under and
in accordance with the Warrant Agreement dated as of ,
(the “Warrant Agreement”), between
the Company and the Warrant Agent and is subject to the terms and provisions contained in the Warrant Agreement, to all of which
terms and provisions the Holder of this Warrant Certificate consents by acceptance hereof. Copies of the Warrant Agreement are
on file at the above-mentioned office of the Warrant Agent.
[If Warrants are attached to Other Securities
and are not immediately detachable — Prior to the Detachable Date, this Warrant Certificate may be exchanged or transferred
only together with the [Title of Other Securities] (the “Other Securities”) to which this Warrant Certificate
was initially attached, and only for the purpose of effecting or in conjunction with, an exchange or transfer of such Other Security.
Additionally, on or prior to the Detachable Date, each transfer of such Other Security on the register of the Other Securities
shall operate also to transfer this Warrant Certificate. After such date, transfer of this] [If Warrants are attached to
Other Securities and are immediately detachable — Transfer of this] Warrant Certificate may be registered when
this Warrant Certificate is surrendered at the corporate trust office of the Warrant Agent by the registered owner or such owner’s
assigns, in the manner and subject to the limitations provided in the Warrant Agreement.
[If Other Securities with Warrants which
are not immediately detachable — Except as provided in the immediately preceding paragraph, after] [ If Other
Securities with Warrants which are immediately detachable or Warrants alone — After] countersignature by the
Warrant Agent and prior to the expiration of this Warrant Certificate, this Warrant Certificate may be exchanged at the corporate
trust office of the Warrant Agent for Warrant Certificates representing Warrants for the same aggregate number of Warrant Securities.
This Warrant Certificate shall not entitle
the Holder hereof to any of the rights of a holder of the Warrant Securities, including, without limitation, the right to receive
payments of dividends or distributions, if any, on the Warrant Securities (except to the extent set forth in the Warrant Agreement)
or to exercise any voting rights.
Reference is hereby made to the further provisions
of this Warrant Certificate set forth on the reverse hereof, which further provisions shall for all purposes have the same effect
as if set forth at this place.
This Warrant Certificate shall not be valid
or obligatory for any purpose until countersigned by the Warrant Agent.
IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed in its name and on its behalf by the facsimile signatures of its duly authorized officers.
Dated: |
|
|
|
|
|
|
|
|
|
|
ADVANCED CELL TECHNOLOGY, INC. |
|
|
|
|
|
|
|
By: |
|
|
|
|
|
|
|
|
Its: |
|
|
|
|
|
|
|
|
|
|
|
|
Countersigned: |
|
|
|
|
|
|
|
|
|
|
|
As Warrant Agent |
|
|
|
|
|
|
|
By: |
|
|
|
|
Authorized Signature |
[REVERSE OF WARRANT CERTIFICATE]
(Instructions for Exercise of Warrant)
To exercise any Warrants evidenced hereby for
Warrant Securities (as hereinafter defined), the Holder must pay, in lawful money of the United States of America, [in cash or
by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available funds],
the Warrant Price in full for Warrants exercised, to [Warrant Agent] [address of Warrant Agent], Attn:
, which payment must specify the name of the Holder and the number of Warrants exercised by such Holder. In addition, the Holder
must complete the information required below and present this Warrant Certificate in person or by mail (certified or registered
mail is recommended) to the Warrant Agent at the appropriate address set forth above. This Warrant Certificate, completed and duly
executed, must be received by the Warrant Agent within five business days of the payment.
(To be executed upon exercise of Warrants)
The undersigned hereby irrevocably elects to
exercise Warrants, evidenced
by this Warrant Certificate, to purchase
shares of the [Title of Warrant Securities] (the “Warrant Securities”), of Advanced Cell Technology, Inc.
and represents that he has tendered payment for such Warrant Securities, in lawful money of the United States of America, [in cash
or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available
funds], to the order of Advanced Cell Technology, Inc., c/o [insert name and address of Warrant Agent], in the amount of $
in accordance with the terms hereof. The undersigned requests that said
Warrant Securities be in fully registered form in the authorized denominations, registered in such names and delivered all as specified
in accordance with the instructions set forth below.
If the number of Warrants exercised is less
than all of the Warrants evidenced hereby, the undersigned requests that a new Warrant Certificate evidencing the Warrants for
the number of Warrant Securities remaining unexercised be issued and delivered to the undersigned unless otherwise specified in
the instructions below.
Dated: |
|
|
Name: |
|
|
Please Print |
|
|
Address: |
|
|
|
|
|
(Insert Social Security or Other Identifying Number of Holder) |
Signature Guaranteed: |
|
|
|
Signature |
|
(Signature must conform in all respects to name of holder as specified
on the face of this Warrant Certificate and must bear a signature guarantee by a FINRA member firm).
This Warrant may be exercised at the following addresses:
[Instructions as to form and delivery of Warrant Securities and,
if applicable, Warrant Certificates evidencing Warrants for the number of Warrant Securities remaining unexercised—complete
as appropriate.]
ASSIGNMENT
[Form of assignment to be executed if Warrant
Holder desires to transfer Warrant)
FOR VALUE RECEIVED,
hereby sells, assigns and transfers unto:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Please print name and address including zip code) |
|
Please print Social Security or other identifying number |
the right represented by the within Warrant to purchase
shares of [Title of Warrant Securities] of Advanced Cell Technology, Inc. to which the within Warrant relates and appoints
attorney to transfer such right on the books of the Warrant Agent with full power of substitution in the premises.
(Signature must conform in all respects to name of holder as specified
on the face of the Warrant)
Signature Guaranteed
EXHIBIT 4.11
ADVANCED CELL TECHNOLOGY, INC.
and
[·],
AS WARRANT AGENT
FORM OF DEBT SECURITIES
WARRANT AGREEMENT
DATED AS OF [·]
ADVANCED CELL TECHNOLOGY, INC.
FORM OF DEBT SECURITIES WARRANT AGREEMENT
DEBT SECURITIES WARRANT AGREEMENT (this
“Agreement”), dated as of
between ADVANCED CELL TECHNOLOGY, INC., a Delaware corporation (the “Company”) and
, a [corporation] [national banking association] organized and existing under the laws of
and having a corporate trust office in
, as warrant agent (the “Warrant Agent”).
WHEREAS, the Company has entered into
an indenture dated as of [
(the “Senior Indenture”), with
, as trustee (such trustee, and any successors to such trustee, herein called the “Senior Trustee”), providing for
the issuance from time to time of its unsubordinated debt securities, to be issued in one or more series as provided in the Senior
Indenture (the “Debt Securities”);] [
(the “Subordinated Indenture”), with
, as trustee (such trustee, and any successors to such trustee, herein called the “Subordinated Trustee”), providing
for the issuance from time to time of its subordinated debt securities, to be issued in one or more series as provided in the Subordinated
Indenture (the “Debt Securities”);]
WHEREAS, the Company proposes to sell
[If Warrants are sold with other securities- title of such other securities being offered (the “Other Securities”)
with] warrant certificates evidencing one or more warrants (the “Warrants” or, individually, a “Warrant”)
representing the right to purchase [title of Debt Securities purchasable through exercise of Warrants] (the “Warrant Debt
Securities”), such warrant certificates and other warrant certificates issued pursuant to this Agreement being herein called
the “Warrant Certificates,” and
WHEREAS, the Company desires the Warrant
Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance, registration,
transfer, exchange, exercise and replacement of the Warrant Certificates, and in this Agreement wishes to set forth, among other
things, the form and provisions of the Warrant Certificates and the terms and conditions on which they may be issued, registered,
transferred, exchanged, exercised and replaced.
NOW, THEREFORE, in consideration of the
premises and of the mutual agreements herein contained, the parties hereto agree as follows:
ARTICLE 1
ISSUANCE OF WARRANTS AND EXECUTION AND DELIVERY
OF WARRANT
CERTIFICATES
1.1 Issuance of Warrants. [If Warrants
alone—Upon issuance, each Warrant Certificate shall evidence one or more Warrants.] [If Other Securities and Warrants—Warrant
Certificates shall be [initially] issued in connection with the issuance of the Other Securities [but shall be separately transferable
on and after
(the “Detachable Date”)] [and shall not be separately transferable] and each Warrant Certificate shall evidence one
or more Warrants.] [If Other Securities and Warrants—Warrant Certificates shall be initially issued in units with the Other
Securities and each Warrant Certificate included in such a unit shall evidence
Warrants for each [$
principal amount] [
shares] of Other Securities included in such unit].
1.2 Execution and Delivery of Warrant Certificates.
Each Warrant Certificate, whenever issued, shall be in registered form substantially in the form set forth in Exhibit A hereto,
shall be dated the date of its countersignature by the Warrant Agent and may have such letters, numbers, or other marks of identification
or designation and such legends or endorsements printed, lithographed or engraved thereon as the officers of the Company executing
the same may approve (execution thereof to be conclusive evidence of such approval) and as are not inconsistent with the provisions
of this Agreement, or as may be required to comply with any law or with any rule or regulation made pursuant thereto or with
any rule or regulation of any securities exchange on which the Warrants may be listed, or to conform to usage. The Warrant
Certificates shall be signed on behalf of the Company by any of its present or future chief executive officers, presidents, senior
vice presidents, vice presidents, chief financial officers, chief legal officers, treasurers, assistant treasurers, controllers,
assistant controllers, secretaries or assistant secretaries under its corporate seal reproduced thereon. Such signatures may be
manual or facsimile signatures of such authorized officers and may be imprinted or otherwise reproduced on the Warrant Certificates.
The seal of the Company may be in the form of a facsimile thereof and may be impressed, affixed, imprinted or otherwise reproduced
on the Warrant Certificates.
No Warrant Certificate shall be valid for any
purpose, and no Warrant evidenced thereby shall be exercisable, until such Warrant Certificate has been countersigned by the manual
signature of the Warrant Agent. Such signature by the Warrant Agent upon any Warrant Certificate executed by the Company shall
be conclusive evidence that the Warrant Certificate so countersigned has been duly issued hereunder.
In case any officer of the Company who shall
have signed any of the Warrant Certificates either manually or by facsimile signature shall cease to be such officer before the
Warrant Certificates so signed shall have been countersigned and delivered by the Warrant Agent, such Warrant Certificates may
be countersigned and delivered notwithstanding that the person who signed such Warrant Certificates ceased to be such officer of
the Company; and any Warrant Certificate may be signed on behalf of the Company by such persons as, at the actual date of the execution
of such Warrant Certificate, shall be the proper officers of the Company, although at the date of the execution of this Agreement
any such person was not such officer.
The term “holder” or “holder
of a Warrant Certificate” as used herein shall mean any person in whose name at the time any Warrant Certificate shall be
registered upon the books to be maintained by the Warrant Agent for that purpose [If Other Securities and Warrants are not immediately
detachable—or upon the registration of the Other Securities prior to the Detachable Date. Prior to the Detachable Date, the
Company will, or will cause the registrar of the Other Securities to, make available at all times to the Warrant Agent such information
as to holders of the Other Securities as may be necessary to keep the Warrant Agent’s records up to date].
1.3 Issuance of Warrant Certificates.
Warrant Certificates evidencing the right to purchase Warrant Debt Securities may be executed by the Company and delivered to the
Warrant Agent upon the execution of this Warrant Agreement or from time to time thereafter. The Warrant Agent shall, upon receipt
of Warrant Certificates duly executed on behalf of the Company, countersign such Warrant Certificates and shall deliver such Warrant
Certificates to or upon the order of the Company.
ARTICLE 2
WARRANT PRICE, DURATION AND EXERCISE OF WARRANTS
2.1 Warrant Price. During the period specified
in Section 2.2, each Warrant shall, subject to the terms of this Warrant Agreement and the applicable Warrant Certificate,
entitle the holder thereof, to purchase the principal amount of Warrant Debt Securities specified in the applicable Warrant Certificate
at an exercise price of
% of the principal amount thereof [plus accrued amortization, if any, of the original issue discount of the Warrant Debt Securities]
[plus accrued interest, if any, from the most recent date from which interest shall have been paid on the Warrant Debt Securities
or, if no interest shall have been paid on the Warrant Debt Securities, from the date of their initial issuance.] [The original
issue discount ($
for each $1,000 principal amount of Warrant Debt Securities) will be amortized at a
% annual rate, computed on a[n] [semi-] annual basis [using a 360-day year consisting of twelve 30-day months].] Such purchase
price for the Warrant Debt Securities is referred to in this Agreement as the “Warrant Price.”
2.2 Duration of Warrants. Each Warrant
Certificate may be exercised in whole or in part at any time, as specified herein, on or after [the date thereof] [
] and at or before [
] p.m., [City] time, on
or such later date as the Company may designate by notice to the Warrant Agent and the holders of Warrant Certificates mailed to
their addresses as set forth in the record books of the Warrant Agent (the “Expiration Date”). Each Warrant not exercised
at or before [
] p.m., [City] time, on the Expiration Date shall become void, and all rights of the holder of the Warrant Certificate evidencing
such Warrant under this Agreement shall cease.
2.3 Exercise Of Warrants.
(a) During the period specified
in Section 2.2, the Warrants may be exercised to purchase a whole number of Warrant Debt Securities in registered form by
providing certain information as set forth on the reverse side of the Warrant Certificate and by paying in full, in lawful money
of the United States of America, [in cash or by certified check or official bank check in New York Clearing House funds] [by bank
wire transfer in immediately available funds] the Warrant Price for each Warrant Debt Security with respect to which a Warrant
is being exercised to the Warrant Agent at its corporate trust office, provided that such exercise is subject to receipt within
five business days of such payment by the Warrant Agent of the Warrant Certificate with the form of election to purchase Warrant
Debt Securities set forth on the reverse side of the Warrant Certificate properly completed and duly executed. The date on which
payment in full of the Warrant Price is received by the Warrant Agent shall, subject to receipt of the Warrant Certificate as
aforesaid, be deemed to be the date on which the Warrant is exercised; provided, however, that if, at the date of receipt of such
Warrant Certificates and payment in full of the Warrant Price, the transfer books for the Warrant Debt Securities purchasable
upon the exercise of such Warrants shall be closed, no such receipt of such Warrant Certificates and no such payment of such Warrant
Price shall be effective to constitute the person so designated to be named as the holder of record of such Warrant Debt Securities
on such date, but shall be effective to constitute such person as the holder of record of such Warrant Debt Securities for all
purposes at the opening of business on the next succeeding day on which the transfer books for the Warrant Debt Securities purchasable
upon the exercise of such Warrants shall be opened, and the certificates for the Warrant Debt Securities in respect of which such
Warrants are then exercised shall be issuable as of the date on such next succeeding day on which the transfer books shall next
be opened, and until such date the Company shall be under no duty to deliver any certificate for such Warrant Debt Securities.
The Warrant Agent shall deposit all funds received by it in payment of the Warrant Price in an account of the Company maintained
with it and shall advise the Company by telephone at the end of each day on which a payment for the exercise of Warrants
is received of the amount so deposited to its account. The Warrant Agent shall promptly confirm such telephone advice to the Company
in writing.
(b) The Warrant Agent shall, from
time to time, as promptly as practicable, advise the Company of (i) the number of Warrant Debt Securities with respect to
which Warrants were exercised, (ii) the instructions of each holder of the Warrant Certificates evidencing such Warrants with
respect to delivery of the Warrant Debt Securities to which such holder is entitled upon such exercise, (iii) delivery of
Warrant Certificates evidencing the balance, if any, of the Warrants for the remaining Warrant Debt Securities after such exercise,
and (iv) such other information as the Company or the [Senior] [Subordinated] Trustee shall reasonably require.
(c) As soon as practicable after
the exercise of any Warrant, the Company shall issue, pursuant to the Indenture, in authorized denominations, to or upon the order
of the holder of the Warrant Certificate evidencing such Warrant, the Warrant Debt Securities to which such holder is entitled,
in fully registered form, registered in such name or names as may be directed by such holder. If fewer than all of the Warrants
evidenced by such Warrant Certificate are exercised, the Company shall execute, and an authorized officer of the Warrant Agent
shall manually countersign and deliver, a new Warrant Certificate evidencing Warrants for the number of Warrant Debt Securities
remaining unexercised.
(d) The Company shall not be required
to pay any stamp or other tax or other governmental charge required to be paid in connection with any transfer involved in the
issue of the Warrant Debt Securities, and in the event that any such transfer is involved, the Company shall not be required to
issue or deliver any Warrant Debt Securities until such tax or other charge shall have been paid or it has been established to
the Company’s satisfaction that no such tax or other charge is due.
(e) Prior to the issuance of any
Warrants there shall have been reserved, and the Company shall at all times through the Expiration Date keep reserved, out of its
authorized but unissued Warrant Debt Securities, a number of shares sufficient to provide for the exercise of the Warrants.
ARTICLE 3
OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS
OF WARRANT
CERTIFICATES
3.1 No Rights As Holders of Warrant Debt Securities
Conferred By Warrants or Warrant Certificates. No Warrant Certificate or Warrant evidenced thereby shall entitle the holder
thereof to any of the rights of a holder of Warrant Debt Securities, including, without limitation, the right to receive the payment
of principal of (or premium, if any) or interest, if any, on the Warrant Debt Securities or to enforce any of the covenants in
the Indenture.
3.2 Lost, Stolen, Mutilated or Destroyed Warrant
Certificates. Upon receipt by the Warrant Agent of evidence reasonably satisfactory to it and the Company of the ownership
of and the loss, theft, destruction or mutilation of any Warrant Certificate and/or indemnity reasonably satisfactory to the Warrant
Agent and the Company and, in the case of mutilation, upon surrender of the mutilated Warrant Certificate to the Warrant Agent
for cancellation, then, in the absence of notice to the Company or the Warrant Agent that such Warrant Certificate has been acquired
by a bona fide purchaser, the Company shall execute, and an authorized officer of the Warrant Agent shall manually countersign
and deliver, in exchange for or in lieu of the lost, stolen, destroyed or mutilated Warrant Certificate, a new Warrant Certificate
of the same tenor and evidencing Warrants for a like principal amount of Warrant Debt Securities. Upon the issuance of any new
Warrant Certificate under this Section 3.2, the Company may require the payment of a sum sufficient to cover any tax or other
governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Warrant
Agent) in connection therewith. Every substitute Warrant Certificate executed and delivered pursuant to this Section 3.2 in
lieu of any lost, stolen or destroyed Warrant Certificate shall represent an additional contractual obligation of the Company,
whether or not the lost, stolen or destroyed Warrant Certificate shall be at any time enforceable by anyone, and shall be entitled
to the benefits of this Agreement equally and proportionately with any and all other Warrant Certificates duly executed and delivered
hereunder. The provisions of this Section 3.2 are exclusive and shall preclude (to the extent lawful) all other rights and
remedies with respect to the replacement of mutilated, lost, stolen or destroyed Warrant Certificates.
3.3 Holder Of Warrant Certificate May Enforce
Rights. Notwithstanding any of the provisions of this Agreement, any holder of any Warrant Certificate, without the consent
of the Warrant Agent, the [Senior] [Subordinated] Trustee, the holder of any Warrant Debt Securities or the holder of any other
Warrant Certificate, may, in such holder’s own behalf and for such holder’s own benefit, enforce, and may institute
and maintain any suit, action or proceeding against the Company suitable to enforce, or otherwise in respect of, such holder’s
right to exercise the Warrants evidenced by such holder’s Warrant Certificate in the manner provided in such holder’s
Warrant Certificates and in this Agreement.
3.4 Merger, Sale, Conveyance or Lease.
In case of (a) any share exchange, merger or similar transaction of the Company with or into another person or entity (other
than a share exchange, merger or similar transaction in which the Company is the acquiring or surviving corporation) or (b) the
sale, exchange, lease, transfer or other disposition of all or substantially all of the properties and assets of the Company as
an entirety (in any such case, a “Reorganization Event”), then, as a condition of such Reorganization Event, lawful
provisions shall be made, and duly executed documents evidencing the same from the Company’s successor shall be delivered
to the holders of the Warrants, so that such successor shall succeed to and be substituted for the Company, and assume all the
Company’s obligations under, this Agreement and the Warrants. The Company shall thereupon be relieved of any further obligation
hereunder or under the Warrants, and the Company as the predecessor corporation may thereupon or at any time thereafter be dissolved,
wound up or liquidated. Such successor or assuming entity thereupon may cause to be signed, and may issue either in its own name
or in the name of the Company, any or all of the Warrants issuable hereunder which heretofore shall not have been signed by the
Company, and may execute and deliver securities in its own name, in fulfillment of its obligations to deliver Warrant Debt Securities
upon exercise of the Warrants. All the Warrants so issued shall in all respects have the same legal rank and benefit under this
Agreement as the Warrants theretofore or thereafter issued in accordance with the terms of this Agreement as though all of such
Warrants had been issued at the date of the execution hereof. In any case of any such Reorganization Event, such changes in phraseology
and form (but not in substance) may be made in the Warrants thereafter to be issued as may be appropriate. The Warrant Agent may
receive a written opinion of legal counsel as conclusive evidence that any such Reorganization Event complies with the provisions
of this Section 3.4.
3.5 Notice To Warrantholders. In case
the Company shall (a) effect any Reorganization Event or (b) make any distribution on or in respect of the [title of
Warrant Debt Securities] in connection with the dissolution, liquidation or winding up of the Company, then the Company shall mail
to each holder of Warrants at such holder’s address as it shall appear on the books of the Warrant Agent, at least ten days
prior to the applicable date hereinafter specified, a notice stating the date on which such Reorganization Event, dissolution,
liquidation or winding up is expected to become effective, and the date as of which it is expected that holders of [title of Warrant
Debt Securities] of record shall be entitled to exchange their shares of [title of Warrant Debt Securities] for securities or other
property deliverable upon such Reorganization Event, dissolution, liquidation or winding up. No failure to mail such notice nor
any defect therein or in the mailing thereof shall affect any such transaction.
ARTICLE 4
EXCHANGE AND TRANSFER OF WARRANT CERTIFICATES
4.1 Exchange and Transfer of Warrant Certificates.
[If Other Securities with Warrants which are immediately detachable—Upon] [If Other Securities with Warrants which are not
immediately detachable—Prior to the Detachable Date, a Warrant Certificate may be exchanged or transferred only together
with the Other Security to which the Warrant Certificate was initially attached, and only for the purpose of effecting or in conjunction
with an exchange or transfer of such Other Security. Prior to any Detachable Date, each transfer of the Other Security shall operate
also to transfer the related Warrant Certificates. After the Detachable Date, upon] surrender at the corporate trust office of
the Warrant Agent, Warrant Certificates evidencing Warrants may be exchanged for Warrant Certificates in other denominations evidencing
such Warrants or the transfer thereof may be registered in whole or in part; provided that such other Warrant Certificates evidence
Warrants for the same aggregate principal amount of Warrant Debt Securities as the Warrant Certificates so surrendered. The Warrant
Agent shall keep, at its corporate trust office, books in which, subject to such reasonable regulations as it may prescribe, it
shall register Warrant Certificates and exchanges and transfers of outstanding Warrant Certificates, upon surrender of the Warrant
Certificates to the Warrant Agent at its corporate trust office for exchange or registration of transfer, properly endorsed or
accompanied by appropriate instruments of registration of transfer and written instructions for transfer, all in form satisfactory
to the Company and the Warrant Agent. No service charge shall be made for any exchange or registration of transfer of Warrant Certificates,
but the Company may require payment of a sum sufficient to cover any stamp or other tax or other governmental charge that may be
imposed in connection with any such exchange or registration of transfer. Whenever any Warrant Certificates are so surrendered
for exchange or registration of transfer, an authorized officer of the Warrant Agent shall manually countersign and deliver to
the person or persons entitled thereto a Warrant Certificate or Warrant Certificates duly authorized and executed by the Company,
as so requested. The Warrant Agent shall not be required to effect any exchange or registration of transfer which will result in
the issuance of a Warrant Certificate evidencing a Warrant for a fraction of a Warrant Debt Security or a number of Warrants for
a whole number of Warrant Debt Securities and a fraction of a Warrant Debt Security. All Warrant Certificates issued upon any exchange
or registration of transfer of Warrant Certificates shall be the valid obligations of the Company, evidencing the same obligations
and entitled to the same benefits under this Agreement as the Warrant Certificate surrendered for such exchange or registration
of transfer.
4.2 Treatment of Holders of Warrant Certificates.
[If Other Securities and Warrants are not immediately detachable—Prior to the Detachable Date, the Company, the Warrant Agent
and all other persons may treat the owner of the Other Security as the owner of the Warrant Certificates initially attached thereto
for any purpose and as the person entitled to exercise the rights represented by the Warrants evidenced by such Warrant Certificates,
any notice to the contrary notwithstanding. After the Detachable Date and prior to due presentment of a Warrant Certificate for
registration of transfer, the] [The] Company, the Warrant Agent and all other persons may treat the registered holder of a Warrant
Certificate as the absolute owner thereof for any purpose and as the person entitled to exercise the rights represented by the
Warrants evidenced thereby, any notice to the contrary notwithstanding.
4.3 Cancellation of Warrant Certificates.
Any Warrant Certificate surrendered for exchange, registration of transfer or exercise of the Warrants evidenced thereby shall,
if surrendered to the Company, be delivered to the Warrant Agent and all Warrant Certificates surrendered or so delivered to the
Warrant Agent shall be promptly canceled by the Warrant Agent and shall not be reissued and, except as expressly permitted by this
Agreement, no Warrant Certificate shall be issued hereunder in exchange therefor or in lieu thereof. The Warrant Agent shall deliver
to the Company from time to time or otherwise dispose of canceled Warrant Certificates in a manner satisfactory to the Company.
ARTICLE 5
CONCERNING THE WARRANT AGENT
5.1 Warrant Agent. The Company hereby
appoints
as Warrant Agent of the Company in respect of the Warrants and the Warrant Certificates upon the terms and subject to the conditions
herein set forth, and
hereby accepts such appointment. The Warrant Agent shall have the powers and authority granted to and conferred upon it in the
Warrant Certificates and hereby and such further powers and authority to act on behalf of the Company as the Company may hereafter
grant to or confer upon it. All of the terms and provisions with respect to such powers and authority contained in the Warrant
Certificates are subject to and governed by the terms and provisions hereof.
5.2 Conditions of Warrant Agent’s Obligations.
The Warrant Agent accepts its obligations herein set forth upon the terms and conditions hereof, including the following to all
of which the Company agrees and to all of which the rights hereunder of the holders from time to time of the Warrant Certificates
shall be subject:
(a) Compensation and Indemnification.
The Company agrees promptly to pay the Warrant Agent the compensation to be agreed upon with the Company for all services rendered
by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket expenses (including reasonable counsel fees)
incurred without negligence, bad faith or willful misconduct by the Warrant Agent in connection with the services rendered hereunder
by the Warrant Agent. The Company also agrees to indemnify the Warrant Agent for, and to hold it harmless against, any loss, liability
or expense incurred without negligence, bad faith or willful misconduct on the part of the Warrant Agent, arising out of or in
connection with its acting as Warrant Agent hereunder, including the reasonable costs and expenses of defending against any claim
of such liability.
(b) Agent for the Company. In acting
under this Warrant Agreement and in connection with the Warrant Certificates, the Warrant Agent is acting solely as agent of the
Company and does not assume any obligations or relationship of agency or trust for or with any of the holders of Warrant Certificates
or beneficial owners of Warrants.
(c) Counsel. The Warrant Agent may
consult with counsel satisfactory to it, which may include counsel for the Company, and the written advice of such counsel shall
be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith
and in accordance with the advice of such counsel.
(d) Documents. The Warrant Agent
shall be protected and shall incur no liability for or in respect of any action taken or omitted by it in reliance upon any Warrant
Certificate, notice, direction, consent, certificate, affidavit, statement or other paper or document reasonably believed by it
to be genuine and to have been presented or signed by the proper parties.
(e) Certain Transactions. The Warrant
Agent, and its officers, directors and employees, may become the owner of, or acquire any interest in, Warrants, with the same
rights that it or they would have if it were not the Warrant Agent hereunder, and, to the extent permitted by applicable law, it
or they may engage or be interested in any financial or other transaction with the Company and may act on, or as depositary, trustee
or agent for, any committee or body of holders of Warrant Debt Securities or other obligations of the Company as freely as if it
were not the Warrant Agent hereunder. Nothing in this Warrant Agreement shall be deemed to prevent the Warrant Agent from acting
as [Senior] [Subordinated] Trustee under the [Senior] [Subordinated] Indenture.
(f) No Liability for Interest. Unless
otherwise agreed with the Company, the Warrant Agent shall have no liability for interest on any monies at any time received by
it pursuant to any of the provisions of this Agreement or of the Warrant Certificates.
(g) No Liability for Invalidity.
The Warrant Agent shall have no liability with respect to any invalidity of this Agreement or any of the Warrant Certificates (except
as to the Warrant Agent’s countersignature thereon).
(h) No Responsibility for Representations.
The Warrant Agent shall not be responsible for any of the recitals or representations herein or in the Warrant Certificates (except
as to the Warrant Agent’s countersignature thereon), all of which are made solely by the Company.
(i) No Implied Obligations. The Warrant
Agent shall be obligated to perform only such duties as are herein and in the Warrant Certificates specifically set forth and no
implied duties or obligations shall be read into this Agreement or the Warrant Certificates against the Warrant Agent. The Warrant
Agent shall not be under any obligation to take any action hereunder which may tend to involve it in any expense or liability,
the payment of which within a reasonable time is not, in its reasonable opinion, assured to it. The Warrant Agent shall not be
accountable or under any duty or responsibility for the use by the Company of any of the Warrant Certificates authenticated by
the Warrant Agent and delivered by it to the Company pursuant to this Agreement or for the application by the Company of the proceeds
of the Warrant Certificates. The Warrant Agent shall have no duty or responsibility in case of any default by the Company in the
performance of its covenants or agreements contained herein or in the Warrant Certificates or in the case of the receipt of any
written demand from a holder of a Warrant Certificate with respect to such default, including, without limiting the generality
of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or, except
as provided in Section 6.2 hereof, to make any demand upon the Company.
5.3 Resignation , Removal and Appointment
of Successors.
(a) The Company agrees, for the benefit
of the holders from time to time of the Warrant Certificates, that there shall at all times be a Warrant Agent hereunder until
all the Warrants have been exercised or are no longer exercisable.
(b) The Warrant Agent may at any
time resign as agent by giving written notice to the Company of such intention on its part, specifying the date on which its desired
resignation shall become effective; provided that such date shall not be less than three months after the date on which such notice
is given unless the Company otherwise agrees. The Warrant Agent hereunder may be removed at any time by the filing with it of an
instrument in writing signed by or on behalf of the Company and specifying such removal and the intended date when it shall become
effective. Such resignation or removal shall take effect upon the appointment by the Company, as hereinafter provided, of a successor
Warrant Agent (which shall be a bank or trust company authorized under the laws of the jurisdiction of its organization to exercise
corporate trust powers) and the acceptance of such appointment by such successor Warrant Agent. The obligation of the Company under
Section 5.2(a) shall continue to the extent set forth therein notwithstanding the resignation or removal of the Warrant
Agent.
(c) In case at any time the Warrant
Agent shall resign, or shall be removed, or shall become incapable of acting, or shall be adjudged a bankrupt or insolvent, or
shall commence a voluntary case under the Federal bankruptcy laws, as now or hereafter constituted, or under any other applicable
Federal or state bankruptcy, insolvency or similar law or shall consent to the appointment of or taking possession by a receiver,
custodian, liquidator, assignee, trustee, sequestrator (or other similar official) of the Warrant Agent or its property or affairs,
or shall make an assignment for the benefit of creditors, or shall admit in writing its inability to pay its debts generally as
they become due, or shall take corporate action in furtherance of any such action, or a decree or order for relief by a court having
jurisdiction in the premises shall have been entered in respect of the Warrant Agent in an involuntary case under the Federal bankruptcy
laws, as now or hereafter constituted, or any other applicable Federal or state bankruptcy, insolvency or similar law, or a decree
or order by a court having jurisdiction in the premises shall have been entered for the appointment of a receiver, custodian, liquidator,
assignee, trustee, sequestrator (or similar official) of the Warrant Agent or of its property or affairs, or any public officer
shall take charge or control of the Warrant Agent or of its property or affairs for the purpose of rehabilitation, conservation,
winding up or liquidation, a successor Warrant Agent, qualified as aforesaid, shall be appointed by the Company by an instrument
in writing, filed with the successor Warrant Agent. Upon the appointment as aforesaid of a successor Warrant Agent and acceptance
by the successor Warrant Agent of such appointment, the Warrant Agent shall cease to be Warrant Agent hereunder.
(d) Any successor Warrant Agent appointed
hereunder shall execute, acknowledge and deliver to its predecessor and to the Company an instrument accepting such appointment
hereunder, and thereupon such successor Warrant Agent, without any further act, deed or conveyance, shall become vested with all
the authority, rights, powers, trusts, immunities, duties and obligations of such predecessor with like effect as if originally
named as Warrant Agent hereunder, and such predecessor, upon payment of its charges and disbursements then unpaid, shall thereupon
become obligated to transfer, deliver and pay over, and such successor Warrant Agent shall be entitled to receive, all monies,
securities and other property on deposit with or held by such predecessor, as Warrant Agent hereunder.
(e) Any corporation into which the
Warrant Agent hereunder may be merged or converted or any corporation with which the Warrant Agent may be consolidated, or any
corporation resulting from any merger, conversion or consolidation to which the Warrant Agent shall be a party, or any corporation
to which the Warrant Agent shall sell or otherwise transfer all or substantially all the assets and business of the Warrant Agent,
provided that it shall be qualified as aforesaid, shall be the successor Warrant Agent under this Agreement without the execution
or filing of any paper or any further act on the part of any of the parties hereto.
ARTICLE 6
MISCELLANEOUS
6.1 Amendment. This Agreement may be amended
by the parties hereto, without the consent of the holder of any Warrant Certificate, for the purpose of curing any ambiguity, or
of curing, correcting or supplementing any defective provision contained herein, or making any other provisions with respect to
matters or questions arising under this Agreement as the Company and the Warrant Agent may deem necessary or desirable; provided
that such action shall not materially adversely affect the interests of the holders of the Warrant Certificates.
6.2 Notices and Demands to the Company and
Warrant Agent. If the Warrant Agent shall receive any notice or demand addressed to the Company by the holder of a Warrant
Certificate pursuant to the provisions of the Warrant Certificates, the Warrant Agent shall promptly forward such notice or demand
to the Company.
6.3 Addresses. Any communication from
the Company to the Warrant Agent with respect to this Agreement shall be addressed to
, Attention:
and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Advanced
Cell Technology, Inc., 33 Locke Dr., Marlborough, MA 01752, Attention: Chief Financial Officer (or such other address
as shall be specified in writing by the Warrant Agent or by the Company).
6.4 Governing Law. This Agreement and
each Warrant Certificate issued hereunder shall be governed by and construed in accordance with the laws of the State of New York.
6.5 Delivery Of Prospectus. The Company
shall furnish to the Warrant Agent sufficient copies of a prospectus meeting the requirements of the Securities Act of 1933, as
amended, relating to the Warrant Debt Securities deliverable upon exercise of the Warrants (the “Prospectus”), and
the Warrant Agent agrees that upon the exercise of any Warrant, the Warrant Agent will deliver to the holder of the Warrant Certificate
evidencing such Warrant, prior to or concurrently with the delivery of the Warrant Debt Securities issued upon such exercise, a
Prospectus. The Warrant Agent shall not, by reason of any such delivery, assume any responsibility for the accuracy or adequacy
of such Prospectus.
6.6 Obtaining of Governmental Approvals.
The Company will from time to time take all action which may be necessary to obtain and keep effective any and all permits, consents
and approvals of governmental agencies and authorities and securities act filings under United States Federal and state laws (including
without limitation a registration statement in respect of the Warrants and Warrant Debt Securities under the Securities Act of
1933, as amended), which may be or become requisite in connection with the issuance, sale, transfer, and delivery of the Warrant
Debt Securities issued upon exercise of the Warrants, the issuance, sale, transfer and delivery of the Warrants or upon the expiration
of the period during which the Warrants are exercisable.
6.7 Persons Having Rights Under Warrant Agreement.
Nothing in this Agreement shall give to any person other than the Company, the Warrant Agent and the holders of the Warrant Certificates
any right, remedy or claim under or by reason of this Agreement.
6.8 Headings. The descriptive headings
of the several Articles and Sections of this Agreement are inserted for convenience only and shall not control or affect the meaning
or construction of any of the provisions hereof.
6.9 Counterparts. This Agreement may be
executed in any number of counterparts, each of which as so executed shall be deemed to be an original, but such counterparts shall
together constitute but one and the same instrument.
6.10 Inspection of Agreement. A copy of
this Agreement shall be available at all reasonable times at the principal corporate trust office of the Warrant Agent for inspection
by the holder of any Warrant Certificate. The Warrant Agent may require such holder to submit his Warrant Certificate for inspection
by it.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement
to be duly executed, all as of the day and year first above written.
|
ADVANCED CELL TECHNOLOGY, INC. |
|
|
|
By |
|
|
|
Its |
|
|
|
|
|
WARRANT AGENT |
|
|
|
By |
|
|
|
Its |
[SIGNATURE PAGE TO DEBT SECURITIES WARRANT AGREEMENT]
EXHIBIT A
FORM OF WARRANT CERTIFICATE
[FACE OF WARRANT CERTIFICATE]
[[Form if Warrants are attached to Other Securities and are not immediately detachable.] |
|
[Prior to , this Warrant Certificate cannot be transferred or exchanged unless attached to a [Title of Other Securities].] |
|
|
|
[Form of Legend if Warrants are not immediately exercisable.] |
|
[Prior to , Warrants evidenced by this Warrant Certificate cannot be exercised.] |
EXERCISABLE ONLY IF COUNTERSIGNED BY THE WARRANT
AGENT AS
PROVIDED HEREIN
VOID AFTER [ ] P.M.,
[CITY] TIME, ON ,
ADVANCED CELL TECHNOLOGY, INC.
WARRANT CERTIFICATE REPRESENTING
WARRANTS TO PURCHASE
[TITLE OF WARRANT DEBT SECURITIES]
This certifies that
or registered assigns is the registered owner of the above indicated number of Warrants, each Warrant entitling such owner [If
Warrants are attached to Other Securities and are not immediately detachable —, subject to the registered owner qualifying
as a “Holder” of this Warrant Certificate, as hereinafter defined)] to purchase, at any time [after [
] p.m., [City] time, on
and] on or before [ ] p.m., [City] time, on
, $ principal amount of [Title of Warrant Debt Securities] (the “Warrant Debt
Securities”), of Advanced Cell Technology, Inc. (the “Company”), issued or to be issued under the Indenture
(as hereinafter defined), on the following basis: during the period from
, through and including
, each Warrant shall entitle the Holder thereof, subject to the provisions of this Agreement, to purchase the principal amount
of Warrant Debt Securities stated in the Warrant Certificate at the warrant price (the “Warrant Price”) of
% of the principal amount thereof [plus accrued amortization, if any, of the original issue discount of the Warrant Debt Securities]
[plus accrued interest, if any, from the most recent date from which interest shall have been paid on the Warrant Debt Securities
or, if no interest shall have been paid on the Warrant Debt Securities, from the date of their original issuance]. [The original
issue discount ($ for each $1,000 principal amount of Warrant Debt Securities) will
be amortized at a % annual rate, computed on a[n] [semi-]annual basis [using a 360-day year
consisting of twelve 30-day months]. The Holder may exercise the Warrants evidenced hereby by providing certain information set
forth on the back hereof and by paying in full, in lawful money of the United States of America, [in cash or by certified check
or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available funds], the Warrant Price
for each Warrant Debt Security with respect to which this Warrant is exercised to the Warrant Agent (as hereinafter defined) and
by surrendering this Warrant Certificate, with the purchase form on the back hereof duly executed, at the corporate trust office
of [name of Warrant Agent], or its successor as warrant agent (the “Warrant Agent”), which is, on the date hereof,
at the address specified on the reverse hereof, and upon compliance with and subject to the conditions set forth herein and in
the Warrant Agreement (as hereinafter defined).
The term “Holder” as used herein
shall mean [If Warrants are attached to Other Securities and are not immediately detachable—, prior to
, (the “Detachable Date”), the registered owner of the Company’s [title
of Other Securities] to which this Warrant Certificate was initially attached, and after such Detachable Date,] the person in whose
name at the time this Warrant Certificate shall be registered upon the books to be maintained by the Warrant Agent for that purpose
pursuant to Section 4 of the Warrant Agreement.
The Warrants evidenced by this Warrant Certificate
may be exercised to purchase Warrant Debt Securities in the principal amount of $1,000 or any integral multiple thereof in registered
form. Upon any exercise of fewer than all of the Warrants evidenced by this Warrant Certificate, there shall be issued to the Holder
hereof a new Warrant Certificate evidencing Warrants for the aggregate principal amount of Warrant Debt Securities remaining unexercised.
This Warrant Certificate is issued under and
in accordance with the Warrant Agreement dated as of ,
(the “Warrant Agreement”), between the Company and the Warrant Agent and is subject
to the terms and provisions contained in the Warrant Agreement, to all of which terms and provisions the Holder of this Warrant
Certificate consents by acceptance hereof. Copies of the Warrant Agreement are on file at the above-mentioned office of the Warrant
Agent.
The Warrant Debt Securities to be issued and
delivered upon the exercise of Warrants evidenced by this Warrant Certificate will be issued under and in accordance with an Indenture,
[dated as of
, (the “Senior Indenture”), between the Company and
, as trustee (such trustee, and any successors to such trustee, the “Senior Trustee”)] [dated as of
,
, (the “Subordinated Indenture”), between the Company and
, as trustee (such trustee, and any successors to such trustee, the “Subordinated Trustee”)] and will be subject to
the terms and provisions contained in the Warrant Debt Securities and in the Indenture. Copies of the [Senior] [Subordinated] Indenture,
including the form of the Warrant Debt Securities, are on file at the corporate trust office of the Trustee.
[If Warrants are attached to Other Securities
and are not immediately detachable—Prior to the Detachable Date, this Warrant Certificate may be exchanged or transferred
only together with the [Title of Other Securities] (the “Other Securities”) to which this Warrant Certificate was
initially attached, and only for the purpose of effecting or in conjunction with, an exchange or transfer of such Other Security.
Additionally, on or prior to the Detachable Date, each transfer of such Other Security on the register of the Other Securities
shall operate also to transfer this Warrant Certificate. After such date, transfer of this] [If Warrants are attached to Other
Securities and are immediately detachable—Transfer of this] Warrant Certificate may be registered when this Warrant Certificate
is surrendered at the corporate trust office of the Warrant Agent by the registered owner or such owner’s assigns, in the
manner and subject to the limitations provided in the Warrant Agreement.
[If Other Securities with Warrants which are
not immediately detachable-Except as provided in the immediately preceding paragraph, after] [If Other Securities with Warrants
which are immediately detachable or Warrants alone—After] countersignature by the Warrant Agent and prior to the expiration
of this Warrant Certificate, this Warrant Certificate may be exchanged at the corporate trust office of the Warrant Agent for Warrant
Certificates representing Warrants for the same aggregate principal amount of Warrant Debt Securities.
This Warrant Certificate shall not entitle the
Holder hereof to any of the rights of a holder of the Warrant Debt Securities, including, without limitation, the right to receive
payments of principal of (and premium, if any) or interest, if any, on the Warrant Debt Securities or to enforce any of the covenants
of the Indenture.
Reference is hereby made to the further provisions
of this Warrant Certificate set forth on the reverse hereof, which further provisions shall for all purposes have the same effect
as if set forth at this place.
This Warrant Certificate shall not be valid or
obligatory for any purpose until countersigned by the Warrant Agent.
IN WITNESS WHEREOF, the Company has caused
this Warrant to be executed in its name and on its behalf by the facsimile signatures of its duly authorized officers.
Dated: |
|
|
|
|
|
|
|
|
|
|
ADVANCED CELL TECHNOLOGY, INC. |
|
|
|
|
|
|
|
By |
|
|
|
|
|
|
|
|
Its |
|
|
|
|
|
|
|
|
|
|
|
|
Countersigned: |
|
|
|
|
|
|
|
|
|
|
|
As Warrant Agent |
|
|
|
|
|
|
|
By |
|
|
|
|
Authorized Signature |
[REVERSE OF WARRANT CERTIFICATE]
(Instructions for Exercise of Warrant)
To exercise any Warrants evidenced hereby for
Warrant Debt Securities (as hereinafter defined), the Holder must pay, in lawful money of the United States of America, [in cash
or by certified check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available
funds], the Warrant Price in full for Warrants exercised, to [Warrant Agent] [address of Warrant Agent], Attn:
, which payment must specify the name of the Holder and the number of Warrants exercised by such Holder. In addition, the Holder
must complete the information required below and present this Warrant Certificate in person or by mail (certified or registered
mail is recommended) to the Warrant Agent at the appropriate address set forth above. This Warrant Certificate, completed and duly
executed, must be received by the Warrant Agent within five business days of the payment.
(To be executed upon exercise of Warrants)
The undersigned hereby irrevocably elects to
exercise Warrants,
represented by this Warrant Certificate, to purchase $ principal amount of the [Title
of Warrant Debt Securities] (the “Warrant Debt Securities”) of Advanced Cell Technology, Inc. and represents that
he has tendered payment for such Warrant Debt Securities, in lawful money of the United States of America, [in cash or by certified
check or official bank check in New York Clearing House funds] [by bank wire transfer in immediately available funds], to the order
of Advanced Cell Technology, Inc., c/o [insert name and address of Warrant Agent], in the amount of $
in accordance with the terms hereof. The undersigned requests that said principal amount of Warrant Debt Securities be in fully
registered form in the authorized denominations, registered in such names and delivered all as specified in accordance with the
instructions set forth below.
If the number of Warrants exercised is less than
all the Warrants evidenced hereby, the undersigned requests that a new Warrant Certificate evidencing the Warrants for the aggregate
principal amount of Warrant Debt Securities remaining unexercised be issued and delivered to the undersigned unless otherwise specified
in the instructions below.
Dated |
|
Name |
|
|
Please Print |
|
|
Address: |
|
|
|
|
|
|
|
|
|
(Insert Social Security or Other Identifying Number of Holder) |
|
Signature Guaranteed |
|
|
|
Signature |
|
(Signature must conform in all respects to name of holder as specified
on the face of this Warrant Certificate and must bear a signature guarantee by a FINRA member firm).
This Warrant may be exercised at the following addresses:
By hand at
By mail at
[Instructions as to form and delivery of Warrant Debt Securities
and, if applicable, Warrant Certificates evidencing Warrants for the number of Warrant Debt Securities remaining unexercised—complete
as appropriate.]
ASSIGNMENT
[Form of assignment to be executed if Warrant
Holder desires to transfer Warrant]
FOR VALUE RECEIVED,
hereby sells, assigns and transfers unto:
|
|
|
|
|
|
|
|
|
(Please print name and address including zip code) |
|
Please print Social Security or other identifying number |
the right represented by the within Warrant to purchase $
aggregate principal amount of [Title of Warrant Debt Securities] of Advanced Cell Technology, Inc. to which the within Warrant
relates and appoints
attorney to transfer such right on the books of the Warrant Agent with full power of substitution in the premises.
(Signature must conform in all respects to name of holder as specified
on the face of the Warrant)
Signature Guaranteed
Exhibit 5.1
October 14, 2014
Advanced Cell Technology, Inc.
33 Locke Drive
Marlborough, Massachusetts 01752
Re: Securities Being Registered under
Registration Statement on Form S-3
Ladies and Gentlemen:
We have acted as counsel to you in connection
with your filing of a Registration Statement on Form S-3 (as amended or supplemented, the “Registration Statement”)
pursuant to the Securities Act of 1933, as amended (the “Securities Act”), relating to the registration of up to $100,000,000
of any combination of (i) common stock, par value $0.001 per share (the “Common Stock”), of Advanced Cell Technology,
Inc., a Delaware corporation (the “Company”), (ii) preferred stock, par value $0.001 per share, of the Company
(the “Preferred Stock”), (iii) debt securities of the Company (“Debt Securities”), (iv) warrants to
purchase Common Stock, Preferred Stock or Debt Securities (“Warrants”), (v) depositary shares, each evidencing
a fraction of a Preferred Share (“Depositary Shares”), (vi) stock purchase units or contracts of the Company (the “Stock
Purchase Units or Contracts”), obligating the holders thereof to purchase from or sell to the Company, or the Company to
sell to or purchase from such holders, Common Stock, Preferred Stock or Depositary Shares at a future date or dates, (vii) subscription
rights to purchase securities of the Company (“Subscription Rights”) and (viii) units comprised of Common Stock,
Preferred Stock, Debt Securities, Warrants, Depositary Shares, Stock Purchase Units or Contracts, Subscription Rights and other
securities in any combination (“Units”). The Common Stock, Preferred Stock, Debt Securities, Warrants, Depositary Shares,
Stock Purchase Units or Contracts, Subscription Rights and Units are sometimes referred to collectively herein as the “Securities.”
Securities may be issued in an unspecified number (with respect to Common Stock, Preferred Stock, Warrants for Common Stock or
Preferred Stock, Depositary Shares, Stock Purchase Units or Contracts, Subscription Rights or Units) or in an unspecified principal
amount (with respect to Debt Securities or Warrants for Debt Securities). The Registration Statement provides that the Securities
may be offered separately or together, in separate series, in amounts, at prices and on terms to be set forth in one or more prospectus
supplements (each a “Prospectus Supplement”) to the prospectus contained in the Registration Statement.
We have reviewed such documents and made
such examination of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent
verification, on certificates of public officials and, as to matters of fact material to the opinions set forth below, on certificates
of officers of the Company.
The opinions set forth below are limited
to the Delaware General Corporation Law (which includes reported judicial decisions interpreting the Delaware General Corporation
Law), the law of New York, and the federal law of the United States. Without limiting the generality of the foregoing, we express
no opinion with respect to (i) state securities or “blue sky” laws, or (ii) state or federal antitrust laws.
For purposes of the opinions set forth below,
without limiting any other exceptions or qualifications set forth herein, we have assumed that after the issuance of any Securities
offered pursuant to the Registration Statement, the total number of issued shares of Common Stock or Preferred Stock, as applicable,
together with the total number of shares of such stock issuable upon the exercise, exchange, conversion or settlement, as the case
may be, of any exercisable, exchangeable or convertible security (including without limitation any Debt Security, Warrant, Stock
Purchase Unit or Contract, Subscription Right or Unit), as the case may be, then outstanding, will not exceed the total number
of authorized shares of Common Stock or Preferred Stock, as applicable, under the Company’s certificate of incorporation
as then in effect (the “Charter”).
For purposes of the opinions set forth below,
we refer to the following as the “Future Authorization and Issuance” of Securities:
| · | with respect to any of the Securities, (a) the authorization by the Company of the amount, terms and issuance of such
Securities (the “Authorization”) and (b) the issuance of such Securities in accordance with the Authorization
therefor upon the receipt by the Company of the consideration (which, in the case of shares of Common Stock or Preferred Stock,
is not less than the par value of such shares) to be paid therefor in accordance with the Authorization; |
| · | with respect to Preferred Stock, (a) the establishment of the terms of such Preferred Stock by the Company in conformity
with the Charter and applicable law and (b) the execution, acknowledgement and filing with the Delaware Secretary of State,
and the effectiveness of, a certificate of designations to the Charter setting forth the terms of such Preferred Stock in accordance
with the Charter and applicable law; |
| · | with respect to Debt Securities, (a) the authorization, execution and delivery of the indenture or a supplemental indenture
relating to such Securities by the Company and the trustee thereunder and/or (b) the establishment of the terms of such Securities
by the Company in conformity with the applicable indenture or supplemental indenture and applicable law, and (c) the execution,
authentication and issuance of such Securities in accordance with the applicable indenture or supplemental indenture and applicable
law; |
| · | with respect to Depositary Shares, (a) the authorization, execution and delivery
by the Company and the depository of the deposit agreement under which such Depositary Shares are to be issued, (b) the establishment
of the terms of such Depositary Shares by the Company in conformity with the deposit agreement and applicable law, (c) the
authorization, issuance and delivery to the depository of the shares of Preferred Stock represented by the Depositary Shares in
accordance with the Charter and applicable law, and (d) the execution, countersignature and issuance of depositary receipts
evidencing the Depositary Shares in accordance with the deposit agreement and applicable law; and |
| · | with respect to Warrants, Stock Purchase Units or Contracts, Subscription Rights or Units, (a) the authorization, execution
and delivery by the Company and the other parties thereto of any agreement under which such Securities are to be issued and (b) the
establishment of the terms of such Securities, and the execution and delivery of such Securities, in conformity with any applicable
agreement under which such Securities are to be issued and applicable law. |
Based upon the foregoing, and subject to
the additional qualifications set forth below, we are of the opinion that:
1.
Upon the Future Authorization and Issuance of shares of Common Stock, such shares of Common Stock, will be validly issued,
fully paid and nonassessable.
2.
Upon the Future Authorization and Issuance of shares of Preferred Stock, such shares of Preferred Stock will be validly
issued, fully paid and nonassessable.
3.
Upon the Future Authorization and Issuance of Debt Securities, such Debt Securities will be valid and binding obligations
of the Company.
4.
Upon the Future Authorization and Issuance of Warrants, such Warrants will be valid and binding obligations of the Company.
5.
Upon the Future Authorization and Issuance of Depositary Shares, such Depositary Shares
will be validly issued and will entitle the holders thereof to the rights specified in such Depositary Shares and the deposit agreement.
6.
Upon the Future Authorization and Issuance of Stock Purchase Units or Contracts, such Stock Purchase Units or Contracts
will be valid and binding obligations of the Company.
7.
Upon the Future Authorization and Issuance of Subscription Rights, such Subscription Rights will be valid and binding obligations
of the Company.
8.
Upon the Future Authorization and Issuance of Units, such Units will be valid and binding obligations of the Company.
The opinions expressed above are subject
to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general application affecting
the rights and remedies of creditors and to general principles of equity.
This opinion letter and the opinions it
contains shall be interpreted in accordance with the Legal Opinion Principles issued by the Committee on Legal Opinions of the
American Bar Association’s Business Law Section as published in 53 Business Lawyer 831 (May 1998).
We hereby consent to the inclusion of this
opinion as Exhibit 5.1 to the Registration Statement and to the references to our firm under the caption “Legal Matters”
in the Registration Statement. In giving our consent, we do not admit that we are in the category of persons whose consent is required
under Section 7 of the Securities Act or the rules and regulations thereunder.
Very truly yours,
/s/ Goodwin Procter LLP
GOODWIN PROCTER LLP
Exhibit 12.1
RATIO OF EARNINGS TO COMBINED FIXED CHARGES
AND PREFERENCE DIVIDENDS
(in thousands)
| |
Fiscal Year Ended December 31, 2009 | | |
Fiscal Year Ended December 31, 2010 | | |
Fiscal Year Ended December 31, 2011 | | |
Fiscal Year Ended December 31, 2012 | | |
Fiscal Year Ended
December 31, 2013 | | |
Nine Months Ended September 30, 2014 | |
Ratio of earnings to fixed charges | |
| 0.03 | | |
| (0.96) | | |
| 0.69 | | |
| (2.11) | | |
| (21.13) | | |
| (47.07) | |
Ratio of combined fixed charges and preference dividends to earnings | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | | |
| – | |
Deficiency of earnings available to cover fixed charges | |
| | | |
| (a) | | |
| | | |
| (b) | | |
| (c) | | |
| (d) | |
____________
| (a) | Earnings in fiscal year ended December 31, 2010 were inadequate to cover combined fixed charges and preference dividends.
The coverage deficiency was approximately $47.6 million. |
| (b) | Earnings in the fiscal year ended December 31, 2012 were inadequate to cover combined fixed charges and preference dividends.
The coverage deficiency was approximately $33.4 million. |
| (c) | Earnings in the fiscal year ended December 31, 2013 were inadequate to cover combined fixed charges and preference dividends.
The coverage deficiency was approximately $31.1 million. |
| (d) | Earnings in the nine months ended September 30, 2014 were inadequate to cover combined fixed charges and preference dividends.
The coverage deficiency was approximately $29.6 million. |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration
Statement on Form S-3 of Advanced Cell Technology, Inc. and Subsidiary (collectively, the "Company") of our reports dated
April 1, 2014, relating to our audits of the consolidated financial statements and internal control over financial reporting, which
appear in the Annual Report on Form 10-K of the Company for the year ended December 31, 2013.
Our report dated April 1, 2014, on the effectiveness of internal
control over financial reporting as of December 31, 2013, expressed an opinion that the Company had not maintained effective internal
control over financial reporting as of December 31, 2013, based on criteria established in Internal Control - Integrated Framework
issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013.
We also consent to the reference to our Firm under the caption
"Experts" in the Prospectus, which is part of this Registration Statement.
SingerLewak LLP
/s/ SingerLewak LLP
Los Angeles, California
October 14, 2014